{
  "entities": [
    {
      "id": "E1",
      "type": "Compound",
      "name": "roflumilast",
      "attributes": {},
      "source_chunk_ids": [
        "d3da59e0f52baa49faea378b5fac5a17"
      ],
      "confidence": 0.95,
      "evidence": "Roflumilast is a selective",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Target",
      "name": "phosphodiesterase-4",
      "attributes": {
        "target_type": "enzyme"
      },
      "source_chunk_ids": [
        "d3da59e0f52baa49faea378b5fac5a17"
      ],
      "confidence": 0.9,
      "evidence": "phosphodiesterase-4 inhibitor",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Condition",
      "name": "COPD",
      "attributes": {
        "condition_type": "disease"
      },
      "source_chunk_ids": [
        "d3da59e0f52baa49faea378b5fac5a17"
      ],
      "confidence": 0.95,
      "evidence": "therapy for COPD",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Condition",
      "name": "chronic bronchitis",
      "attributes": {
        "condition_type": "disease"
      },
      "source_chunk_ids": [
        "d3da59e0f52baa49faea378b5fac5a17"
      ],
      "confidence": 0.85,
      "evidence": "symptoms of chronic bronchitis",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Effect",
      "name": "improving lung function",
      "attributes": {
        "level": "systemic",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "d3da59e0f52baa49faea378b5fac5a17"
      ],
      "confidence": 0.8,
      "evidence": "improving lung function",
      "verified": true
    },
    {
      "id": "E6",
      "type": "Effect",
      "name": "reducing exacerbation rates",
      "attributes": {
        "level": "systemic",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "d3da59e0f52baa49faea378b5fac5a17"
      ],
      "confidence": 0.8,
      "evidence": "reducing exacerbation rates",
      "verified": true
    },
    {
      "id": "E7",
      "type": "Effect",
      "name": "anti-inflammatory activity",
      "attributes": {
        "level": "cellular",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "d3da59e0f52baa49faea378b5fac5a17"
      ],
      "confidence": 0.75,
      "evidence": "anti-inflammatory activity",
      "verified": true
    },
    {
      "id": "E8",
      "type": "AdverseEvent",
      "name": "nausea",
      "attributes": {
        "severity": "mild to moderate"
      },
      "source_chunk_ids": [
        "d3da59e0f52baa49faea378b5fac5a17"
      ],
      "confidence": 0.8,
      "evidence": "nausea",
      "verified": true
    },
    {
      "id": "E9",
      "type": "AdverseEvent",
      "name": "diarrhea",
      "attributes": {
        "severity": "mild to moderate"
      },
      "source_chunk_ids": [
        "d3da59e0f52baa49faea378b5fac5a17"
      ],
      "confidence": 0.8,
      "evidence": "diarrhea",
      "verified": true
    },
    {
      "id": "E10",
      "type": "AdverseEvent",
      "name": "weight loss",
      "attributes": {
        "severity": "mild to moderate"
      },
      "source_chunk_ids": [
        "d3da59e0f52baa49faea378b5fac5a17"
      ],
      "confidence": 0.8,
      "evidence": "weight loss",
      "verified": true
    },
    {
      "id": "E11",
      "type": "Study",
      "name": "phase III trials",
      "attributes": {
        "design": "phase III trials"
      },
      "source_chunk_ids": [
        "d3da59e0f52baa49faea378b5fac5a17"
      ],
      "confidence": 0.85,
      "evidence": "several phase III trials",
      "verified": true
    },
    {
      "id": "E12",
      "type": "Evidence",
      "name": "clinical trial",
      "attributes": {
        "evidence_level": 4
      },
      "source_chunk_ids": [
        "d3da59e0f52baa49faea378b5fac5a17"
      ],
      "confidence": 0.8,
      "evidence": "phase III trials",
      "verified": true
    },
    {
      "id": "E13",
      "type": "Study",
      "name": "4 registration studies",
      "attributes": {
        "design": "registration studies"
      },
      "source_chunk_ids": [
        "d3da59e0f52baa49faea378b5fac5a17"
      ],
      "confidence": 0.8,
      "evidence": "4 registration studies",
      "verified": true
    },
    {
      "id": "E14",
      "type": "Evidence",
      "name": "registration studies",
      "attributes": {
        "evidence_level": 4
      },
      "source_chunk_ids": [
        "d3da59e0f52baa49faea378b5fac5a17"
      ],
      "confidence": 0.75,
      "evidence": "registration studies",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Condition",
      "name": "chronic obstructive airways disease",
      "attributes": {
        "condition_type": "disease"
      },
      "source_chunk_ids": [
        "d05f126c25b11e1889fd080365b5f49b"
      ],
      "confidence": 0.95,
      "evidence": "Chronic obstructive airways disease (COPD)",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Condition",
      "name": "fixed airway obstruction",
      "attributes": {
        "condition_type": "symptom"
      },
      "source_chunk_ids": [
        "d05f126c25b11e1889fd080365b5f49b"
      ],
      "confidence": 0.85,
      "evidence": "fixed airway obstruction",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Condition",
      "name": "hyperinflation",
      "attributes": {
        "condition_type": "symptom"
      },
      "source_chunk_ids": [
        "d05f126c25b11e1889fd080365b5f49b"
      ],
      "confidence": 0.85,
      "evidence": "hyperinflation",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Condition",
      "name": "dyspnea",
      "attributes": {
        "condition_type": "symptom"
      },
      "source_chunk_ids": [
        "d05f126c25b11e1889fd080365b5f49b"
      ],
      "confidence": 0.85,
      "evidence": "dyspnea",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Condition",
      "name": "mucus hypersecretion",
      "attributes": {
        "condition_type": "symptom"
      },
      "source_chunk_ids": [
        "d05f126c25b11e1889fd080365b5f49b"
      ],
      "confidence": 0.85,
      "evidence": "mucus hypersecretion",
      "verified": true
    },
    {
      "id": "E6",
      "type": "Condition",
      "name": "chronic cough",
      "attributes": {
        "condition_type": "symptom"
      },
      "source_chunk_ids": [
        "d05f126c25b11e1889fd080365b5f49b"
      ],
      "confidence": 0.85,
      "evidence": "chronic cough",
      "verified": true
    },
    {
      "id": "E7",
      "type": "Condition",
      "name": "impairment of overall health status",
      "attributes": {
        "condition_type": "symptom"
      },
      "source_chunk_ids": [
        "d05f126c25b11e1889fd080365b5f49b"
      ],
      "confidence": 0.8,
      "evidence": "impairment of the overall health status",
      "verified": true
    },
    {
      "id": "E8",
      "type": "Effect",
      "name": "chronic inflammation",
      "attributes": {
        "level": "systemic",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "d05f126c25b11e1889fd080365b5f49b"
      ],
      "confidence": 0.9,
      "evidence": "chronic inflammation",
      "verified": true
    },
    {
      "id": "E9",
      "type": "Effect",
      "name": "airway remodeling",
      "attributes": {
        "level": "cellular",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "d05f126c25b11e1889fd080365b5f49b"
      ],
      "confidence": 0.85,
      "evidence": "airway remodeling",
      "verified": true
    },
    {
      "id": "E10",
      "type": "Effect",
      "name": "destruction of alveolar tissue",
      "attributes": {
        "level": "cellular",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "d05f126c25b11e1889fd080365b5f49b"
      ],
      "confidence": 0.85,
      "evidence": "destruction of alveolar tissue",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Condition",
      "name": "COPD",
      "attributes": {
        "condition_type": "disease"
      },
      "source_chunk_ids": [
        "b340c01e8afdeed34a553f42af6cfc37"
      ],
      "confidence": 0.95,
      "evidence": "COPD",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Condition",
      "name": "cigarette smoking",
      "attributes": {
        "condition_type": "risk_factor"
      },
      "source_chunk_ids": [
        "b340c01e8afdeed34a553f42af6cfc37"
      ],
      "confidence": 0.9,
      "evidence": "cigarette smoking",
      "verified": true
    },
    {
      "id": "E3",
      "type": "TraditionalUse",
      "name": "smoking cessation",
      "attributes": {},
      "source_chunk_ids": [
        "b340c01e8afdeed34a553f42af6cfc37"
      ],
      "confidence": 0.85,
      "evidence": "smoking cessation",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Target",
      "name": "long-acting muscarinic antagonists",
      "attributes": {
        "target_type": "antagonist"
      },
      "source_chunk_ids": [
        "b340c01e8afdeed34a553f42af6cfc37"
      ],
      "confidence": 0.8,
      "evidence": "long-acting muscarinic antagonists (LAMA)",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Target",
      "name": "long acting beta-adrenoceptor agonists",
      "attributes": {
        "target_type": "agonist"
      },
      "source_chunk_ids": [
        "b340c01e8afdeed34a553f42af6cfc37"
      ],
      "confidence": 0.8,
      "evidence": "long acting beta-adrenoceptor agonists (LABA)",
      "verified": true
    },
    {
      "id": "E6",
      "type": "Target",
      "name": "inhaled corticosteroids",
      "attributes": {
        "target_type": "corticosteroid"
      },
      "source_chunk_ids": [
        "b340c01e8afdeed34a553f42af6cfc37"
      ],
      "confidence": 0.8,
      "evidence": "inhaled corticosteroids (ICS)",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Condition",
      "name": "COPD",
      "attributes": {
        "condition_type": "disease"
      },
      "source_chunk_ids": [
        "16db1237b95878aba5316196e824be35"
      ],
      "confidence": 0.95,
      "evidence": "COPD patients",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Effect",
      "name": "improvements in lung function",
      "attributes": {
        "level": "systemic",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "16db1237b95878aba5316196e824be35"
      ],
      "confidence": 0.8,
      "evidence": "improvements in lung function",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Effect",
      "name": "improvements in exercise tolerance",
      "attributes": {
        "level": "systemic",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "16db1237b95878aba5316196e824be35"
      ],
      "confidence": 0.8,
      "evidence": "improvements in exercise tolerance",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Effect",
      "name": "improvements in quality of life",
      "attributes": {
        "level": "systemic",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "16db1237b95878aba5316196e824be35"
      ],
      "confidence": 0.8,
      "evidence": "improvements in quality of life",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Effect",
      "name": "reducing exacerbations",
      "attributes": {
        "level": "systemic",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "16db1237b95878aba5316196e824be35"
      ],
      "confidence": 0.7,
      "evidence": "reducing exacerbations",
      "verified": true
    },
    {
      "id": "E6",
      "type": "Effect",
      "name": "rate of decline in lung function",
      "attributes": {
        "level": "systemic",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "16db1237b95878aba5316196e824be35"
      ],
      "confidence": 0.7,
      "evidence": "rate of decline in lung function",
      "verified": true
    },
    {
      "id": "E7",
      "type": "Effect",
      "name": "improve systemic features of COPD",
      "attributes": {
        "level": "systemic",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "16db1237b95878aba5316196e824be35"
      ],
      "confidence": 0.7,
      "evidence": "improve the systemic features of COPD",
      "verified": true
    },
    {
      "id": "E8",
      "type": "AdverseEvent",
      "name": "increase morbidity and mortality due to cardiac comorbidity",
      "attributes": {
        "severity": "severe"
      },
      "source_chunk_ids": [
        "16db1237b95878aba5316196e824be35"
      ],
      "confidence": 0.75,
      "evidence": "increase morbidity and mortality due to cardiac comorbidity",
      "verified": true
    },
    {
      "id": "E9",
      "type": "Condition",
      "name": "exacerbations",
      "attributes": {
        "condition_type": "symptom"
      },
      "source_chunk_ids": [
        "16db1237b95878aba5316196e824be35"
      ],
      "confidence": 0.85,
      "evidence": "experience exacerbations",
      "verified": true
    },
    {
      "id": "E10",
      "type": "Effect",
      "name": "sustained clinical efficacy",
      "attributes": {
        "level": "systemic",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "16db1237b95878aba5316196e824be35"
      ],
      "confidence": 0.8,
      "evidence": "sustained clinical efficacy",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Target",
      "name": "phosphodiesterase",
      "attributes": {
        "target_type": "enzyme"
      },
      "source_chunk_ids": [
        "577d177f1cd27b22ce2d1d8fc371d264"
      ],
      "confidence": 0.9,
      "evidence": "Phosphodiesterase inhibition",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Condition",
      "name": "COPD",
      "attributes": {
        "condition_type": "disease"
      },
      "source_chunk_ids": [
        "577d177f1cd27b22ce2d1d8fc371d264"
      ],
      "confidence": 0.95,
      "evidence": "treatment of COPD",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Study",
      "name": "Hirsch et al. 1922",
      "attributes": {
        "year": 1922
      },
      "source_chunk_ids": [
        "577d177f1cd27b22ce2d1d8fc371d264"
      ],
      "confidence": 0.8,
      "evidence": "Hirsch and colleagues in 1922",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Evidence",
      "name": "historical evidence",
      "attributes": {
        "evidence_level": 3
      },
      "source_chunk_ids": [
        "577d177f1cd27b22ce2d1d8fc371d264"
      ],
      "confidence": 0.7,
      "evidence": "old concept in the treatment of COPD",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Compound",
      "name": "aminophylline",
      "attributes": {},
      "source_chunk_ids": [
        "577d177f1cd27b22ce2d1d8fc371d264"
      ],
      "confidence": 0.9,
      "evidence": "aminophylline",
      "verified": true
    },
    {
      "id": "E6",
      "type": "Compound",
      "name": "theophylline",
      "attributes": {},
      "source_chunk_ids": [
        "577d177f1cd27b22ce2d1d8fc371d264"
      ],
      "confidence": 0.9,
      "evidence": "theophylline",
      "verified": true
    },
    {
      "id": "E7",
      "type": "AdverseEvent",
      "name": "cardiovascular side effects",
      "attributes": {
        "severity": "dose-dependent"
      },
      "source_chunk_ids": [
        "577d177f1cd27b22ce2d1d8fc371d264"
      ],
      "confidence": 0.85,
      "evidence": "cardiovascular side effects",
      "verified": true
    },
    {
      "id": "E8",
      "type": "AdverseEvent",
      "name": "gastrointestinal side effects",
      "attributes": {
        "severity": "dose-dependent"
      },
      "source_chunk_ids": [
        "577d177f1cd27b22ce2d1d8fc371d264"
      ],
      "confidence": 0.85,
      "evidence": "gastrointestinal side effects",
      "verified": true
    },
    {
      "id": "E9",
      "type": "Target",
      "name": "phosphoinositide 3 kinase",
      "attributes": {
        "target_type": "enzyme"
      },
      "source_chunk_ids": [
        "577d177f1cd27b22ce2d1d8fc371d264"
      ],
      "confidence": 0.8,
      "evidence": "phosphoinositide 3 kinase",
      "verified": true
    },
    {
      "id": "E10",
      "type": "Target",
      "name": "PDE4",
      "attributes": {
        "target_type": "isoenzyme"
      },
      "source_chunk_ids": [
        "577d177f1cd27b22ce2d1d8fc371d264"
      ],
      "confidence": 0.9,
      "evidence": "PDE4-isoenzyme",
      "verified": true
    },
    {
      "id": "E11",
      "type": "Compound",
      "name": "cilomilast",
      "attributes": {},
      "source_chunk_ids": [
        "577d177f1cd27b22ce2d1d8fc371d264"
      ],
      "confidence": 0.85,
      "evidence": "cilomilast",
      "verified": true
    },
    {
      "id": "E12",
      "type": "Compound",
      "name": "roflumilast",
      "attributes": {},
      "source_chunk_ids": [
        "577d177f1cd27b22ce2d1d8fc371d264"
      ],
      "confidence": 0.85,
      "evidence": "roflumilast",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Study",
      "name": "clinical trials with roflumilast",
      "attributes": {
        "design": "clinical trials"
      },
      "source_chunk_ids": [
        "0fa23b10f4e8e0997dd85df3a652c237"
      ],
      "confidence": 0.8,
      "evidence": "most recent clinical trials with the PDE4-inhibitor, roflumilast",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Evidence",
      "name": "clinical trial evidence",
      "attributes": {
        "evidence_level": 4
      },
      "source_chunk_ids": [
        "0fa23b10f4e8e0997dd85df3a652c237"
      ],
      "confidence": 0.75,
      "evidence": "clinical trials with the PDE4-inhibitor, roflumilast",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Compound",
      "name": "roflumilast",
      "attributes": {},
      "source_chunk_ids": [
        "0fa23b10f4e8e0997dd85df3a652c237"
      ],
      "confidence": 0.95,
      "evidence": "PDE4-inhibitor, roflumilast",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Target",
      "name": "PDE4",
      "attributes": {
        "target_type": "enzyme"
      },
      "source_chunk_ids": [
        "0fa23b10f4e8e0997dd85df3a652c237"
      ],
      "confidence": 0.85,
      "evidence": "PDE4-inhibitor",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Condition",
      "name": "COPD",
      "attributes": {
        "condition_type": "disease"
      },
      "source_chunk_ids": [
        "0fa23b10f4e8e0997dd85df3a652c237"
      ],
      "confidence": 0.9,
      "evidence": "patients with COPD",
      "verified": true
    },
    {
      "id": "E6",
      "type": "Dosage",
      "name": "once daily dosing",
      "attributes": {
        "frequency": "once daily"
      },
      "source_chunk_ids": [
        "0fa23b10f4e8e0997dd85df3a652c237"
      ],
      "confidence": 0.7,
      "evidence": "once daily dosing",
      "verified": true
    },
    {
      "id": "E7",
      "type": "AdverseEvent",
      "name": "mild and self-limiting side effects",
      "attributes": {
        "severity": "mild"
      },
      "source_chunk_ids": [
        "0fa23b10f4e8e0997dd85df3a652c237"
      ],
      "confidence": 0.8,
      "evidence": "overall mild and self limiting side effects",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Target",
      "name": "PDE4",
      "attributes": {
        "target_type": "enzyme"
      },
      "source_chunk_ids": [
        "f7ccc3f0bdbc744b33647af3f0e19a2a"
      ],
      "confidence": 0.95,
      "evidence": "inhibiting PDE4",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Effect",
      "name": "reduction in activity of pro-inflammatory and structural cells",
      "attributes": {
        "level": "cellular",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "f7ccc3f0bdbc744b33647af3f0e19a2a"
      ],
      "confidence": 0.85,
      "evidence": "reduction in activity of several pro-inflammatory and structural cells",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Condition",
      "name": "COPD",
      "attributes": {
        "condition_type": "disease"
      },
      "source_chunk_ids": [
        "f7ccc3f0bdbc744b33647af3f0e19a2a"
      ],
      "confidence": 0.9,
      "evidence": "pathophysiology of COPD",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Effect",
      "name": "suppress pro-inflammatory cell recruitment, cytokine and chemokine production and emphysematous changes",
      "attributes": {
        "level": "cellular",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "f7ccc3f0bdbc744b33647af3f0e19a2a"
      ],
      "confidence": 0.8,
      "evidence": "suppress pro-inflammatory cell recruitment, cytokine and chemokine production and emphysematous changes",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Evidence",
      "name": "animal models",
      "attributes": {
        "evidence_level": 2
      },
      "source_chunk_ids": [
        "f7ccc3f0bdbc744b33647af3f0e19a2a"
      ],
      "confidence": 0.75,
      "evidence": "animal models of COPD",
      "verified": true
    },
    {
      "id": "E6",
      "type": "Evidence",
      "name": "clinical trials",
      "attributes": {
        "evidence_level": 4
      },
      "source_chunk_ids": [
        "f7ccc3f0bdbc744b33647af3f0e19a2a"
      ],
      "confidence": 0.8,
      "evidence": "early clinical trials with PDE4-inhibitors",
      "verified": true
    },
    {
      "id": "E1",
      "type": "CompoundClass",
      "name": "PDE4-inhibitors",
      "attributes": {},
      "source_chunk_ids": [
        "d30445d9b19a7b38c12c667157a29923"
      ],
      "confidence": 0.95,
      "evidence": "PDE4-inhibitors",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Compound",
      "name": "CDP840",
      "attributes": {},
      "source_chunk_ids": [
        "d30445d9b19a7b38c12c667157a29923"
      ],
      "confidence": 0.9,
      "evidence": "CDP840",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Condition",
      "name": "allergen-induced late asthmatic responses",
      "attributes": {
        "condition_type": "symptom"
      },
      "source_chunk_ids": [
        "d30445d9b19a7b38c12c667157a29923"
      ],
      "confidence": 0.85,
      "evidence": "allergen-induced late asthmatic responses",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Effect",
      "name": "protection against allergen-induced late asthmatic responses",
      "attributes": {
        "level": "systemic",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "d30445d9b19a7b38c12c667157a29923"
      ],
      "confidence": 0.8,
      "evidence": "protection against allergen-induced late asthmatic responses",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Compound",
      "name": "theophylline",
      "attributes": {},
      "source_chunk_ids": [
        "d30445d9b19a7b38c12c667157a29923"
      ],
      "confidence": 0.9,
      "evidence": "theophylline",
      "verified": true
    },
    {
      "id": "E6",
      "type": "Condition",
      "name": "allergen-induced late phase reactions",
      "attributes": {
        "condition_type": "symptom"
      },
      "source_chunk_ids": [
        "d30445d9b19a7b38c12c667157a29923"
      ],
      "confidence": 0.85,
      "evidence": "allergen-induced late phase reactions",
      "verified": true
    },
    {
      "id": "E7",
      "type": "Effect",
      "name": "inhibition of allergen-induced late phase reactions",
      "attributes": {
        "level": "systemic",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "d30445d9b19a7b38c12c667157a29923"
      ],
      "confidence": 0.8,
      "evidence": "inhibit allergen-induced late phase reactions",
      "verified": true
    },
    {
      "id": "E8",
      "type": "Compound",
      "name": "cilomilast",
      "attributes": {},
      "source_chunk_ids": [
        "d30445d9b19a7b38c12c667157a29923"
      ],
      "confidence": 0.9,
      "evidence": "cilomilast",
      "verified": true
    },
    {
      "id": "E9",
      "type": "Compound",
      "name": "roflumilast",
      "attributes": {},
      "source_chunk_ids": [
        "d30445d9b19a7b38c12c667157a29923"
      ],
      "confidence": 0.9,
      "evidence": "roflumilast",
      "verified": true
    },
    {
      "id": "E10",
      "type": "Condition",
      "name": "COPD",
      "attributes": {
        "condition_type": "disease"
      },
      "source_chunk_ids": [
        "d30445d9b19a7b38c12c667157a29923"
      ],
      "confidence": 0.95,
      "evidence": "COPD",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Compound",
      "name": "cilomilast",
      "attributes": {},
      "source_chunk_ids": [
        "503d1a8b5827d6a43ff07e54866e86c2"
      ],
      "confidence": 0.95,
      "evidence": "PDE4-inhibitor cilomilast",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Target",
      "name": "PDE4",
      "attributes": {
        "target_type": "enzyme"
      },
      "source_chunk_ids": [
        "503d1a8b5827d6a43ff07e54866e86c2"
      ],
      "confidence": 0.9,
      "evidence": "PDE4-inhibitor",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Study",
      "name": "dose finding study in COPD patients",
      "attributes": {
        "design": "dose finding study",
        "duration": "6 weeks"
      },
      "source_chunk_ids": [
        "503d1a8b5827d6a43ff07e54866e86c2"
      ],
      "confidence": 0.85,
      "evidence": "dose finding study in patients with moderate to severe COPD",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Evidence",
      "name": "clinical study",
      "attributes": {
        "evidence_level": 4
      },
      "source_chunk_ids": [
        "503d1a8b5827d6a43ff07e54866e86c2"
      ],
      "confidence": 0.8,
      "evidence": "dose finding study in patients",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Condition",
      "name": "COPD",
      "attributes": {
        "condition_type": "disease"
      },
      "source_chunk_ids": [
        "503d1a8b5827d6a43ff07e54866e86c2"
      ],
      "confidence": 0.95,
      "evidence": "patients with moderate to severe COPD",
      "verified": true
    },
    {
      "id": "E6",
      "type": "Effect",
      "name": "increased FEV1",
      "attributes": {
        "level": "systemic",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "503d1a8b5827d6a43ff07e54866e86c2"
      ],
      "confidence": 0.9,
      "evidence": "significantly increasing baseline FEV1 by 11%",
      "verified": true
    },
    {
      "id": "E7",
      "type": "Effect",
      "name": "improved lung function",
      "attributes": {
        "level": "systemic",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "503d1a8b5827d6a43ff07e54866e86c2"
      ],
      "confidence": 0.85,
      "evidence": "improvement in baseline lung function",
      "verified": true
    },
    {
      "id": "E8",
      "type": "Effect",
      "name": "no immediate bronchodilator response",
      "attributes": {
        "level": "systemic",
        "valence": "neutral"
      },
      "source_chunk_ids": [
        "503d1a8b5827d6a43ff07e54866e86c2"
      ],
      "confidence": 0.8,
      "evidence": "failed to produce an immediate bronchodilator response",
      "verified": true
    },
    {
      "id": "E9",
      "type": "Evidence",
      "name": "in vitro evidence",
      "attributes": {
        "evidence_level": 2
      },
      "source_chunk_ids": [
        "503d1a8b5827d6a43ff07e54866e86c2"
      ],
      "confidence": 0.7,
      "evidence": "numerous in vitro",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Study",
      "name": "longer-term study with cilomilast",
      "attributes": {
        "design": "longer-term study",
        "year": null,
        "doi": null
      },
      "source_chunk_ids": [
        "b8f1dac29022a4872ad9bc6d1d9f23e1"
      ],
      "confidence": 0.85,
      "evidence": "Another longer-term study with cilomilast",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Evidence",
      "name": "clinical trial",
      "attributes": {
        "evidence_level": 4
      },
      "source_chunk_ids": [
        "b8f1dac29022a4872ad9bc6d1d9f23e1"
      ],
      "confidence": 0.8,
      "evidence": "clinical trials",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Compound",
      "name": "cilomilast",
      "attributes": {},
      "source_chunk_ids": [
        "b8f1dac29022a4872ad9bc6d1d9f23e1"
      ],
      "confidence": 0.95,
      "evidence": "cilomilast",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Condition",
      "name": "COPD",
      "attributes": {
        "condition_type": "disease"
      },
      "source_chunk_ids": [
        "b8f1dac29022a4872ad9bc6d1d9f23e1"
      ],
      "confidence": 0.9,
      "evidence": "COPD exacerbations",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Effect",
      "name": "improvements in lung function",
      "attributes": {
        "level": "systemic",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "b8f1dac29022a4872ad9bc6d1d9f23e1"
      ],
      "confidence": 0.85,
      "evidence": "improvements in lung function",
      "verified": true
    },
    {
      "id": "E6",
      "type": "Effect",
      "name": "reduction in COPD exacerbations",
      "attributes": {
        "level": "systemic",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "b8f1dac29022a4872ad9bc6d1d9f23e1"
      ],
      "confidence": 0.85,
      "evidence": "reduction in COPD exacerbations",
      "verified": true
    },
    {
      "id": "E7",
      "type": "Effect",
      "name": "improvements in quality of life scores",
      "attributes": {
        "level": "systemic",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "b8f1dac29022a4872ad9bc6d1d9f23e1"
      ],
      "confidence": 0.85,
      "evidence": "improvements in quality of life scores",
      "verified": true
    },
    {
      "id": "E8",
      "type": "Effect",
      "name": "anti-inflammatory activity",
      "attributes": {
        "level": "cellular",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "b8f1dac29022a4872ad9bc6d1d9f23e1"
      ],
      "confidence": 0.8,
      "evidence": "anti-inflammatory activity",
      "verified": true
    },
    {
      "id": "E9",
      "type": "Target",
      "name": "PDE4",
      "attributes": {
        "target_type": "enzyme"
      },
      "source_chunk_ids": [
        "b8f1dac29022a4872ad9bc6d1d9f23e1"
      ],
      "confidence": 0.9,
      "evidence": "PDE4-inhibitors",
      "verified": true
    },
    {
      "id": "E10",
      "type": "Target",
      "name": "sensory nerve function",
      "attributes": {
        "target_type": "process"
      },
      "source_chunk_ids": [
        "b8f1dac29022a4872ad9bc6d1d9f23e1"
      ],
      "confidence": 0.75,
      "evidence": "modulation of sensory nerve function",
      "verified": true
    },
    {
      "id": "E11",
      "type": "Target",
      "name": "CFTR",
      "attributes": {
        "target_type": "receptor"
      },
      "source_chunk_ids": [
        "b8f1dac29022a4872ad9bc6d1d9f23e1"
      ],
      "confidence": 0.85,
      "evidence": "cystic fibrosis transmembrane receptor (CFTR)",
      "verified": true
    },
    {
      "id": "E12",
      "type": "Effect",
      "name": "reduced mucus production",
      "attributes": {
        "level": "cellular",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "b8f1dac29022a4872ad9bc6d1d9f23e1"
      ],
      "confidence": 0.8,
      "evidence": "reduce mucus production",
      "verified": true
    },
    {
      "id": "E13",
      "type": "Effect",
      "name": "increased ciliary beat frequency",
      "attributes": {
        "level": "cellular",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "b8f1dac29022a4872ad9bc6d1d9f23e1"
      ],
      "confidence": 0.8,
      "evidence": "increase ciliary beat frequency",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Study",
      "name": "Phase III studies with cilomilast",
      "attributes": {
        "design": "Phase III clinical trials",
        "sample_size": null,
        "duration": "24 weeks",
        "year": null,
        "doi": null
      },
      "source_chunk_ids": [
        "da025e1e40f7f7ab07600fa502c279bc"
      ],
      "confidence": 0.95,
      "evidence": "Phase III studies with cilomilast",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Evidence",
      "name": "clinical trial",
      "attributes": {
        "evidence_level": 4
      },
      "source_chunk_ids": [
        "da025e1e40f7f7ab07600fa502c279bc"
      ],
      "confidence": 0.9,
      "evidence": "Phase III studies",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Compound",
      "name": "cilomilast",
      "attributes": {},
      "source_chunk_ids": [
        "da025e1e40f7f7ab07600fa502c279bc"
      ],
      "confidence": 0.95,
      "evidence": "cilomilast",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Condition",
      "name": "lung function impairment",
      "attributes": {
        "condition_type": "symptom"
      },
      "source_chunk_ids": [
        "da025e1e40f7f7ab07600fa502c279bc"
      ],
      "confidence": 0.8,
      "evidence": "lung function",
      "verified": true
    },
    {
      "id": "E5",
      "type": "AdverseEvent",
      "name": "gastrointestinal side effects",
      "attributes": {
        "severity": null
      },
      "source_chunk_ids": [
        "da025e1e40f7f7ab07600fa502c279bc"
      ],
      "confidence": 0.85,
      "evidence": "gastrointestinal side effects",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Compound",
      "name": "cilomilast",
      "attributes": {},
      "source_chunk_ids": [
        "12e35efaee014f47451619f7b5f942e1"
      ],
      "confidence": 0.95,
      "evidence": "failure of cilomilast",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Target",
      "name": "PDE4",
      "attributes": {
        "target_type": "enzyme"
      },
      "source_chunk_ids": [
        "12e35efaee014f47451619f7b5f942e1"
      ],
      "confidence": 0.9,
      "evidence": "targeting PDE4",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Condition",
      "name": "COPD",
      "attributes": {
        "condition_type": "disease"
      },
      "source_chunk_ids": [
        "12e35efaee014f47451619f7b5f942e1"
      ],
      "confidence": 0.9,
      "evidence": "treatment of COPD",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Compound",
      "name": "roflumilast",
      "attributes": {},
      "source_chunk_ids": [
        "12e35efaee014f47451619f7b5f942e1"
      ],
      "confidence": 0.95,
      "evidence": "PDE4-inhibitor roflumilast",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Effect",
      "name": "PDE4-inhibition",
      "attributes": {
        "level": "molecular",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "12e35efaee014f47451619f7b5f942e1"
      ],
      "confidence": 0.8,
      "evidence": "PDE4-inhibition",
      "verified": true
    },
    {
      "id": "E6",
      "type": "Effect",
      "name": "clinical benefit",
      "attributes": {
        "level": "systemic",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "12e35efaee014f47451619f7b5f942e1"
      ],
      "confidence": 0.75,
      "evidence": "clinical benefit",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Compound",
      "name": "roflumilast",
      "attributes": {},
      "source_chunk_ids": [
        "bd1d5728b17cf842c58e616ac92b9f31"
      ],
      "confidence": 0.95,
      "evidence": "roflumilast is rapidly absorbed",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Target",
      "name": "CYP3A4",
      "attributes": {
        "target_type": "enzyme"
      },
      "source_chunk_ids": [
        "bd1d5728b17cf842c58e616ac92b9f31"
      ],
      "confidence": 0.9,
      "evidence": "metabolized by CYP3A4",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Target",
      "name": "CYP1A2",
      "attributes": {
        "target_type": "enzyme"
      },
      "source_chunk_ids": [
        "bd1d5728b17cf842c58e616ac92b9f31"
      ],
      "confidence": 0.9,
      "evidence": "metabolized by CYP1A2 enzymes",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Compound",
      "name": "N-oxide",
      "attributes": {},
      "source_chunk_ids": [
        "bd1d5728b17cf842c58e616ac92b9f31"
      ],
      "confidence": 0.9,
      "evidence": "N-oxide, being the major metabolite",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Target",
      "name": "PDE4",
      "attributes": {
        "target_type": "enzyme"
      },
      "source_chunk_ids": [
        "bd1d5728b17cf842c58e616ac92b9f31"
      ],
      "confidence": 0.85,
      "evidence": "selectivity for the PDE4 isoenzymes",
      "verified": true
    },
    {
      "id": "E6",
      "type": "Effect",
      "name": "rapid absorption",
      "attributes": {
        "level": "systemic",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "bd1d5728b17cf842c58e616ac92b9f31"
      ],
      "confidence": 0.8,
      "evidence": "rapidly absorbed with a t_{max}",
      "verified": true
    },
    {
      "id": "E7",
      "type": "Effect",
      "name": "linear dose-proportional pharmacokinetics",
      "attributes": {
        "level": "systemic",
        "valence": "neutral"
      },
      "source_chunk_ids": [
        "bd1d5728b17cf842c58e616ac92b9f31"
      ],
      "confidence": 0.8,
      "evidence": "shows linearly dose-proportional pharmacokinetics",
      "verified": true
    },
    {
      "id": "E8",
      "type": "Effect",
      "name": "once-daily administration warranted",
      "attributes": {
        "level": "systemic",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "bd1d5728b17cf842c58e616ac92b9f31"
      ],
      "confidence": 0.75,
      "evidence": "warranting a once-daily administration",
      "verified": true
    },
    {
      "id": "E9",
      "type": "Effect",
      "name": "rapid metabolism",
      "attributes": {
        "level": "molecular",
        "valence": "neutral"
      },
      "source_chunk_ids": [
        "bd1d5728b17cf842c58e616ac92b9f31"
      ],
      "confidence": 0.8,
      "evidence": "rapidly metabolized by CYP3A4",
      "verified": true
    },
    {
      "id": "E10",
      "type": "Effect",
      "name": "selectivity for PDE4",
      "attributes": {
        "level": "molecular",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "bd1d5728b17cf842c58e616ac92b9f31"
      ],
      "confidence": 0.8,
      "evidence": "possesses selectivity for the PDE4 isoenzymes",
      "verified": true
    },
    {
      "id": "E11",
      "type": "Effect",
      "name": "accounts for effects in humans",
      "attributes": {
        "level": "systemic",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "bd1d5728b17cf842c58e616ac92b9f31"
      ],
      "confidence": 0.75,
      "evidence": "largely accounts for its effects in humans",
      "verified": true
    },
    {
      "id": "E12",
      "type": "Effect",
      "name": "excretion via urine",
      "attributes": {
        "level": "systemic",
        "valence": "neutral"
      },
      "source_chunk_ids": [
        "bd1d5728b17cf842c58e616ac92b9f31"
      ],
      "confidence": 0.8,
      "evidence": "mainly excreted via the urine",
      "verified": true
    },
    {
      "id": "E13",
      "type": "Effect",
      "name": "no major drug interactions",
      "attributes": {
        "level": "systemic",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "bd1d5728b17cf842c58e616ac92b9f31"
      ],
      "confidence": 0.7,
      "evidence": "no major drug interactions reported",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Study",
      "name": "M2-107 trial",
      "attributes": {
        "design": "double-blind parallel trial",
        "sample_size": 1411,
        "duration": "24 weeks"
      },
      "source_chunk_ids": [
        "95b98aea101680bd29a2709c666b863d"
      ],
      "confidence": 0.9,
      "evidence": "double-blind, parallel trial (M2-107)",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Evidence",
      "name": "clinical trial",
      "attributes": {
        "evidence_level": 4
      },
      "source_chunk_ids": [
        "95b98aea101680bd29a2709c666b863d"
      ],
      "confidence": 0.85,
      "evidence": "clinical studies",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Condition",
      "name": "COPD",
      "attributes": {
        "condition_type": "disease"
      },
      "source_chunk_ids": [
        "95b98aea101680bd29a2709c666b863d"
      ],
      "confidence": 0.95,
      "evidence": "patients with moderate to severe COPD",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Dosage",
      "name": "roflumilast 250 \u00b5g once daily for 24 weeks",
      "attributes": {
        "amount": 250,
        "unit": "\u00b5g",
        "frequency": "once daily",
        "duration": "24 weeks",
        "route": "oral"
      },
      "source_chunk_ids": [
        "95b98aea101680bd29a2709c666b863d"
      ],
      "confidence": 0.8,
      "evidence": "roflumilast 250 \u00b5g once daily during 24 weeks",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Dosage",
      "name": "roflumilast 500 \u00b5g once daily for 24 weeks",
      "attributes": {
        "amount": 500,
        "unit": "\u00b5g",
        "frequency": "once daily",
        "duration": "24 weeks",
        "route": "oral"
      },
      "source_chunk_ids": [
        "95b98aea101680bd29a2709c666b863d"
      ],
      "confidence": 0.8,
      "evidence": "roflumilast 500 \u00b5g once daily during 24 weeks",
      "verified": true
    },
    {
      "id": "E6",
      "type": "Effect",
      "name": "improved post-bronchodilator FEV1",
      "attributes": {
        "level": "systemic",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "95b98aea101680bd29a2709c666b863d"
      ],
      "confidence": 0.85,
      "evidence": "improvements in terms of post-bronchodilator FEV1",
      "verified": true
    },
    {
      "id": "E7",
      "type": "Effect",
      "name": "improved health-related quality of life",
      "attributes": {
        "level": "systemic",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "95b98aea101680bd29a2709c666b863d"
      ],
      "confidence": 0.7,
      "evidence": "health-related quality of life",
      "verified": true
    },
    {
      "id": "E8",
      "type": "Effect",
      "name": "reduced number of COPD exacerbations",
      "attributes": {
        "level": "systemic",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "95b98aea101680bd29a2709c666b863d"
      ],
      "confidence": 0.75,
      "evidence": "number of COPD-",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Study",
      "name": "roflumilast COPD study",
      "attributes": {
        "design": "clinical trial",
        "duration": "one year",
        "year": null,
        "doi": null,
        "sample_size": null
      },
      "source_chunk_ids": [
        "4b04451fef8aaea9305e782c5693abb7"
      ],
      "confidence": 0.8,
      "evidence": "subjects with moderate to (very) severe COPD received roflumilast for one year",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Evidence",
      "name": "clinical trial",
      "attributes": {
        "evidence_level": 4
      },
      "source_chunk_ids": [
        "4b04451fef8aaea9305e782c5693abb7"
      ],
      "confidence": 0.75,
      "evidence": "study, subjects with moderate to (very) severe COPD",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Condition",
      "name": "COPD",
      "attributes": {
        "condition_type": "disease"
      },
      "source_chunk_ids": [
        "4b04451fef8aaea9305e782c5693abb7"
      ],
      "confidence": 0.9,
      "evidence": "subjects with moderate to (very) severe COPD",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Condition",
      "name": "exacerbations",
      "attributes": {
        "condition_type": "symptom"
      },
      "source_chunk_ids": [
        "4b04451fef8aaea9305e782c5693abb7"
      ],
      "confidence": 0.85,
      "evidence": "exacerbations (p=0.0114)",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Effect",
      "name": "improvement in baseline FEV1",
      "attributes": {
        "level": "systemic",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "4b04451fef8aaea9305e782c5693abb7"
      ],
      "confidence": 0.8,
      "evidence": "small but significant improvement in baseline FEV1",
      "verified": true
    },
    {
      "id": "E6",
      "type": "Effect",
      "name": "reduction in exacerbation rates",
      "attributes": {
        "level": "systemic",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "4b04451fef8aaea9305e782c5693abb7"
      ],
      "confidence": 0.8,
      "evidence": "modest reduction in exacerbation rates",
      "verified": true
    },
    {
      "id": "E7",
      "type": "Effect",
      "name": "no significant change in quality of life scores",
      "attributes": {
        "level": "systemic",
        "valence": "neutral"
      },
      "source_chunk_ids": [
        "4b04451fef8aaea9305e782c5693abb7"
      ],
      "confidence": 0.75,
      "evidence": "quality of life scores did not reach statistical significance",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Study",
      "name": "M2-127",
      "attributes": {
        "design": "randomized controlled trial",
        "sample_size": 933,
        "duration": "24 weeks",
        "intervention": "roflumilast + salmeterol vs placebo + salmeterol"
      },
      "source_chunk_ids": [
        "c674c321267d06ecbf909fb4707589a9"
      ],
      "confidence": 0.9,
      "evidence": "patients were randomized to either roflumilast (n=466) or placebo (n=467) treatment in combination with salmeterol during 24 weeks",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Study",
      "name": "M2-128",
      "attributes": {
        "design": "randomized controlled trial",
        "sample_size": 743,
        "duration": "24 weeks",
        "intervention": "roflumilast + tiotropium vs placebo + tiotropium"
      },
      "source_chunk_ids": [
        "c674c321267d06ecbf909fb4707589a9"
      ],
      "confidence": 0.9,
      "evidence": "patients received either roflumilast (n=371) or placebo (n=372) in combination with tiotropium for 24 weeks",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Evidence",
      "name": "clinical trial",
      "attributes": {
        "evidence_level": 4
      },
      "source_chunk_ids": [
        "c674c321267d06ecbf909fb4707589a9"
      ],
      "confidence": 0.85,
      "evidence": "randomized controlled trials (RCT) with roflumilast",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Compound",
      "name": "roflumilast",
      "attributes": {},
      "source_chunk_ids": [
        "c674c321267d06ecbf909fb4707589a9"
      ],
      "confidence": 0.95,
      "evidence": "roflumilast",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Condition",
      "name": "COPD",
      "attributes": {
        "condition_type": "disease",
        "severity": "moderate to severe"
      },
      "source_chunk_ids": [
        "c674c321267d06ecbf909fb4707589a9"
      ],
      "confidence": 0.95,
      "evidence": "patients with moderate to severe COPD",
      "verified": true
    },
    {
      "id": "E6",
      "type": "Effect",
      "name": "improved lung function",
      "attributes": {
        "level": "systemic",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "c674c321267d06ecbf909fb4707589a9"
      ],
      "confidence": 0.8,
      "evidence": "improvements in both the pre- and post-bronchodilator FEV1",
      "verified": true
    },
    {
      "id": "E7",
      "type": "Effect",
      "name": "fewer exacerbations",
      "attributes": {
        "level": "systemic",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "c674c321267d06ecbf909fb4707589a9"
      ],
      "confidence": 0.75,
      "evidence": "patients on roflumilast tended to have fewer exacerbations",
      "verified": true
    },
    {
      "id": "E8",
      "type": "AdverseEvent",
      "name": "nausea",
      "attributes": {
        "severity": "frequent"
      },
      "source_chunk_ids": [
        "c674c321267d06ecbf909fb4707589a9"
      ],
      "confidence": 0.85,
      "evidence": "nausea",
      "verified": true
    },
    {
      "id": "E9",
      "type": "AdverseEvent",
      "name": "diarrhea",
      "attributes": {
        "severity": "frequent"
      },
      "source_chunk_ids": [
        "c674c321267d06ecbf909fb4707589a9"
      ],
      "confidence": 0.85,
      "evidence": "diarrhea",
      "verified": true
    },
    {
      "id": "E10",
      "type": "AdverseEvent",
      "name": "mild weight loss",
      "attributes": {
        "severity": "mild"
      },
      "source_chunk_ids": [
        "c674c321267d06ecbf909fb4707589a9"
      ],
      "confidence": 0.8,
      "evidence": "mild weight loss (mean 1.8 and 2 kg)",
      "verified": true
    },
    {
      "id": "E11",
      "type": "AdverseEvent",
      "name": "withdrawals",
      "attributes": {
        "severity": "significant"
      },
      "source_chunk_ids": [
        "c674c321267d06ecbf909fb4707589a9"
      ],
      "confidence": 0.75,
      "evidence": "significantly more withdrawals in the salmeterol-roflumilast-arm",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Study",
      "name": "Calverley et al M2-124 and M2-125",
      "attributes": {
        "design": "randomized controlled trial",
        "duration": "52 weeks",
        "sample_size": "pooled data analysis",
        "year": "2010-2011"
      },
      "source_chunk_ids": [
        "7e90254c89ce0bab70742a624689f904"
      ],
      "confidence": 0.9,
      "evidence": "studies reported by Calverley et al (M2-124 and M2-125)",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Evidence",
      "name": "clinical trial",
      "attributes": {
        "evidence_level": 4
      },
      "source_chunk_ids": [
        "7e90254c89ce0bab70742a624689f904"
      ],
      "confidence": 0.85,
      "evidence": "randomized controlled trial design",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Compound",
      "name": "roflumilast",
      "attributes": {},
      "source_chunk_ids": [
        "7e90254c89ce0bab70742a624689f904"
      ],
      "confidence": 0.95,
      "evidence": "roflumilast",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Condition",
      "name": "COPD",
      "attributes": {
        "condition_type": "disease"
      },
      "source_chunk_ids": [
        "7e90254c89ce0bab70742a624689f904"
      ],
      "confidence": 0.95,
      "evidence": "symptomatic, (very) severe COPD",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Effect",
      "name": "increase in pre-bronchodilator FEV1",
      "attributes": {
        "level": "systemic",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "7e90254c89ce0bab70742a624689f904"
      ],
      "confidence": 0.85,
      "evidence": "mean increase in pre-bronchodilator FEV1 of 48 mL",
      "verified": true
    },
    {
      "id": "E6",
      "type": "Effect",
      "name": "decrease in exacerbations",
      "attributes": {
        "level": "systemic",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "7e90254c89ce0bab70742a624689f904"
      ],
      "confidence": 0.85,
      "evidence": "decrease in both moderate and severe exacerbations by on mean 17%",
      "verified": true
    },
    {
      "id": "E7",
      "type": "AdverseEvent",
      "name": "headache",
      "attributes": {
        "severity": "mild"
      },
      "source_chunk_ids": [
        "7e90254c89ce0bab70742a624689f904"
      ],
      "confidence": 0.8,
      "evidence": "head ache",
      "verified": true
    },
    {
      "id": "E8",
      "type": "AdverseEvent",
      "name": "insomnia",
      "attributes": {
        "severity": "mild"
      },
      "source_chunk_ids": [
        "7e90254c89ce0bab70742a624689f904"
      ],
      "confidence": 0.8,
      "evidence": "insomnia",
      "verified": true
    },
    {
      "id": "E9",
      "type": "AdverseEvent",
      "name": "nausea",
      "attributes": {
        "severity": "mild"
      },
      "source_chunk_ids": [
        "7e90254c89ce0bab70742a624689f904"
      ],
      "confidence": 0.8,
      "evidence": "nausea",
      "verified": true
    },
    {
      "id": "E10",
      "type": "AdverseEvent",
      "name": "diarrhea",
      "attributes": {
        "severity": "mild"
      },
      "source_chunk_ids": [
        "7e90254c89ce0bab70742a624689f904"
      ],
      "confidence": 0.8,
      "evidence": "diarrhea",
      "verified": true
    },
    {
      "id": "E11",
      "type": "AdverseEvent",
      "name": "weight loss",
      "attributes": {
        "severity": "moderate"
      },
      "source_chunk_ids": [
        "7e90254c89ce0bab70742a624689f904"
      ],
      "confidence": 0.8,
      "evidence": "mean weight loss of 2.1 kg",
      "verified": true
    },
    {
      "id": "E12",
      "type": "Condition",
      "name": "mortality due to COPD",
      "attributes": {
        "condition_type": "outcome"
      },
      "source_chunk_ids": [
        "7e90254c89ce0bab70742a624689f904"
      ],
      "confidence": 0.75,
      "evidence": "mortality due to COPD was similar",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Compound",
      "name": "cilomilast",
      "attributes": {},
      "source_chunk_ids": [
        "bad1df79303107b1e26c316464594926"
      ],
      "confidence": 0.9,
      "evidence": "cilomilast",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Compound",
      "name": "roflumilast",
      "attributes": {},
      "source_chunk_ids": [
        "bad1df79303107b1e26c316464594926"
      ],
      "confidence": 0.9,
      "evidence": "roflumilast",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Effect",
      "name": "improvements in lung function",
      "attributes": {
        "level": "systemic",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "bad1df79303107b1e26c316464594926"
      ],
      "confidence": 0.85,
      "evidence": "improvements in lung function",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Effect",
      "name": "reduction in exacerbation rates",
      "attributes": {
        "level": "systemic",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "bad1df79303107b1e26c316464594926"
      ],
      "confidence": 0.85,
      "evidence": "exacerbation rates",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Effect",
      "name": "improvements in quality of life scores",
      "attributes": {
        "level": "systemic",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "bad1df79303107b1e26c316464594926"
      ],
      "confidence": 0.85,
      "evidence": "quality of life scores",
      "verified": true
    },
    {
      "id": "E6",
      "type": "Effect",
      "name": "bronchodilating action",
      "attributes": {
        "level": "systemic",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "bad1df79303107b1e26c316464594926"
      ],
      "confidence": 0.8,
      "evidence": "bronchodilating action",
      "verified": true
    },
    {
      "id": "E7",
      "type": "Effect",
      "name": "anti-inflammatory activity",
      "attributes": {
        "level": "cellular",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "bad1df79303107b1e26c316464594926"
      ],
      "confidence": 0.85,
      "evidence": "anti-inflammatory activity",
      "verified": true
    },
    {
      "id": "E8",
      "type": "Effect",
      "name": "reduction in pro-inflammatory cell numbers",
      "attributes": {
        "level": "cellular",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "bad1df79303107b1e26c316464594926"
      ],
      "confidence": 0.8,
      "evidence": "reduction in pro-inflammatory cell numbers",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Study",
      "name": "Study [43, 44]",
      "attributes": {},
      "source_chunk_ids": [
        "8fbd93fb1b66921dca70e07abddb636a"
      ],
      "confidence": 0.8,
      "evidence": "[43, 44]",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Study",
      "name": "Study [30]",
      "attributes": {},
      "source_chunk_ids": [
        "8fbd93fb1b66921dca70e07abddb636a"
      ],
      "confidence": 0.8,
      "evidence": "[30]",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Study",
      "name": "Study [45]",
      "attributes": {
        "design": "in vitro"
      },
      "source_chunk_ids": [
        "8fbd93fb1b66921dca70e07abddb636a"
      ],
      "confidence": 0.85,
      "evidence": "in vitro studies [45]",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Evidence",
      "name": "in vitro evidence",
      "attributes": {
        "evidence_level": 2
      },
      "source_chunk_ids": [
        "8fbd93fb1b66921dca70e07abddb636a"
      ],
      "confidence": 0.8,
      "evidence": "in vitro studies",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Compound",
      "name": "cilomilast",
      "attributes": {},
      "source_chunk_ids": [
        "8fbd93fb1b66921dca70e07abddb636a"
      ],
      "confidence": 0.95,
      "evidence": "cilomilast",
      "verified": true
    },
    {
      "id": "E6",
      "type": "Effect",
      "name": "suppression of inflammatory cell numbers",
      "attributes": {
        "level": "cellular",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "8fbd93fb1b66921dca70e07abddb636a"
      ],
      "confidence": 0.85,
      "evidence": "suppression of inflammatory cell numbers",
      "verified": true
    },
    {
      "id": "E7",
      "type": "Effect",
      "name": "reduced airway CD8+ T lymphocytes and CD68+ macrophages",
      "attributes": {
        "level": "cellular",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "8fbd93fb1b66921dca70e07abddb636a"
      ],
      "confidence": 0.85,
      "evidence": "reduced airway CD8+ T lymphocytes and CD68+ macrophages",
      "verified": true
    },
    {
      "id": "E8",
      "type": "Effect",
      "name": "reduced TNF-alpha level",
      "attributes": {
        "level": "molecular",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "8fbd93fb1b66921dca70e07abddb636a"
      ],
      "confidence": 0.8,
      "evidence": "reduced the level of TNF-alpha",
      "verified": true
    },
    {
      "id": "E9",
      "type": "Effect",
      "name": "reduced GMCSF level",
      "attributes": {
        "level": "molecular",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "8fbd93fb1b66921dca70e07abddb636a"
      ],
      "confidence": 0.8,
      "evidence": "GMCSF (46% decrease)",
      "verified": true
    },
    {
      "id": "E10",
      "type": "Effect",
      "name": "reduced neutrophil chemotactic factors level",
      "attributes": {
        "level": "molecular",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "8fbd93fb1b66921dca70e07abddb636a"
      ],
      "confidence": 0.8,
      "evidence": "neutrophil chemotactic factors (35% decrease)",
      "verified": true
    },
    {
      "id": "E11",
      "type": "Effect",
      "name": "no effect on IL-8 release",
      "attributes": {
        "level": "molecular",
        "valence": "neutral"
      },
      "source_chunk_ids": [
        "8fbd93fb1b66921dca70e07abddb636a"
      ],
      "confidence": 0.75,
      "evidence": "no effect on IL-8 released",
      "verified": true
    },
    {
      "id": "E12",
      "type": "Target",
      "name": "inflammatory response",
      "attributes": {
        "target_type": "process"
      },
      "source_chunk_ids": [
        "8fbd93fb1b66921dca70e07abddb636a"
      ],
      "confidence": 0.7,
      "evidence": "inhibition of the inflammatory response",
      "verified": true
    },
    {
      "id": "E13",
      "type": "Condition",
      "name": "COPD",
      "attributes": {
        "condition_type": "disease"
      },
      "source_chunk_ids": [
        "8fbd93fb1b66921dca70e07abddb636a"
      ],
      "confidence": 0.9,
      "evidence": "COPD patients",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Condition",
      "name": "COPD",
      "attributes": {
        "condition_type": "disease"
      },
      "source_chunk_ids": [
        "d7bfa800a140bc0c63f9a05e7385e18e"
      ],
      "confidence": 0.95,
      "evidence": "treatment of COPD",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Product",
      "name": "tiotropium bromide",
      "attributes": {},
      "source_chunk_ids": [
        "d7bfa800a140bc0c63f9a05e7385e18e"
      ],
      "confidence": 0.9,
      "evidence": "tiotropium bromide",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Effect",
      "name": "reduction in exacerbations",
      "attributes": {
        "level": "systemic",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "d7bfa800a140bc0c63f9a05e7385e18e"
      ],
      "confidence": 0.85,
      "evidence": "reduction in exacerbations",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Effect",
      "name": "no reduction in inflammatory cells",
      "attributes": {
        "level": "cellular",
        "valence": "neutral"
      },
      "source_chunk_ids": [
        "d7bfa800a140bc0c63f9a05e7385e18e"
      ],
      "confidence": 0.8,
      "evidence": "not accompanied by a reduction in inflammatory cells",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Effect",
      "name": "rise in pro-inflammatory mediators",
      "attributes": {
        "level": "molecular",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "d7bfa800a140bc0c63f9a05e7385e18e"
      ],
      "confidence": 0.75,
      "evidence": "sputum levels of pro-inflammatory mediators tended to rise",
      "verified": true
    },
    {
      "id": "E6",
      "type": "Effect",
      "name": "improvements in lung function",
      "attributes": {
        "level": "systemic",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "d7bfa800a140bc0c63f9a05e7385e18e"
      ],
      "confidence": 0.8,
      "evidence": "improvements in lung function",
      "verified": true
    },
    {
      "id": "E7",
      "type": "Product",
      "name": "glucocorticosteroids",
      "attributes": {},
      "source_chunk_ids": [
        "d7bfa800a140bc0c63f9a05e7385e18e"
      ],
      "confidence": 0.85,
      "evidence": "glucocorticosteroids",
      "verified": true
    },
    {
      "id": "E8",
      "type": "Product",
      "name": "fluticasone",
      "attributes": {},
      "source_chunk_ids": [
        "d7bfa800a140bc0c63f9a05e7385e18e"
      ],
      "confidence": 0.9,
      "evidence": "fluticasone",
      "verified": true
    },
    {
      "id": "E9",
      "type": "Study",
      "name": "Study [48]",
      "attributes": {
        "design": "long-term study",
        "sample_size": 101,
        "duration": "2.5 years"
      },
      "source_chunk_ids": [
        "d7bfa800a140bc0c63f9a05e7385e18e"
      ],
      "confidence": 0.85,
      "evidence": "101 patients previously steroid-na\u00efve",
      "verified": true
    },
    {
      "id": "E10",
      "type": "Evidence",
      "name": "clinical study",
      "attributes": {
        "evidence_level": 3
      },
      "source_chunk_ids": [
        "d7bfa800a140bc0c63f9a05e7385e18e"
      ],
      "confidence": 0.8,
      "evidence": "long-term study",
      "verified": true
    },
    {
      "id": "E11",
      "type": "Effect",
      "name": "reduction in inflammatory cell numbers",
      "attributes": {
        "level": "cellular",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "d7bfa800a140bc0c63f9a05e7385e18e"
      ],
      "confidence": 0.85,
      "evidence": "significant reduction in inflammatory cell numbers",
      "verified": true
    },
    {
      "id": "E12",
      "type": "Product",
      "name": "salmeterol",
      "attributes": {},
      "source_chunk_ids": [
        "d7bfa800a140bc0c63f9a05e7385e18e"
      ],
      "confidence": 0.8,
      "evidence": "salmeterol",
      "verified": true
    },
    {
      "id": "E13",
      "type": "Effect",
      "name": "no additive anti-inflammatory effect",
      "attributes": {
        "level": "cellular",
        "valence": "neutral"
      },
      "source_chunk_ids": [
        "d7bfa800a140bc0c63f9a05e7385e18e"
      ],
      "confidence": 0.75,
      "evidence": "no evidence of any additive or synergistic anti-inflammatory effect",
      "verified": true
    },
    {
      "id": "E14",
      "type": "Effect",
      "name": "improvement in lung function with combination",
      "attributes": {
        "level": "systemic",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "d7bfa800a140bc0c63f9a05e7385e18e"
      ],
      "confidence": 0.8,
      "evidence": "improvement in lung function",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Target",
      "name": "airway smooth muscle",
      "attributes": {
        "target_type": "tissue"
      },
      "source_chunk_ids": [
        "a4c8875444a9e50f272646ddc96fe9b4"
      ],
      "confidence": 0.85,
      "evidence": "relaxation of airway smooth muscle",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Effect",
      "name": "relaxation of airway smooth muscle",
      "attributes": {
        "level": "cellular",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "a4c8875444a9e50f272646ddc96fe9b4"
      ],
      "confidence": 0.8,
      "evidence": "relaxation of airway smooth muscle",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Effect",
      "name": "anti-inflammatory activity",
      "attributes": {
        "level": "cellular",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "a4c8875444a9e50f272646ddc96fe9b4"
      ],
      "confidence": 0.85,
      "evidence": "combination therapy was associated with anti-inflammatory activity",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Study",
      "name": "Study [49]",
      "attributes": {
        "design": "comparative study"
      },
      "source_chunk_ids": [
        "a4c8875444a9e50f272646ddc96fe9b4"
      ],
      "confidence": 0.75,
      "evidence": "evidenced by the comparable changes in rates of decline in lung function between salmeterol versus combination therapy [49]",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Study",
      "name": "Study [50]",
      "attributes": {
        "design": "clinical study",
        "duration": "12-13 weeks"
      },
      "source_chunk_ids": [
        "a4c8875444a9e50f272646ddc96fe9b4"
      ],
      "confidence": 0.75,
      "evidence": "combination therapy was associated with anti-inflammatory activity [50] after 12-13 weeks of treatment",
      "verified": true
    },
    {
      "id": "E6",
      "type": "Study",
      "name": "Study [51]",
      "attributes": {
        "design": "clinical study"
      },
      "source_chunk_ids": [
        "a4c8875444a9e50f272646ddc96fe9b4"
      ],
      "confidence": 0.75,
      "evidence": "the lack of effect of this treatment on lung function parameters [51]",
      "verified": true
    },
    {
      "id": "E7",
      "type": "Study",
      "name": "Study [48]",
      "attributes": {
        "design": "clinical study"
      },
      "source_chunk_ids": [
        "a4c8875444a9e50f272646ddc96fe9b4"
      ],
      "confidence": 0.7,
      "evidence": "reports of a reduction [48]",
      "verified": true
    },
    {
      "id": "E8",
      "type": "Study",
      "name": "Study [52]",
      "attributes": {
        "design": "clinical study"
      },
      "source_chunk_ids": [
        "a4c8875444a9e50f272646ddc96fe9b4"
      ],
      "confidence": 0.7,
      "evidence": "increase [52]",
      "verified": true
    },
    {
      "id": "E9",
      "type": "Condition",
      "name": "COPD",
      "attributes": {
        "condition_type": "disease"
      },
      "source_chunk_ids": [
        "a4c8875444a9e50f272646ddc96fe9b4"
      ],
      "confidence": 0.9,
      "evidence": "patients with COPD",
      "verified": true
    },
    {
      "id": "E10",
      "type": "Target",
      "name": "histone deacetylase (HDAC)-2",
      "attributes": {
        "target_type": "enzyme"
      },
      "source_chunk_ids": [
        "a4c8875444a9e50f272646ddc96fe9b4"
      ],
      "confidence": 0.9,
      "evidence": "reduction in the activity of histone deacetylase (HDAC)-2",
      "verified": true
    },
    {
      "id": "E11",
      "type": "Effect",
      "name": "corticosteroid resistance",
      "attributes": {
        "level": "systemic",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "a4c8875444a9e50f272646ddc96fe9b4"
      ],
      "confidence": 0.85,
      "evidence": "corticosteroid resistance in patients with COPD",
      "verified": true
    },
    {
      "id": "E12",
      "type": "Evidence",
      "name": "in vitro evidence",
      "attributes": {
        "evidence_level": 2
      },
      "source_chunk_ids": [
        "a4c8875444a9e50f272646ddc96fe9b4"
      ],
      "confidence": 0.7,
      "evidence": "evidence of a (relative) corticosteroid resistance",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Target",
      "name": "PDE4-inhibitors",
      "attributes": {
        "target_type": "enzyme"
      },
      "source_chunk_ids": [
        "241527c44b0da752d04e8ae195c2b217"
      ],
      "confidence": 0.9,
      "evidence": "systemically administered PDE4-inhibitors",
      "verified": true
    },
    {
      "id": "E2",
      "type": "AdverseEvent",
      "name": "nausea",
      "attributes": {
        "severity": "potential"
      },
      "source_chunk_ids": [
        "241527c44b0da752d04e8ae195c2b217"
      ],
      "confidence": 0.85,
      "evidence": "produce nausea as side-effects",
      "verified": true
    },
    {
      "id": "E3",
      "type": "AdverseEvent",
      "name": "headache",
      "attributes": {
        "severity": "potential"
      },
      "source_chunk_ids": [
        "241527c44b0da752d04e8ae195c2b217"
      ],
      "confidence": 0.85,
      "evidence": "headache as side-effects",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Target",
      "name": "PDE4D isoenzymes",
      "attributes": {
        "target_type": "enzyme"
      },
      "source_chunk_ids": [
        "241527c44b0da752d04e8ae195c2b217"
      ],
      "confidence": 0.8,
      "evidence": "inhibition of the PDE4D isoenzymes",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Compound",
      "name": "UK-500,001",
      "attributes": {},
      "source_chunk_ids": [
        "92ee628ff47e1bebfed8efff9dc3c924"
      ],
      "confidence": 0.95,
      "evidence": "UK-500,001",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Target",
      "name": "PDE4",
      "attributes": {
        "target_type": "enzyme"
      },
      "source_chunk_ids": [
        "92ee628ff47e1bebfed8efff9dc3c924"
      ],
      "confidence": 0.9,
      "evidence": "PDE4-inhibitors",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Condition",
      "name": "COPD",
      "attributes": {
        "condition_type": "disease"
      },
      "source_chunk_ids": [
        "92ee628ff47e1bebfed8efff9dc3c924"
      ],
      "confidence": 0.95,
      "evidence": "COPD",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Study",
      "name": "Study [55]",
      "attributes": {
        "design": "clinical trial",
        "duration": "6 weeks"
      },
      "source_chunk_ids": [
        "92ee628ff47e1bebfed8efff9dc3c924"
      ],
      "confidence": 0.85,
      "evidence": "after 6 weeks of treatment [55]",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Evidence",
      "name": "clinical trial",
      "attributes": {
        "evidence_level": 4
      },
      "source_chunk_ids": [
        "92ee628ff47e1bebfed8efff9dc3c924"
      ],
      "confidence": 0.8,
      "evidence": "evaluated in respiratory disease",
      "verified": true
    },
    {
      "id": "E6",
      "type": "Compound",
      "name": "GSK256066",
      "attributes": {},
      "source_chunk_ids": [
        "92ee628ff47e1bebfed8efff9dc3c924"
      ],
      "confidence": 0.95,
      "evidence": "GSK256066",
      "verified": true
    },
    {
      "id": "E7",
      "type": "Condition",
      "name": "allergic airway response",
      "attributes": {
        "condition_type": "symptom"
      },
      "source_chunk_ids": [
        "92ee628ff47e1bebfed8efff9dc3c924"
      ],
      "confidence": 0.85,
      "evidence": "allergic airway response",
      "verified": true
    },
    {
      "id": "E8",
      "type": "Study",
      "name": "Study [56]",
      "attributes": {
        "design": "clinical trial",
        "duration": "1 week"
      },
      "source_chunk_ids": [
        "92ee628ff47e1bebfed8efff9dc3c924"
      ],
      "confidence": 0.85,
      "evidence": "after 1 week of treatment [56]",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Target",
      "name": "PDE4",
      "attributes": {
        "target_type": "enzyme"
      },
      "source_chunk_ids": [
        "efbf083d2a7a9f13233ec0b391a4ce96"
      ],
      "confidence": 0.85,
      "evidence": "PDE4-inhibitors",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Target",
      "name": "PDE3",
      "attributes": {
        "target_type": "enzyme"
      },
      "source_chunk_ids": [
        "efbf083d2a7a9f13233ec0b391a4ce96"
      ],
      "confidence": 0.85,
      "evidence": "PDE3 is also present",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Condition",
      "name": "COPD",
      "attributes": {
        "condition_type": "disease"
      },
      "source_chunk_ids": [
        "efbf083d2a7a9f13233ec0b391a4ce96"
      ],
      "confidence": 0.9,
      "evidence": "treatment of COPD",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Effect",
      "name": "inhibits macrophage function",
      "attributes": {
        "level": "cellular",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "efbf083d2a7a9f13233ec0b391a4ce96"
      ],
      "confidence": 0.8,
      "evidence": "poor at inhibiting macrophage function",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Effect",
      "name": "bronchodilator effects",
      "attributes": {
        "level": "systemic",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "efbf083d2a7a9f13233ec0b391a4ce96"
      ],
      "confidence": 0.85,
      "evidence": "PDE3-inhibition can produce bronchodilator effects",
      "verified": true
    },
    {
      "id": "E6",
      "type": "Effect",
      "name": "promotes chloride ion secretion",
      "attributes": {
        "level": "cellular",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "efbf083d2a7a9f13233ec0b391a4ce96"
      ],
      "confidence": 0.8,
      "evidence": "promote chloride ion secretion",
      "verified": true
    },
    {
      "id": "E7",
      "type": "Effect",
      "name": "additive or synergistic actions on cell function",
      "attributes": {
        "level": "cellular",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "efbf083d2a7a9f13233ec0b391a4ce96"
      ],
      "confidence": 0.75,
      "evidence": "additive or potentially synergistic actions on cell function",
      "verified": true
    },
    {
      "id": "E8",
      "type": "Effect",
      "name": "anti-inflammatory activity",
      "attributes": {
        "level": "cellular",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "efbf083d2a7a9f13233ec0b391a4ce96"
      ],
      "confidence": 0.8,
      "evidence": "anti-inflammatory activity",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Target",
      "name": "PDE7",
      "attributes": {
        "target_type": "enzyme"
      },
      "source_chunk_ids": [
        "019e08c07d722aa9b0d108941fa07228"
      ],
      "confidence": 0.95,
      "evidence": "targeting PDE7",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Condition",
      "name": "COPD",
      "attributes": {
        "condition_type": "disease"
      },
      "source_chunk_ids": [
        "019e08c07d722aa9b0d108941fa07228"
      ],
      "confidence": 0.9,
      "evidence": "pathogenesis of COPD",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Target",
      "name": "PDE4",
      "attributes": {
        "target_type": "enzyme"
      },
      "source_chunk_ids": [
        "019e08c07d722aa9b0d108941fa07228"
      ],
      "confidence": 0.9,
      "evidence": "PDE4 selective inhibitor",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Effect",
      "name": "suppressed airway inflammation",
      "attributes": {
        "level": "systemic",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "019e08c07d722aa9b0d108941fa07228"
      ],
      "confidence": 0.85,
      "evidence": "suppressed various indices of airway inflammation",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Evidence",
      "name": "in vitro",
      "attributes": {
        "evidence_level": 2
      },
      "source_chunk_ids": [
        "019e08c07d722aa9b0d108941fa07228"
      ],
      "confidence": 0.8,
      "evidence": "failed to modify cell function in vitro",
      "verified": true
    },
    {
      "id": "E6",
      "type": "Evidence",
      "name": "in vivo",
      "attributes": {
        "evidence_level": 3
      },
      "source_chunk_ids": [
        "019e08c07d722aa9b0d108941fa07228"
      ],
      "confidence": 0.75,
      "evidence": "in mice exposed to cigarette",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Target",
      "name": "PDE4",
      "attributes": {
        "target_type": "enzyme"
      },
      "source_chunk_ids": [
        "fb3aee050dcc2b237b5adb8e4c8661de"
      ],
      "confidence": 0.9,
      "evidence": "targeting of PDE4",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Target",
      "name": "PDE7",
      "attributes": {
        "target_type": "enzyme"
      },
      "source_chunk_ids": [
        "fb3aee050dcc2b237b5adb8e4c8661de"
      ],
      "confidence": 0.9,
      "evidence": "targeting of PDE7",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Condition",
      "name": "COPD",
      "attributes": {
        "condition_type": "disease"
      },
      "source_chunk_ids": [
        "fb3aee050dcc2b237b5adb8e4c8661de"
      ],
      "confidence": 0.95,
      "evidence": "treatment of COPD",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Effect",
      "name": "inhibitory activity",
      "attributes": {
        "level": "molecular",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "fb3aee050dcc2b237b5adb8e4c8661de"
      ],
      "confidence": 0.8,
      "evidence": "greater inhibitory activity",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Compound",
      "name": "theophylline",
      "attributes": {},
      "source_chunk_ids": [
        "fd7aebf77c1caac407be5ee5c8a6a308"
      ],
      "confidence": 0.95,
      "evidence": "non-selective PDE-inhibitor theophylline",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Compound",
      "name": "cilomilast",
      "attributes": {},
      "source_chunk_ids": [
        "fd7aebf77c1caac407be5ee5c8a6a308"
      ],
      "confidence": 0.95,
      "evidence": "selective PDE4-inhibitors cilomilast",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Compound",
      "name": "roflumilast",
      "attributes": {},
      "source_chunk_ids": [
        "fd7aebf77c1caac407be5ee5c8a6a308"
      ],
      "confidence": 0.95,
      "evidence": "roflumilast",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Target",
      "name": "PDE4",
      "attributes": {
        "target_type": "enzyme"
      },
      "source_chunk_ids": [
        "fd7aebf77c1caac407be5ee5c8a6a308"
      ],
      "confidence": 0.9,
      "evidence": "selective PDE4-inhibitors",
      "verified": true
    },
    {
      "id": "E5",
      "type": "AdverseEvent",
      "name": "nausea",
      "attributes": {
        "severity": "common"
      },
      "source_chunk_ids": [
        "fd7aebf77c1caac407be5ee5c8a6a308"
      ],
      "confidence": 0.85,
      "evidence": "nausea",
      "verified": true
    },
    {
      "id": "E6",
      "type": "AdverseEvent",
      "name": "headache",
      "attributes": {
        "severity": "common"
      },
      "source_chunk_ids": [
        "fd7aebf77c1caac407be5ee5c8a6a308"
      ],
      "confidence": 0.85,
      "evidence": "headache",
      "verified": true
    },
    {
      "id": "E7",
      "type": "AdverseEvent",
      "name": "insomnia",
      "attributes": {
        "severity": "common"
      },
      "source_chunk_ids": [
        "fd7aebf77c1caac407be5ee5c8a6a308"
      ],
      "confidence": 0.85,
      "evidence": "insomnia",
      "verified": true
    },
    {
      "id": "E8",
      "type": "AdverseEvent",
      "name": "diarrhea",
      "attributes": {
        "severity": "common"
      },
      "source_chunk_ids": [
        "fd7aebf77c1caac407be5ee5c8a6a308"
      ],
      "confidence": 0.85,
      "evidence": "diarrhea",
      "verified": true
    },
    {
      "id": "E9",
      "type": "AdverseEvent",
      "name": "weight loss",
      "attributes": {
        "severity": "modest"
      },
      "source_chunk_ids": [
        "fd7aebf77c1caac407be5ee5c8a6a308"
      ],
      "confidence": 0.8,
      "evidence": "modest weight loss",
      "verified": true
    },
    {
      "id": "E10",
      "type": "Study",
      "name": "6-12 months randomized controlled trials",
      "attributes": {
        "design": "randomized controlled trial",
        "duration": "6-12 months"
      },
      "source_chunk_ids": [
        "fd7aebf77c1caac407be5ee5c8a6a308"
      ],
      "confidence": 0.9,
      "evidence": "6-12 months randomized controlled trials",
      "verified": true
    },
    {
      "id": "E11",
      "type": "Evidence",
      "name": "clinical trial",
      "attributes": {
        "evidence_level": 4
      },
      "source_chunk_ids": [
        "fd7aebf77c1caac407be5ee5c8a6a308"
      ],
      "confidence": 0.85,
      "evidence": "randomized controlled trials",
      "verified": true
    },
    {
      "id": "E12",
      "type": "Condition",
      "name": "COPD",
      "attributes": {
        "condition_type": "disease"
      },
      "source_chunk_ids": [
        "fd7aebf77c1caac407be5ee5c8a6a308"
      ],
      "confidence": 0.9,
      "evidence": "COPD-patients",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Study",
      "name": "M2-124/125 studies",
      "attributes": {
        "design": "pooled data analysis"
      },
      "source_chunk_ids": [
        "5924c502444e71f851db89ce6bbf22a9"
      ],
      "confidence": 0.9,
      "evidence": "pooled data analysis of the M2-124/125 studies",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Study",
      "name": "M2-127/128 studies",
      "attributes": {},
      "source_chunk_ids": [
        "5924c502444e71f851db89ce6bbf22a9"
      ],
      "confidence": 0.85,
      "evidence": "M2-127/128 studies",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Evidence",
      "name": "clinical trial",
      "attributes": {
        "evidence_level": 4
      },
      "source_chunk_ids": [
        "5924c502444e71f851db89ce6bbf22a9"
      ],
      "confidence": 0.8,
      "evidence": "registration trials",
      "verified": true
    },
    {
      "id": "E4",
      "type": "AdverseEvent",
      "name": "diarrhea",
      "attributes": {
        "severity": "common"
      },
      "source_chunk_ids": [
        "5924c502444e71f851db89ce6bbf22a9"
      ],
      "confidence": 0.9,
      "evidence": "most common side effects were diarrhea",
      "verified": true
    },
    {
      "id": "E5",
      "type": "AdverseEvent",
      "name": "weight loss",
      "attributes": {
        "severity": "common"
      },
      "source_chunk_ids": [
        "5924c502444e71f851db89ce6bbf22a9"
      ],
      "confidence": 0.9,
      "evidence": "most common side effects were weight loss",
      "verified": true
    },
    {
      "id": "E6",
      "type": "AdverseEvent",
      "name": "serious side effects",
      "attributes": {
        "severity": "serious"
      },
      "source_chunk_ids": [
        "5924c502444e71f851db89ce6bbf22a9"
      ],
      "confidence": 0.8,
      "evidence": "serious side effects were noted",
      "verified": true
    },
    {
      "id": "E7",
      "type": "AdverseEvent",
      "name": "drop-outs due to side effects",
      "attributes": {
        "severity": "moderate"
      },
      "source_chunk_ids": [
        "5924c502444e71f851db89ce6bbf22a9"
      ],
      "confidence": 0.75,
      "evidence": "drop-outs due to side effects",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Study",
      "name": "COPD safety pooled analysis",
      "attributes": {
        "design": "pooled analysis",
        "sample_size": 12000,
        "population": "COPD patients"
      },
      "source_chunk_ids": [
        "a1f64eddcf4fe4ff7c23eb53177b72df"
      ],
      "confidence": 0.95,
      "evidence": "COPD safety pooled analysis, including over 12,000 COPD patients",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Evidence",
      "name": "pooled analysis of RCTs",
      "attributes": {
        "evidence_level": 3
      },
      "source_chunk_ids": [
        "a1f64eddcf4fe4ff7c23eb53177b72df"
      ],
      "confidence": 0.85,
      "evidence": "pooled analysis, including over 12,000 COPD patients from several RCT trials",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Product",
      "name": "roflumilast",
      "attributes": {},
      "source_chunk_ids": [
        "a1f64eddcf4fe4ff7c23eb53177b72df"
      ],
      "confidence": 0.95,
      "evidence": "roflumilast 250 \u00b5g, roflumilast 500 \u00b5g",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Dosage",
      "name": "250 \u00b5g roflumilast",
      "attributes": {
        "amount": 250,
        "unit": "\u00b5g",
        "route": "oral"
      },
      "source_chunk_ids": [
        "a1f64eddcf4fe4ff7c23eb53177b72df"
      ],
      "confidence": 0.9,
      "evidence": "roflumilast 250 \u00b5g",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Dosage",
      "name": "500 \u00b5g roflumilast",
      "attributes": {
        "amount": 500,
        "unit": "\u00b5g",
        "route": "oral"
      },
      "source_chunk_ids": [
        "a1f64eddcf4fe4ff7c23eb53177b72df"
      ],
      "confidence": 0.9,
      "evidence": "roflumilast 500 \u00b5g",
      "verified": true
    },
    {
      "id": "E6",
      "type": "Condition",
      "name": "COPD",
      "attributes": {
        "condition_type": "disease"
      },
      "source_chunk_ids": [
        "a1f64eddcf4fe4ff7c23eb53177b72df"
      ],
      "confidence": 0.95,
      "evidence": "COPD patients",
      "verified": true
    },
    {
      "id": "E7",
      "type": "AdverseEvent",
      "name": "suicide",
      "attributes": {
        "severity": "severe"
      },
      "source_chunk_ids": [
        "a1f64eddcf4fe4ff7c23eb53177b72df"
      ],
      "confidence": 0.9,
      "evidence": "3 cases of suicides were reported",
      "verified": true
    },
    {
      "id": "E8",
      "type": "Condition",
      "name": "depression",
      "attributes": {
        "condition_type": "disorder"
      },
      "source_chunk_ids": [
        "a1f64eddcf4fe4ff7c23eb53177b72df"
      ],
      "confidence": 0.8,
      "evidence": "potentially pre-existent depression",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Compound",
      "name": "roflumilast",
      "attributes": {},
      "source_chunk_ids": [
        "7427d3098ef3b448f43c2f4abff2c963"
      ],
      "confidence": 0.95,
      "evidence": "roflumilast",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Target",
      "name": "PDE4",
      "attributes": {
        "target_type": "enzyme"
      },
      "source_chunk_ids": [
        "7427d3098ef3b448f43c2f4abff2c963"
      ],
      "confidence": 0.9,
      "evidence": "PDE4-inhibition",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Effect",
      "name": "promoted IL-8 secretion",
      "attributes": {
        "level": "cellular",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "7427d3098ef3b448f43c2f4abff2c963"
      ],
      "confidence": 0.85,
      "evidence": "promoted IL-8 secretion",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Effect",
      "name": "induced neutrophil recruitment",
      "attributes": {
        "level": "systemic",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "7427d3098ef3b448f43c2f4abff2c963"
      ],
      "confidence": 0.85,
      "evidence": "induced neutrophil recruitment",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Effect",
      "name": "promoted chemokine expression",
      "attributes": {
        "level": "cellular",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "7427d3098ef3b448f43c2f4abff2c963"
      ],
      "confidence": 0.85,
      "evidence": "promoted chemokine expression",
      "verified": true
    },
    {
      "id": "E6",
      "type": "Effect",
      "name": "promote inflammation",
      "attributes": {
        "level": "systemic",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "7427d3098ef3b448f43c2f4abff2c963"
      ],
      "confidence": 0.8,
      "evidence": "potentially promote inflammation",
      "verified": true
    },
    {
      "id": "E7",
      "type": "Effect",
      "name": "anti-inflammatory effects",
      "attributes": {
        "level": "systemic",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "7427d3098ef3b448f43c2f4abff2c963"
      ],
      "confidence": 0.9,
      "evidence": "anti-inflammatory effects",
      "verified": true
    },
    {
      "id": "E8",
      "type": "Condition",
      "name": "smoke-induced inflammation",
      "attributes": {
        "condition_type": "disease"
      },
      "source_chunk_ids": [
        "7427d3098ef3b448f43c2f4abff2c963"
      ],
      "confidence": 0.85,
      "evidence": "smoke-induced inflammation",
      "verified": true
    },
    {
      "id": "E9",
      "type": "Effect",
      "name": "reduced macrophage and neutrophil cell numbers",
      "attributes": {
        "level": "cellular",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "7427d3098ef3b448f43c2f4abff2c963"
      ],
      "confidence": 0.85,
      "evidence": "reduced the rise in macrophage and neutrophil cell numbers",
      "verified": true
    },
    {
      "id": "E10",
      "type": "Compound",
      "name": "cilomilast",
      "attributes": {},
      "source_chunk_ids": [
        "7427d3098ef3b448f43c2f4abff2c963"
      ],
      "confidence": 0.95,
      "evidence": "cilomilast",
      "verified": true
    },
    {
      "id": "E11",
      "type": "Effect",
      "name": "reduce inflammatory cell numbers",
      "attributes": {
        "level": "cellular",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "7427d3098ef3b448f43c2f4abff2c963"
      ],
      "confidence": 0.9,
      "evidence": "reduce inflammatory cell numbers",
      "verified": true
    },
    {
      "id": "E12",
      "type": "Condition",
      "name": "airway inflammation",
      "attributes": {
        "condition_type": "disease"
      },
      "source_chunk_ids": [
        "7427d3098ef3b448f43c2f4abff2c963"
      ],
      "confidence": 0.9,
      "evidence": "airway inflammation",
      "verified": true
    },
    {
      "id": "E13",
      "type": "Evidence",
      "name": "cell culture experiments",
      "attributes": {
        "evidence_level": 2
      },
      "source_chunk_ids": [
        "7427d3098ef3b448f43c2f4abff2c963"
      ],
      "confidence": 0.85,
      "evidence": "cell culture experiments",
      "verified": true
    },
    {
      "id": "E14",
      "type": "Evidence",
      "name": "preclinical model",
      "attributes": {
        "evidence_level": 3
      },
      "source_chunk_ids": [
        "7427d3098ef3b448f43c2f4abff2c963"
      ],
      "confidence": 0.85,
      "evidence": "preclinical model",
      "verified": true
    },
    {
      "id": "E15",
      "type": "Evidence",
      "name": "human clinical data",
      "attributes": {
        "evidence_level": 4
      },
      "source_chunk_ids": [
        "7427d3098ef3b448f43c2f4abff2c963"
      ],
      "confidence": 0.9,
      "evidence": "human clinical data",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Study",
      "name": "6-12 months RCTs",
      "attributes": {
        "design": "randomized controlled trial",
        "duration": "6-12 months"
      },
      "source_chunk_ids": [
        "83928fa24d30d5f0aa90872b012a3c3b"
      ],
      "confidence": 0.9,
      "evidence": "several 6-12 months RCTs",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Evidence",
      "name": "clinical trial",
      "attributes": {
        "evidence_level": 4
      },
      "source_chunk_ids": [
        "83928fa24d30d5f0aa90872b012a3c3b"
      ],
      "confidence": 0.85,
      "evidence": "RCTs",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Compound",
      "name": "roflumilast",
      "attributes": {},
      "source_chunk_ids": [
        "83928fa24d30d5f0aa90872b012a3c3b"
      ],
      "confidence": 0.95,
      "evidence": "roflumilast",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Target",
      "name": "PDE4",
      "attributes": {
        "target_type": "enzyme"
      },
      "source_chunk_ids": [
        "83928fa24d30d5f0aa90872b012a3c3b"
      ],
      "confidence": 0.9,
      "evidence": "PDE4-inhibitor",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Condition",
      "name": "COPD",
      "attributes": {
        "condition_type": "disease"
      },
      "source_chunk_ids": [
        "83928fa24d30d5f0aa90872b012a3c3b"
      ],
      "confidence": 0.95,
      "evidence": "COPD",
      "verified": true
    },
    {
      "id": "E6",
      "type": "Effect",
      "name": "bronchodilation",
      "attributes": {
        "level": "systemic",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "83928fa24d30d5f0aa90872b012a3c3b"
      ],
      "confidence": 0.8,
      "evidence": "bronchodilation",
      "verified": true
    },
    {
      "id": "E7",
      "type": "Effect",
      "name": "decrease in exacerbation rates",
      "attributes": {
        "level": "systemic",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "83928fa24d30d5f0aa90872b012a3c3b"
      ],
      "confidence": 0.85,
      "evidence": "decrease in exacerbation rates",
      "verified": true
    },
    {
      "id": "E8",
      "type": "Effect",
      "name": "improvements in lung function",
      "attributes": {
        "level": "systemic",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "83928fa24d30d5f0aa90872b012a3c3b"
      ],
      "confidence": 0.85,
      "evidence": "improvements in lung function",
      "verified": true
    },
    {
      "id": "E9",
      "type": "Effect",
      "name": "anti-inflammatory activity",
      "attributes": {
        "level": "cellular",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "83928fa24d30d5f0aa90872b012a3c3b"
      ],
      "confidence": 0.7,
      "evidence": "suggests anti-inflammatory activity",
      "verified": true
    },
    {
      "id": "E10",
      "type": "AdverseEvent",
      "name": "nausea",
      "attributes": {
        "severity": "mild to moderate"
      },
      "source_chunk_ids": [
        "83928fa24d30d5f0aa90872b012a3c3b"
      ],
      "confidence": 0.8,
      "evidence": "nausea",
      "verified": true
    },
    {
      "id": "E11",
      "type": "AdverseEvent",
      "name": "headache",
      "attributes": {
        "severity": "mild to moderate"
      },
      "source_chunk_ids": [
        "83928fa24d30d5f0aa90872b012a3c3b"
      ],
      "confidence": 0.8,
      "evidence": "headache",
      "verified": true
    },
    {
      "id": "E12",
      "type": "AdverseEvent",
      "name": "diarrhea",
      "attributes": {
        "severity": "mild to moderate"
      },
      "source_chunk_ids": [
        "83928fa24d30d5f0aa90872b012a3c3b"
      ],
      "confidence": 0.8,
      "evidence": "diarrhea",
      "verified": true
    },
    {
      "id": "E13",
      "type": "AdverseEvent",
      "name": "weight loss",
      "attributes": {
        "severity": "mild to moderate"
      },
      "source_chunk_ids": [
        "83928fa24d30d5f0aa90872b012a3c3b"
      ],
      "confidence": 0.8,
      "evidence": "weight loss",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Study",
      "name": "Martorana et al. 2005",
      "attributes": {
        "design": "animal study",
        "year": 2005,
        "doi": "10.1164/rccm.200411-1549OC"
      },
      "source_chunk_ids": [
        "02bfdb1a471d34d508cc70fe28bfefbc"
      ],
      "confidence": 0.95,
      "evidence": "Martorana PA, Beume R, Lucattelli M, Wollin L, Lungarella G. Roflumilast fully prevents emphysema in mice chronically exposed to cigarette smoke. Am J Respir Crit Care Med. 2005;172:848-53.",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Evidence",
      "name": "in vivo animal study",
      "attributes": {
        "evidence_level": 3
      },
      "source_chunk_ids": [
        "02bfdb1a471d34d508cc70fe28bfefbc"
      ],
      "confidence": 0.9,
      "evidence": "mice chronically exposed to cigarette smoke",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Compound",
      "name": "roflumilast",
      "attributes": {},
      "source_chunk_ids": [
        "02bfdb1a471d34d508cc70fe28bfefbc"
      ],
      "confidence": 0.95,
      "evidence": "Roflumilast fully prevents emphysema",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Condition",
      "name": "emphysema",
      "attributes": {
        "condition_type": "disease"
      },
      "source_chunk_ids": [
        "02bfdb1a471d34d508cc70fe28bfefbc"
      ],
      "confidence": 0.9,
      "evidence": "fully prevents emphysema",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Study",
      "name": "Leclerc et al. 2006",
      "attributes": {
        "year": 2006,
        "design": "experimental study",
        "doi": "10.1183/09031936.06.00058605"
      },
      "source_chunk_ids": [
        "9406d882d2f995fe6c1e382a7a3f7f6e"
      ],
      "confidence": 0.95,
      "evidence": "Leclerc O, Lagente V, Planquois JM, et al. Eur Respir J. 2006;27:1102-9",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Evidence",
      "name": "in vivo study",
      "attributes": {
        "evidence_level": 3
      },
      "source_chunk_ids": [
        "9406d882d2f995fe6c1e382a7a3f7f6e"
      ],
      "confidence": 0.85,
      "evidence": "cigarette smoke-induced inflammation in mice",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Target",
      "name": "MMP-12",
      "attributes": {
        "target_type": "enzyme"
      },
      "source_chunk_ids": [
        "9406d882d2f995fe6c1e382a7a3f7f6e"
      ],
      "confidence": 0.9,
      "evidence": "Involvement of MMP-12",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Target",
      "name": "phosphodiesterase type 4",
      "attributes": {
        "target_type": "enzyme"
      },
      "source_chunk_ids": [
        "9406d882d2f995fe6c1e382a7a3f7f6e"
      ],
      "confidence": 0.9,
      "evidence": "phosphodiesterase type 4",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Condition",
      "name": "inflammation",
      "attributes": {
        "condition_type": "symptom"
      },
      "source_chunk_ids": [
        "9406d882d2f995fe6c1e382a7a3f7f6e"
      ],
      "confidence": 0.9,
      "evidence": "cigarette smoke-induced inflammation",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Study",
      "name": "Fortin et al. 2009",
      "attributes": {
        "design": "multi-target antisense approach",
        "year": 2009,
        "doi": "10.1186/1465-9921-10-39"
      },
      "source_chunk_ids": [
        "852cf327078a543563d0bbb0fbd1ce4f"
      ],
      "confidence": 0.9,
      "evidence": "Fortin M, D'Anjou H, Higgins ME, Gougeon J, Aube P, Moktefi K, et al. A multi-target antisense approach against PDE4 and PDE7 reduces smoke-induced lung inflammation in mice. RespirRes. 2009;10:39.",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Evidence",
      "name": "in vivo study",
      "attributes": {
        "evidence_level": 3
      },
      "source_chunk_ids": [
        "852cf327078a543563d0bbb0fbd1ce4f"
      ],
      "confidence": 0.85,
      "evidence": "reduces smoke-induced lung inflammation in mice",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Target",
      "name": "PDE4",
      "attributes": {
        "target_type": "enzyme"
      },
      "source_chunk_ids": [
        "852cf327078a543563d0bbb0fbd1ce4f"
      ],
      "confidence": 0.9,
      "evidence": "multi-target antisense approach against PDE4",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Target",
      "name": "PDE7",
      "attributes": {
        "target_type": "enzyme"
      },
      "source_chunk_ids": [
        "852cf327078a543563d0bbb0fbd1ce4f"
      ],
      "confidence": 0.9,
      "evidence": "multi-target antisense approach against PDE7",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Condition",
      "name": "lung inflammation",
      "attributes": {
        "condition_type": "disease"
      },
      "source_chunk_ids": [
        "852cf327078a543563d0bbb0fbd1ce4f"
      ],
      "confidence": 0.9,
      "evidence": "smoke-induced lung inflammation",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Study",
      "name": "Harbinson et al. 1997",
      "attributes": {
        "design": "clinical trial",
        "year": 1997,
        "doi": "10.1008-14"
      },
      "source_chunk_ids": [
        "feaeb3b686cde5cb4689ee112496f99e"
      ],
      "confidence": 0.9,
      "evidence": "Harbinson PL, MacLeod D, Hawksworth R, O'Toole S, Sullivan PJ, Heath P, et al. The effect of a novel orally active selective PDE4 isoenzyme inhibitor (CDP840) on allergen-induced responses in asthmatic subjects. EurRespirJ. 1997;10:1008-14.",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Evidence",
      "name": "clinical trial",
      "attributes": {
        "evidence_level": 4
      },
      "source_chunk_ids": [
        "feaeb3b686cde5cb4689ee112496f99e"
      ],
      "confidence": 0.85,
      "evidence": "The effect of a novel orally active selective PDE4 isoenzyme inhibitor (CDP840) on allergen-induced responses in asthmatic subjects.",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Compound",
      "name": "CDP840",
      "attributes": {},
      "source_chunk_ids": [
        "feaeb3b686cde5cb4689ee112496f99e"
      ],
      "confidence": 0.95,
      "evidence": "CDP840",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Target",
      "name": "PDE4 isoenzyme",
      "attributes": {
        "target_type": "enzyme"
      },
      "source_chunk_ids": [
        "feaeb3b686cde5cb4689ee112496f99e"
      ],
      "confidence": 0.9,
      "evidence": "PDE4 isoenzyme",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Condition",
      "name": "asthma",
      "attributes": {
        "condition_type": "disease"
      },
      "source_chunk_ids": [
        "feaeb3b686cde5cb4689ee112496f99e"
      ],
      "confidence": 0.9,
      "evidence": "asthmatic subjects",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Study",
      "name": "Sullivan et al. 1994",
      "attributes": {
        "design": "clinical trial",
        "year": 1994,
        "doi": "Lancet. 1994;343:1006-8"
      },
      "source_chunk_ids": [
        "edf74691ddc1d4670fa27a294451132b"
      ],
      "confidence": 0.95,
      "evidence": "Sullivan P, Bekir S, Jaffar Z, Page C, Jeffery P, Costello J. Anti-inflammatory effects of low-dose oral theophylline in atopic asthma",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Evidence",
      "name": "clinical trial",
      "attributes": {
        "evidence_level": 4
      },
      "source_chunk_ids": [
        "edf74691ddc1d4670fa27a294451132b"
      ],
      "confidence": 0.85,
      "evidence": "Anti-inflammatory effects of low-dose oral theophylline in atopic asthma",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Compound",
      "name": "theophylline",
      "attributes": {},
      "source_chunk_ids": [
        "edf74691ddc1d4670fa27a294451132b"
      ],
      "confidence": 0.9,
      "evidence": "low-dose oral theophylline",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Dosage",
      "name": "low-dose oral theophylline",
      "attributes": {
        "route": "oral",
        "dose_level": "low"
      },
      "source_chunk_ids": [
        "edf74691ddc1d4670fa27a294451132b"
      ],
      "confidence": 0.8,
      "evidence": "low-dose oral theophylline",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Condition",
      "name": "atopic asthma",
      "attributes": {
        "condition_type": "disease"
      },
      "source_chunk_ids": [
        "edf74691ddc1d4670fa27a294451132b"
      ],
      "confidence": 0.95,
      "evidence": "atopic asthma",
      "verified": true
    },
    {
      "id": "E6",
      "type": "Effect",
      "name": "anti-inflammatory effects",
      "attributes": {
        "level": "systemic",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "edf74691ddc1d4670fa27a294451132b"
      ],
      "confidence": 0.9,
      "evidence": "Anti-inflammatory effects",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Study",
      "name": "Grootendorst et al. 2003",
      "attributes": {
        "design": "single-dose study",
        "year": 2003,
        "doi": "PulmPharmacolTher. 2003;16:115-20"
      },
      "source_chunk_ids": [
        "1a23212ad32defc30b5b3252ee96f4b2"
      ],
      "confidence": 0.95,
      "evidence": "Grootendorst DC, Gauw SA, Baan R, Kelly J, Murdoch RD, Sterk PJ, et al. Does a single dose of the phosphodiesterase 4 inhibitor, cilomilast (15 mg), induce bronchodilation in patients with chronic obstructive pulmonary disease? PulmPharmacolTher. 2003;16:115-20",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Evidence",
      "name": "clinical study",
      "attributes": {
        "evidence_level": 3
      },
      "source_chunk_ids": [
        "1a23212ad32defc30b5b3252ee96f4b2"
      ],
      "confidence": 0.85,
      "evidence": "single dose study in patients with chronic obstructive pulmonary disease",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Compound",
      "name": "cilomilast",
      "attributes": {},
      "source_chunk_ids": [
        "1a23212ad32defc30b5b3252ee96f4b2"
      ],
      "confidence": 0.95,
      "evidence": "phosphodiesterase 4 inhibitor, cilomilast",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Target",
      "name": "phosphodiesterase 4",
      "attributes": {
        "target_type": "enzyme"
      },
      "source_chunk_ids": [
        "1a23212ad32defc30b5b3252ee96f4b2"
      ],
      "confidence": 0.9,
      "evidence": "phosphodiesterase 4 inhibitor",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Dosage",
      "name": "15 mg single dose",
      "attributes": {
        "amount": 15,
        "unit": "mg",
        "frequency": "single dose",
        "route": "oral"
      },
      "source_chunk_ids": [
        "1a23212ad32defc30b5b3252ee96f4b2"
      ],
      "confidence": 0.9,
      "evidence": "cilomilast (15 mg)",
      "verified": true
    },
    {
      "id": "E6",
      "type": "Condition",
      "name": "chronic obstructive pulmonary disease",
      "attributes": {
        "condition_type": "disease"
      },
      "source_chunk_ids": [
        "1a23212ad32defc30b5b3252ee96f4b2"
      ],
      "confidence": 0.95,
      "evidence": "patients with chronic obstructive pulmonary disease",
      "verified": true
    },
    {
      "id": "E7",
      "type": "Effect",
      "name": "bronchodilation",
      "attributes": {
        "level": "systemic",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "1a23212ad32defc30b5b3252ee96f4b2"
      ],
      "confidence": 0.85,
      "evidence": "induce bronchodilation",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Study",
      "name": "Schmidt et al. 2000",
      "attributes": {
        "year": 2000,
        "design": "in vitro study",
        "doi": "10.1111/j.1476-5381.2000.tb03150.x"
      },
      "source_chunk_ids": [
        "09eae867b613fcf41c04abba4faf3cf4"
      ],
      "confidence": 0.95,
      "evidence": "Schmidt DT, Watson N, Dent G, Ruhlmann E, Branscheid D, Magnussen H, et al. The effect of selective and non-selective phosphodiesterase inhibitors on allergen- and leukotriene C(4)-induced contractions in passively sensitized human airways. BrJPharmacol. 2000;131:1607-18.",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Evidence",
      "name": "in vitro",
      "attributes": {
        "evidence_level": 2
      },
      "source_chunk_ids": [
        "09eae867b613fcf41c04abba4faf3cf4"
      ],
      "confidence": 0.9,
      "evidence": "passively sensitized human airways",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Target",
      "name": "phosphodiesterase",
      "attributes": {
        "target_type": "enzyme"
      },
      "source_chunk_ids": [
        "09eae867b613fcf41c04abba4faf3cf4"
      ],
      "confidence": 0.9,
      "evidence": "phosphodiesterase inhibitors",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Condition",
      "name": "airway contraction",
      "attributes": {
        "condition_type": "symptom"
      },
      "source_chunk_ids": [
        "09eae867b613fcf41c04abba4faf3cf4"
      ],
      "confidence": 0.85,
      "evidence": "allergen- and leukotriene C(4)-induced contractions",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Effect",
      "name": "inhibition of contraction",
      "attributes": {
        "level": "cellular",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "09eae867b613fcf41c04abba4faf3cf4"
      ],
      "confidence": 0.8,
      "evidence": "The effect of selective and non-selective phosphodiesterase inhibitors",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Study",
      "name": "Billington et al. 2008",
      "attributes": {
        "design": "in vitro study",
        "year": 2008,
        "doi": "10.1165/rcmb.2007-0123OC"
      },
      "source_chunk_ids": [
        "5561f3ec3037001fe3ba570909b12152"
      ],
      "confidence": 0.9,
      "evidence": "Billington CK, Le Jeune IR, Young KW, Hall IP. A major functional role for phosphodiesterase 4D5 in human airway smooth muscle cells. AmJRespirCell MolBiol. 2008;38:1-7.",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Evidence",
      "name": "in vitro",
      "attributes": {
        "evidence_level": 2
      },
      "source_chunk_ids": [
        "5561f3ec3037001fe3ba570909b12152"
      ],
      "confidence": 0.85,
      "evidence": "in human airway smooth muscle cells",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Target",
      "name": "phosphodiesterase 4D5",
      "attributes": {
        "target_type": "enzyme"
      },
      "source_chunk_ids": [
        "5561f3ec3037001fe3ba570909b12152"
      ],
      "confidence": 0.95,
      "evidence": "phosphodiesterase 4D5",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Effect",
      "name": "major functional role in airway smooth muscle cells",
      "attributes": {
        "level": "cellular",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "5561f3ec3037001fe3ba570909b12152"
      ],
      "confidence": 0.8,
      "evidence": "A major functional role for phosphodiesterase 4D5 in human airway smooth muscle cells",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Study",
      "name": "Rabe et al. 1993",
      "attributes": {
        "authors": "Rabe KF, Tenor H, Dent G, Schudt C, Liebig S, Magnussen H",
        "year": 1993,
        "title": "Phosphodiesterase isozymes modulating inherent tone in human airways: identification and characterization",
        "journal": "AmJPhysiol",
        "pages": "L458-L64"
      },
      "source_chunk_ids": [
        "59dc58c6e7f2d089a9f39db1e2ada317"
      ],
      "confidence": 0.95,
      "evidence": "Rabe KF, Tenor H, Dent G, Schudt C, Liebig S, Magnussen H. Phosphodiesterase isozymes modulating inherent tone in human airways: identification and characterization. AmJPhysiol. 1993;264:L458-L64",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Evidence",
      "name": "in vitro study",
      "attributes": {
        "evidence_level": 2
      },
      "source_chunk_ids": [
        "59dc58c6e7f2d089a9f39db1e2ada317"
      ],
      "confidence": 0.8,
      "evidence": "identification and characterization",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Target",
      "name": "phosphodiesterase isozymes",
      "attributes": {
        "target_type": "enzyme"
      },
      "source_chunk_ids": [
        "59dc58c6e7f2d089a9f39db1e2ada317"
      ],
      "confidence": 0.9,
      "evidence": "Phosphodiesterase isozymes",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Condition",
      "name": "inherent tone in human airways",
      "attributes": {
        "condition_type": "physiological process"
      },
      "source_chunk_ids": [
        "59dc58c6e7f2d089a9f39db1e2ada317"
      ],
      "confidence": 0.85,
      "evidence": "inherent tone in human airways",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Study",
      "name": "Torphy et al. 1993",
      "attributes": {
        "design": "in vitro study",
        "year": 1993,
        "doi": "JPharmacolExpTher. 1993;265:1213-23"
      },
      "source_chunk_ids": [
        "72c4c562d6f1298f0247a37cdea5be1c"
      ],
      "confidence": 0.95,
      "evidence": "Torphy TJ, Undem BJ, Cieslinski LB, Luttmann MA, Reeves ML, Hay DW. Identification, characterization and functional role of phosphodiesterase isozymes in human airway smooth muscle. JPharmacolExpTher. 1993;265:1213-23",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Evidence",
      "name": "in vitro",
      "attributes": {
        "evidence_level": 2
      },
      "source_chunk_ids": [
        "72c4c562d6f1298f0247a37cdea5be1c"
      ],
      "confidence": 0.9,
      "evidence": "Identification, characterization and functional role of phosphodiesterase isozymes in human airway smooth muscle",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Target",
      "name": "phosphodiesterase isozymes",
      "attributes": {
        "target_type": "enzyme"
      },
      "source_chunk_ids": [
        "72c4c562d6f1298f0247a37cdea5be1c"
      ],
      "confidence": 0.9,
      "evidence": "phosphodiesterase isozymes",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Condition",
      "name": "airway smooth muscle dysfunction",
      "attributes": {
        "condition_type": "physiological condition"
      },
      "source_chunk_ids": [
        "72c4c562d6f1298f0247a37cdea5be1c"
      ],
      "confidence": 0.7,
      "evidence": "human airway smooth muscle",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Study",
      "name": "Grootendorst et al. 2003",
      "attributes": {
        "design": "single-dose study",
        "sample_size": null,
        "year": 2003,
        "doi": null
      },
      "source_chunk_ids": [
        "17c1ee2f2ae3cf1232090ce9cf825084"
      ],
      "confidence": 0.95,
      "evidence": "Grootendorst DC, Gauw SA, Baan R, Kelly J, Murdoch RD, Sterk PJ, et al. 2003",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Evidence",
      "name": "clinical study",
      "attributes": {
        "evidence_level": 4
      },
      "source_chunk_ids": [
        "17c1ee2f2ae3cf1232090ce9cf825084"
      ],
      "confidence": 0.85,
      "evidence": "Does a single dose... induce bronchodilation in patients",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Compound",
      "name": "cilomilast",
      "attributes": {},
      "source_chunk_ids": [
        "17c1ee2f2ae3cf1232090ce9cf825084"
      ],
      "confidence": 0.9,
      "evidence": "phosphodiesterase 4 inhibitor, cilomilast",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Target",
      "name": "phosphodiesterase 4",
      "attributes": {
        "target_type": "enzyme"
      },
      "source_chunk_ids": [
        "17c1ee2f2ae3cf1232090ce9cf825084"
      ],
      "confidence": 0.9,
      "evidence": "phosphodiesterase 4 inhibitor",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Dosage",
      "name": "15 mg single dose",
      "attributes": {
        "amount": 15,
        "unit": "mg",
        "frequency": "single dose",
        "duration": null,
        "route": null
      },
      "source_chunk_ids": [
        "17c1ee2f2ae3cf1232090ce9cf825084"
      ],
      "confidence": 0.8,
      "evidence": "cilomilast (15 mg)",
      "verified": true
    },
    {
      "id": "E6",
      "type": "Condition",
      "name": "chronic obstructive pulmonary disease",
      "attributes": {
        "condition_type": "disease"
      },
      "source_chunk_ids": [
        "17c1ee2f2ae3cf1232090ce9cf825084"
      ],
      "confidence": 0.95,
      "evidence": "patients with chronic obstructive pulmonary disease",
      "verified": true
    },
    {
      "id": "E7",
      "type": "Effect",
      "name": "bronchodilation",
      "attributes": {
        "level": "systemic",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "17c1ee2f2ae3cf1232090ce9cf825084"
      ],
      "confidence": 0.85,
      "evidence": "induce bronchodilation",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Study",
      "name": "Rennard et al. 2006",
      "attributes": {
        "design": "placebo-controlled study",
        "duration": "6-month",
        "year": 2006,
        "doi": "10.1378/chest.129.1.56"
      },
      "source_chunk_ids": [
        "eb9b577f7044f90f2ba8ea427361c0fd"
      ],
      "confidence": 0.95,
      "evidence": "Rennard SI, Schachter N, Strek M, Rickard K, Amit O. Cilomilast for COPD: results of a 6-month, placebo-controlled study",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Evidence",
      "name": "clinical trial",
      "attributes": {
        "evidence_level": 4
      },
      "source_chunk_ids": [
        "eb9b577f7044f90f2ba8ea427361c0fd"
      ],
      "confidence": 0.9,
      "evidence": "placebo-controlled study",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Compound",
      "name": "cilomilast",
      "attributes": {},
      "source_chunk_ids": [
        "eb9b577f7044f90f2ba8ea427361c0fd"
      ],
      "confidence": 0.95,
      "evidence": "Cilomilast for COPD",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Condition",
      "name": "COPD",
      "attributes": {
        "condition_type": "disease"
      },
      "source_chunk_ids": [
        "eb9b577f7044f90f2ba8ea427361c0fd"
      ],
      "confidence": 0.95,
      "evidence": "Cilomilast for COPD",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Target",
      "name": "phosphodiesterase 4",
      "attributes": {
        "target_type": "enzyme"
      },
      "source_chunk_ids": [
        "eb9b577f7044f90f2ba8ea427361c0fd"
      ],
      "confidence": 0.9,
      "evidence": "selective inhibitor of phosphodiesterase 4",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Study",
      "name": "Gamble et al. 2003",
      "attributes": {
        "design": "clinical study",
        "year": 2003,
        "doi": "10.1164/rccm.200301-041OC"
      },
      "source_chunk_ids": [
        "01e25bc254035d1a46722b5dfd544939"
      ],
      "confidence": 0.95,
      "evidence": "Gamble E, Grootendorst DC, Brightling CE, et al. 2003",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Evidence",
      "name": "clinical study",
      "attributes": {
        "evidence_level": 4
      },
      "source_chunk_ids": [
        "01e25bc254035d1a46722b5dfd544939"
      ],
      "confidence": 0.85,
      "evidence": "Antiinflammatory effects in chronic obstructive pulmonary disease",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Compound",
      "name": "cilomilast",
      "attributes": {},
      "source_chunk_ids": [
        "01e25bc254035d1a46722b5dfd544939"
      ],
      "confidence": 0.9,
      "evidence": "phosphodiesterase-4 inhibitor cilomilast",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Target",
      "name": "phosphodiesterase-4",
      "attributes": {
        "target_type": "enzyme"
      },
      "source_chunk_ids": [
        "01e25bc254035d1a46722b5dfd544939"
      ],
      "confidence": 0.9,
      "evidence": "phosphodiesterase-4 inhibitor",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Condition",
      "name": "chronic obstructive pulmonary disease",
      "attributes": {
        "condition_type": "disease"
      },
      "source_chunk_ids": [
        "01e25bc254035d1a46722b5dfd544939"
      ],
      "confidence": 0.95,
      "evidence": "chronic obstructive pulmonary disease",
      "verified": true
    },
    {
      "id": "E6",
      "type": "Effect",
      "name": "anti-inflammatory effects",
      "attributes": {
        "level": "systemic",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "01e25bc254035d1a46722b5dfd544939"
      ],
      "confidence": 0.85,
      "evidence": "Antiinflammatory effects",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Study",
      "name": "Undem et al. 1994",
      "attributes": {
        "authors": "Undem BJ, Meeker SN, Chen J",
        "year": 1994,
        "title": "Inhibition of neurally mediated nonadrenergic, noncholinergic contractions of guinea pig bronchus by isozyme-selective phosphodiesterase inhibitors",
        "journal": "JPharmacolExpTher",
        "volume": 271,
        "pages": "811-7"
      },
      "source_chunk_ids": [
        "4359b4c9ed96903c8f384a4e15da0f4e"
      ],
      "confidence": 0.95,
      "evidence": "[31] Undem BJ, Meeker SN, Chen J. Inhibition of neurally mediated nonadrenergic, noncholinergic contractions of guinea pig bronchus by isozyme-selective phosphodiesterase inhibitors. JPharmacolExpTher. 1994;271:811-7.",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Evidence",
      "name": "in vitro study",
      "attributes": {
        "evidence_level": 2
      },
      "source_chunk_ids": [
        "4359b4c9ed96903c8f384a4e15da0f4e"
      ],
      "confidence": 0.8,
      "evidence": "Inhibition of neurally mediated nonadrenergic, noncholinergic contractions of guinea pig bronchus",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Target",
      "name": "phosphodiesterase",
      "attributes": {
        "target_type": "enzyme"
      },
      "source_chunk_ids": [
        "4359b4c9ed96903c8f384a4e15da0f4e"
      ],
      "confidence": 0.85,
      "evidence": "isozyme-selective phosphodiesterase inhibitors",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Effect",
      "name": "inhibition of bronchial contractions",
      "attributes": {
        "level": "cellular",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "4359b4c9ed96903c8f384a4e15da0f4e"
      ],
      "confidence": 0.9,
      "evidence": "Inhibition of neurally mediated nonadrenergic, noncholinergic contractions of guinea pig bronchus",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Study",
      "name": "Spina et al. 1995",
      "attributes": {
        "design": "in vitro study",
        "year": 1995,
        "doi": "BrJPharmacol. 1995;116:2334-40"
      },
      "source_chunk_ids": [
        "361074e7a8013654488b85851f300853"
      ],
      "confidence": 0.9,
      "evidence": "Spina D, Harrison S, Page CP. Regulation by phosphodiesterase isoenzymes of non-adrenergic non- cholinergic contraction in guinea-pig isolated main bronchus. BrJPharmacol. 1995;116:2334-40",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Evidence",
      "name": "in vitro",
      "attributes": {
        "evidence_level": 2
      },
      "source_chunk_ids": [
        "361074e7a8013654488b85851f300853"
      ],
      "confidence": 0.85,
      "evidence": "guinea-pig isolated main bronchus",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Target",
      "name": "phosphodiesterase isoenzymes",
      "attributes": {
        "target_type": "enzyme"
      },
      "source_chunk_ids": [
        "361074e7a8013654488b85851f300853"
      ],
      "confidence": 0.9,
      "evidence": "phosphodiesterase isoenzymes",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Effect",
      "name": "non-adrenergic non-cholinergic contraction",
      "attributes": {
        "level": "cellular",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "361074e7a8013654488b85851f300853"
      ],
      "confidence": 0.8,
      "evidence": "non-adrenergic non- cholinergic contraction",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Study",
      "name": "Liu et al. 2005",
      "attributes": {
        "design": "in vitro study",
        "year": 2005,
        "doi": "10.1124/jpet.105.0846"
      },
      "source_chunk_ids": [
        "11a44f329fcd36113c0e17e623392e5b"
      ],
      "confidence": 0.9,
      "evidence": "Liu S, Veilleux A, Zhang L, Young A, Kwok E, Laliberte F, et al. 2005",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Evidence",
      "name": "in vitro",
      "attributes": {
        "evidence_level": 2
      },
      "source_chunk_ids": [
        "11a44f329fcd36113c0e17e623392e5b"
      ],
      "confidence": 0.85,
      "evidence": "in vitro",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Target",
      "name": "cystic fibrosis transmembrane conductance regulator",
      "attributes": {
        "target_type": "transporter"
      },
      "source_chunk_ids": [
        "11a44f329fcd36113c0e17e623392e5b"
      ],
      "confidence": 0.95,
      "evidence": "cystic fibrosis transmembrane conductance regulator",
      "verified": true
    },
    {
      "id": "E4",
      "type": "CompoundClass",
      "name": "type 3 phosphodiesterase inhibitors",
      "attributes": {},
      "source_chunk_ids": [
        "11a44f329fcd36113c0e17e623392e5b"
      ],
      "confidence": 0.8,
      "evidence": "type 3 phosphodiesterase inhibitors",
      "verified": true
    },
    {
      "id": "E5",
      "type": "CompoundClass",
      "name": "type 4D phosphodiesterase inhibitors",
      "attributes": {},
      "source_chunk_ids": [
        "11a44f329fcd36113c0e17e623392e5b"
      ],
      "confidence": 0.8,
      "evidence": "type 4D phosphodiesterase inhibitors",
      "verified": true
    },
    {
      "id": "E6",
      "type": "Effect",
      "name": "activation of cystic fibrosis transmembrane conductance regulator",
      "attributes": {
        "level": "molecular",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "11a44f329fcd36113c0e17e623392e5b"
      ],
      "confidence": 0.85,
      "evidence": "Dynamic activation of cystic fibrosis transmembrane conductance regulator",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Study",
      "name": "Cervin & Lindgren 1998",
      "attributes": {
        "year": 1998,
        "design": "in vitro study"
      },
      "source_chunk_ids": [
        "c49b4d51cc23f718748f08945558e701"
      ],
      "confidence": 0.9,
      "evidence": "Cervin A, Lindgren S. ... in vitro. 1998",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Evidence",
      "name": "in vitro",
      "attributes": {
        "evidence_level": 2
      },
      "source_chunk_ids": [
        "c49b4d51cc23f718748f08945558e701"
      ],
      "confidence": 0.85,
      "evidence": "in vitro",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Study",
      "name": "Mata et al. 2005",
      "attributes": {
        "year": 2005,
        "design": "in vitro study"
      },
      "source_chunk_ids": [
        "c49b4d51cc23f718748f08945558e701"
      ],
      "confidence": 0.9,
      "evidence": "Mata M, ... in human airway epithelial cells. 2005",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Study",
      "name": "Rennard et al. 2008",
      "attributes": {
        "year": 2008,
        "design": "clinical trial"
      },
      "source_chunk_ids": [
        "c49b4d51cc23f718748f08945558e701"
      ],
      "confidence": 0.85,
      "evidence": "Rennard S, ... The efficacy and safety of cilomilast in COPD. 2008",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Evidence",
      "name": "clinical trial",
      "attributes": {
        "evidence_level": 4
      },
      "source_chunk_ids": [
        "c49b4d51cc23f718748f08945558e701"
      ],
      "confidence": 0.8,
      "evidence": "clinical trial",
      "verified": true
    },
    {
      "id": "E6",
      "type": "Study",
      "name": "Hatzelmann et al. 2010",
      "attributes": {
        "year": 2010,
        "design": "preclinical pharmacology"
      },
      "source_chunk_ids": [
        "c49b4d51cc23f718748f08945558e701"
      ],
      "confidence": 0.9,
      "evidence": "Hatzelmann A, ... The preclinical pharmacology of roflumilast. 2010",
      "verified": true
    },
    {
      "id": "E7",
      "type": "Evidence",
      "name": "preclinical",
      "attributes": {
        "evidence_level": 3
      },
      "source_chunk_ids": [
        "c49b4d51cc23f718748f08945558e701"
      ],
      "confidence": 0.85,
      "evidence": "preclinical pharmacology",
      "verified": true
    },
    {
      "id": "E8",
      "type": "Study",
      "name": "Gross et al. 2010",
      "attributes": {
        "year": 2010,
        "design": "clinical study"
      },
      "source_chunk_ids": [
        "c49b4d51cc23f718748f08945558e701"
      ],
      "confidence": 0.85,
      "evidence": "Gross NJ, ... Treatment of COPD with roflumilast. 2010",
      "verified": true
    },
    {
      "id": "E9",
      "type": "Study",
      "name": "Rabe et al. 2005",
      "attributes": {
        "year": 2005,
        "design": "randomized controlled trial"
      },
      "source_chunk_ids": [
        "c49b4d51cc23f718748f08945558e701"
      ],
      "confidence": 0.9,
      "evidence": "Rabe KF, ... a randomised controlled trial. 2005",
      "verified": true
    },
    {
      "id": "E10",
      "type": "Study",
      "name": "Calverley et al. 2007",
      "attributes": {
        "year": 2007,
        "design": "clinical trial"
      },
      "source_chunk_ids": [
        "c49b4d51cc23f718748f08945558e701"
      ],
      "confidence": 0.85,
      "evidence": "Calverley PM, ... Effect of 1-year treatment with roflumilast. 2007",
      "verified": true
    },
    {
      "id": "E11",
      "type": "Study",
      "name": "Calverley et al. 2009",
      "attributes": {
        "year": 2009,
        "design": "randomized clinical trials"
      },
      "source_chunk_ids": [
        "c49b4d51cc23f718748f08945558e701"
      ],
      "confidence": 0.9,
      "evidence": "Calverley PM, ... two randomised clinical trials. 2009",
      "verified": true
    },
    {
      "id": "E12",
      "type": "Compound",
      "name": "cilomilast",
      "attributes": {},
      "source_chunk_ids": [
        "c49b4d51cc23f718748f08945558e701"
      ],
      "confidence": 0.95,
      "evidence": "cilomilast",
      "verified": true
    },
    {
      "id": "E13",
      "type": "Compound",
      "name": "roflumilast",
      "attributes": {},
      "source_chunk_ids": [
        "c49b4d51cc23f718748f08945558e701"
      ],
      "confidence": 0.95,
      "evidence": "roflumilast",
      "verified": true
    },
    {
      "id": "E14",
      "type": "Target",
      "name": "phosphodiesterase 4",
      "attributes": {
        "target_type": "enzyme"
      },
      "source_chunk_ids": [
        "c49b4d51cc23f718748f08945558e701"
      ],
      "confidence": 0.9,
      "evidence": "phosphodiesterase 4",
      "verified": true
    },
    {
      "id": "E15",
      "type": "Condition",
      "name": "COPD",
      "attributes": {
        "condition_type": "disease"
      },
      "source_chunk_ids": [
        "c49b4d51cc23f718748f08945558e701"
      ],
      "confidence": 0.95,
      "evidence": "chronic obstructive pulmonary disease",
      "verified": true
    },
    {
      "id": "E16",
      "type": "Effect",
      "name": "decreased MUC5AC expression",
      "attributes": {
        "level": "cellular",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "c49b4d51cc23f718748f08945558e701"
      ],
      "confidence": 0.8,
      "evidence": "decreases MUC5AC expression",
      "verified": true
    },
    {
      "id": "E17",
      "type": "Effect",
      "name": "anti-inflammatory",
      "attributes": {
        "level": "systemic",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "c49b4d51cc23f718748f08945558e701"
      ],
      "confidence": 0.75,
      "evidence": "anti-inflammatory treatment",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Study",
      "name": "Roflumilast in moderate-to-severe COPD treated with long-acting bronchodilators: two randomised clinical trials",
      "attributes": {
        "design": "randomised clinical trials",
        "year": 2009,
        "doi": "10.1016/S0140-6736(09)61252-6"
      },
      "source_chunk_ids": [
        "6cc6e7e03a095713ef7c4d3c9ec42092"
      ],
      "confidence": 0.95,
      "evidence": "two randomised clinical trials",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Evidence",
      "name": "randomised clinical trial",
      "attributes": {
        "evidence_level": 4
      },
      "source_chunk_ids": [
        "6cc6e7e03a095713ef7c4d3c9ec42092"
      ],
      "confidence": 0.9,
      "evidence": "two randomised clinical trials",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Condition",
      "name": "chronic obstructive pulmonary disease",
      "attributes": {
        "condition_type": "disease",
        "severity": "moderate-to-severe"
      },
      "source_chunk_ids": [
        "6cc6e7e03a095713ef7c4d3c9ec42092"
      ],
      "confidence": 0.95,
      "evidence": "moderate-to-severe chronic obstructive pulmonary disease",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Study",
      "name": "Grootendorst et al. 2007",
      "attributes": {
        "design": "clinical study",
        "year": 2007,
        "doi": "10.1136/thx.2006.075937"
      },
      "source_chunk_ids": [
        "948cf060b565040a6e42486beef08481"
      ],
      "confidence": 0.95,
      "evidence": "Grootendorst DC, Gauw SA, Verhoosel RM, Sterk PJ, Hospers JJ, Bredenbroker D, et al. Reduction in sputum neutrophil and eosinophil numbers by the PDE4 inhibitor roflumilast in patients with COPD. Thorax. 2007;62:1081-7.",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Evidence",
      "name": "clinical study",
      "attributes": {
        "evidence_level": 4
      },
      "source_chunk_ids": [
        "948cf060b565040a6e42486beef08481"
      ],
      "confidence": 0.85,
      "evidence": "Reduction in sputum neutrophil and eosinophil numbers by the PDE4 inhibitor roflumilast in patients with COPD",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Compound",
      "name": "roflumilast",
      "attributes": {},
      "source_chunk_ids": [
        "948cf060b565040a6e42486beef08481"
      ],
      "confidence": 0.9,
      "evidence": "PDE4 inhibitor roflumilast",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Condition",
      "name": "COPD",
      "attributes": {
        "condition_type": "disease"
      },
      "source_chunk_ids": [
        "948cf060b565040a6e42486beef08481"
      ],
      "confidence": 0.95,
      "evidence": "patients with COPD",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Effect",
      "name": "reduction in sputum neutrophil numbers",
      "attributes": {
        "level": "cellular",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "948cf060b565040a6e42486beef08481"
      ],
      "confidence": 0.85,
      "evidence": "Reduction in sputum neutrophil numbers",
      "verified": true
    },
    {
      "id": "E6",
      "type": "Effect",
      "name": "reduction in sputum eosinophil numbers",
      "attributes": {
        "level": "cellular",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "948cf060b565040a6e42486beef08481"
      ],
      "confidence": 0.85,
      "evidence": "Reduction in sputum eosinophil numbers",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Study",
      "name": "Hohlfeld et al. 2008",
      "attributes": {
        "design": "randomized placebo-controlled trial",
        "year": 2008,
        "doi": "10.1016/j.pupt.2008.06.001"
      },
      "source_chunk_ids": [
        "0c739efb94b8e9c2390c4ec066ebd0cf"
      ],
      "confidence": 0.95,
      "evidence": "randomized placebo-controlled trial",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Evidence",
      "name": "clinical trial",
      "attributes": {
        "evidence_level": 4
      },
      "source_chunk_ids": [
        "0c739efb94b8e9c2390c4ec066ebd0cf"
      ],
      "confidence": 0.9,
      "evidence": "randomized placebo-controlled trial",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Compound",
      "name": "roflumilast",
      "attributes": {},
      "source_chunk_ids": [
        "0c739efb94b8e9c2390c4ec066ebd0cf"
      ],
      "confidence": 0.95,
      "evidence": "Roflumilast attenuates",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Condition",
      "name": "pulmonary inflammation",
      "attributes": {
        "condition_type": "symptom"
      },
      "source_chunk_ids": [
        "0c739efb94b8e9c2390c4ec066ebd0cf"
      ],
      "confidence": 0.9,
      "evidence": "pulmonary inflammation",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Effect",
      "name": "attenuation of inflammation",
      "attributes": {
        "level": "systemic",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "0c739efb94b8e9c2390c4ec066ebd0cf"
      ],
      "confidence": 0.85,
      "evidence": "attenuates pulmonary inflammation",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Study",
      "name": "Profita et al. 2003",
      "attributes": {
        "design": "effect study",
        "year": 2003,
        "doi": "10.1136/thorax.58.7.573"
      },
      "source_chunk_ids": [
        "049d1bee9df30c07fd34918b3cc69cfb"
      ],
      "confidence": 0.95,
      "evidence": "Profita M, Chiappara G, Mirabella F, Di Giorgi R, Chimenti L, Costanzo G, et al. Effect of cilomilast (Ariflo) on TNF-alpha, IL-8, and GM-CSF release by airway cells of patients with COPD. Thorax. 2003;58:573-9.",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Evidence",
      "name": "in vitro study",
      "attributes": {
        "evidence_level": 2
      },
      "source_chunk_ids": [
        "049d1bee9df30c07fd34918b3cc69cfb"
      ],
      "confidence": 0.8,
      "evidence": "release by airway cells",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Compound",
      "name": "cilomilast",
      "attributes": {},
      "source_chunk_ids": [
        "049d1bee9df30c07fd34918b3cc69cfb"
      ],
      "confidence": 0.9,
      "evidence": "cilomilast (Ariflo)",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Product",
      "name": "Ariflo",
      "attributes": {},
      "source_chunk_ids": [
        "049d1bee9df30c07fd34918b3cc69cfb"
      ],
      "confidence": 0.85,
      "evidence": "cilomilast (Ariflo)",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Target",
      "name": "TNF-alpha",
      "attributes": {
        "target_type": "cytokine"
      },
      "source_chunk_ids": [
        "049d1bee9df30c07fd34918b3cc69cfb"
      ],
      "confidence": 0.9,
      "evidence": "TNF-alpha",
      "verified": true
    },
    {
      "id": "E6",
      "type": "Target",
      "name": "IL-8",
      "attributes": {
        "target_type": "cytokine"
      },
      "source_chunk_ids": [
        "049d1bee9df30c07fd34918b3cc69cfb"
      ],
      "confidence": 0.9,
      "evidence": "IL-8",
      "verified": true
    },
    {
      "id": "E7",
      "type": "Target",
      "name": "GM-CSF",
      "attributes": {
        "target_type": "cytokine"
      },
      "source_chunk_ids": [
        "049d1bee9df30c07fd34918b3cc69cfb"
      ],
      "confidence": 0.9,
      "evidence": "GM-CSF",
      "verified": true
    },
    {
      "id": "E8",
      "type": "Condition",
      "name": "COPD",
      "attributes": {
        "condition_type": "disease"
      },
      "source_chunk_ids": [
        "049d1bee9df30c07fd34918b3cc69cfb"
      ],
      "confidence": 0.95,
      "evidence": "patients with COPD",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Study",
      "name": "Powrie et al. 2007",
      "attributes": {
        "design": "clinical study",
        "year": 2007,
        "doi": "10.1183/09031936.00077207"
      },
      "source_chunk_ids": [
        "8cadbf95b6dada0e049f53377a8c2d8a"
      ],
      "confidence": 0.9,
      "evidence": "Powrie DJ, Wilkinson TMA, Donaldson GC, Jones P, Scrine K, Viel K, et al. Effect of tiotropium on sputum and serum inflammatory markers and exacerbations in COPD. European Respiratory Journal. 2007;30:472-8.",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Evidence",
      "name": "clinical study",
      "attributes": {
        "evidence_level": 4
      },
      "source_chunk_ids": [
        "8cadbf95b6dada0e049f53377a8c2d8a"
      ],
      "confidence": 0.85,
      "evidence": "Effect of tiotropium on sputum and serum inflammatory markers and exacerbations in COPD",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Compound",
      "name": "tiotropium",
      "attributes": {},
      "source_chunk_ids": [
        "8cadbf95b6dada0e049f53377a8c2d8a"
      ],
      "confidence": 0.95,
      "evidence": "tiotropium",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Condition",
      "name": "COPD",
      "attributes": {
        "condition_type": "disease"
      },
      "source_chunk_ids": [
        "8cadbf95b6dada0e049f53377a8c2d8a"
      ],
      "confidence": 0.9,
      "evidence": "exacerbations in COPD",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Effect",
      "name": "reduction of inflammatory markers",
      "attributes": {
        "level": "systemic",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "8cadbf95b6dada0e049f53377a8c2d8a"
      ],
      "confidence": 0.8,
      "evidence": "Effect of tiotropium on sputum and serum inflammatory markers",
      "verified": true
    },
    {
      "id": "E6",
      "type": "Effect",
      "name": "reduction of exacerbations",
      "attributes": {
        "level": "systemic",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "8cadbf95b6dada0e049f53377a8c2d8a"
      ],
      "confidence": 0.8,
      "evidence": "exacerbations in COPD",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Study",
      "name": "Perng et al. 2009",
      "attributes": {
        "design": "clinical study",
        "year": 2009,
        "doi": "10.1183/09031936.00115308"
      },
      "source_chunk_ids": [
        "05ed8adf6fdbe0c5d48ccfb61f912859"
      ],
      "confidence": 0.95,
      "evidence": "Perng DW, Tao CW, Su KC, Tsai CC, Liu LY, Lee YC. Anti-inflammatory effects of salmeterol/fluticasone, tiotropium/fluticasone or tiotropium in COPD. European Respiratory Journal. 2009;33:778-84.",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Evidence",
      "name": "clinical study",
      "attributes": {
        "evidence_level": 4
      },
      "source_chunk_ids": [
        "05ed8adf6fdbe0c5d48ccfb61f912859"
      ],
      "confidence": 0.85,
      "evidence": "Anti-inflammatory effects of salmeterol/fluticasone, tiotropium/fluticasone or tiotropium in COPD",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Condition",
      "name": "COPD",
      "attributes": {
        "condition_type": "disease"
      },
      "source_chunk_ids": [
        "05ed8adf6fdbe0c5d48ccfb61f912859"
      ],
      "confidence": 0.9,
      "evidence": "in COPD",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Effect",
      "name": "anti-inflammatory effects",
      "attributes": {
        "level": "systemic",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "05ed8adf6fdbe0c5d48ccfb61f912859"
      ],
      "confidence": 0.9,
      "evidence": "Anti-inflammatory effects",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Study",
      "name": "Lapperre et al. 2009",
      "attributes": {
        "design": "clinical trial",
        "year": 2009,
        "doi": "Ann Intern Med. 2009;151:517-27"
      },
      "source_chunk_ids": [
        "0a9e34fed0d9214e0939ccf1189daf17"
      ],
      "confidence": 0.95,
      "evidence": "Lapperre TS, et al. Effect of fluticasone with and without salmeterol on pulmonary outcomes in chronic obstructive pulmonary disease. Ann Intern Med. 2009;151:517-27",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Evidence",
      "name": "clinical trial",
      "attributes": {
        "evidence_level": 4
      },
      "source_chunk_ids": [
        "0a9e34fed0d9214e0939ccf1189daf17"
      ],
      "confidence": 0.85,
      "evidence": "Effect of fluticasone with and without salmeterol on pulmonary outcomes",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Condition",
      "name": "chronic obstructive pulmonary disease",
      "attributes": {
        "condition_type": "disease"
      },
      "source_chunk_ids": [
        "0a9e34fed0d9214e0939ccf1189daf17"
      ],
      "confidence": 0.9,
      "evidence": "chronic obstructive pulmonary disease",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Study",
      "name": "Bourbeau et al. 2007",
      "attributes": {
        "design": "randomised controlled trial",
        "year": 2007,
        "doi": "10.1136/thx.2006.067777"
      },
      "source_chunk_ids": [
        "52048991eb853d98cc8bfeb718b8608a"
      ],
      "confidence": 0.95,
      "evidence": "randomised controlled trial. Thorax. 2007",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Evidence",
      "name": "clinical trial",
      "attributes": {
        "evidence_level": 4
      },
      "source_chunk_ids": [
        "52048991eb853d98cc8bfeb718b8608a"
      ],
      "confidence": 0.9,
      "evidence": "randomised controlled trial",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Product",
      "name": "salmeterol/fluticasone propionate",
      "attributes": {},
      "source_chunk_ids": [
        "52048991eb853d98cc8bfeb718b8608a"
      ],
      "confidence": 0.95,
      "evidence": "salmeterol/fluticasone propionate",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Condition",
      "name": "COPD",
      "attributes": {
        "condition_type": "disease"
      },
      "source_chunk_ids": [
        "52048991eb853d98cc8bfeb718b8608a"
      ],
      "confidence": 0.95,
      "evidence": "airway inflammation in COPD",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Effect",
      "name": "airway inflammation reduction",
      "attributes": {
        "level": "systemic",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "52048991eb853d98cc8bfeb718b8608a"
      ],
      "confidence": 0.8,
      "evidence": "Effect on airway inflammation",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Study",
      "name": "Burgin et al. 2010",
      "attributes": {
        "design": "design study",
        "year": 2010,
        "doi": "10.1038/nbt.1600"
      },
      "source_chunk_ids": [
        "b5bc78602466937ee5f50e899808a7a0"
      ],
      "confidence": 0.95,
      "evidence": "Burgin AB, Magnusson OT, Singh J, Witte P, Staker BL, Bjornsson JM, et al. Design of phosphodiesterase 4D (PDE4D) allosteric modulators for enhancing cognition with improved safety. NatBiotechnol. 2010;28:63-70.",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Evidence",
      "name": "in vitro study",
      "attributes": {
        "evidence_level": 2
      },
      "source_chunk_ids": [
        "b5bc78602466937ee5f50e899808a7a0"
      ],
      "confidence": 0.8,
      "evidence": "Design of phosphodiesterase 4D (PDE4D) allosteric modulators",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Target",
      "name": "PDE4D",
      "attributes": {
        "target_type": "enzyme"
      },
      "source_chunk_ids": [
        "b5bc78602466937ee5f50e899808a7a0"
      ],
      "confidence": 0.9,
      "evidence": "phosphodiesterase 4D (PDE4D)",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Effect",
      "name": "enhanced cognition",
      "attributes": {
        "level": "behavioral",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "b5bc78602466937ee5f50e899808a7a0"
      ],
      "confidence": 0.85,
      "evidence": "enhancing cognition",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Effect",
      "name": "improved safety",
      "attributes": {
        "level": "systemic",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "b5bc78602466937ee5f50e899808a7a0"
      ],
      "confidence": 0.85,
      "evidence": "improved safety",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Study",
      "name": "Vestbo et al. 2009",
      "attributes": {
        "design": "controlled trial",
        "duration": "6 weeks",
        "year": 2009,
        "doi": "10.1183/09031936.00139508"
      },
      "source_chunk_ids": [
        "0aa623c11cf813c715d3df311191096d"
      ],
      "confidence": 0.95,
      "evidence": "A controlled trial of 6-weeks' treatment",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Evidence",
      "name": "clinical trial",
      "attributes": {
        "evidence_level": 4
      },
      "source_chunk_ids": [
        "0aa623c11cf813c715d3df311191096d"
      ],
      "confidence": 0.85,
      "evidence": "controlled trial",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Compound",
      "name": "phosphodiesterase type-4 inhibitor",
      "attributes": {},
      "source_chunk_ids": [
        "0aa623c11cf813c715d3df311191096d"
      ],
      "confidence": 0.9,
      "evidence": "novel inhaled phosphodiesterase type-4 inhibitor",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Condition",
      "name": "COPD",
      "attributes": {
        "condition_type": "disease"
      },
      "source_chunk_ids": [
        "0aa623c11cf813c715d3df311191096d"
      ],
      "confidence": 0.95,
      "evidence": "in COPD",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Study",
      "name": "Singh et al. 2010",
      "attributes": {
        "design": "allergen challenge study",
        "year": 2010,
        "doi": "10.1186/1465-9921-11-26"
      },
      "source_chunk_ids": [
        "f00830d2dd322fac2e728aa9e107196a"
      ],
      "confidence": 0.95,
      "evidence": "Singh D, Petavy F, Macdonald AJ, Lazaar AL, O'Connor BJ. The inhaled phosphodiesterase 4 inhibitor GSK256066 reduces allergen challenge responses in asthma. RespirRes. 2010;11:26-35.",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Evidence",
      "name": "clinical study",
      "attributes": {
        "evidence_level": 4
      },
      "source_chunk_ids": [
        "f00830d2dd322fac2e728aa9e107196a"
      ],
      "confidence": 0.85,
      "evidence": "allergen challenge responses in asthma",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Compound",
      "name": "GSK256066",
      "attributes": {},
      "source_chunk_ids": [
        "f00830d2dd322fac2e728aa9e107196a"
      ],
      "confidence": 0.95,
      "evidence": "GSK256066",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Target",
      "name": "phosphodiesterase 4",
      "attributes": {
        "target_type": "enzyme"
      },
      "source_chunk_ids": [
        "f00830d2dd322fac2e728aa9e107196a"
      ],
      "confidence": 0.9,
      "evidence": "phosphodiesterase 4 inhibitor",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Condition",
      "name": "asthma",
      "attributes": {
        "condition_type": "disease"
      },
      "source_chunk_ids": [
        "f00830d2dd322fac2e728aa9e107196a"
      ],
      "confidence": 0.95,
      "evidence": "asthma",
      "verified": true
    },
    {
      "id": "E6",
      "type": "Effect",
      "name": "reduces allergen challenge responses",
      "attributes": {
        "level": "systemic",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "f00830d2dd322fac2e728aa9e107196a"
      ],
      "confidence": 0.85,
      "evidence": "reduces allergen challenge responses",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Study",
      "name": "Selige et al. 2010",
      "attributes": {
        "design": "in vitro study",
        "year": 2010,
        "doi": "10.1002/jcp.22041"
      },
      "source_chunk_ids": [
        "38e9263045a01a1ebdba8acb990a4e15"
      ],
      "confidence": 0.9,
      "evidence": "Selige J, Tenor H, Hatzelmann A, Dunkern T. Cytokine-dependent balance of mitogenic effects in primary human lung fibroblasts related to cyclic AMP signaling and phosphodiesterase 4 inhibition. JCell Physiol. 2010;223:317-26.",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Evidence",
      "name": "in vitro",
      "attributes": {
        "evidence_level": 2
      },
      "source_chunk_ids": [
        "38e9263045a01a1ebdba8acb990a4e15"
      ],
      "confidence": 0.85,
      "evidence": "primary human lung fibroblasts",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Target",
      "name": "phosphodiesterase 4",
      "attributes": {
        "target_type": "enzyme"
      },
      "source_chunk_ids": [
        "38e9263045a01a1ebdba8acb990a4e15"
      ],
      "confidence": 0.9,
      "evidence": "phosphodiesterase 4 inhibition",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Target",
      "name": "cyclic AMP signaling",
      "attributes": {
        "target_type": "pathway"
      },
      "source_chunk_ids": [
        "38e9263045a01a1ebdba8acb990a4e15"
      ],
      "confidence": 0.85,
      "evidence": "cyclic AMP signaling",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Effect",
      "name": "mitogenic effects",
      "attributes": {
        "level": "cellular",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "38e9263045a01a1ebdba8acb990a4e15"
      ],
      "confidence": 0.8,
      "evidence": "mitogenic effects",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Study",
      "name": "Brunnee et al. 1992",
      "attributes": {
        "design": "clinical study",
        "year": 1992,
        "doi": "EurRespirJ. 1992;5:982-5"
      },
      "source_chunk_ids": [
        "0639a30770cfda8a03530e87691800c0"
      ],
      "confidence": 0.95,
      "evidence": "Brunnee T, Engelstatter R, Steinijans VW, Kunkel G. Bronchodilatory effect of inhaled zardaverine, a phosphodiesterase III and IV inhibitor, in patients with asthma. EurRespirJ. 1992;5:982-5",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Evidence",
      "name": "clinical study",
      "attributes": {
        "evidence_level": 4
      },
      "source_chunk_ids": [
        "0639a30770cfda8a03530e87691800c0"
      ],
      "confidence": 0.85,
      "evidence": "Bronchodilatory effect of inhaled zardaverine, a phosphodiesterase III and IV inhibitor, in patients with asthma",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Compound",
      "name": "zardaverine",
      "attributes": {},
      "source_chunk_ids": [
        "0639a30770cfda8a03530e87691800c0"
      ],
      "confidence": 0.95,
      "evidence": "zardaverine, a phosphodiesterase III and IV inhibitor",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Target",
      "name": "phosphodiesterase III",
      "attributes": {
        "target_type": "enzyme"
      },
      "source_chunk_ids": [
        "0639a30770cfda8a03530e87691800c0"
      ],
      "confidence": 0.9,
      "evidence": "phosphodiesterase III and IV inhibitor",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Target",
      "name": "phosphodiesterase IV",
      "attributes": {
        "target_type": "enzyme"
      },
      "source_chunk_ids": [
        "0639a30770cfda8a03530e87691800c0"
      ],
      "confidence": 0.9,
      "evidence": "phosphodiesterase III and IV inhibitor",
      "verified": true
    },
    {
      "id": "E6",
      "type": "Condition",
      "name": "asthma",
      "attributes": {
        "condition_type": "disease"
      },
      "source_chunk_ids": [
        "0639a30770cfda8a03530e87691800c0"
      ],
      "confidence": 0.95,
      "evidence": "patients with asthma",
      "verified": true
    },
    {
      "id": "E7",
      "type": "Effect",
      "name": "bronchodilatory effect",
      "attributes": {
        "level": "systemic",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "0639a30770cfda8a03530e87691800c0"
      ],
      "confidence": 0.9,
      "evidence": "Bronchodilatory effect",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Study",
      "name": "Ukena et al. 1995",
      "attributes": {
        "design": "clinical study",
        "year": 1995,
        "doi": "10.1016/0954-6111(95)90006-3"
      },
      "source_chunk_ids": [
        "2ceab326b96221c13f60c9a0ca1d6e33"
      ],
      "confidence": 0.9,
      "evidence": "Ukena D, Rentz K, Reiber C, Sybrecht GW. Effects of the mixed phosphodiesterase III/IV inhibitor, zardaverine, on airway function in patients with chronic airflow obstruction. Respir Med. 1995;89:441-4.",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Evidence",
      "name": "clinical study",
      "attributes": {
        "evidence_level": 4
      },
      "source_chunk_ids": [
        "2ceab326b96221c13f60c9a0ca1d6e33"
      ],
      "confidence": 0.85,
      "evidence": "Effects of the mixed phosphodiesterase III/IV inhibitor, zardaverine, on airway function in patients with chronic airflow obstruction",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Compound",
      "name": "zardaverine",
      "attributes": {},
      "source_chunk_ids": [
        "2ceab326b96221c13f60c9a0ca1d6e33"
      ],
      "confidence": 0.95,
      "evidence": "zardaverine",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Target",
      "name": "phosphodiesterase III",
      "attributes": {
        "target_type": "enzyme"
      },
      "source_chunk_ids": [
        "2ceab326b96221c13f60c9a0ca1d6e33"
      ],
      "confidence": 0.8,
      "evidence": "phosphodiesterase III",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Target",
      "name": "phosphodiesterase IV",
      "attributes": {
        "target_type": "enzyme"
      },
      "source_chunk_ids": [
        "2ceab326b96221c13f60c9a0ca1d6e33"
      ],
      "confidence": 0.8,
      "evidence": "phosphodiesterase IV",
      "verified": true
    },
    {
      "id": "E6",
      "type": "Condition",
      "name": "chronic airflow obstruction",
      "attributes": {
        "condition_type": "disease"
      },
      "source_chunk_ids": [
        "2ceab326b96221c13f60c9a0ca1d6e33"
      ],
      "confidence": 0.9,
      "evidence": "chronic airflow obstruction",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Study",
      "name": "Boswell-Smith et al. 2006",
      "attributes": {
        "design": "pharmacological study",
        "year": 2006,
        "doi": "10.1124/jpet.106.104000"
      },
      "source_chunk_ids": [
        "a5d0c29d4ce8db8f32c8eab4151136de"
      ],
      "confidence": 0.95,
      "evidence": "Boswell-Smith V, Spina D, Oxford AW, Comer MB, Seeds EA, Page CP. The pharmacology of two novel long-acting phosphodiesterase 3/4 inhibitors, RPL554 and RPL565. J Pharmacol Exp Ther. 2006;318:840-8.",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Evidence",
      "name": "in vitro/in vivo pharmacology",
      "attributes": {
        "evidence_level": 2
      },
      "source_chunk_ids": [
        "a5d0c29d4ce8db8f32c8eab4151136de"
      ],
      "confidence": 0.85,
      "evidence": "The pharmacology of two novel long-acting phosphodiesterase 3/4 inhibitors",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Compound",
      "name": "RPL554",
      "attributes": {},
      "source_chunk_ids": [
        "a5d0c29d4ce8db8f32c8eab4151136de"
      ],
      "confidence": 0.9,
      "evidence": "RPL554 [9,10-dimethoxy-2(2,4,6-trimethylphenylimino)-3-(n-carbamoyl-2-aminoethyl) -3,4,6,7-tetrahydro-2H-pyrimido[6,1-a]isoquinolin-4-one]",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Compound",
      "name": "RPL565",
      "attributes": {},
      "source_chunk_ids": [
        "a5d0c29d4ce8db8f32c8eab4151136de"
      ],
      "confidence": 0.9,
      "evidence": "RPL565 [6,7-dihydro-2-(2,6-diisopropylphenoxy)-9,10-dimethoxy-4H-pyrimido[6,1-a]isoquinolin-4-one]",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Target",
      "name": "phosphodiesterase 3",
      "attributes": {
        "target_type": "enzyme"
      },
      "source_chunk_ids": [
        "a5d0c29d4ce8db8f32c8eab4151136de"
      ],
      "confidence": 0.8,
      "evidence": "phosphodiesterase 3/4 inhibitors",
      "verified": true
    },
    {
      "id": "E6",
      "type": "Target",
      "name": "phosphodiesterase 4",
      "attributes": {
        "target_type": "enzyme"
      },
      "source_chunk_ids": [
        "a5d0c29d4ce8db8f32c8eab4151136de"
      ],
      "confidence": 0.8,
      "evidence": "phosphodiesterase 3/4 inhibitors",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Study",
      "name": "Smith et al. 2003",
      "attributes": {
        "year": 2003,
        "doi": "10.1152/ajplung.00323.2002"
      },
      "source_chunk_ids": [
        "7949872a54d13aa8a93f2554b6522bbd"
      ],
      "confidence": 0.95,
      "evidence": "Smith SJ, Brookes-Fazakerley S, Donnelly LE, Barnes PJ, Barnette MS, Giembycz MA. Ubiquitous expression of phosphodiesterase 7A in human proinflammatory and immune cells. Am J Physiol Lung Cell Mol Physiol. 2003;284:L279-L89.",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Evidence",
      "name": "in vitro",
      "attributes": {
        "evidence_level": 2
      },
      "source_chunk_ids": [
        "7949872a54d13aa8a93f2554b6522bbd"
      ],
      "confidence": 0.8,
      "evidence": "Ubiquitous expression of phosphodiesterase 7A in human proinflammatory and immune cells",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Target",
      "name": "phosphodiesterase 7A",
      "attributes": {
        "target_type": "enzyme"
      },
      "source_chunk_ids": [
        "7949872a54d13aa8a93f2554b6522bbd"
      ],
      "confidence": 0.9,
      "evidence": "phosphodiesterase 7A",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Study",
      "name": "McCluskie et al. 2006",
      "attributes": {
        "authors": "McCluskie K, Klein U, Linnevers C, Ji YH, Yang A, Husfeld C, et al.",
        "year": 2006,
        "title": "Phosphodiesterase type 4 inhibitors cause proinflammatory effects in vivo",
        "journal": "J Pharmacol Exp Ther",
        "volume": 319,
        "pages": "468-76"
      },
      "source_chunk_ids": [
        "0e69cb76d1afa7d5470bf5357aaaf0ad"
      ],
      "confidence": 0.95,
      "evidence": "McCluskie K, Klein U, Linnevers C, Ji YH, Yang A, Husfeld C, et al. Phosphodiesterase type 4 inhibitors cause proinflammatory effects in vivo. J Pharmacol Exp Ther. 2006;319:468-76.",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Evidence",
      "name": "in vivo study",
      "attributes": {
        "evidence_level": 3
      },
      "source_chunk_ids": [
        "0e69cb76d1afa7d5470bf5357aaaf0ad"
      ],
      "confidence": 0.9,
      "evidence": "cause proinflammatory effects in vivo",
      "verified": true
    },
    {
      "id": "E3",
      "type": "CompoundClass",
      "name": "phosphodiesterase type 4 inhibitors",
      "attributes": {},
      "source_chunk_ids": [
        "0e69cb76d1afa7d5470bf5357aaaf0ad"
      ],
      "confidence": 0.95,
      "evidence": "Phosphodiesterase type 4 inhibitors",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Effect",
      "name": "proinflammatory effects",
      "attributes": {
        "level": "systemic",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "0e69cb76d1afa7d5470bf5357aaaf0ad"
      ],
      "confidence": 0.9,
      "evidence": "cause proinflammatory effects",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Study",
      "name": "Hertz et al. 2009",
      "attributes": {
        "design": "in vitro study",
        "year": 2009,
        "doi": "10.1073/pnas.0911684106"
      },
      "source_chunk_ids": [
        "941177bcd34d6994d1cfbd541d2ce611"
      ],
      "confidence": 0.95,
      "evidence": "Hertz AL, Bender AT, et al. 2009",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Evidence",
      "name": "in vitro",
      "attributes": {
        "evidence_level": 2
      },
      "source_chunk_ids": [
        "941177bcd34d6994d1cfbd541d2ce611"
      ],
      "confidence": 0.9,
      "evidence": "in human monocyte-derived macrophages",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Target",
      "name": "PDE4",
      "attributes": {
        "target_type": "enzyme"
      },
      "source_chunk_ids": [
        "941177bcd34d6994d1cfbd541d2ce611"
      ],
      "confidence": 0.85,
      "evidence": "PDE4 inhibition",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Effect",
      "name": "chemokine expression",
      "attributes": {
        "level": "cellular",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "941177bcd34d6994d1cfbd541d2ce611"
      ],
      "confidence": 0.9,
      "evidence": "induce chemokine expression",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Study",
      "name": "Martorana et al. 2008",
      "attributes": {
        "design": "experimental animal study",
        "year": 2008,
        "doi": "10.1186/1471-2466-8-17"
      },
      "source_chunk_ids": [
        "ae95eede0920c33e4d35e253a10eb44f"
      ],
      "confidence": 0.95,
      "evidence": "Martorana PA, Lunghi B, Lucattelli M, De CG, Beume R, Lungarella G. Effect of roflumilast on inflammatory cells in the lungs of cigarette smoke-exposed mice. BMC Pulm Med. 2008;8:17.",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Evidence",
      "name": "in vivo animal study",
      "attributes": {
        "evidence_level": 2
      },
      "source_chunk_ids": [
        "ae95eede0920c33e4d35e253a10eb44f"
      ],
      "confidence": 0.9,
      "evidence": "cigarette smoke-exposed mice",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Compound",
      "name": "roflumilast",
      "attributes": {},
      "source_chunk_ids": [
        "ae95eede0920c33e4d35e253a10eb44f"
      ],
      "confidence": 0.95,
      "evidence": "Effect of roflumilast",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Condition",
      "name": "lung inflammation",
      "attributes": {
        "condition_type": "symptom"
      },
      "source_chunk_ids": [
        "ae95eede0920c33e4d35e253a10eb44f"
      ],
      "confidence": 0.85,
      "evidence": "inflammatory cells in the lungs",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Target",
      "name": "inflammatory cells",
      "attributes": {
        "target_type": "cellular"
      },
      "source_chunk_ids": [
        "ae95eede0920c33e4d35e253a10eb44f"
      ],
      "confidence": 0.8,
      "evidence": "inflammatory cells in the lungs",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Study",
      "name": "Gamble et al. 2001",
      "attributes": {
        "design": "double-blind placebo-controlled parallel-group quantitative study",
        "year": 2001,
        "doi": "10.1183/09031936.01.00223801"
      },
      "source_chunk_ids": [
        "5697ce8ba96c3e8cef46bff87e6ec1e3"
      ],
      "confidence": 0.95,
      "evidence": "Gamble E, Pavord ID, Vignola AM, Kroegel C, Morell F, Hansel TT, et al. Cilomilast reduces CD8+ T-lymphocytes and macrophages in patients with chronic obstructive pulmonary disease (COPD): a double-blind placebo-controlled, parallel-group quantitative study of bronchial biopsies. Eur Respir J. 2001;17:P2238.",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Evidence",
      "name": "clinical trial",
      "attributes": {
        "evidence_level": 4
      },
      "source_chunk_ids": [
        "5697ce8ba96c3e8cef46bff87e6ec1e3"
      ],
      "confidence": 0.9,
      "evidence": "double-blind placebo-controlled, parallel-group quantitative study",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Compound",
      "name": "cilomilast",
      "attributes": {},
      "source_chunk_ids": [
        "5697ce8ba96c3e8cef46bff87e6ec1e3"
      ],
      "confidence": 0.95,
      "evidence": "Cilomilast reduces CD8+ T-lymphocytes and macrophages",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Condition",
      "name": "chronic obstructive pulmonary disease",
      "attributes": {
        "condition_type": "disease"
      },
      "source_chunk_ids": [
        "5697ce8ba96c3e8cef46bff87e6ec1e3"
      ],
      "confidence": 0.95,
      "evidence": "patients with chronic obstructive pulmonary disease (COPD)",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Target",
      "name": "CD8+ T-lymphocytes",
      "attributes": {
        "target_type": "immune cell"
      },
      "source_chunk_ids": [
        "5697ce8ba96c3e8cef46bff87e6ec1e3"
      ],
      "confidence": 0.9,
      "evidence": "reduces CD8+ T-lymphocytes",
      "verified": true
    },
    {
      "id": "E6",
      "type": "Target",
      "name": "macrophages",
      "attributes": {
        "target_type": "immune cell"
      },
      "source_chunk_ids": [
        "5697ce8ba96c3e8cef46bff87e6ec1e3"
      ],
      "confidence": 0.9,
      "evidence": "reduces macrophages",
      "verified": true
    },
    {
      "id": "E7",
      "type": "Effect",
      "name": "reduction of CD8+ T-lymphocytes",
      "attributes": {
        "level": "cellular",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "5697ce8ba96c3e8cef46bff87e6ec1e3"
      ],
      "confidence": 0.85,
      "evidence": "reduces CD8+ T-lymphocytes",
      "verified": true
    },
    {
      "id": "E8",
      "type": "Effect",
      "name": "reduction of macrophages",
      "attributes": {
        "level": "cellular",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "5697ce8ba96c3e8cef46bff87e6ec1e3"
      ],
      "confidence": 0.85,
      "evidence": "reduces macrophages",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Study",
      "name": "Gantner et al. 1997",
      "attributes": {
        "design": "comparative study",
        "year": 1997,
        "doi": "10.1016/S0091-6749(97)70147-5"
      },
      "source_chunk_ids": [
        "bc39ce905dc631263982061cf7e0bf91"
      ],
      "confidence": 0.95,
      "evidence": "Gantner F, Tenor H, Gekeler V, Schudt C, Wendel A, Hatzelmann A. Phosphodiesterase profiles of highly purified human peripheral blood leukocyte populations from normal and atopic individuals: a comparative study. J Allergy Clin Immunol. 1997;100:527-35.",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Evidence",
      "name": "in vitro study",
      "attributes": {
        "evidence_level": 2
      },
      "source_chunk_ids": [
        "bc39ce905dc631263982061cf7e0bf91"
      ],
      "confidence": 0.85,
      "evidence": "Phosphodiesterase profiles of highly purified human peripheral blood leukocyte populations",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Target",
      "name": "phosphodiesterase",
      "attributes": {
        "target_type": "enzyme"
      },
      "source_chunk_ids": [
        "bc39ce905dc631263982061cf7e0bf91"
      ],
      "confidence": 0.9,
      "evidence": "Phosphodiesterase profiles",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Condition",
      "name": "atopic individuals",
      "attributes": {
        "condition_type": "disorder"
      },
      "source_chunk_ids": [
        "bc39ce905dc631263982061cf7e0bf91"
      ],
      "confidence": 0.8,
      "evidence": "atopic individuals",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Study",
      "name": "Hatzelmann & Schudt 2001",
      "attributes": {
        "design": "in vitro study",
        "year": 2001,
        "doi": "J Pharmacol Exp Ther. 2001;297:267-79"
      },
      "source_chunk_ids": [
        "b5ffaf7ab1f0233a248df8e0be7855ef"
      ],
      "confidence": 0.95,
      "evidence": "Hatzelmann A, Schudt C. Anti-inflammatory and immunomodulatory potential of the novel PDE4 inhibitor roflumilast in vitro. J Pharmacol Exp Ther. 2001;297:267-79",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Evidence",
      "name": "in vitro",
      "attributes": {
        "evidence_level": 2
      },
      "source_chunk_ids": [
        "b5ffaf7ab1f0233a248df8e0be7855ef"
      ],
      "confidence": 0.9,
      "evidence": "in vitro",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Compound",
      "name": "roflumilast",
      "attributes": {},
      "source_chunk_ids": [
        "b5ffaf7ab1f0233a248df8e0be7855ef"
      ],
      "confidence": 0.95,
      "evidence": "roflumilast",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Target",
      "name": "PDE4",
      "attributes": {
        "target_type": "enzyme"
      },
      "source_chunk_ids": [
        "b5ffaf7ab1f0233a248df8e0be7855ef"
      ],
      "confidence": 0.9,
      "evidence": "PDE4 inhibitor",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Effect",
      "name": "anti-inflammatory",
      "attributes": {
        "level": "cellular",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "b5ffaf7ab1f0233a248df8e0be7855ef"
      ],
      "confidence": 0.85,
      "evidence": "Anti-inflammatory",
      "verified": true
    },
    {
      "id": "E6",
      "type": "Effect",
      "name": "immunomodulatory",
      "attributes": {
        "level": "cellular",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "b5ffaf7ab1f0233a248df8e0be7855ef"
      ],
      "confidence": 0.85,
      "evidence": "immunomodulatory potential",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Study",
      "name": "Peter et al. 2007",
      "attributes": {
        "year": 2007,
        "design": "in vitro study"
      },
      "source_chunk_ids": [
        "6c73b4f133f163528a6a109ecab7e777"
      ],
      "confidence": 0.9,
      "evidence": "Peter D, Jin SL, Conti M, Hatzelmann A, Zitt C. Differential expression and function of phosphodiesterase 4 (PDE4) subtypes in human primary CD4+ T cells: predominant role of PDE4D. J Immunol. 2007;178:4820-31.",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Evidence",
      "name": "in vitro",
      "attributes": {
        "evidence_level": 2
      },
      "source_chunk_ids": [
        "6c73b4f133f163528a6a109ecab7e777"
      ],
      "confidence": 0.85,
      "evidence": "human primary CD4+ T cells",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Target",
      "name": "PDE4",
      "attributes": {
        "target_type": "enzyme"
      },
      "source_chunk_ids": [
        "6c73b4f133f163528a6a109ecab7e777"
      ],
      "confidence": 0.95,
      "evidence": "phosphodiesterase 4 (PDE4)",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Target",
      "name": "PDE4D",
      "attributes": {
        "target_type": "enzyme"
      },
      "source_chunk_ids": [
        "6c73b4f133f163528a6a109ecab7e777"
      ],
      "confidence": 0.9,
      "evidence": "predominant role of PDE4D",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Study",
      "name": "Essayan et al. 1997",
      "attributes": {
        "authors": "Essayan DM, Kagey-Sobotka A, Lichtenstein LM, Huang SK",
        "year": 1997,
        "journal": "Journal of Pharmacology & Experimental Therapeutics",
        "volume": 282,
        "pages": "505-12"
      },
      "source_chunk_ids": [
        "38e3828512e60dcbb82231d02c1956d7"
      ],
      "confidence": 0.95,
      "evidence": "Essayan DM, Kagey-Sobotka A, Lichtenstein LM, Huang SK. Journal of Pharmacology & Experimental Therapeutics. 1997;282:505-12",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Evidence",
      "name": "in vitro study",
      "attributes": {
        "evidence_level": 2
      },
      "source_chunk_ids": [
        "38e3828512e60dcbb82231d02c1956d7"
      ],
      "confidence": 0.8,
      "evidence": "Differential regulation of human antigen-specific Th1 and Th2 lymphocyte responses",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Target",
      "name": "Th1 lymphocytes",
      "attributes": {
        "target_type": "immune cell"
      },
      "source_chunk_ids": [
        "38e3828512e60dcbb82231d02c1956d7"
      ],
      "confidence": 0.85,
      "evidence": "Th1 lymphocyte responses",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Target",
      "name": "Th2 lymphocytes",
      "attributes": {
        "target_type": "immune cell"
      },
      "source_chunk_ids": [
        "38e3828512e60dcbb82231d02c1956d7"
      ],
      "confidence": 0.85,
      "evidence": "Th2 lymphocyte responses",
      "verified": true
    },
    {
      "id": "E5",
      "type": "CompoundClass",
      "name": "isozyme selective cyclic nucleotide phosphodiesterase inhibitors",
      "attributes": {},
      "source_chunk_ids": [
        "38e3828512e60dcbb82231d02c1956d7"
      ],
      "confidence": 0.9,
      "evidence": "isozyme selective cyclic nucleotide phosphodiesterase inhibitors",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Study",
      "name": "Ma et al. 2008",
      "attributes": {
        "design": "in vitro study",
        "year": 2008,
        "doi": "10.1016/j.intimp.2008.07.006"
      },
      "source_chunk_ids": [
        "3f52a6af43a5aadec2501dc1c25dc57d"
      ],
      "confidence": 0.9,
      "evidence": "Ma R, Yang BY, Wu CY. A selective phosphodiesterase 4 (PDE4) inhibitor ZI-n-91 suppresses IL-17 production by human memory Th17 cells. IntImmunopharmacol. 2008;8:1408-17.",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Evidence",
      "name": "in vitro",
      "attributes": {
        "evidence_level": 2
      },
      "source_chunk_ids": [
        "3f52a6af43a5aadec2501dc1c25dc57d"
      ],
      "confidence": 0.85,
      "evidence": "A selective phosphodiesterase 4 (PDE4) inhibitor ZI-n-91 suppresses IL-17 production by human memory Th17 cells",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Compound",
      "name": "ZI-n-91",
      "attributes": {},
      "source_chunk_ids": [
        "3f52a6af43a5aadec2501dc1c25dc57d"
      ],
      "confidence": 0.95,
      "evidence": "ZI-n-91",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Target",
      "name": "PDE4",
      "attributes": {
        "target_type": "enzyme"
      },
      "source_chunk_ids": [
        "3f52a6af43a5aadec2501dc1c25dc57d"
      ],
      "confidence": 0.9,
      "evidence": "phosphodiesterase 4 (PDE4)",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Effect",
      "name": "suppression of IL-17 production",
      "attributes": {
        "level": "cellular",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "3f52a6af43a5aadec2501dc1c25dc57d"
      ],
      "confidence": 0.85,
      "evidence": "suppresses IL-17 production",
      "verified": true
    },
    {
      "id": "E6",
      "type": "Target",
      "name": "human memory Th17 cells",
      "attributes": {
        "target_type": "cell type"
      },
      "source_chunk_ids": [
        "3f52a6af43a5aadec2501dc1c25dc57d"
      ],
      "confidence": 0.8,
      "evidence": "human memory Th17 cells",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Study",
      "name": "Gantner et al. 1998",
      "attributes": {
        "design": "in vitro study",
        "year": 1998,
        "doi": "BrJPharmacol. 1998;123:1031-8"
      },
      "source_chunk_ids": [
        "c6f94c44d89487b5622bd86510d3dc74"
      ],
      "confidence": 0.95,
      "evidence": "Gantner F, Gotz C, Gekeler V, Schudt C, Wendel A, Hatzelmann A. Phosphodiesterase profile of human B lymphocytes from normal and atopic donors and the effects of PDE inhibition on B cell proliferation. BrJPharmacol. 1998;123:1031-8",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Evidence",
      "name": "in vitro",
      "attributes": {
        "evidence_level": 2
      },
      "source_chunk_ids": [
        "c6f94c44d89487b5622bd86510d3dc74"
      ],
      "confidence": 0.9,
      "evidence": "Phosphodiesterase profile of human B lymphocytes",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Target",
      "name": "phosphodiesterase",
      "attributes": {
        "target_type": "enzyme"
      },
      "source_chunk_ids": [
        "c6f94c44d89487b5622bd86510d3dc74"
      ],
      "confidence": 0.85,
      "evidence": "Phosphodiesterase profile",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Effect",
      "name": "B cell proliferation",
      "attributes": {
        "level": "cellular",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "c6f94c44d89487b5622bd86510d3dc74"
      ],
      "confidence": 0.8,
      "evidence": "effects of PDE inhibition on B cell proliferation",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Study",
      "name": "Parkkonen et al. 2007",
      "attributes": {
        "year": 2007,
        "authors": "Parkkonen J, Hasala H, Moilanen E, Giembycz MA, Kankaanranta H"
      },
      "source_chunk_ids": [
        "809e8182aea21fb055ecd9f3c97daa3e"
      ],
      "confidence": 0.95,
      "evidence": "Parkkonen J, Hasala H, Moilanen E, Giembycz MA, Kankaanranta H. Phosphodiesterase 4 inhibitors delay human eosinophil and neutrophil apoptosis in the absence and presence of salbutamol. Pulm Pharmacol Ther. 2007.",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Evidence",
      "name": "in vitro study",
      "attributes": {
        "evidence_level": 2
      },
      "source_chunk_ids": [
        "809e8182aea21fb055ecd9f3c97daa3e"
      ],
      "confidence": 0.85,
      "evidence": "Phosphodiesterase 4 inhibitors delay human eosinophil and neutrophil apoptosis",
      "verified": true
    },
    {
      "id": "E3",
      "type": "CompoundClass",
      "name": "phosphodiesterase 4 inhibitors",
      "attributes": {},
      "source_chunk_ids": [
        "809e8182aea21fb055ecd9f3c97daa3e"
      ],
      "confidence": 0.9,
      "evidence": "Phosphodiesterase 4 inhibitors",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Effect",
      "name": "delayed apoptosis",
      "attributes": {
        "level": "cellular",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "809e8182aea21fb055ecd9f3c97daa3e"
      ],
      "confidence": 0.9,
      "evidence": "delay human eosinophil and neutrophil apoptosis",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Target",
      "name": "eosinophil",
      "attributes": {
        "target_type": "cell"
      },
      "source_chunk_ids": [
        "809e8182aea21fb055ecd9f3c97daa3e"
      ],
      "confidence": 0.85,
      "evidence": "human eosinophil",
      "verified": true
    },
    {
      "id": "E6",
      "type": "Target",
      "name": "neutrophil",
      "attributes": {
        "target_type": "cell"
      },
      "source_chunk_ids": [
        "809e8182aea21fb055ecd9f3c97daa3e"
      ],
      "confidence": 0.85,
      "evidence": "neutrophil apoptosis",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Study",
      "name": "Jones et al. 2005",
      "attributes": {
        "design": "in vitro study",
        "year": 2005,
        "doi": "10.1016/j.pupt.2004.10.003"
      },
      "source_chunk_ids": [
        "d6d778e85c5d5c0847f77fbe1f6843b0"
      ],
      "confidence": 0.95,
      "evidence": "Jones NA, Boswell-Smith V, Lever R, Page CP. 2005",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Evidence",
      "name": "in vitro",
      "attributes": {
        "evidence_level": 2
      },
      "source_chunk_ids": [
        "d6d778e85c5d5c0847f77fbe1f6843b0"
      ],
      "confidence": 0.9,
      "evidence": "in vitro",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Target",
      "name": "phosphodiesterase isoenzyme",
      "attributes": {
        "target_type": "enzyme"
      },
      "source_chunk_ids": [
        "d6d778e85c5d5c0847f77fbe1f6843b0"
      ],
      "confidence": 0.85,
      "evidence": "selective phosphodiesterase isoenzyme inhibition",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Effect",
      "name": "neutrophil function",
      "attributes": {
        "level": "cellular",
        "valence": "neutral"
      },
      "source_chunk_ids": [
        "d6d778e85c5d5c0847f77fbe1f6843b0"
      ],
      "confidence": 0.8,
      "evidence": "neutrophil function",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Study",
      "name": "Heystek et al. 2003",
      "attributes": {
        "design": "in vitro study",
        "year": 2003,
        "doi": "10.1093/intimm/dxg081"
      },
      "source_chunk_ids": [
        "9a1a3a2fd07bb01ab29d4f610d5f8415"
      ],
      "confidence": 0.9,
      "evidence": "Heystek HC, Thierry AC, Soulard P, Moulon C. Phosphodiesterase 4 inhibitors reduce human dendritic cell inflammatory cytokine production and Th1-polarizing capacity. Int Immunol. 2003;15:827-35.",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Evidence",
      "name": "in vitro",
      "attributes": {
        "evidence_level": 2
      },
      "source_chunk_ids": [
        "9a1a3a2fd07bb01ab29d4f610d5f8415"
      ],
      "confidence": 0.85,
      "evidence": "Phosphodiesterase 4 inhibitors reduce human dendritic cell inflammatory cytokine production and Th1-polarizing capacity",
      "verified": true
    },
    {
      "id": "E3",
      "type": "CompoundClass",
      "name": "phosphodiesterase 4 inhibitors",
      "attributes": {},
      "source_chunk_ids": [
        "9a1a3a2fd07bb01ab29d4f610d5f8415"
      ],
      "confidence": 0.9,
      "evidence": "Phosphodiesterase 4 inhibitors",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Target",
      "name": "phosphodiesterase 4",
      "attributes": {
        "target_type": "enzyme"
      },
      "source_chunk_ids": [
        "9a1a3a2fd07bb01ab29d4f610d5f8415"
      ],
      "confidence": 0.9,
      "evidence": "Phosphodiesterase 4",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Effect",
      "name": "reduced inflammatory cytokine production",
      "attributes": {
        "level": "cellular",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "9a1a3a2fd07bb01ab29d4f610d5f8415"
      ],
      "confidence": 0.85,
      "evidence": "reduce human dendritic cell inflammatory cytokine production",
      "verified": true
    },
    {
      "id": "E6",
      "type": "Effect",
      "name": "reduced Th1-polarizing capacity",
      "attributes": {
        "level": "cellular",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "9a1a3a2fd07bb01ab29d4f610d5f8415"
      ],
      "confidence": 0.85,
      "evidence": "reduce Th1-polarizing capacity",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Study",
      "name": "Gantner et al. 1997",
      "attributes": {
        "design": "in vitro study",
        "year": 1997,
        "doi": "10.1111/j.1476-5381.1997.tb12400.x"
      },
      "source_chunk_ids": [
        "c7a9ab5c46d4c2e3f87017fd63698705"
      ],
      "confidence": 0.9,
      "evidence": "Gantner F, Kupferschmidt R, Schudt C, Wendel A, Hatzelmann A. In vitro differentiation of human monocytes to macrophages",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Evidence",
      "name": "in vitro",
      "attributes": {
        "evidence_level": 2
      },
      "source_chunk_ids": [
        "c7a9ab5c46d4c2e3f87017fd63698705"
      ],
      "confidence": 0.95,
      "evidence": "In vitro differentiation of human monocytes to macrophages",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Target",
      "name": "PDE",
      "attributes": {
        "target_type": "enzyme"
      },
      "source_chunk_ids": [
        "c7a9ab5c46d4c2e3f87017fd63698705"
      ],
      "confidence": 0.85,
      "evidence": "Change of PDE profile",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Target",
      "name": "tumour necrosis factor-alpha",
      "attributes": {
        "target_type": "cytokine"
      },
      "source_chunk_ids": [
        "c7a9ab5c46d4c2e3f87017fd63698705"
      ],
      "confidence": 0.9,
      "evidence": "suppression of tumour necrosis factor-alpha release",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Effect",
      "name": "suppression of TNF-alpha release",
      "attributes": {
        "level": "cellular",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "c7a9ab5c46d4c2e3f87017fd63698705"
      ],
      "confidence": 0.85,
      "evidence": "suppression of tumour necrosis factor-alpha release",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Study",
      "name": "Shichijo et al. 1998",
      "attributes": {
        "design": "in vitro study",
        "year": 1998,
        "doi": "10.1046/j.1365-2222.1998.00396.x"
      },
      "source_chunk_ids": [
        "5b988a712f198d2726111ac597494a61"
      ],
      "confidence": 0.95,
      "evidence": "Shichijo M, Inagaki N, Nakai N, Kimata M, Nakahata T, Serizawa I, et al. The effects of anti-asthma drugs on mediator release from cultured human mast cells. Clin Exp Allergy. 1998;28:1228-36.",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Evidence",
      "name": "in vitro",
      "attributes": {
        "evidence_level": 2
      },
      "source_chunk_ids": [
        "5b988a712f198d2726111ac597494a61"
      ],
      "confidence": 0.9,
      "evidence": "cultured human mast cells",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Target",
      "name": "human mast cells",
      "attributes": {
        "target_type": "cellular"
      },
      "source_chunk_ids": [
        "5b988a712f198d2726111ac597494a61"
      ],
      "confidence": 0.85,
      "evidence": "cultured human mast cells",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Effect",
      "name": "mediator release",
      "attributes": {
        "level": "cellular",
        "valence": "neutral"
      },
      "source_chunk_ids": [
        "5b988a712f198d2726111ac597494a61"
      ],
      "confidence": 0.8,
      "evidence": "mediator release",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Study",
      "name": "Haddad et al. 2002",
      "attributes": {
        "design": "in vitro study",
        "year": 2002,
        "doi": "JPharmacolExpTher. 2002;300:559-66"
      },
      "source_chunk_ids": [
        "8f8c0147f4712b5c8b194c46ee2dcef0"
      ],
      "confidence": 0.95,
      "evidence": "Haddad JJ, Land SC, Tarnow-Mordi WO, Zembala M, Kowalczyk D, Lauterbach R. Immunopharmacological potential of selective phosphodiesterase inhibition. I. Differential regulation of lipopolysaccharide-mediated proinflammatory cytokine (interleukin-6 and tumor necrosis factor-alpha) biosynthesis in alveolar epithelial cells. JPharmacolExpTher. 2002;300:559-66",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Evidence",
      "name": "in vitro",
      "attributes": {
        "evidence_level": 2
      },
      "source_chunk_ids": [
        "8f8c0147f4712b5c8b194c46ee2dcef0"
      ],
      "confidence": 0.9,
      "evidence": "Immunopharmacological potential of selective phosphodiesterase inhibition",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Target",
      "name": "phosphodiesterase",
      "attributes": {
        "target_type": "enzyme"
      },
      "source_chunk_ids": [
        "8f8c0147f4712b5c8b194c46ee2dcef0"
      ],
      "confidence": 0.85,
      "evidence": "selective phosphodiesterase inhibition",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Target",
      "name": "interleukin-6",
      "attributes": {
        "target_type": "cytokine"
      },
      "source_chunk_ids": [
        "8f8c0147f4712b5c8b194c46ee2dcef0"
      ],
      "confidence": 0.9,
      "evidence": "interleukin-6",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Target",
      "name": "tumor necrosis factor-alpha",
      "attributes": {
        "target_type": "cytokine"
      },
      "source_chunk_ids": [
        "8f8c0147f4712b5c8b194c46ee2dcef0"
      ],
      "confidence": 0.9,
      "evidence": "tumor necrosis factor-alpha",
      "verified": true
    },
    {
      "id": "E6",
      "type": "Effect",
      "name": "regulation of proinflammatory cytokine biosynthesis",
      "attributes": {
        "level": "cellular",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "8f8c0147f4712b5c8b194c46ee2dcef0"
      ],
      "confidence": 0.8,
      "evidence": "regulation of lipopolysaccharide-mediated proinflammatory cytokine biosynthesis",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Study",
      "name": "Sanz et al. 2007",
      "attributes": {
        "year": 2007,
        "doi": "10.1038/sj.bjp.0707427"
      },
      "source_chunk_ids": [
        "15c106a338f97b45a48b612a36b4b71a"
      ],
      "confidence": 0.95,
      "evidence": "Sanz MJ, Cortijo J, Taha MA, et al. Br J Pharmacol. 2007;152:481-92",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Evidence",
      "name": "in vitro/in vivo study",
      "attributes": {
        "evidence_level": 2
      },
      "source_chunk_ids": [
        "15c106a338f97b45a48b612a36b4b71a"
      ],
      "confidence": 0.85,
      "evidence": "Br J Pharmacol. 2007;152:481-92",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Compound",
      "name": "roflumilast",
      "attributes": {},
      "source_chunk_ids": [
        "15c106a338f97b45a48b612a36b4b71a"
      ],
      "confidence": 0.95,
      "evidence": "Roflumilast inhibits",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Target",
      "name": "leukocyte-endothelial cell interactions",
      "attributes": {
        "target_type": "process"
      },
      "source_chunk_ids": [
        "15c106a338f97b45a48b612a36b4b71a"
      ],
      "confidence": 0.9,
      "evidence": "inhibits leukocyte-endothelial cell interactions",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Target",
      "name": "adhesion molecules",
      "attributes": {
        "target_type": "molecule"
      },
      "source_chunk_ids": [
        "15c106a338f97b45a48b612a36b4b71a"
      ],
      "confidence": 0.9,
      "evidence": "expression of adhesion molecules",
      "verified": true
    },
    {
      "id": "E6",
      "type": "Target",
      "name": "microvascular permeability",
      "attributes": {
        "target_type": "process"
      },
      "source_chunk_ids": [
        "15c106a338f97b45a48b612a36b4b71a"
      ],
      "confidence": 0.9,
      "evidence": "microvascular permeability",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Study",
      "name": "Kohyama et al. 2002",
      "attributes": {
        "design": "in vitro study",
        "year": 2002,
        "doi": "10.1165/ajrcmb.27.4.487"
      },
      "source_chunk_ids": [
        "c2c52b4ee3fdd6ebe682afd8de05c7fa"
      ],
      "confidence": 0.95,
      "evidence": "Kohyama T, Liu X, Zhu YK, Wen FQ, Wang HJ, Fang Q, et al. Phosphodiesterase 4 inhibitor cilomilast inhibits fibroblast-mediated collagen gel degradation induced by tumor necrosis factor-alpha and neutrophil elastase. Am J Respir Cell Mol Biol. 2002;27:487-94.",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Evidence",
      "name": "in vitro",
      "attributes": {
        "evidence_level": 2
      },
      "source_chunk_ids": [
        "c2c52b4ee3fdd6ebe682afd8de05c7fa"
      ],
      "confidence": 0.9,
      "evidence": "inhibits fibroblast-mediated collagen gel degradation",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Compound",
      "name": "cilomilast",
      "attributes": {},
      "source_chunk_ids": [
        "c2c52b4ee3fdd6ebe682afd8de05c7fa"
      ],
      "confidence": 0.95,
      "evidence": "Phosphodiesterase 4 inhibitor cilomilast",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Target",
      "name": "phosphodiesterase 4",
      "attributes": {
        "target_type": "enzyme"
      },
      "source_chunk_ids": [
        "c2c52b4ee3fdd6ebe682afd8de05c7fa"
      ],
      "confidence": 0.9,
      "evidence": "Phosphodiesterase 4 inhibitor",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Effect",
      "name": "inhibition of fibroblast-mediated collagen gel degradation",
      "attributes": {
        "level": "cellular",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "c2c52b4ee3fdd6ebe682afd8de05c7fa"
      ],
      "confidence": 0.85,
      "evidence": "inhibits fibroblast-mediated collagen gel degradation",
      "verified": true
    },
    {
      "id": "E6",
      "type": "Target",
      "name": "tumor necrosis factor-alpha",
      "attributes": {
        "target_type": "cytokine"
      },
      "source_chunk_ids": [
        "c2c52b4ee3fdd6ebe682afd8de05c7fa"
      ],
      "confidence": 0.85,
      "evidence": "induced by tumor necrosis factor-alpha",
      "verified": true
    },
    {
      "id": "E7",
      "type": "Target",
      "name": "neutrophil elastase",
      "attributes": {
        "target_type": "enzyme"
      },
      "source_chunk_ids": [
        "c2c52b4ee3fdd6ebe682afd8de05c7fa"
      ],
      "confidence": 0.85,
      "evidence": "and neutrophil elastase",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Study",
      "name": "Martin-Chouly et al. 2004",
      "attributes": {
        "design": "in vitro study",
        "year": 2004,
        "doi": "10.1016/j.lfs.2003.12.015"
      },
      "source_chunk_ids": [
        "8c799fd0fdc47dee4b8745217c999baf"
      ],
      "confidence": 0.9,
      "evidence": "Martin-Chouly CA, Astier A, Jacob C, Pruniaux MP, Bertrand C, Lagente V. Modulation of matrix metalloproteinase production from human lung fibroblasts by type 4 phosphodiesterase inhibitors. Life Sci. 2004;75:823-40.",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Evidence",
      "name": "in vitro",
      "attributes": {
        "evidence_level": 2
      },
      "source_chunk_ids": [
        "8c799fd0fdc47dee4b8745217c999baf"
      ],
      "confidence": 0.85,
      "evidence": "Modulation of matrix metalloproteinase production from human lung fibroblasts",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Target",
      "name": "type 4 phosphodiesterase",
      "attributes": {
        "target_type": "enzyme"
      },
      "source_chunk_ids": [
        "8c799fd0fdc47dee4b8745217c999baf"
      ],
      "confidence": 0.9,
      "evidence": "type 4 phosphodiesterase inhibitors",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Effect",
      "name": "modulation of matrix metalloproteinase production",
      "attributes": {
        "level": "cellular",
        "valence": "neutral"
      },
      "source_chunk_ids": [
        "8c799fd0fdc47dee4b8745217c999baf"
      ],
      "confidence": 0.8,
      "evidence": "Modulation of matrix metalloproteinase production",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Study",
      "name": "Dunkern et al. 2007",
      "attributes": {
        "year": 2007,
        "doi": "10.1016/j.ejphar.2007.05.020"
      },
      "source_chunk_ids": [
        "05b03484accfb112df01bd4673317e6e"
      ],
      "confidence": 0.95,
      "evidence": "Dunkern TR, Feurstein D, Rossi GA, Sabatini F, Hatzelmann A. Inhibition of TGF-beta induced lung fibroblast to myofibroblast conversion by phosphodiesterase inhibiting drugs and activators of soluble guanylyl cyclase. Eur J Pharmacol. 2007;572:12-22.",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Evidence",
      "name": "in vitro study",
      "attributes": {
        "evidence_level": 2
      },
      "source_chunk_ids": [
        "05b03484accfb112df01bd4673317e6e"
      ],
      "confidence": 0.85,
      "evidence": "Inhibition of TGF-beta induced lung fibroblast to myofibroblast conversion",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Target",
      "name": "TGF-beta",
      "attributes": {
        "target_type": "cytokine"
      },
      "source_chunk_ids": [
        "05b03484accfb112df01bd4673317e6e"
      ],
      "confidence": 0.9,
      "evidence": "TGF-beta induced lung fibroblast to myofibroblast conversion",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Effect",
      "name": "inhibition of fibroblast to myofibroblast conversion",
      "attributes": {
        "level": "cellular",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "05b03484accfb112df01bd4673317e6e"
      ],
      "confidence": 0.85,
      "evidence": "Inhibition of TGF-beta induced lung fibroblast to myofibroblast conversion",
      "verified": true
    },
    {
      "id": "E5",
      "type": "CompoundClass",
      "name": "phosphodiesterase inhibiting drugs",
      "attributes": {},
      "source_chunk_ids": [
        "05b03484accfb112df01bd4673317e6e"
      ],
      "confidence": 0.8,
      "evidence": "phosphodiesterase inhibiting drugs",
      "verified": true
    },
    {
      "id": "E6",
      "type": "CompoundClass",
      "name": "activators of soluble guanylyl cyclase",
      "attributes": {},
      "source_chunk_ids": [
        "05b03484accfb112df01bd4673317e6e"
      ],
      "confidence": 0.8,
      "evidence": "activators of soluble guanylyl cyclase",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Study",
      "name": "Sabatini et al. 2010",
      "attributes": {
        "design": "in vitro study",
        "year": 2010,
        "doi": "10.1016/j.pupt.2010.02.002"
      },
      "source_chunk_ids": [
        "842552a6ce29cd889db78676fe57a657"
      ],
      "confidence": 0.9,
      "evidence": "Sabatini F, et al. A phosphodiesterase 4 inhibitor, roflumilast N-oxide, inhibits human lung fibroblast functions in vitro. PulmPharmacolTher. 2010;23:283-91.",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Evidence",
      "name": "in vitro",
      "attributes": {
        "evidence_level": 2
      },
      "source_chunk_ids": [
        "842552a6ce29cd889db78676fe57a657"
      ],
      "confidence": 0.95,
      "evidence": "inhibits human lung fibroblast functions in vitro",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Compound",
      "name": "roflumilast N-oxide",
      "attributes": {},
      "source_chunk_ids": [
        "842552a6ce29cd889db78676fe57a657"
      ],
      "confidence": 0.95,
      "evidence": "roflumilast N-oxide",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Target",
      "name": "phosphodiesterase 4",
      "attributes": {
        "target_type": "enzyme"
      },
      "source_chunk_ids": [
        "842552a6ce29cd889db78676fe57a657"
      ],
      "confidence": 0.9,
      "evidence": "phosphodiesterase 4 inhibitor",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Effect",
      "name": "inhibition of human lung fibroblast functions",
      "attributes": {
        "level": "cellular",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "842552a6ce29cd889db78676fe57a657"
      ],
      "confidence": 0.85,
      "evidence": "inhibits human lung fibroblast functions",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Study",
      "name": "Noh et al. 2009",
      "attributes": {
        "design": "in vitro study",
        "year": 2009,
        "doi": "10.1248/bpb.32.1844"
      },
      "source_chunk_ids": [
        "f3a78800fa6a7ca67a9a9f0ad8505069"
      ],
      "confidence": 0.9,
      "evidence": "Noh AL, Yang M, Lee JM, Park H, Lee DS, Yim M. Phosphodiesterase 3 and 4 negatively regulate receptor activator of nuclear factor-kappaB ligand-mediated osteoclast formation by prostaglandin E2. BiolPharmBull. 2009;32:1844-8.",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Evidence",
      "name": "in vitro",
      "attributes": {
        "evidence_level": 2
      },
      "source_chunk_ids": [
        "f3a78800fa6a7ca67a9a9f0ad8505069"
      ],
      "confidence": 0.85,
      "evidence": "BiolPharmBull. 2009;32:1844-8.",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Target",
      "name": "phosphodiesterase 3",
      "attributes": {
        "target_type": "enzyme"
      },
      "source_chunk_ids": [
        "f3a78800fa6a7ca67a9a9f0ad8505069"
      ],
      "confidence": 0.9,
      "evidence": "Phosphodiesterase 3 and 4 negatively regulate",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Target",
      "name": "phosphodiesterase 4",
      "attributes": {
        "target_type": "enzyme"
      },
      "source_chunk_ids": [
        "f3a78800fa6a7ca67a9a9f0ad8505069"
      ],
      "confidence": 0.9,
      "evidence": "Phosphodiesterase 3 and 4 negatively regulate",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Target",
      "name": "receptor activator of nuclear factor-kappaB ligand",
      "attributes": {
        "target_type": "ligand"
      },
      "source_chunk_ids": [
        "f3a78800fa6a7ca67a9a9f0ad8505069"
      ],
      "confidence": 0.85,
      "evidence": "receptor activator of nuclear factor-kappaB ligand-mediated osteoclast formation",
      "verified": true
    },
    {
      "id": "E6",
      "type": "Effect",
      "name": "osteoclast formation",
      "attributes": {
        "level": "cellular",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "f3a78800fa6a7ca67a9a9f0ad8505069"
      ],
      "confidence": 0.8,
      "evidence": "negatively regulate ... osteoclast formation",
      "verified": true
    },
    {
      "id": "E7",
      "type": "Compound",
      "name": "prostaglandin E2",
      "attributes": {},
      "source_chunk_ids": [
        "f3a78800fa6a7ca67a9a9f0ad8505069"
      ],
      "confidence": 0.9,
      "evidence": "by prostaglandin E2",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Study",
      "name": "Tenor et al. 2002",
      "attributes": {
        "year": 2002,
        "design": "in vitro study"
      },
      "source_chunk_ids": [
        "adbc71628f4796d6ce1adc55aecdebba"
      ],
      "confidence": 0.9,
      "evidence": "Tenor H, Hedbom E, Hauselmann HJ, Schudt C, Hatzelmann A. Phosphodiesterase isoenzyme families in human osteoarthritis chondrocytes--functional importance of phosphodiesterase 4. BrJPharmacol. 2002;135:609-18.",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Evidence",
      "name": "in vitro",
      "attributes": {
        "evidence_level": 2
      },
      "source_chunk_ids": [
        "adbc71628f4796d6ce1adc55aecdebba"
      ],
      "confidence": 0.85,
      "evidence": "Phosphodiesterase isoenzyme families in human osteoarthritis chondrocytes",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Condition",
      "name": "osteoarthritis",
      "attributes": {
        "condition_type": "disease"
      },
      "source_chunk_ids": [
        "adbc71628f4796d6ce1adc55aecdebba"
      ],
      "confidence": 0.9,
      "evidence": "human osteoarthritis chondrocytes",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Target",
      "name": "phosphodiesterase 4",
      "attributes": {
        "target_type": "enzyme"
      },
      "source_chunk_ids": [
        "adbc71628f4796d6ce1adc55aecdebba"
      ],
      "confidence": 0.9,
      "evidence": "functional importance of phosphodiesterase 4",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Study",
      "name": "Waddleton et al. 2008",
      "attributes": {
        "year": 2008,
        "doi": "10.1016/j.bcp.2008.07.025"
      },
      "source_chunk_ids": [
        "149e026769c9c50f949729918cf141ef"
      ],
      "confidence": 0.95,
      "evidence": "Waddleton D, Wu W, Feng Y, Thompson C, Wu M, Zhou YP, et al. Phosphodiesterase 3 and 4 comprise the major cAMP metabolizing enzymes responsible for insulin secretion in INS-1 (832/13) cells and rat islets. Biochem Pharmacol. 2008;76:884-93.",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Evidence",
      "name": "in vitro study",
      "attributes": {
        "evidence_level": 2
      },
      "source_chunk_ids": [
        "149e026769c9c50f949729918cf141ef"
      ],
      "confidence": 0.85,
      "evidence": "in INS-1 (832/13) cells and rat islets",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Target",
      "name": "phosphodiesterase 3",
      "attributes": {
        "target_type": "enzyme"
      },
      "source_chunk_ids": [
        "149e026769c9c50f949729918cf141ef"
      ],
      "confidence": 0.9,
      "evidence": "Phosphodiesterase 3",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Target",
      "name": "phosphodiesterase 4",
      "attributes": {
        "target_type": "enzyme"
      },
      "source_chunk_ids": [
        "149e026769c9c50f949729918cf141ef"
      ],
      "confidence": 0.9,
      "evidence": "Phosphodiesterase 4",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Effect",
      "name": "insulin secretion",
      "attributes": {
        "level": "cellular",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "149e026769c9c50f949729918cf141ef"
      ],
      "confidence": 0.9,
      "evidence": "responsible for insulin secretion",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Study",
      "name": "Tashkin et al. 2007",
      "attributes": {
        "design": "trial",
        "sample_size": null,
        "duration": "4 year",
        "year": 2007,
        "doi": null
      },
      "source_chunk_ids": [
        "c5a676cfad3cb843b531204b89815ae7"
      ],
      "confidence": 0.9,
      "evidence": "A 4 year trial of tiotropium",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Evidence",
      "name": "clinical trial",
      "attributes": {
        "evidence_level": 4
      },
      "source_chunk_ids": [
        "c5a676cfad3cb843b531204b89815ae7"
      ],
      "confidence": 0.85,
      "evidence": "trial of tiotropium",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Condition",
      "name": "chronic obstructive pulmonary disease",
      "attributes": {
        "condition_type": "disease"
      },
      "source_chunk_ids": [
        "c5a676cfad3cb843b531204b89815ae7"
      ],
      "confidence": 0.95,
      "evidence": "chronic obstructive pulmonary disease",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Study",
      "name": "Aaron et al. 2007",
      "attributes": {
        "design": "clinical trial",
        "year": 2007,
        "doi": "10.7326/0003-4819-146-8-200704170-00152"
      },
      "source_chunk_ids": [
        "7897de50955264e9f142a39d35bcd9db"
      ],
      "confidence": 0.9,
      "evidence": "Aaron SD, Vandemheen KL, Ferguson EW, Maltals F, Bourbeau J, Goldstein R, et al. Tiotropium in combination with placebo, salmeterol, or fluticasone-salmeterol for treatment of chronic obstructive pulmonary disease. Ann Intern Med. 2007;146:545-55.",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Evidence",
      "name": "clinical trial",
      "attributes": {
        "evidence_level": 4
      },
      "source_chunk_ids": [
        "7897de50955264e9f142a39d35bcd9db"
      ],
      "confidence": 0.85,
      "evidence": "clinical trial in Ann Intern Med",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Condition",
      "name": "chronic obstructive pulmonary disease",
      "attributes": {
        "condition_type": "disease"
      },
      "source_chunk_ids": [
        "7897de50955264e9f142a39d35bcd9db"
      ],
      "confidence": 0.95,
      "evidence": "chronic obstructive pulmonary disease",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Compound",
      "name": "tiotropium",
      "attributes": {},
      "source_chunk_ids": [
        "7897de50955264e9f142a39d35bcd9db"
      ],
      "confidence": 0.9,
      "evidence": "Tiotropium",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Compound",
      "name": "salmeterol",
      "attributes": {},
      "source_chunk_ids": [
        "7897de50955264e9f142a39d35bcd9db"
      ],
      "confidence": 0.9,
      "evidence": "salmeterol",
      "verified": true
    },
    {
      "id": "E6",
      "type": "Compound",
      "name": "fluticasone-salmeterol",
      "attributes": {},
      "source_chunk_ids": [
        "7897de50955264e9f142a39d35bcd9db"
      ],
      "confidence": 0.85,
      "evidence": "fluticasone-salmeterol",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Study",
      "name": "Szafranski et al. 2003",
      "attributes": {
        "design": "clinical trial",
        "year": 2003,
        "doi": "10.1183/09031936.03.00074003"
      },
      "source_chunk_ids": [
        "38a6b974f636ca8be20de4eac5403014"
      ],
      "confidence": 0.9,
      "evidence": "Szafranski W, Cukier A, Ramirez A, Menga G, Sansores R, Nahabedian S, et al. Efficacy and safety of budesonide/formoterol in the management of chronic obstructive pulmonary disease. European Respiratory Journal. 2003;21:74-81.",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Evidence",
      "name": "clinical trial",
      "attributes": {
        "evidence_level": 4
      },
      "source_chunk_ids": [
        "38a6b974f636ca8be20de4eac5403014"
      ],
      "confidence": 0.85,
      "evidence": "Efficacy and safety of budesonide/formoterol",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Product",
      "name": "budesonide/formoterol",
      "attributes": {},
      "source_chunk_ids": [
        "38a6b974f636ca8be20de4eac5403014"
      ],
      "confidence": 0.95,
      "evidence": "budesonide/formoterol",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Condition",
      "name": "chronic obstructive pulmonary disease",
      "attributes": {
        "condition_type": "disease"
      },
      "source_chunk_ids": [
        "38a6b974f636ca8be20de4eac5403014"
      ],
      "confidence": 0.95,
      "evidence": "chronic obstructive pulmonary disease",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Study",
      "name": "Reference 16",
      "attributes": {
        "duration": "6 weeks",
        "design": "clinical trial"
      },
      "source_chunk_ids": [
        "4d392be27b2149bd3cf1077899a18770"
      ],
      "confidence": 0.8,
      "evidence": "Reference 6 weeks",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Study",
      "name": "Reference 27",
      "attributes": {
        "duration": "24 weeks",
        "design": "clinical trial"
      },
      "source_chunk_ids": [
        "4d392be27b2149bd3cf1077899a18770"
      ],
      "confidence": 0.8,
      "evidence": "24 weeks Reference 27",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Study",
      "name": "Reference 35",
      "attributes": {
        "duration": "24 weeks",
        "design": "clinical trial"
      },
      "source_chunk_ids": [
        "4d392be27b2149bd3cf1077899a18770"
      ],
      "confidence": 0.8,
      "evidence": "24 weeks Reference 35",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Evidence",
      "name": "clinical trial",
      "attributes": {
        "evidence_level": 4
      },
      "source_chunk_ids": [
        "4d392be27b2149bd3cf1077899a18770"
      ],
      "confidence": 0.7,
      "evidence": "Treatment Groups",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Product",
      "name": "Cilomilast",
      "attributes": {},
      "source_chunk_ids": [
        "4d392be27b2149bd3cf1077899a18770"
      ],
      "confidence": 0.9,
      "evidence": "Cilomilast 5 mg bid",
      "verified": true
    },
    {
      "id": "E6",
      "type": "Product",
      "name": "Roflumilast",
      "attributes": {},
      "source_chunk_ids": [
        "4d392be27b2149bd3cf1077899a18770"
      ],
      "confidence": 0.9,
      "evidence": "Roflumilast 0.25 mg",
      "verified": true
    },
    {
      "id": "E7",
      "type": "Dosage",
      "name": "5 mg bid",
      "attributes": {
        "amount": 5,
        "unit": "mg",
        "frequency": "bid"
      },
      "source_chunk_ids": [
        "4d392be27b2149bd3cf1077899a18770"
      ],
      "confidence": 0.85,
      "evidence": "Cilomilast 5 mg bid",
      "verified": true
    },
    {
      "id": "E8",
      "type": "Dosage",
      "name": "10 mg bid",
      "attributes": {
        "amount": 10,
        "unit": "mg",
        "frequency": "bid"
      },
      "source_chunk_ids": [
        "4d392be27b2149bd3cf1077899a18770"
      ],
      "confidence": 0.85,
      "evidence": "Cilomilast 10 mg bid",
      "verified": true
    },
    {
      "id": "E9",
      "type": "Dosage",
      "name": "15 mg bid",
      "attributes": {
        "amount": 15,
        "unit": "mg",
        "frequency": "bid"
      },
      "source_chunk_ids": [
        "4d392be27b2149bd3cf1077899a18770"
      ],
      "confidence": 0.85,
      "evidence": "Cilomilast 15 mg bid",
      "verified": true
    },
    {
      "id": "E10",
      "type": "Dosage",
      "name": "0.25 mg",
      "attributes": {
        "amount": 0.25,
        "unit": "mg"
      },
      "source_chunk_ids": [
        "4d392be27b2149bd3cf1077899a18770"
      ],
      "confidence": 0.85,
      "evidence": "Roflumilast 0.25 mg",
      "verified": true
    },
    {
      "id": "E11",
      "type": "Dosage",
      "name": "0.5 mg",
      "attributes": {
        "amount": 0.5,
        "unit": "mg"
      },
      "source_chunk_ids": [
        "4d392be27b2149bd3cf1077899a18770"
      ],
      "confidence": 0.85,
      "evidence": "Roflumilast 0.5 mg",
      "verified": true
    },
    {
      "id": "E12",
      "type": "Effect",
      "name": "FEV1 increase",
      "attributes": {
        "level": "systemic",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "4d392be27b2149bd3cf1077899a18770"
      ],
      "confidence": 0.8,
      "evidence": "160 mL increase over placebo",
      "verified": true
    },
    {
      "id": "E13",
      "type": "Effect",
      "name": "SGRQ score change",
      "attributes": {
        "level": "systemic",
        "valence": "neutral"
      },
      "source_chunk_ids": [
        "4d392be27b2149bd3cf1077899a18770"
      ],
      "confidence": 0.8,
      "evidence": "3.9 units cf placebo",
      "verified": true
    },
    {
      "id": "E14",
      "type": "Effect",
      "name": "FEV1 increase",
      "attributes": {
        "level": "systemic",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "4d392be27b2149bd3cf1077899a18770"
      ],
      "confidence": 0.8,
      "evidence": "40 mL increase over placebo",
      "verified": true
    },
    {
      "id": "E15",
      "type": "Effect",
      "name": "SGRQ score change",
      "attributes": {
        "level": "systemic",
        "valence": "neutral"
      },
      "source_chunk_ids": [
        "4d392be27b2149bd3cf1077899a18770"
      ],
      "confidence": 0.8,
      "evidence": "4.1 units cf placebo",
      "verified": true
    },
    {
      "id": "E16",
      "type": "Effect",
      "name": "exacerbation decrease",
      "attributes": {
        "level": "systemic",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "4d392be27b2149bd3cf1077899a18770"
      ],
      "confidence": 0.8,
      "evidence": "39% decrease",
      "verified": true
    },
    {
      "id": "E17",
      "type": "Effect",
      "name": "FEV1 increase",
      "attributes": {
        "level": "systemic",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "4d392be27b2149bd3cf1077899a18770"
      ],
      "confidence": 0.8,
      "evidence": "64 and 88 ml increase over placebo",
      "verified": true
    },
    {
      "id": "E18",
      "type": "Effect",
      "name": "FEV1 increase",
      "attributes": {
        "level": "systemic",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "4d392be27b2149bd3cf1077899a18770"
      ],
      "confidence": 0.8,
      "evidence": "74 and 97 ml increase over placebo",
      "verified": true
    },
    {
      "id": "E19",
      "type": "Effect",
      "name": "SGRQ score change",
      "attributes": {
        "level": "systemic",
        "valence": "neutral"
      },
      "source_chunk_ids": [
        "4d392be27b2149bd3cf1077899a18770"
      ],
      "confidence": 0.8,
      "evidence": "1.7 units cf placebo",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Study",
      "name": "M2-127",
      "attributes": {
        "design": "randomized controlled trial",
        "duration": "24 weeks",
        "sample_size": 466
      },
      "source_chunk_ids": [
        "545e791f7c21d448db7de6e97f7e3c73"
      ],
      "confidence": 0.8,
      "evidence": "24 weeks (M2-127)",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Study",
      "name": "M2-128",
      "attributes": {
        "design": "randomized controlled trial",
        "duration": "24 weeks",
        "sample_size": 371
      },
      "source_chunk_ids": [
        "545e791f7c21d448db7de6e97f7e3c73"
      ],
      "confidence": 0.8,
      "evidence": "24 weeks (M2-128)",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Evidence",
      "name": "clinical trial",
      "attributes": {
        "evidence_level": 4
      },
      "source_chunk_ids": [
        "545e791f7c21d448db7de6e97f7e3c73"
      ],
      "confidence": 0.75,
      "evidence": "randomized controlled trial",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Product",
      "name": "Roflumilast",
      "attributes": {},
      "source_chunk_ids": [
        "545e791f7c21d448db7de6e97f7e3c73"
      ],
      "confidence": 0.9,
      "evidence": "Roflumilast 0.5 mg od",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Dosage",
      "name": "0.5 mg once daily",
      "attributes": {
        "amount": 0.5,
        "unit": "mg",
        "frequency": "once daily",
        "route": "oral"
      },
      "source_chunk_ids": [
        "545e791f7c21d448db7de6e97f7e3c73"
      ],
      "confidence": 0.85,
      "evidence": "Roflumilast 0.5 mg od",
      "verified": true
    },
    {
      "id": "E6",
      "type": "Condition",
      "name": "COPD",
      "attributes": {
        "condition_type": "disease"
      },
      "source_chunk_ids": [
        "545e791f7c21d448db7de6e97f7e3c73"
      ],
      "confidence": 0.7,
      "evidence": "GOLD IV",
      "verified": true
    },
    {
      "id": "E7",
      "type": "Effect",
      "name": "improved lung function",
      "attributes": {
        "level": "systemic",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "545e791f7c21d448db7de6e97f7e3c73"
      ],
      "confidence": 0.75,
      "evidence": "FEV1 increase over placebo",
      "verified": true
    },
    {
      "id": "E8",
      "type": "Effect",
      "name": "reduced exacerbations",
      "attributes": {
        "level": "systemic",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "545e791f7c21d448db7de6e97f7e3c73"
      ],
      "confidence": 0.8,
      "evidence": "Exacerbations 34% decrease",
      "verified": true
    },
    {
      "id": "E9",
      "type": "Effect",
      "name": "no significant effect on dyspnea",
      "attributes": {
        "level": "systemic",
        "valence": "neutral"
      },
      "source_chunk_ids": [
        "545e791f7c21d448db7de6e97f7e3c73"
      ],
      "confidence": 0.7,
      "evidence": "NS cf placebo/salmeterol",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Study",
      "name": "clinical trial (52 weeks)",
      "attributes": {
        "duration": "52 weeks"
      },
      "source_chunk_ids": [
        "d0a5faf93b3b21951f93e0e2728612ad"
      ],
      "confidence": 0.8,
      "evidence": "52 weeks",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Evidence",
      "name": "clinical trial",
      "attributes": {
        "evidence_level": 4
      },
      "source_chunk_ids": [
        "d0a5faf93b3b21951f93e0e2728612ad"
      ],
      "confidence": 0.75,
      "evidence": "compared with placebo",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Condition",
      "name": "lung function decline",
      "attributes": {
        "condition_type": "symptom"
      },
      "source_chunk_ids": [
        "d0a5faf93b3b21951f93e0e2728612ad"
      ],
      "confidence": 0.85,
      "evidence": "Rate of decline in lung function",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Condition",
      "name": "exacerbations",
      "attributes": {
        "condition_type": "symptom"
      },
      "source_chunk_ids": [
        "d0a5faf93b3b21951f93e0e2728612ad"
      ],
      "confidence": 0.8,
      "evidence": "Exacerbations",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Condition",
      "name": "hospitalizations",
      "attributes": {
        "condition_type": "symptom"
      },
      "source_chunk_ids": [
        "d0a5faf93b3b21951f93e0e2728612ad"
      ],
      "confidence": 0.8,
      "evidence": "Hospitalizations",
      "verified": true
    },
    {
      "id": "E6",
      "type": "Condition",
      "name": "dyspnea",
      "attributes": {
        "condition_type": "symptom"
      },
      "source_chunk_ids": [
        "d0a5faf93b3b21951f93e0e2728612ad"
      ],
      "confidence": 0.8,
      "evidence": "Dyspnea",
      "verified": true
    },
    {
      "id": "E7",
      "type": "Effect",
      "name": "improved lung function",
      "attributes": {
        "level": "systemic",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "d0a5faf93b3b21951f93e0e2728612ad"
      ],
      "confidence": 0.7,
      "evidence": "27 ml increase in Tio/placebo group",
      "verified": true
    },
    {
      "id": "E8",
      "type": "Effect",
      "name": "reduced exacerbations",
      "attributes": {
        "level": "systemic",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "d0a5faf93b3b21951f93e0e2728612ad"
      ],
      "confidence": 0.7,
      "evidence": "Combination therapy reduced incidence",
      "verified": true
    },
    {
      "id": "E9",
      "type": "Effect",
      "name": "improved SGRQ scores",
      "attributes": {
        "level": "systemic",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "d0a5faf93b3b21951f93e0e2728612ad"
      ],
      "confidence": 0.7,
      "evidence": "Tio/placebo (-4.5 units)",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Study",
      "name": "Study 1",
      "attributes": {
        "design": "randomized controlled trial",
        "duration": "3 years",
        "sample_size": 1524
      },
      "source_chunk_ids": [
        "116620b4a25e8274c079fbf67c70b44f"
      ],
      "confidence": 0.8,
      "evidence": "3 yearsPlacebo (1524/851)",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Evidence",
      "name": "clinical trial",
      "attributes": {
        "evidence_level": 4
      },
      "source_chunk_ids": [
        "116620b4a25e8274c079fbf67c70b44f"
      ],
      "confidence": 0.75,
      "evidence": "randomized controlled trial",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Condition",
      "name": "COPD",
      "attributes": {
        "condition_type": "disease"
      },
      "source_chunk_ids": [
        "116620b4a25e8274c079fbf67c70b44f"
      ],
      "confidence": 0.9,
      "evidence": "Mortality (COPD related)",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Effect",
      "name": "improved lung function",
      "attributes": {
        "level": "systemic",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "116620b4a25e8274c079fbf67c70b44f"
      ],
      "confidence": 0.7,
      "evidence": "Postbronchodilator FEV1",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Effect",
      "name": "reduced exacerbations",
      "attributes": {
        "level": "systemic",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "116620b4a25e8274c079fbf67c70b44f"
      ],
      "confidence": 0.7,
      "evidence": "Exacerbations",
      "verified": true
    },
    {
      "id": "E6",
      "type": "Effect",
      "name": "improved quality of life",
      "attributes": {
        "level": "systemic",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "116620b4a25e8274c079fbf67c70b44f"
      ],
      "confidence": 0.7,
      "evidence": "SGRQ",
      "verified": true
    },
    {
      "id": "E7",
      "type": "Study",
      "name": "Study 2",
      "attributes": {
        "design": "randomized controlled trial",
        "duration": "52 weeks",
        "sample_size": 205
      },
      "source_chunk_ids": [
        "116620b4a25e8274c079fbf67c70b44f"
      ],
      "confidence": 0.8,
      "evidence": "52 weeksPlacebo (205/115)",
      "verified": true
    },
    {
      "id": "E8",
      "type": "Evidence",
      "name": "clinical trial",
      "attributes": {
        "evidence_level": 4
      },
      "source_chunk_ids": [
        "116620b4a25e8274c079fbf67c70b44f"
      ],
      "confidence": 0.75,
      "evidence": "randomized controlled trial",
      "verified": true
    },
    {
      "id": "E9",
      "type": "Condition",
      "name": "COPD",
      "attributes": {
        "condition_type": "disease"
      },
      "source_chunk_ids": [
        "116620b4a25e8274c079fbf67c70b44f"
      ],
      "confidence": 0.9,
      "evidence": "Exacerbations",
      "verified": true
    },
    {
      "id": "E10",
      "type": "Effect",
      "name": "improved lung function",
      "attributes": {
        "level": "systemic",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "116620b4a25e8274c079fbf67c70b44f"
      ],
      "confidence": 0.7,
      "evidence": "Prebronchodilator FEV1",
      "verified": true
    },
    {
      "id": "E11",
      "type": "Effect",
      "name": "reduced severe exacerbations",
      "attributes": {
        "level": "systemic",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "116620b4a25e8274c079fbf67c70b44f"
      ],
      "confidence": 0.7,
      "evidence": "reduced mean severe exacerbation rate",
      "verified": true
    },
    {
      "id": "E12",
      "type": "Effect",
      "name": "improved quality of life",
      "attributes": {
        "level": "systemic",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "116620b4a25e8274c079fbf67c70b44f"
      ],
      "confidence": 0.7,
      "evidence": "SGRQ",
      "verified": true
    }
  ],
  "relationships": [
    {
      "id": "R1",
      "type": "ACTS_ON",
      "source_entity_id": "E1",
      "target_entity_id": "E2",
      "attributes": {
        "action": "inhibits"
      },
      "confidence": 0.9,
      "evidence": "phosphodiesterase-4 inhibitor",
      "source_chunk_ids": [
        "d3da59e0f52baa49faea378b5fac5a17"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "TREATS",
      "source_entity_id": "E1",
      "target_entity_id": "E3",
      "attributes": {
        "context": "clinical"
      },
      "confidence": 0.85,
      "evidence": "therapy for COPD",
      "source_chunk_ids": [
        "d3da59e0f52baa49faea378b5fac5a17"
      ],
      "supporting_study_ids": [
        "E11",
        "E13"
      ],
      "verified": true
    },
    {
      "id": "R3",
      "type": "TREATS",
      "source_entity_id": "E1",
      "target_entity_id": "E4",
      "attributes": {
        "context": "clinical"
      },
      "confidence": 0.7,
      "evidence": "patients with symptoms of chronic bronchitis",
      "source_chunk_ids": [
        "d3da59e0f52baa49faea378b5fac5a17"
      ],
      "supporting_study_ids": [
        "E11"
      ],
      "verified": true
    },
    {
      "id": "R4",
      "type": "PRODUCES",
      "source_entity_id": "E1",
      "target_entity_id": "E5",
      "attributes": {},
      "confidence": 0.75,
      "evidence": "improving lung function",
      "source_chunk_ids": [
        "d3da59e0f52baa49faea378b5fac5a17"
      ],
      "supporting_study_ids": [
        "E11"
      ],
      "verified": true
    },
    {
      "id": "R5",
      "type": "PRODUCES",
      "source_entity_id": "E1",
      "target_entity_id": "E6",
      "attributes": {},
      "confidence": 0.75,
      "evidence": "reducing exacerbation rates",
      "source_chunk_ids": [
        "d3da59e0f52baa49faea378b5fac5a17"
      ],
      "supporting_study_ids": [
        "E11"
      ],
      "verified": true
    },
    {
      "id": "R6",
      "type": "PRODUCES",
      "source_entity_id": "E1",
      "target_entity_id": "E7",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "anti-inflammatory activity",
      "source_chunk_ids": [
        "d3da59e0f52baa49faea378b5fac5a17"
      ],
      "supporting_study_ids": [
        "E11"
      ],
      "verified": true
    },
    {
      "id": "R7",
      "type": "CAUSES",
      "source_entity_id": "E1",
      "target_entity_id": "E8",
      "attributes": {
        "context": "clinical",
        "severity": "mild to moderate"
      },
      "confidence": 0.7,
      "evidence": "nausea",
      "source_chunk_ids": [
        "d3da59e0f52baa49faea378b5fac5a17"
      ],
      "supporting_study_ids": [
        "E11"
      ],
      "verified": true
    },
    {
      "id": "R8",
      "type": "CAUSES",
      "source_entity_id": "E1",
      "target_entity_id": "E9",
      "attributes": {
        "context": "clinical",
        "severity": "mild to moderate"
      },
      "confidence": 0.7,
      "evidence": "diarrhea",
      "source_chunk_ids": [
        "d3da59e0f52baa49faea378b5fac5a17"
      ],
      "supporting_study_ids": [
        "E11"
      ],
      "verified": true
    },
    {
      "id": "R9",
      "type": "CAUSES",
      "source_entity_id": "E1",
      "target_entity_id": "E10",
      "attributes": {
        "context": "clinical",
        "severity": "mild to moderate"
      },
      "confidence": 0.7,
      "evidence": "weight loss",
      "source_chunk_ids": [
        "d3da59e0f52baa49faea378b5fac5a17"
      ],
      "supporting_study_ids": [
        "E11"
      ],
      "verified": true
    },
    {
      "id": "R10",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E11",
      "target_entity_id": "E12",
      "attributes": {},
      "confidence": 0.85,
      "evidence": "phase III trials",
      "source_chunk_ids": [
        "d3da59e0f52baa49faea378b5fac5a17"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R11",
      "type": "STUDIES",
      "source_entity_id": "E11",
      "target_entity_id": "E1",
      "attributes": {
        "role": "intervention"
      },
      "confidence": 0.8,
      "evidence": "roflumilast showed sustained clinical efficacy",
      "source_chunk_ids": [
        "d3da59e0f52baa49faea378b5fac5a17"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R12",
      "type": "REPORTS",
      "source_entity_id": "E11",
      "target_entity_id": "E5",
      "attributes": {
        "outcome": "improves"
      },
      "confidence": 0.75,
      "evidence": "improving lung function",
      "source_chunk_ids": [
        "d3da59e0f52baa49faea378b5fac5a17"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R13",
      "type": "REPORTS",
      "source_entity_id": "E11",
      "target_entity_id": "E6",
      "attributes": {
        "outcome": "improves"
      },
      "confidence": 0.75,
      "evidence": "reducing exacerbation rates",
      "source_chunk_ids": [
        "d3da59e0f52baa49faea378b5fac5a17"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R14",
      "type": "REPORTS",
      "source_entity_id": "E11",
      "target_entity_id": "E8",
      "attributes": {
        "outcome": "occurs"
      },
      "confidence": 0.7,
      "evidence": "nausea",
      "source_chunk_ids": [
        "d3da59e0f52baa49faea378b5fac5a17"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R15",
      "type": "REPORTS",
      "source_entity_id": "E11",
      "target_entity_id": "E9",
      "attributes": {
        "outcome": "occurs"
      },
      "confidence": 0.7,
      "evidence": "diarrhea",
      "source_chunk_ids": [
        "d3da59e0f52baa49faea378b5fac5a17"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R16",
      "type": "REPORTS",
      "source_entity_id": "E11",
      "target_entity_id": "E10",
      "attributes": {
        "outcome": "occurs"
      },
      "confidence": 0.7,
      "evidence": "weight loss",
      "source_chunk_ids": [
        "d3da59e0f52baa49faea378b5fac5a17"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R17",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E13",
      "target_entity_id": "E14",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "4 registration studies",
      "source_chunk_ids": [
        "d3da59e0f52baa49faea378b5fac5a17"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R18",
      "type": "STUDIES",
      "source_entity_id": "E13",
      "target_entity_id": "E1",
      "attributes": {
        "role": "intervention"
      },
      "confidence": 0.75,
      "evidence": "promising effects of roflumilast",
      "source_chunk_ids": [
        "d3da59e0f52baa49faea378b5fac5a17"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R1",
      "type": "PRODUCES",
      "source_entity_id": "E1",
      "target_entity_id": "E2",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "present as fixed airway obstruction",
      "source_chunk_ids": [
        "d05f126c25b11e1889fd080365b5f49b"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "PRODUCES",
      "source_entity_id": "E1",
      "target_entity_id": "E3",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "present as hyperinflation",
      "source_chunk_ids": [
        "d05f126c25b11e1889fd080365b5f49b"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "PRODUCES",
      "source_entity_id": "E1",
      "target_entity_id": "E4",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "present as dyspnea",
      "source_chunk_ids": [
        "d05f126c25b11e1889fd080365b5f49b"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R4",
      "type": "PRODUCES",
      "source_entity_id": "E1",
      "target_entity_id": "E5",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "present as mucus hypersecretion",
      "source_chunk_ids": [
        "d05f126c25b11e1889fd080365b5f49b"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R5",
      "type": "PRODUCES",
      "source_entity_id": "E1",
      "target_entity_id": "E6",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "present as chronic cough",
      "source_chunk_ids": [
        "d05f126c25b11e1889fd080365b5f49b"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R6",
      "type": "PRODUCES",
      "source_entity_id": "E1",
      "target_entity_id": "E7",
      "attributes": {},
      "confidence": 0.75,
      "evidence": "impairment of the overall health status",
      "source_chunk_ids": [
        "d05f126c25b11e1889fd080365b5f49b"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R7",
      "type": "PRODUCES",
      "source_entity_id": "E1",
      "target_entity_id": "E8",
      "attributes": {},
      "confidence": 0.85,
      "evidence": "characterized by chronic inflammation",
      "source_chunk_ids": [
        "d05f126c25b11e1889fd080365b5f49b"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R8",
      "type": "PRODUCES",
      "source_entity_id": "E1",
      "target_entity_id": "E9",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "features of airway remodeling",
      "source_chunk_ids": [
        "d05f126c25b11e1889fd080365b5f49b"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R9",
      "type": "PRODUCES",
      "source_entity_id": "E1",
      "target_entity_id": "E10",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "destruction of alveolar tissue",
      "source_chunk_ids": [
        "d05f126c25b11e1889fd080365b5f49b"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R1",
      "type": "SUGGESTS",
      "source_entity_id": "E2",
      "target_entity_id": "E1",
      "attributes": {
        "mapping_type": "direct",
        "role": "etiological_factor"
      },
      "confidence": 0.85,
      "evidence": "cigarette smoking is the most common etiological factor in COPD",
      "source_chunk_ids": [
        "b340c01e8afdeed34a553f42af6cfc37"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "SUGGESTS",
      "source_entity_id": "E3",
      "target_entity_id": "E1",
      "attributes": {
        "mapping_type": "direct",
        "role": "treatment"
      },
      "confidence": 0.8,
      "evidence": "smoking cessation is still the cornerstone in the treatment of COPD",
      "source_chunk_ids": [
        "b340c01e8afdeed34a553f42af6cfc37"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R1",
      "type": "PRODUCES",
      "source_entity_id": "E2",
      "target_entity_id": "E1",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "produce temporary improvements in lung function",
      "source_chunk_ids": [
        "16db1237b95878aba5316196e824be35"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "PRODUCES",
      "source_entity_id": "E3",
      "target_entity_id": "E1",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "produce temporary improvements in exercise tolerance",
      "source_chunk_ids": [
        "16db1237b95878aba5316196e824be35"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "PRODUCES",
      "source_entity_id": "E4",
      "target_entity_id": "E1",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "produce temporary improvements in quality of life",
      "source_chunk_ids": [
        "16db1237b95878aba5316196e824be35"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R4",
      "type": "PRODUCES",
      "source_entity_id": "E5",
      "target_entity_id": "E1",
      "attributes": {
        "verification_needed": true
      },
      "confidence": 0.6,
      "evidence": "reducing exacerbations",
      "source_chunk_ids": [
        "16db1237b95878aba5316196e824be35"
      ],
      "supporting_study_ids": [],
      "verified": false
    },
    {
      "id": "R5",
      "type": "PRODUCES",
      "source_entity_id": "E6",
      "target_entity_id": "E1",
      "attributes": {
        "verification_needed": true
      },
      "confidence": 0.6,
      "evidence": "rate of decline in lung function",
      "source_chunk_ids": [
        "16db1237b95878aba5316196e824be35"
      ],
      "supporting_study_ids": [],
      "verified": false
    },
    {
      "id": "R6",
      "type": "PRODUCES",
      "source_entity_id": "E7",
      "target_entity_id": "E1",
      "attributes": {
        "assertion": "refutes",
        "verification_needed": true
      },
      "confidence": 0.65,
      "evidence": "do not improve the systemic features of COPD",
      "source_chunk_ids": [
        "16db1237b95878aba5316196e824be35"
      ],
      "supporting_study_ids": [],
      "verified": false
    },
    {
      "id": "R7",
      "type": "CAUSES",
      "source_entity_id": "E8",
      "target_entity_id": "E1",
      "attributes": {
        "context": "clinical"
      },
      "confidence": 0.7,
      "evidence": "increase morbidity and mortality due to cardiac comorbidity",
      "source_chunk_ids": [
        "16db1237b95878aba5316196e824be35"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R8",
      "type": "PRODUCES",
      "source_entity_id": "E9",
      "target_entity_id": "E1",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "experience exacerbations",
      "source_chunk_ids": [
        "16db1237b95878aba5316196e824be35"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R9",
      "type": "PRODUCES",
      "source_entity_id": "E10",
      "target_entity_id": "E1",
      "attributes": {},
      "confidence": 0.75,
      "evidence": "sustained clinical efficacy for a more optimal treatment of COPD",
      "source_chunk_ids": [
        "16db1237b95878aba5316196e824be35"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R1",
      "type": "TREATS",
      "source_entity_id": "E1",
      "target_entity_id": "E2",
      "attributes": {
        "context": "historical"
      },
      "confidence": 0.75,
      "evidence": "treatment of COPD",
      "source_chunk_ids": [
        "577d177f1cd27b22ce2d1d8fc371d264"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E3",
      "target_entity_id": "E4",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "Hirsch and colleagues in 1922",
      "source_chunk_ids": [
        "577d177f1cd27b22ce2d1d8fc371d264"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "STUDIES",
      "source_entity_id": "E3",
      "target_entity_id": "E1",
      "attributes": {
        "role": "target",
        "verification_needed": true
      },
      "confidence": 0.65,
      "evidence": "Phosphodiesterase inhibition",
      "source_chunk_ids": [
        "577d177f1cd27b22ce2d1d8fc371d264"
      ],
      "supporting_study_ids": [],
      "verified": false
    },
    {
      "id": "R4",
      "type": "ACTS_ON",
      "source_entity_id": "E5",
      "target_entity_id": "E1",
      "attributes": {
        "action": "inhibits"
      },
      "confidence": 0.8,
      "evidence": "non-selective phosphodiesterase (PDE)-inhibitors",
      "source_chunk_ids": [
        "577d177f1cd27b22ce2d1d8fc371d264"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R5",
      "type": "ACTS_ON",
      "source_entity_id": "E6",
      "target_entity_id": "E1",
      "attributes": {
        "action": "inhibits"
      },
      "confidence": 0.8,
      "evidence": "non-selective phosphodiesterase (PDE)-inhibitors",
      "source_chunk_ids": [
        "577d177f1cd27b22ce2d1d8fc371d264"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R6",
      "type": "CAUSES",
      "source_entity_id": "E5",
      "target_entity_id": "E7",
      "attributes": {
        "context": "clinical",
        "severity": "dose-dependent"
      },
      "confidence": 0.7,
      "evidence": "causing many dose-dependent, mostly cardiovascular",
      "source_chunk_ids": [
        "577d177f1cd27b22ce2d1d8fc371d264"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R7",
      "type": "CAUSES",
      "source_entity_id": "E5",
      "target_entity_id": "E8",
      "attributes": {
        "context": "clinical",
        "severity": "dose-dependent"
      },
      "confidence": 0.7,
      "evidence": "causing many dose-dependent, mostly gastrointestinal",
      "source_chunk_ids": [
        "577d177f1cd27b22ce2d1d8fc371d264"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R8",
      "type": "CAUSES",
      "source_entity_id": "E6",
      "target_entity_id": "E7",
      "attributes": {
        "context": "clinical",
        "severity": "dose-dependent"
      },
      "confidence": 0.7,
      "evidence": "causing many dose-dependent, mostly cardiovascular",
      "source_chunk_ids": [
        "577d177f1cd27b22ce2d1d8fc371d264"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R9",
      "type": "CAUSES",
      "source_entity_id": "E6",
      "target_entity_id": "E8",
      "attributes": {
        "context": "clinical",
        "severity": "dose-dependent"
      },
      "confidence": 0.7,
      "evidence": "causing many dose-dependent, mostly gastrointestinal",
      "source_chunk_ids": [
        "577d177f1cd27b22ce2d1d8fc371d264"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R10",
      "type": "ACTS_ON",
      "source_entity_id": "E6",
      "target_entity_id": "E9",
      "attributes": {
        "action": "inhibits"
      },
      "confidence": 0.75,
      "evidence": "inhibition of phosphoinositide 3 kinase",
      "source_chunk_ids": [
        "577d177f1cd27b22ce2d1d8fc371d264"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R11",
      "type": "ACTS_ON",
      "source_entity_id": "E11",
      "target_entity_id": "E10",
      "attributes": {
        "action": "inhibits"
      },
      "confidence": 0.8,
      "evidence": "PDE4-inhibitors, cilomilast",
      "source_chunk_ids": [
        "577d177f1cd27b22ce2d1d8fc371d264"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R12",
      "type": "ACTS_ON",
      "source_entity_id": "E12",
      "target_entity_id": "E10",
      "attributes": {
        "action": "inhibits"
      },
      "confidence": 0.8,
      "evidence": "PDE4-inhibitors, roflumilast",
      "source_chunk_ids": [
        "577d177f1cd27b22ce2d1d8fc371d264"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R13",
      "type": "TREATS",
      "source_entity_id": "E10",
      "target_entity_id": "E2",
      "attributes": {
        "context": "potential"
      },
      "confidence": 0.7,
      "evidence": "promising target for disease modifying therapy",
      "source_chunk_ids": [
        "577d177f1cd27b22ce2d1d8fc371d264"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R1",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E1",
      "target_entity_id": "E2",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "clinical trials with the PDE4-inhibitor, roflumilast",
      "source_chunk_ids": [
        "0fa23b10f4e8e0997dd85df3a652c237"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "STUDIES",
      "source_entity_id": "E1",
      "target_entity_id": "E3",
      "attributes": {
        "role": "intervention"
      },
      "confidence": 0.85,
      "evidence": "clinical trials with the PDE4-inhibitor, roflumilast",
      "source_chunk_ids": [
        "0fa23b10f4e8e0997dd85df3a652c237"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "ACTS_ON",
      "source_entity_id": "E3",
      "target_entity_id": "E4",
      "attributes": {
        "action": "inhibits"
      },
      "confidence": 0.9,
      "evidence": "PDE4-inhibitor, roflumilast",
      "source_chunk_ids": [
        "0fa23b10f4e8e0997dd85df3a652c237"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R4",
      "type": "REPORTS",
      "source_entity_id": "E1",
      "target_entity_id": "E5",
      "attributes": {
        "outcome": "improves"
      },
      "confidence": 0.8,
      "evidence": "showing clinical efficacy in patients with COPD",
      "source_chunk_ids": [
        "0fa23b10f4e8e0997dd85df3a652c237"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R5",
      "type": "TREATS",
      "source_entity_id": "E3",
      "target_entity_id": "E5",
      "attributes": {
        "context": "clinical"
      },
      "confidence": 0.75,
      "evidence": "showing clinical efficacy in patients with COPD",
      "source_chunk_ids": [
        "0fa23b10f4e8e0997dd85df3a652c237"
      ],
      "supporting_study_ids": [
        "E1"
      ],
      "verified": true
    },
    {
      "id": "R6",
      "type": "TESTED_AT",
      "source_entity_id": "E1",
      "target_entity_id": "E6",
      "attributes": {
        "verification_needed": true
      },
      "confidence": 0.65,
      "evidence": "once daily dosing",
      "source_chunk_ids": [
        "0fa23b10f4e8e0997dd85df3a652c237"
      ],
      "supporting_study_ids": [],
      "verified": false
    },
    {
      "id": "R7",
      "type": "REPORTS",
      "source_entity_id": "E1",
      "target_entity_id": "E7",
      "attributes": {
        "outcome": "observed"
      },
      "confidence": 0.7,
      "evidence": "overall mild and self limiting side effects",
      "source_chunk_ids": [
        "0fa23b10f4e8e0997dd85df3a652c237"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R8",
      "type": "CAUSES",
      "source_entity_id": "E3",
      "target_entity_id": "E7",
      "attributes": {
        "context": "clinical",
        "severity": "mild",
        "verification_needed": true
      },
      "confidence": 0.6,
      "evidence": "overall mild and self limiting side effects",
      "source_chunk_ids": [
        "0fa23b10f4e8e0997dd85df3a652c237"
      ],
      "supporting_study_ids": [
        "E1"
      ],
      "verified": false
    },
    {
      "id": "R1",
      "type": "PRODUCES",
      "source_entity_id": "E1",
      "target_entity_id": "E2",
      "attributes": {
        "action": "inhibition"
      },
      "confidence": 0.85,
      "evidence": "inhibiting PDE4 have consistently shown a reduction in activity",
      "source_chunk_ids": [
        "f7ccc3f0bdbc744b33647af3f0e19a2a"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "SUGGESTS",
      "source_entity_id": "E1",
      "target_entity_id": "E3",
      "attributes": {
        "mapping_type": "direct"
      },
      "confidence": 0.8,
      "evidence": "PDE4-inhibition could offer a novel approach to anti-inflammatory and/or disease-modifying therapy for COPD",
      "source_chunk_ids": [
        "f7ccc3f0bdbc744b33647af3f0e19a2a"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "PRODUCES",
      "source_entity_id": "E1",
      "target_entity_id": "E4",
      "attributes": {
        "action": "inhibition"
      },
      "confidence": 0.75,
      "evidence": "inhibition of PDE4 can suppress pro-inflammatory cell recruitment",
      "source_chunk_ids": [
        "f7ccc3f0bdbc744b33647af3f0e19a2a"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R4",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E5",
      "target_entity_id": "E4",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "animal models of COPD show that inhibition of PDE4 can suppress",
      "source_chunk_ids": [
        "f7ccc3f0bdbc744b33647af3f0e19a2a"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R5",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E6",
      "target_entity_id": "E1",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "early clinical trials with PDE4-inhibitors",
      "source_chunk_ids": [
        "f7ccc3f0bdbc744b33647af3f0e19a2a"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R1",
      "type": "HAS_CLASS",
      "source_entity_id": "E2",
      "target_entity_id": "E1",
      "attributes": {},
      "confidence": 0.85,
      "evidence": "PDE4-inhibitors, including CDP840",
      "source_chunk_ids": [
        "d30445d9b19a7b38c12c667157a29923"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "PRODUCES",
      "source_entity_id": "E2",
      "target_entity_id": "E4",
      "attributes": {},
      "confidence": 0.75,
      "evidence": "offered some degree of protection",
      "source_chunk_ids": [
        "d30445d9b19a7b38c12c667157a29923"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "TREATS",
      "source_entity_id": "E2",
      "target_entity_id": "E3",
      "attributes": {
        "context": "clinical"
      },
      "confidence": 0.7,
      "evidence": "protection against allergen-induced late asthmatic responses",
      "source_chunk_ids": [
        "d30445d9b19a7b38c12c667157a29923"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R4",
      "type": "PRODUCES",
      "source_entity_id": "E5",
      "target_entity_id": "E7",
      "attributes": {},
      "confidence": 0.75,
      "evidence": "inhibit allergen-induced late phase reactions",
      "source_chunk_ids": [
        "d30445d9b19a7b38c12c667157a29923"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R5",
      "type": "TREATS",
      "source_entity_id": "E5",
      "target_entity_id": "E6",
      "attributes": {
        "context": "clinical"
      },
      "confidence": 0.7,
      "evidence": "inhibit allergen-induced late phase reactions",
      "source_chunk_ids": [
        "d30445d9b19a7b38c12c667157a29923"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R6",
      "type": "HAS_CLASS",
      "source_entity_id": "E8",
      "target_entity_id": "E1",
      "attributes": {},
      "confidence": 0.85,
      "evidence": "PDE4-inhibitors cilomilast",
      "source_chunk_ids": [
        "d30445d9b19a7b38c12c667157a29923"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R7",
      "type": "HAS_CLASS",
      "source_entity_id": "E9",
      "target_entity_id": "E1",
      "attributes": {},
      "confidence": 0.85,
      "evidence": "PDE4-inhibitors roflumilast",
      "source_chunk_ids": [
        "d30445d9b19a7b38c12c667157a29923"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R8",
      "type": "TREATS",
      "source_entity_id": "E8",
      "target_entity_id": "E10",
      "attributes": {
        "context": "clinical",
        "verification_needed": true
      },
      "confidence": 0.65,
      "evidence": "studied in COPD",
      "source_chunk_ids": [
        "d30445d9b19a7b38c12c667157a29923"
      ],
      "supporting_study_ids": [],
      "verified": false
    },
    {
      "id": "R9",
      "type": "TREATS",
      "source_entity_id": "E9",
      "target_entity_id": "E10",
      "attributes": {
        "context": "clinical",
        "verification_needed": true
      },
      "confidence": 0.65,
      "evidence": "studied in COPD",
      "source_chunk_ids": [
        "d30445d9b19a7b38c12c667157a29923"
      ],
      "supporting_study_ids": [],
      "verified": false
    },
    {
      "id": "R1",
      "type": "ACTS_ON",
      "source_entity_id": "E1",
      "target_entity_id": "E2",
      "attributes": {
        "action": "inhibits"
      },
      "confidence": 0.9,
      "evidence": "PDE4-inhibitor cilomilast",
      "source_chunk_ids": [
        "503d1a8b5827d6a43ff07e54866e86c2"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E3",
      "target_entity_id": "E4",
      "attributes": {},
      "confidence": 0.85,
      "evidence": "dose finding study",
      "source_chunk_ids": [
        "503d1a8b5827d6a43ff07e54866e86c2"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "STUDIES",
      "source_entity_id": "E3",
      "target_entity_id": "E1",
      "attributes": {
        "role": "intervention"
      },
      "confidence": 0.9,
      "evidence": "cilomilast was evaluated",
      "source_chunk_ids": [
        "503d1a8b5827d6a43ff07e54866e86c2"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R4",
      "type": "REPORTS",
      "source_entity_id": "E3",
      "target_entity_id": "E5",
      "attributes": {
        "outcome": "studied"
      },
      "confidence": 0.9,
      "evidence": "patients with moderate to severe COPD",
      "source_chunk_ids": [
        "503d1a8b5827d6a43ff07e54866e86c2"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R5",
      "type": "REPORTS",
      "source_entity_id": "E3",
      "target_entity_id": "E6",
      "attributes": {
        "outcome": "improves"
      },
      "confidence": 0.85,
      "evidence": "significantly increasing baseline FEV1 by 11%",
      "source_chunk_ids": [
        "503d1a8b5827d6a43ff07e54866e86c2"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R6",
      "type": "REPORTS",
      "source_entity_id": "E3",
      "target_entity_id": "E7",
      "attributes": {
        "outcome": "improves"
      },
      "confidence": 0.8,
      "evidence": "improvement in baseline lung function",
      "source_chunk_ids": [
        "503d1a8b5827d6a43ff07e54866e86c2"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R7",
      "type": "REPORTS",
      "source_entity_id": "E3",
      "target_entity_id": "E8",
      "attributes": {
        "outcome": "no_effect"
      },
      "confidence": 0.75,
      "evidence": "failed to produce an immediate bronchodilator response",
      "source_chunk_ids": [
        "503d1a8b5827d6a43ff07e54866e86c2"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R8",
      "type": "TREATS",
      "source_entity_id": "E1",
      "target_entity_id": "E5",
      "attributes": {
        "context": "clinical"
      },
      "confidence": 0.8,
      "evidence": "significantly increasing baseline FEV1 in COPD",
      "source_chunk_ids": [
        "503d1a8b5827d6a43ff07e54866e86c2"
      ],
      "supporting_study_ids": [
        "E3"
      ],
      "verified": true
    },
    {
      "id": "R9",
      "type": "PRODUCES",
      "source_entity_id": "E1",
      "target_entity_id": "E6",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "cilomilast...increasing baseline FEV1",
      "source_chunk_ids": [
        "503d1a8b5827d6a43ff07e54866e86c2"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R10",
      "type": "PRODUCES",
      "source_entity_id": "E1",
      "target_entity_id": "E7",
      "attributes": {},
      "confidence": 0.75,
      "evidence": "improvement in baseline lung function",
      "source_chunk_ids": [
        "503d1a8b5827d6a43ff07e54866e86c2"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R11",
      "type": "PRODUCES",
      "source_entity_id": "E1",
      "target_entity_id": "E8",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "cilomilast failed to produce an immediate bronchodilator response",
      "source_chunk_ids": [
        "503d1a8b5827d6a43ff07e54866e86c2"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R12",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E3",
      "target_entity_id": "E9",
      "attributes": {
        "verification_needed": true
      },
      "confidence": 0.65,
      "evidence": "consistent with numerous in vitro",
      "source_chunk_ids": [
        "503d1a8b5827d6a43ff07e54866e86c2"
      ],
      "supporting_study_ids": [],
      "verified": false
    },
    {
      "id": "R1",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E1",
      "target_entity_id": "E2",
      "attributes": {},
      "confidence": 0.85,
      "evidence": "clinical trials",
      "source_chunk_ids": [
        "b8f1dac29022a4872ad9bc6d1d9f23e1"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "STUDIES",
      "source_entity_id": "E1",
      "target_entity_id": "E3",
      "attributes": {
        "role": "intervention"
      },
      "confidence": 0.9,
      "evidence": "study with cilomilast",
      "source_chunk_ids": [
        "b8f1dac29022a4872ad9bc6d1d9f23e1"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "REPORTS",
      "source_entity_id": "E1",
      "target_entity_id": "E4",
      "attributes": {
        "outcome": "improves"
      },
      "confidence": 0.85,
      "evidence": "COPD exacerbations",
      "source_chunk_ids": [
        "b8f1dac29022a4872ad9bc6d1d9f23e1"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R4",
      "type": "REPORTS",
      "source_entity_id": "E1",
      "target_entity_id": "E5",
      "attributes": {
        "outcome": "improves"
      },
      "confidence": 0.85,
      "evidence": "improvements in lung function",
      "source_chunk_ids": [
        "b8f1dac29022a4872ad9bc6d1d9f23e1"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R5",
      "type": "REPORTS",
      "source_entity_id": "E1",
      "target_entity_id": "E6",
      "attributes": {
        "outcome": "improves"
      },
      "confidence": 0.85,
      "evidence": "reduction in COPD exacerbations",
      "source_chunk_ids": [
        "b8f1dac29022a4872ad9bc6d1d9f23e1"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R6",
      "type": "REPORTS",
      "source_entity_id": "E1",
      "target_entity_id": "E7",
      "attributes": {
        "outcome": "improves"
      },
      "confidence": 0.85,
      "evidence": "improvements in quality of life scores",
      "source_chunk_ids": [
        "b8f1dac29022a4872ad9bc6d1d9f23e1"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R7",
      "type": "TREATS",
      "source_entity_id": "E3",
      "target_entity_id": "E4",
      "attributes": {
        "context": "clinical"
      },
      "confidence": 0.8,
      "evidence": "reduction in COPD exacerbations",
      "source_chunk_ids": [
        "b8f1dac29022a4872ad9bc6d1d9f23e1"
      ],
      "supporting_study_ids": [
        "E1"
      ],
      "verified": true
    },
    {
      "id": "R8",
      "type": "PRODUCES",
      "source_entity_id": "E3",
      "target_entity_id": "E8",
      "attributes": {},
      "confidence": 0.75,
      "evidence": "anti-inflammatory activity",
      "source_chunk_ids": [
        "b8f1dac29022a4872ad9bc6d1d9f23e1"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R9",
      "type": "ACTS_ON",
      "source_entity_id": "E3",
      "target_entity_id": "E9",
      "attributes": {
        "action": "inhibits"
      },
      "confidence": 0.85,
      "evidence": "PDE4-inhibitors",
      "source_chunk_ids": [
        "b8f1dac29022a4872ad9bc6d1d9f23e1"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R10",
      "type": "ACTS_ON",
      "source_entity_id": "E3",
      "target_entity_id": "E10",
      "attributes": {
        "action": "modulates"
      },
      "confidence": 0.7,
      "evidence": "modulation of sensory nerve function",
      "source_chunk_ids": [
        "b8f1dac29022a4872ad9bc6d1d9f23e1"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R11",
      "type": "ACTS_ON",
      "source_entity_id": "E3",
      "target_entity_id": "E11",
      "attributes": {
        "action": "activates"
      },
      "confidence": 0.75,
      "evidence": "activation of the CFTR",
      "source_chunk_ids": [
        "b8f1dac29022a4872ad9bc6d1d9f23e1"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R12",
      "type": "PRODUCES",
      "source_entity_id": "E3",
      "target_entity_id": "E12",
      "attributes": {},
      "confidence": 0.75,
      "evidence": "reduce mucus production",
      "source_chunk_ids": [
        "b8f1dac29022a4872ad9bc6d1d9f23e1"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R13",
      "type": "PRODUCES",
      "source_entity_id": "E3",
      "target_entity_id": "E13",
      "attributes": {},
      "confidence": 0.75,
      "evidence": "increase ciliary beat frequency",
      "source_chunk_ids": [
        "b8f1dac29022a4872ad9bc6d1d9f23e1"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R1",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E1",
      "target_entity_id": "E2",
      "attributes": {},
      "confidence": 0.9,
      "evidence": "Phase III studies",
      "source_chunk_ids": [
        "da025e1e40f7f7ab07600fa502c279bc"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "STUDIES",
      "source_entity_id": "E1",
      "target_entity_id": "E3",
      "attributes": {
        "role": "intervention"
      },
      "confidence": 0.95,
      "evidence": "studies with cilomilast",
      "source_chunk_ids": [
        "da025e1e40f7f7ab07600fa502c279bc"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "REPORTS",
      "source_entity_id": "E1",
      "target_entity_id": "E4",
      "attributes": {
        "outcome": "no_effect"
      },
      "confidence": 0.85,
      "evidence": "no significant improvement in lung function",
      "source_chunk_ids": [
        "da025e1e40f7f7ab07600fa502c279bc"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R4",
      "type": "REPORTS",
      "source_entity_id": "E1",
      "target_entity_id": "E5",
      "attributes": {
        "outcome": "observed"
      },
      "confidence": 0.8,
      "evidence": "associated with gastrointestinal side effects",
      "source_chunk_ids": [
        "da025e1e40f7f7ab07600fa502c279bc"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R5",
      "type": "CAUSES",
      "source_entity_id": "E3",
      "target_entity_id": "E5",
      "attributes": {
        "context": "clinical",
        "severity": null
      },
      "confidence": 0.75,
      "evidence": "treatment with cilomilast was frequently associated",
      "source_chunk_ids": [
        "da025e1e40f7f7ab07600fa502c279bc"
      ],
      "supporting_study_ids": [
        "E1"
      ],
      "verified": true
    },
    {
      "id": "R1",
      "type": "ACTS_ON",
      "source_entity_id": "E1",
      "target_entity_id": "E2",
      "attributes": {
        "action": "inhibits"
      },
      "confidence": 0.85,
      "evidence": "targeting PDE4",
      "source_chunk_ids": [
        "12e35efaee014f47451619f7b5f942e1"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "TREATS",
      "source_entity_id": "E1",
      "target_entity_id": "E3",
      "attributes": {
        "context": "clinical",
        "outcome": "no_effect"
      },
      "confidence": 0.8,
      "evidence": "failure of cilomilast",
      "source_chunk_ids": [
        "12e35efaee014f47451619f7b5f942e1"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "PRODUCES",
      "source_entity_id": "E5",
      "target_entity_id": "E6",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "PDE4-inhibition ... produce ... clinical benefit",
      "source_chunk_ids": [
        "12e35efaee014f47451619f7b5f942e1"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R4",
      "type": "ACTS_ON",
      "source_entity_id": "E4",
      "target_entity_id": "E2",
      "attributes": {
        "action": "inhibits"
      },
      "confidence": 0.9,
      "evidence": "PDE4-inhibitor roflumilast",
      "source_chunk_ids": [
        "12e35efaee014f47451619f7b5f942e1"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R1",
      "type": "ACTS_ON",
      "source_entity_id": "E1",
      "target_entity_id": "E2",
      "attributes": {
        "action": "metabolized by"
      },
      "confidence": 0.85,
      "evidence": "metabolized by CYP3A4",
      "source_chunk_ids": [
        "bd1d5728b17cf842c58e616ac92b9f31"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "ACTS_ON",
      "source_entity_id": "E1",
      "target_entity_id": "E3",
      "attributes": {
        "action": "metabolized by"
      },
      "confidence": 0.85,
      "evidence": "metabolized by CYP1A2 enzymes",
      "source_chunk_ids": [
        "bd1d5728b17cf842c58e616ac92b9f31"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "PRODUCES",
      "source_entity_id": "E1",
      "target_entity_id": "E4",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "N-oxide, being the major metabolite",
      "source_chunk_ids": [
        "bd1d5728b17cf842c58e616ac92b9f31"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R4",
      "type": "ACTS_ON",
      "source_entity_id": "E4",
      "target_entity_id": "E5",
      "attributes": {
        "action": "selective for"
      },
      "confidence": 0.8,
      "evidence": "selectivity for the PDE4 isoenzymes",
      "source_chunk_ids": [
        "bd1d5728b17cf842c58e616ac92b9f31"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R5",
      "type": "PRODUCES",
      "source_entity_id": "E1",
      "target_entity_id": "E6",
      "attributes": {},
      "confidence": 0.75,
      "evidence": "rapidly absorbed with a t_{max}",
      "source_chunk_ids": [
        "bd1d5728b17cf842c58e616ac92b9f31"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R6",
      "type": "PRODUCES",
      "source_entity_id": "E1",
      "target_entity_id": "E7",
      "attributes": {},
      "confidence": 0.75,
      "evidence": "shows linearly dose-proportional pharmacokinetics",
      "source_chunk_ids": [
        "bd1d5728b17cf842c58e616ac92b9f31"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R7",
      "type": "PRODUCES",
      "source_entity_id": "E1",
      "target_entity_id": "E8",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "warranting a once-daily administration",
      "source_chunk_ids": [
        "bd1d5728b17cf842c58e616ac92b9f31"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R8",
      "type": "PRODUCES",
      "source_entity_id": "E1",
      "target_entity_id": "E9",
      "attributes": {},
      "confidence": 0.75,
      "evidence": "rapidly metabolized by CYP3A4",
      "source_chunk_ids": [
        "bd1d5728b17cf842c58e616ac92b9f31"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R9",
      "type": "PRODUCES",
      "source_entity_id": "E4",
      "target_entity_id": "E10",
      "attributes": {},
      "confidence": 0.75,
      "evidence": "possesses selectivity for the PDE4 isoenzymes",
      "source_chunk_ids": [
        "bd1d5728b17cf842c58e616ac92b9f31"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R10",
      "type": "PRODUCES",
      "source_entity_id": "E4",
      "target_entity_id": "E11",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "largely accounts for its effects in humans",
      "source_chunk_ids": [
        "bd1d5728b17cf842c58e616ac92b9f31"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R11",
      "type": "PRODUCES",
      "source_entity_id": "E1",
      "target_entity_id": "E12",
      "attributes": {},
      "confidence": 0.75,
      "evidence": "mainly excreted via the urine",
      "source_chunk_ids": [
        "bd1d5728b17cf842c58e616ac92b9f31"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R12",
      "type": "PRODUCES",
      "source_entity_id": "E1",
      "target_entity_id": "E13",
      "attributes": {
        "verification_needed": true
      },
      "confidence": 0.65,
      "evidence": "no major drug interactions reported",
      "source_chunk_ids": [
        "bd1d5728b17cf842c58e616ac92b9f31"
      ],
      "supporting_study_ids": [],
      "verified": false
    },
    {
      "id": "R1",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E1",
      "target_entity_id": "E2",
      "attributes": {},
      "confidence": 0.9,
      "evidence": "clinical studies",
      "source_chunk_ids": [
        "95b98aea101680bd29a2709c666b863d"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "REPORTS",
      "source_entity_id": "E1",
      "target_entity_id": "E3",
      "attributes": {
        "outcome": "studied"
      },
      "confidence": 0.9,
      "evidence": "patients with moderate to severe COPD",
      "source_chunk_ids": [
        "95b98aea101680bd29a2709c666b863d"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "TESTED_AT",
      "source_entity_id": "E1",
      "target_entity_id": "E4",
      "attributes": {},
      "confidence": 0.85,
      "evidence": "roflumilast 250 \u00b5g once daily during 24 weeks",
      "source_chunk_ids": [
        "95b98aea101680bd29a2709c666b863d"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R4",
      "type": "TESTED_AT",
      "source_entity_id": "E1",
      "target_entity_id": "E5",
      "attributes": {},
      "confidence": 0.85,
      "evidence": "roflumilast 500 \u00b5g once daily during 24 weeks",
      "source_chunk_ids": [
        "95b98aea101680bd29a2709c666b863d"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R5",
      "type": "REPORTS",
      "source_entity_id": "E1",
      "target_entity_id": "E6",
      "attributes": {
        "outcome": "improves"
      },
      "confidence": 0.85,
      "evidence": "improvements in terms of post-bronchodilator FEV1",
      "source_chunk_ids": [
        "95b98aea101680bd29a2709c666b863d"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R6",
      "type": "REPORTS",
      "source_entity_id": "E1",
      "target_entity_id": "E7",
      "attributes": {
        "outcome": "improves"
      },
      "confidence": 0.7,
      "evidence": "health-related quality of life",
      "source_chunk_ids": [
        "95b98aea101680bd29a2709c666b863d"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R7",
      "type": "REPORTS",
      "source_entity_id": "E1",
      "target_entity_id": "E8",
      "attributes": {
        "outcome": "improves"
      },
      "confidence": 0.75,
      "evidence": "number of COPD-",
      "source_chunk_ids": [
        "95b98aea101680bd29a2709c666b863d"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R1",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E1",
      "target_entity_id": "E2",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "study, subjects with moderate to (very) severe COPD",
      "source_chunk_ids": [
        "4b04451fef8aaea9305e782c5693abb7"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "REPORTS",
      "source_entity_id": "E1",
      "target_entity_id": "E3",
      "attributes": {
        "outcome": "studied"
      },
      "confidence": 0.85,
      "evidence": "subjects with moderate to (very) severe COPD",
      "source_chunk_ids": [
        "4b04451fef8aaea9305e782c5693abb7"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "REPORTS",
      "source_entity_id": "E1",
      "target_entity_id": "E4",
      "attributes": {
        "outcome": "improves"
      },
      "confidence": 0.8,
      "evidence": "exacerbations (p=0.0114)",
      "source_chunk_ids": [
        "4b04451fef8aaea9305e782c5693abb7"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R4",
      "type": "REPORTS",
      "source_entity_id": "E1",
      "target_entity_id": "E5",
      "attributes": {
        "outcome": "improves"
      },
      "confidence": 0.75,
      "evidence": "small but significant improvement in baseline FEV1",
      "source_chunk_ids": [
        "4b04451fef8aaea9305e782c5693abb7"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R5",
      "type": "REPORTS",
      "source_entity_id": "E1",
      "target_entity_id": "E6",
      "attributes": {
        "outcome": "improves"
      },
      "confidence": 0.75,
      "evidence": "modest reduction in exacerbation rates",
      "source_chunk_ids": [
        "4b04451fef8aaea9305e782c5693abb7"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R6",
      "type": "REPORTS",
      "source_entity_id": "E1",
      "target_entity_id": "E7",
      "attributes": {
        "outcome": "no_effect"
      },
      "confidence": 0.7,
      "evidence": "quality of life scores did not reach statistical significance",
      "source_chunk_ids": [
        "4b04451fef8aaea9305e782c5693abb7"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R1",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E1",
      "target_entity_id": "E3",
      "attributes": {},
      "confidence": 0.85,
      "evidence": "randomized controlled trial",
      "source_chunk_ids": [
        "c674c321267d06ecbf909fb4707589a9"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E2",
      "target_entity_id": "E3",
      "attributes": {},
      "confidence": 0.85,
      "evidence": "randomized controlled trial",
      "source_chunk_ids": [
        "c674c321267d06ecbf909fb4707589a9"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "STUDIES",
      "source_entity_id": "E1",
      "target_entity_id": "E4",
      "attributes": {
        "role": "intervention"
      },
      "confidence": 0.9,
      "evidence": "roflumilast (n=466) or placebo",
      "source_chunk_ids": [
        "c674c321267d06ecbf909fb4707589a9"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R4",
      "type": "STUDIES",
      "source_entity_id": "E2",
      "target_entity_id": "E4",
      "attributes": {
        "role": "intervention"
      },
      "confidence": 0.9,
      "evidence": "roflumilast (n=371) or placebo",
      "source_chunk_ids": [
        "c674c321267d06ecbf909fb4707589a9"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R5",
      "type": "REPORTS",
      "source_entity_id": "E1",
      "target_entity_id": "E5",
      "attributes": {
        "outcome": "improves"
      },
      "confidence": 0.85,
      "evidence": "patients with moderate to severe COPD",
      "source_chunk_ids": [
        "c674c321267d06ecbf909fb4707589a9"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R6",
      "type": "REPORTS",
      "source_entity_id": "E2",
      "target_entity_id": "E5",
      "attributes": {
        "outcome": "improves"
      },
      "confidence": 0.85,
      "evidence": "patients with moderate to severe COPD",
      "source_chunk_ids": [
        "c674c321267d06ecbf909fb4707589a9"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R7",
      "type": "REPORTS",
      "source_entity_id": "E1",
      "target_entity_id": "E6",
      "attributes": {
        "outcome": "improves"
      },
      "confidence": 0.8,
      "evidence": "improvements in both the pre- and post-bronchodilator FEV1",
      "source_chunk_ids": [
        "c674c321267d06ecbf909fb4707589a9"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R8",
      "type": "REPORTS",
      "source_entity_id": "E2",
      "target_entity_id": "E6",
      "attributes": {
        "outcome": "improves"
      },
      "confidence": 0.8,
      "evidence": "improvements in both the pre- and post-bronchodilator FEV1",
      "source_chunk_ids": [
        "c674c321267d06ecbf909fb4707589a9"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R9",
      "type": "REPORTS",
      "source_entity_id": "E1",
      "target_entity_id": "E7",
      "attributes": {
        "outcome": "improves"
      },
      "confidence": 0.75,
      "evidence": "patients on roflumilast tended to have fewer exacerbations",
      "source_chunk_ids": [
        "c674c321267d06ecbf909fb4707589a9"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R10",
      "type": "REPORTS",
      "source_entity_id": "E2",
      "target_entity_id": "E7",
      "attributes": {
        "outcome": "improves"
      },
      "confidence": 0.75,
      "evidence": "patients on roflumilast tended to have fewer exacerbations",
      "source_chunk_ids": [
        "c674c321267d06ecbf909fb4707589a9"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R11",
      "type": "REPORTS",
      "source_entity_id": "E1",
      "target_entity_id": "E8",
      "attributes": {
        "outcome": "causes"
      },
      "confidence": 0.8,
      "evidence": "nausea",
      "source_chunk_ids": [
        "c674c321267d06ecbf909fb4707589a9"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R12",
      "type": "REPORTS",
      "source_entity_id": "E2",
      "target_entity_id": "E8",
      "attributes": {
        "outcome": "causes"
      },
      "confidence": 0.8,
      "evidence": "nausea",
      "source_chunk_ids": [
        "c674c321267d06ecbf909fb4707589a9"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R13",
      "type": "REPORTS",
      "source_entity_id": "E1",
      "target_entity_id": "E9",
      "attributes": {
        "outcome": "causes"
      },
      "confidence": 0.8,
      "evidence": "diarrhea",
      "source_chunk_ids": [
        "c674c321267d06ecbf909fb4707589a9"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R14",
      "type": "REPORTS",
      "source_entity_id": "E2",
      "target_entity_id": "E9",
      "attributes": {
        "outcome": "causes"
      },
      "confidence": 0.8,
      "evidence": "diarrhea",
      "source_chunk_ids": [
        "c674c321267d06ecbf909fb4707589a9"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R15",
      "type": "REPORTS",
      "source_entity_id": "E1",
      "target_entity_id": "E10",
      "attributes": {
        "outcome": "causes"
      },
      "confidence": 0.75,
      "evidence": "mild weight loss (mean 1.8 and 2 kg)",
      "source_chunk_ids": [
        "c674c321267d06ecbf909fb4707589a9"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R16",
      "type": "REPORTS",
      "source_entity_id": "E2",
      "target_entity_id": "E10",
      "attributes": {
        "outcome": "causes"
      },
      "confidence": 0.75,
      "evidence": "mild weight loss (mean 1.8 and 2 kg)",
      "source_chunk_ids": [
        "c674c321267d06ecbf909fb4707589a9"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R17",
      "type": "REPORTS",
      "source_entity_id": "E1",
      "target_entity_id": "E11",
      "attributes": {
        "outcome": "causes"
      },
      "confidence": 0.7,
      "evidence": "significantly more withdrawals in the salmeterol-roflumilast-arm",
      "source_chunk_ids": [
        "c674c321267d06ecbf909fb4707589a9"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R18",
      "type": "TREATS",
      "source_entity_id": "E4",
      "target_entity_id": "E5",
      "attributes": {
        "context": "clinical"
      },
      "confidence": 0.8,
      "evidence": "roflumilast in large groups of patients with moderate to severe COPD",
      "source_chunk_ids": [
        "c674c321267d06ecbf909fb4707589a9"
      ],
      "supporting_study_ids": [
        "E1",
        "E2"
      ],
      "verified": true
    },
    {
      "id": "R19",
      "type": "CAUSES",
      "source_entity_id": "E4",
      "target_entity_id": "E8",
      "attributes": {
        "context": "clinical",
        "severity": "frequent"
      },
      "confidence": 0.75,
      "evidence": "roflumilast-related side effects consisted of nausea",
      "source_chunk_ids": [
        "c674c321267d06ecbf909fb4707589a9"
      ],
      "supporting_study_ids": [
        "E1",
        "E2"
      ],
      "verified": true
    },
    {
      "id": "R20",
      "type": "CAUSES",
      "source_entity_id": "E4",
      "target_entity_id": "E9",
      "attributes": {
        "context": "clinical",
        "severity": "frequent"
      },
      "confidence": 0.75,
      "evidence": "roflumilast-related side effects consisted of diarrhea",
      "source_chunk_ids": [
        "c674c321267d06ecbf909fb4707589a9"
      ],
      "supporting_study_ids": [
        "E1",
        "E2"
      ],
      "verified": true
    },
    {
      "id": "R21",
      "type": "CAUSES",
      "source_entity_id": "E4",
      "target_entity_id": "E10",
      "attributes": {
        "context": "clinical",
        "severity": "mild"
      },
      "confidence": 0.7,
      "evidence": "roflumilast-related side effects consisted of mild weight loss",
      "source_chunk_ids": [
        "c674c321267d06ecbf909fb4707589a9"
      ],
      "supporting_study_ids": [
        "E1",
        "E2"
      ],
      "verified": true
    },
    {
      "id": "R22",
      "type": "CAUSES",
      "source_entity_id": "E4",
      "target_entity_id": "E11",
      "attributes": {
        "context": "clinical",
        "severity": "significant",
        "verification_needed": true
      },
      "confidence": 0.65,
      "evidence": "drop-out rate was larger in the roflumilast-arm",
      "source_chunk_ids": [
        "c674c321267d06ecbf909fb4707589a9"
      ],
      "supporting_study_ids": [
        "E1"
      ],
      "verified": false
    },
    {
      "id": "R1",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E1",
      "target_entity_id": "E2",
      "attributes": {},
      "confidence": 0.9,
      "evidence": "randomized controlled trial design",
      "source_chunk_ids": [
        "7e90254c89ce0bab70742a624689f904"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "STUDIES",
      "source_entity_id": "E1",
      "target_entity_id": "E3",
      "attributes": {
        "role": "intervention"
      },
      "confidence": 0.9,
      "evidence": "patients received either roflumilast or placebo",
      "source_chunk_ids": [
        "7e90254c89ce0bab70742a624689f904"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "REPORTS",
      "source_entity_id": "E1",
      "target_entity_id": "E4",
      "attributes": {
        "outcome": "improves"
      },
      "confidence": 0.85,
      "evidence": "COPD characterized by chronic cough, sputum production and exacerbations",
      "source_chunk_ids": [
        "7e90254c89ce0bab70742a624689f904"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R4",
      "type": "REPORTS",
      "source_entity_id": "E1",
      "target_entity_id": "E5",
      "attributes": {
        "outcome": "improves"
      },
      "confidence": 0.8,
      "evidence": "mean increase in pre-bronchodilator FEV1 of 48 mL",
      "source_chunk_ids": [
        "7e90254c89ce0bab70742a624689f904"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R5",
      "type": "REPORTS",
      "source_entity_id": "E1",
      "target_entity_id": "E6",
      "attributes": {
        "outcome": "improves"
      },
      "confidence": 0.8,
      "evidence": "decrease in both moderate and severe exacerbations by on mean 17%",
      "source_chunk_ids": [
        "7e90254c89ce0bab70742a624689f904"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R6",
      "type": "REPORTS",
      "source_entity_id": "E1",
      "target_entity_id": "E7",
      "attributes": {
        "outcome": "causes"
      },
      "confidence": 0.75,
      "evidence": "head ache",
      "source_chunk_ids": [
        "7e90254c89ce0bab70742a624689f904"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R7",
      "type": "REPORTS",
      "source_entity_id": "E1",
      "target_entity_id": "E8",
      "attributes": {
        "outcome": "causes"
      },
      "confidence": 0.75,
      "evidence": "insomnia",
      "source_chunk_ids": [
        "7e90254c89ce0bab70742a624689f904"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R8",
      "type": "REPORTS",
      "source_entity_id": "E1",
      "target_entity_id": "E9",
      "attributes": {
        "outcome": "causes"
      },
      "confidence": 0.75,
      "evidence": "nausea",
      "source_chunk_ids": [
        "7e90254c89ce0bab70742a624689f904"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R9",
      "type": "REPORTS",
      "source_entity_id": "E1",
      "target_entity_id": "E10",
      "attributes": {
        "outcome": "causes"
      },
      "confidence": 0.75,
      "evidence": "diarrhea",
      "source_chunk_ids": [
        "7e90254c89ce0bab70742a624689f904"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R10",
      "type": "REPORTS",
      "source_entity_id": "E1",
      "target_entity_id": "E11",
      "attributes": {
        "outcome": "causes"
      },
      "confidence": 0.75,
      "evidence": "mean weight loss of 2.1 kg",
      "source_chunk_ids": [
        "7e90254c89ce0bab70742a624689f904"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R11",
      "type": "REPORTS",
      "source_entity_id": "E1",
      "target_entity_id": "E12",
      "attributes": {
        "outcome": "no_effect"
      },
      "confidence": 0.7,
      "evidence": "mortality due to COPD was similar",
      "source_chunk_ids": [
        "7e90254c89ce0bab70742a624689f904"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R12",
      "type": "TREATS",
      "source_entity_id": "E3",
      "target_entity_id": "E4",
      "attributes": {
        "context": "clinical"
      },
      "confidence": 0.8,
      "evidence": "roflumilast treated-patients had improvement in lung function and reduction in exacerbations",
      "source_chunk_ids": [
        "7e90254c89ce0bab70742a624689f904"
      ],
      "supporting_study_ids": [
        "E1"
      ],
      "verified": true
    },
    {
      "id": "R13",
      "type": "PRODUCES",
      "source_entity_id": "E3",
      "target_entity_id": "E5",
      "attributes": {},
      "confidence": 0.75,
      "evidence": "mean increase in pre-bronchodilator FEV1 of 48 mL",
      "source_chunk_ids": [
        "7e90254c89ce0bab70742a624689f904"
      ],
      "supporting_study_ids": [
        "E1"
      ],
      "verified": true
    },
    {
      "id": "R14",
      "type": "PRODUCES",
      "source_entity_id": "E3",
      "target_entity_id": "E6",
      "attributes": {},
      "confidence": 0.75,
      "evidence": "decrease in both moderate and severe exacerbations by on mean 17%",
      "source_chunk_ids": [
        "7e90254c89ce0bab70742a624689f904"
      ],
      "supporting_study_ids": [
        "E1"
      ],
      "verified": true
    },
    {
      "id": "R15",
      "type": "CAUSES",
      "source_entity_id": "E3",
      "target_entity_id": "E7",
      "attributes": {
        "context": "clinical",
        "severity": "mild"
      },
      "confidence": 0.7,
      "evidence": "head ache",
      "source_chunk_ids": [
        "7e90254c89ce0bab70742a624689f904"
      ],
      "supporting_study_ids": [
        "E1"
      ],
      "verified": true
    },
    {
      "id": "R16",
      "type": "CAUSES",
      "source_entity_id": "E3",
      "target_entity_id": "E8",
      "attributes": {
        "context": "clinical",
        "severity": "mild"
      },
      "confidence": 0.7,
      "evidence": "insomnia",
      "source_chunk_ids": [
        "7e90254c89ce0bab70742a624689f904"
      ],
      "supporting_study_ids": [
        "E1"
      ],
      "verified": true
    },
    {
      "id": "R17",
      "type": "CAUSES",
      "source_entity_id": "E3",
      "target_entity_id": "E9",
      "attributes": {
        "context": "clinical",
        "severity": "mild"
      },
      "confidence": 0.7,
      "evidence": "nausea",
      "source_chunk_ids": [
        "7e90254c89ce0bab70742a624689f904"
      ],
      "supporting_study_ids": [
        "E1"
      ],
      "verified": true
    },
    {
      "id": "R18",
      "type": "CAUSES",
      "source_entity_id": "E3",
      "target_entity_id": "E10",
      "attributes": {
        "context": "clinical",
        "severity": "mild"
      },
      "confidence": 0.7,
      "evidence": "diarrhea",
      "source_chunk_ids": [
        "7e90254c89ce0bab70742a624689f904"
      ],
      "supporting_study_ids": [
        "E1"
      ],
      "verified": true
    },
    {
      "id": "R19",
      "type": "CAUSES",
      "source_entity_id": "E3",
      "target_entity_id": "E11",
      "attributes": {
        "context": "clinical",
        "severity": "moderate"
      },
      "confidence": 0.7,
      "evidence": "mean weight loss of 2.1 kg",
      "source_chunk_ids": [
        "7e90254c89ce0bab70742a624689f904"
      ],
      "supporting_study_ids": [
        "E1"
      ],
      "verified": true
    },
    {
      "id": "R1",
      "type": "PRODUCES",
      "source_entity_id": "E1",
      "target_entity_id": "E6",
      "attributes": {
        "assertion": "refutes"
      },
      "confidence": 0.75,
      "evidence": "cannot be attributed to a direct bronchodilating action of this drug class, as we have previously discussed for cilomilast",
      "source_chunk_ids": [
        "bad1df79303107b1e26c316464594926"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "PRODUCES",
      "source_entity_id": "E2",
      "target_entity_id": "E7",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "anti-inflammatory activity of roflumilast",
      "source_chunk_ids": [
        "bad1df79303107b1e26c316464594926"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "PRODUCES",
      "source_entity_id": "E7",
      "target_entity_id": "E3",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "beneficial actions are secondary to an anti-inflammatory activity",
      "source_chunk_ids": [
        "bad1df79303107b1e26c316464594926"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R4",
      "type": "PRODUCES",
      "source_entity_id": "E7",
      "target_entity_id": "E4",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "beneficial actions are secondary to an anti-inflammatory activity",
      "source_chunk_ids": [
        "bad1df79303107b1e26c316464594926"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R5",
      "type": "PRODUCES",
      "source_entity_id": "E7",
      "target_entity_id": "E5",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "beneficial actions are secondary to an anti-inflammatory activity",
      "source_chunk_ids": [
        "bad1df79303107b1e26c316464594926"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R6",
      "type": "PRODUCES",
      "source_entity_id": "E7",
      "target_entity_id": "E8",
      "attributes": {
        "verification_needed": true
      },
      "confidence": 0.65,
      "evidence": "anti-inflammatory activity of roflumilast, although the reduction in pro-inflammatory cell numbers",
      "source_chunk_ids": [
        "bad1df79303107b1e26c316464594926"
      ],
      "supporting_study_ids": [],
      "verified": false
    },
    {
      "id": "R1",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E3",
      "target_entity_id": "E4",
      "attributes": {},
      "confidence": 0.85,
      "evidence": "in vitro studies",
      "source_chunk_ids": [
        "8fbd93fb1b66921dca70e07abddb636a"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "STUDIES",
      "source_entity_id": "E1",
      "target_entity_id": "E5",
      "attributes": {
        "role": "intervention"
      },
      "confidence": 0.7,
      "evidence": "found in two other studies",
      "source_chunk_ids": [
        "8fbd93fb1b66921dca70e07abddb636a"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "STUDIES",
      "source_entity_id": "E2",
      "target_entity_id": "E5",
      "attributes": {
        "role": "intervention"
      },
      "confidence": 0.7,
      "evidence": "[30]",
      "source_chunk_ids": [
        "8fbd93fb1b66921dca70e07abddb636a"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R4",
      "type": "STUDIES",
      "source_entity_id": "E3",
      "target_entity_id": "E5",
      "attributes": {
        "role": "intervention"
      },
      "confidence": 0.85,
      "evidence": "cilomilast reduced",
      "source_chunk_ids": [
        "8fbd93fb1b66921dca70e07abddb636a"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R5",
      "type": "REPORTS",
      "source_entity_id": "E1",
      "target_entity_id": "E6",
      "attributes": {
        "outcome": "improves"
      },
      "confidence": 0.75,
      "evidence": "suppression of inflammatory cell numbers [43, 44]",
      "source_chunk_ids": [
        "8fbd93fb1b66921dca70e07abddb636a"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R6",
      "type": "REPORTS",
      "source_entity_id": "E2",
      "target_entity_id": "E7",
      "attributes": {
        "outcome": "improves"
      },
      "confidence": 0.75,
      "evidence": "reduced airway CD8+ T lymphocytes and CD68+ macrophages [30]",
      "source_chunk_ids": [
        "8fbd93fb1b66921dca70e07abddb636a"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R7",
      "type": "REPORTS",
      "source_entity_id": "E3",
      "target_entity_id": "E8",
      "attributes": {
        "outcome": "improves"
      },
      "confidence": 0.8,
      "evidence": "reduced the level of TNF-alpha [45]",
      "source_chunk_ids": [
        "8fbd93fb1b66921dca70e07abddb636a"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R8",
      "type": "REPORTS",
      "source_entity_id": "E3",
      "target_entity_id": "E9",
      "attributes": {
        "outcome": "improves"
      },
      "confidence": 0.8,
      "evidence": "GMCSF (46% decrease) [45]",
      "source_chunk_ids": [
        "8fbd93fb1b66921dca70e07abddb636a"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R9",
      "type": "REPORTS",
      "source_entity_id": "E3",
      "target_entity_id": "E10",
      "attributes": {
        "outcome": "improves"
      },
      "confidence": 0.8,
      "evidence": "neutrophil chemotactic factors (35% decrease) [45]",
      "source_chunk_ids": [
        "8fbd93fb1b66921dca70e07abddb636a"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R10",
      "type": "REPORTS",
      "source_entity_id": "E3",
      "target_entity_id": "E11",
      "attributes": {
        "outcome": "no_effect"
      },
      "confidence": 0.75,
      "evidence": "no effect on IL-8 [45]",
      "source_chunk_ids": [
        "8fbd93fb1b66921dca70e07abddb636a"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R11",
      "type": "PRODUCES",
      "source_entity_id": "E5",
      "target_entity_id": "E6",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "suppression of inflammatory cell numbers",
      "source_chunk_ids": [
        "8fbd93fb1b66921dca70e07abddb636a"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R12",
      "type": "PRODUCES",
      "source_entity_id": "E5",
      "target_entity_id": "E7",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "reduced airway CD8+ T lymphocytes and CD68+ macrophages",
      "source_chunk_ids": [
        "8fbd93fb1b66921dca70e07abddb636a"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R13",
      "type": "PRODUCES",
      "source_entity_id": "E5",
      "target_entity_id": "E8",
      "attributes": {},
      "confidence": 0.75,
      "evidence": "cilomilast reduced the level of TNF-alpha",
      "source_chunk_ids": [
        "8fbd93fb1b66921dca70e07abddb636a"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R14",
      "type": "PRODUCES",
      "source_entity_id": "E5",
      "target_entity_id": "E9",
      "attributes": {},
      "confidence": 0.75,
      "evidence": "GMCSF (46% decrease)",
      "source_chunk_ids": [
        "8fbd93fb1b66921dca70e07abddb636a"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R15",
      "type": "PRODUCES",
      "source_entity_id": "E5",
      "target_entity_id": "E10",
      "attributes": {},
      "confidence": 0.75,
      "evidence": "neutrophil chemotactic factors (35% decrease)",
      "source_chunk_ids": [
        "8fbd93fb1b66921dca70e07abddb636a"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R16",
      "type": "PRODUCES",
      "source_entity_id": "E5",
      "target_entity_id": "E11",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "no effect on IL-8",
      "source_chunk_ids": [
        "8fbd93fb1b66921dca70e07abddb636a"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R17",
      "type": "ACTS_ON",
      "source_entity_id": "E5",
      "target_entity_id": "E12",
      "attributes": {
        "action": "inhibits",
        "verification_needed": true
      },
      "confidence": 0.65,
      "evidence": "inhibition of the inflammatory response",
      "source_chunk_ids": [
        "8fbd93fb1b66921dca70e07abddb636a"
      ],
      "supporting_study_ids": [],
      "verified": false
    },
    {
      "id": "R18",
      "type": "TREATS",
      "source_entity_id": "E5",
      "target_entity_id": "E13",
      "attributes": {
        "context": "clinical"
      },
      "confidence": 0.7,
      "evidence": "COPD patients",
      "source_chunk_ids": [
        "8fbd93fb1b66921dca70e07abddb636a"
      ],
      "supporting_study_ids": [
        "E1",
        "E2",
        "E3"
      ],
      "verified": true
    },
    {
      "id": "R1",
      "type": "TREATS",
      "source_entity_id": "E2",
      "target_entity_id": "E1",
      "attributes": {
        "context": "clinical"
      },
      "confidence": 0.85,
      "evidence": "COPD-patients treated with tiotropium bromide",
      "source_chunk_ids": [
        "d7bfa800a140bc0c63f9a05e7385e18e"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "REPORTS",
      "source_entity_id": "E9",
      "target_entity_id": "E3",
      "attributes": {
        "outcome": "improves"
      },
      "confidence": 0.8,
      "evidence": "reduction in exacerbations",
      "source_chunk_ids": [
        "d7bfa800a140bc0c63f9a05e7385e18e"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "REPORTS",
      "source_entity_id": "E9",
      "target_entity_id": "E4",
      "attributes": {
        "outcome": "no_effect"
      },
      "confidence": 0.75,
      "evidence": "not accompanied by a reduction in inflammatory cells",
      "source_chunk_ids": [
        "d7bfa800a140bc0c63f9a05e7385e18e"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R4",
      "type": "REPORTS",
      "source_entity_id": "E9",
      "target_entity_id": "E5",
      "attributes": {
        "outcome": "worsens"
      },
      "confidence": 0.7,
      "evidence": "pro-inflammatory mediators tended to rise",
      "source_chunk_ids": [
        "d7bfa800a140bc0c63f9a05e7385e18e"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R5",
      "type": "REPORTS",
      "source_entity_id": "E9",
      "target_entity_id": "E6",
      "attributes": {
        "outcome": "improves"
      },
      "confidence": 0.8,
      "evidence": "improvements in lung function",
      "source_chunk_ids": [
        "d7bfa800a140bc0c63f9a05e7385e18e"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R6",
      "type": "TREATS",
      "source_entity_id": "E7",
      "target_entity_id": "E1",
      "attributes": {
        "context": "clinical"
      },
      "confidence": 0.8,
      "evidence": "glucocorticosteroids can reduce airway inflammation in COPD",
      "source_chunk_ids": [
        "d7bfa800a140bc0c63f9a05e7385e18e"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R7",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E9",
      "target_entity_id": "E10",
      "attributes": {},
      "confidence": 0.85,
      "evidence": "long-term study",
      "source_chunk_ids": [
        "d7bfa800a140bc0c63f9a05e7385e18e"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R8",
      "type": "STUDIES",
      "source_entity_id": "E9",
      "target_entity_id": "E8",
      "attributes": {
        "role": "intervention"
      },
      "confidence": 0.9,
      "evidence": "treated with fluticasone",
      "source_chunk_ids": [
        "d7bfa800a140bc0c63f9a05e7385e18e"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R9",
      "type": "REPORTS",
      "source_entity_id": "E9",
      "target_entity_id": "E11",
      "attributes": {
        "outcome": "improves"
      },
      "confidence": 0.85,
      "evidence": "significant reduction in inflammatory cell numbers",
      "source_chunk_ids": [
        "d7bfa800a140bc0c63f9a05e7385e18e"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R10",
      "type": "STUDIES",
      "source_entity_id": "E9",
      "target_entity_id": "E12",
      "attributes": {
        "role": "intervention"
      },
      "confidence": 0.8,
      "evidence": "combination therapy (salmeterol and fluticasone)",
      "source_chunk_ids": [
        "d7bfa800a140bc0c63f9a05e7385e18e"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R11",
      "type": "REPORTS",
      "source_entity_id": "E9",
      "target_entity_id": "E13",
      "attributes": {
        "outcome": "no_effect"
      },
      "confidence": 0.75,
      "evidence": "no evidence of any additive or synergistic anti-inflammatory effect",
      "source_chunk_ids": [
        "d7bfa800a140bc0c63f9a05e7385e18e"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R12",
      "type": "REPORTS",
      "source_entity_id": "E9",
      "target_entity_id": "E14",
      "attributes": {
        "outcome": "improves"
      },
      "confidence": 0.8,
      "evidence": "improvement in lung function",
      "source_chunk_ids": [
        "d7bfa800a140bc0c63f9a05e7385e18e"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R1",
      "type": "PRODUCES",
      "source_entity_id": "E2",
      "target_entity_id": "E3",
      "attributes": {
        "verification_needed": true
      },
      "confidence": 0.65,
      "evidence": "FEV1 seen with combination therapy of ICS and LABA can be explained by relaxation of airway smooth muscle rather than a consequence of a synergistic or additive anti-inflammatory action",
      "source_chunk_ids": [
        "a4c8875444a9e50f272646ddc96fe9b4"
      ],
      "supporting_study_ids": [],
      "verified": false
    },
    {
      "id": "R2",
      "type": "REPORTS",
      "source_entity_id": "E4",
      "target_entity_id": "E2",
      "attributes": {
        "outcome": "explains"
      },
      "confidence": 0.7,
      "evidence": "evidenced by the comparable changes in rates of decline in lung function between salmeterol versus combination therapy [49]",
      "source_chunk_ids": [
        "a4c8875444a9e50f272646ddc96fe9b4"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "REPORTS",
      "source_entity_id": "E5",
      "target_entity_id": "E3",
      "attributes": {
        "outcome": "associated"
      },
      "confidence": 0.75,
      "evidence": "combination therapy was associated with anti-inflammatory activity [50]",
      "source_chunk_ids": [
        "a4c8875444a9e50f272646ddc96fe9b4"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R4",
      "type": "REPORTS",
      "source_entity_id": "E6",
      "target_entity_id": "E3",
      "attributes": {
        "outcome": "no_effect"
      },
      "confidence": 0.7,
      "evidence": "the lack of effect of this treatment on lung function parameters [51]",
      "source_chunk_ids": [
        "a4c8875444a9e50f272646ddc96fe9b4"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R5",
      "type": "REPORTS",
      "source_entity_id": "E7",
      "target_entity_id": "E3",
      "attributes": {
        "outcome": "reduction",
        "verification_needed": true
      },
      "confidence": 0.65,
      "evidence": "reports of a reduction [48]",
      "source_chunk_ids": [
        "a4c8875444a9e50f272646ddc96fe9b4"
      ],
      "supporting_study_ids": [],
      "verified": false
    },
    {
      "id": "R6",
      "type": "REPORTS",
      "source_entity_id": "E8",
      "target_entity_id": "E3",
      "attributes": {
        "outcome": "increase",
        "verification_needed": true
      },
      "confidence": 0.65,
      "evidence": "increase [52]",
      "source_chunk_ids": [
        "a4c8875444a9e50f272646ddc96fe9b4"
      ],
      "supporting_study_ids": [],
      "verified": false
    },
    {
      "id": "R7",
      "type": "SUGGESTS",
      "source_entity_id": "E12",
      "target_entity_id": "E11",
      "attributes": {
        "mapping_type": "direct"
      },
      "confidence": 0.7,
      "evidence": "evidence of a (relative) corticosteroid resistance",
      "source_chunk_ids": [
        "a4c8875444a9e50f272646ddc96fe9b4"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R8",
      "type": "PRODUCES",
      "source_entity_id": "E10",
      "target_entity_id": "E11",
      "attributes": {},
      "confidence": 0.75,
      "evidence": "reduction in the activity of histone deacetylase (HDAC)-2",
      "source_chunk_ids": [
        "a4c8875444a9e50f272646ddc96fe9b4"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R1",
      "type": "CAUSES",
      "source_entity_id": "E1",
      "target_entity_id": "E2",
      "attributes": {
        "context": "clinical",
        "severity": "potential"
      },
      "confidence": 0.75,
      "evidence": "PDE4-inhibitors produce nausea as side-effects",
      "source_chunk_ids": [
        "241527c44b0da752d04e8ae195c2b217"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "CAUSES",
      "source_entity_id": "E1",
      "target_entity_id": "E3",
      "attributes": {
        "context": "clinical",
        "severity": "potential"
      },
      "confidence": 0.75,
      "evidence": "PDE4-inhibitors produce headache as side-effects",
      "source_chunk_ids": [
        "241527c44b0da752d04e8ae195c2b217"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "ACTS_ON",
      "source_entity_id": "E1",
      "target_entity_id": "E4",
      "attributes": {
        "action": "inhibits"
      },
      "confidence": 0.7,
      "evidence": "side-effects like nausea are due to inhibition of PDE4D isoenzymes",
      "source_chunk_ids": [
        "241527c44b0da752d04e8ae195c2b217"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R1",
      "type": "ACTS_ON",
      "source_entity_id": "E1",
      "target_entity_id": "E2",
      "attributes": {
        "action": "inhibits"
      },
      "confidence": 0.9,
      "evidence": "PDE4-inhibitor, UK-500,001",
      "source_chunk_ids": [
        "92ee628ff47e1bebfed8efff9dc3c924"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "STUDIES",
      "source_entity_id": "E4",
      "target_entity_id": "E1",
      "attributes": {
        "role": "intervention"
      },
      "confidence": 0.85,
      "evidence": "UK-500,001 failed to demonstrate",
      "source_chunk_ids": [
        "92ee628ff47e1bebfed8efff9dc3c924"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E4",
      "target_entity_id": "E5",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "evaluated in respiratory disease",
      "source_chunk_ids": [
        "92ee628ff47e1bebfed8efff9dc3c924"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R4",
      "type": "REPORTS",
      "source_entity_id": "E4",
      "target_entity_id": "E3",
      "attributes": {
        "outcome": "no_effect"
      },
      "confidence": 0.85,
      "evidence": "failed to demonstrate any improvement",
      "source_chunk_ids": [
        "92ee628ff47e1bebfed8efff9dc3c924"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R5",
      "type": "ACTS_ON",
      "source_entity_id": "E6",
      "target_entity_id": "E2",
      "attributes": {
        "action": "inhibits"
      },
      "confidence": 0.9,
      "evidence": "PDE4-inhibitor, GSK256066",
      "source_chunk_ids": [
        "92ee628ff47e1bebfed8efff9dc3c924"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R6",
      "type": "STUDIES",
      "source_entity_id": "E8",
      "target_entity_id": "E6",
      "attributes": {
        "role": "intervention"
      },
      "confidence": 0.85,
      "evidence": "GSK256066, with low systemic exposure",
      "source_chunk_ids": [
        "92ee628ff47e1bebfed8efff9dc3c924"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R7",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E8",
      "target_entity_id": "E5",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "evaluated in respiratory disease",
      "source_chunk_ids": [
        "92ee628ff47e1bebfed8efff9dc3c924"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R8",
      "type": "REPORTS",
      "source_entity_id": "E8",
      "target_entity_id": "E7",
      "attributes": {
        "outcome": "improves"
      },
      "confidence": 0.85,
      "evidence": "attenuate the acute and late phase",
      "source_chunk_ids": [
        "92ee628ff47e1bebfed8efff9dc3c924"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R1",
      "type": "ACTS_ON",
      "source_entity_id": "E1",
      "target_entity_id": "E4",
      "attributes": {
        "action": "inhibits",
        "assertion": "refutes"
      },
      "confidence": 0.75,
      "evidence": "PDE4-inhibitors are relatively poor at inhibiting macrophage function",
      "source_chunk_ids": [
        "efbf083d2a7a9f13233ec0b391a4ce96"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "ACTS_ON",
      "source_entity_id": "E2",
      "target_entity_id": "E5",
      "attributes": {
        "action": "produces"
      },
      "confidence": 0.8,
      "evidence": "PDE3-inhibition can produce bronchodilator effects",
      "source_chunk_ids": [
        "efbf083d2a7a9f13233ec0b391a4ce96"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "ACTS_ON",
      "source_entity_id": "E2",
      "target_entity_id": "E6",
      "attributes": {
        "action": "promotes"
      },
      "confidence": 0.75,
      "evidence": "promote chloride ion secretion",
      "source_chunk_ids": [
        "efbf083d2a7a9f13233ec0b391a4ce96"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R4",
      "type": "PRODUCES",
      "source_entity_id": "E2",
      "target_entity_id": "E7",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "Mixed PDE-inhibitors can serve to have additive or synergistic actions",
      "source_chunk_ids": [
        "efbf083d2a7a9f13233ec0b391a4ce96"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R5",
      "type": "TREATS",
      "source_entity_id": "E2",
      "target_entity_id": "E3",
      "attributes": {
        "context": "theoretical",
        "verification_needed": true
      },
      "confidence": 0.65,
      "evidence": "mixed PDE3/4 inhibitors could be of greater utility in COPD",
      "source_chunk_ids": [
        "efbf083d2a7a9f13233ec0b391a4ce96"
      ],
      "supporting_study_ids": [],
      "verified": false
    },
    {
      "id": "R6",
      "type": "PRODUCES",
      "source_entity_id": "E7",
      "target_entity_id": "E8",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "mixed PDE3/4 inhibitors with long duration of action coupled with anti-inflammatory activity",
      "source_chunk_ids": [
        "efbf083d2a7a9f13233ec0b391a4ce96"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R1",
      "type": "SUGGESTS",
      "source_entity_id": "E1",
      "target_entity_id": "E2",
      "attributes": {
        "mapping_type": "direct"
      },
      "confidence": 0.8,
      "evidence": "targeting PDE7 may also be beneficial in COPD",
      "source_chunk_ids": [
        "019e08c07d722aa9b0d108941fa07228"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "ACTS_ON",
      "source_entity_id": "E1",
      "target_entity_id": "E3",
      "attributes": {
        "action": "enhances",
        "outcome": "no_effect"
      },
      "confidence": 0.7,
      "evidence": "enhance the inhibitory action of a PDE4 selective inhibitor",
      "source_chunk_ids": [
        "019e08c07d722aa9b0d108941fa07228"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "PRODUCES",
      "source_entity_id": "E1",
      "target_entity_id": "E4",
      "attributes": {},
      "confidence": 0.75,
      "evidence": "targeting both PDE4 and PDE7 suppressed airway inflammation",
      "source_chunk_ids": [
        "019e08c07d722aa9b0d108941fa07228"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R4",
      "type": "REPORTS",
      "source_entity_id": "E5",
      "target_entity_id": "E1",
      "attributes": {
        "outcome": "no_effect"
      },
      "confidence": 0.8,
      "evidence": "targeting PDE7 failed to modify cell function in vitro",
      "source_chunk_ids": [
        "019e08c07d722aa9b0d108941fa07228"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R6",
      "type": "REPORTS",
      "source_entity_id": "E6",
      "target_entity_id": "E4",
      "attributes": {
        "outcome": "improves"
      },
      "confidence": 0.7,
      "evidence": "suppressed airway inflammation in mice",
      "source_chunk_ids": [
        "019e08c07d722aa9b0d108941fa07228"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R1",
      "type": "PRODUCES",
      "source_entity_id": "E1",
      "target_entity_id": "E4",
      "attributes": {
        "action": "targeting"
      },
      "confidence": 0.75,
      "evidence": "targeting of PDE4",
      "source_chunk_ids": [
        "fb3aee050dcc2b237b5adb8e4c8661de"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "PRODUCES",
      "source_entity_id": "E2",
      "target_entity_id": "E4",
      "attributes": {
        "action": "targeting"
      },
      "confidence": 0.75,
      "evidence": "targeting of PDE7",
      "source_chunk_ids": [
        "fb3aee050dcc2b237b5adb8e4c8661de"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "TREATS",
      "source_entity_id": "E4",
      "target_entity_id": "E3",
      "attributes": {
        "context": "therapeutic"
      },
      "confidence": 0.7,
      "evidence": "treatment of COPD",
      "source_chunk_ids": [
        "fb3aee050dcc2b237b5adb8e4c8661de"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R1",
      "type": "ACTS_ON",
      "source_entity_id": "E2",
      "target_entity_id": "E4",
      "attributes": {
        "action": "inhibits"
      },
      "confidence": 0.85,
      "evidence": "selective PDE4-inhibitors cilomilast",
      "source_chunk_ids": [
        "fd7aebf77c1caac407be5ee5c8a6a308"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "ACTS_ON",
      "source_entity_id": "E3",
      "target_entity_id": "E4",
      "attributes": {
        "action": "inhibits"
      },
      "confidence": 0.85,
      "evidence": "selective PDE4-inhibitors roflumilast",
      "source_chunk_ids": [
        "fd7aebf77c1caac407be5ee5c8a6a308"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E10",
      "target_entity_id": "E11",
      "attributes": {},
      "confidence": 0.9,
      "evidence": "randomized controlled trials",
      "source_chunk_ids": [
        "fd7aebf77c1caac407be5ee5c8a6a308"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R4",
      "type": "STUDIES",
      "source_entity_id": "E10",
      "target_entity_id": "E3",
      "attributes": {
        "role": "intervention"
      },
      "confidence": 0.85,
      "evidence": "roflumilast-related adverse events",
      "source_chunk_ids": [
        "fd7aebf77c1caac407be5ee5c8a6a308"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R5",
      "type": "REPORTS",
      "source_entity_id": "E10",
      "target_entity_id": "E5",
      "attributes": {
        "outcome": "observed"
      },
      "confidence": 0.8,
      "evidence": "nausea",
      "source_chunk_ids": [
        "fd7aebf77c1caac407be5ee5c8a6a308"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R6",
      "type": "REPORTS",
      "source_entity_id": "E10",
      "target_entity_id": "E6",
      "attributes": {
        "outcome": "observed"
      },
      "confidence": 0.8,
      "evidence": "headache",
      "source_chunk_ids": [
        "fd7aebf77c1caac407be5ee5c8a6a308"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R7",
      "type": "REPORTS",
      "source_entity_id": "E10",
      "target_entity_id": "E7",
      "attributes": {
        "outcome": "observed"
      },
      "confidence": 0.8,
      "evidence": "insomnia",
      "source_chunk_ids": [
        "fd7aebf77c1caac407be5ee5c8a6a308"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R8",
      "type": "REPORTS",
      "source_entity_id": "E10",
      "target_entity_id": "E8",
      "attributes": {
        "outcome": "observed"
      },
      "confidence": 0.8,
      "evidence": "diarrhea",
      "source_chunk_ids": [
        "fd7aebf77c1caac407be5ee5c8a6a308"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R9",
      "type": "REPORTS",
      "source_entity_id": "E10",
      "target_entity_id": "E9",
      "attributes": {
        "outcome": "observed"
      },
      "confidence": 0.75,
      "evidence": "modest weight loss",
      "source_chunk_ids": [
        "fd7aebf77c1caac407be5ee5c8a6a308"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R10",
      "type": "CAUSES",
      "source_entity_id": "E3",
      "target_entity_id": "E5",
      "attributes": {
        "context": "clinical",
        "severity": "common"
      },
      "confidence": 0.7,
      "evidence": "roflumilast-related adverse events included nausea",
      "source_chunk_ids": [
        "fd7aebf77c1caac407be5ee5c8a6a308"
      ],
      "supporting_study_ids": [
        "E10"
      ],
      "verified": true
    },
    {
      "id": "R11",
      "type": "CAUSES",
      "source_entity_id": "E3",
      "target_entity_id": "E6",
      "attributes": {
        "context": "clinical",
        "severity": "common"
      },
      "confidence": 0.7,
      "evidence": "roflumilast-related adverse events included headache",
      "source_chunk_ids": [
        "fd7aebf77c1caac407be5ee5c8a6a308"
      ],
      "supporting_study_ids": [
        "E10"
      ],
      "verified": true
    },
    {
      "id": "R12",
      "type": "CAUSES",
      "source_entity_id": "E3",
      "target_entity_id": "E7",
      "attributes": {
        "context": "clinical",
        "severity": "common"
      },
      "confidence": 0.7,
      "evidence": "roflumilast-related adverse events included insomnia",
      "source_chunk_ids": [
        "fd7aebf77c1caac407be5ee5c8a6a308"
      ],
      "supporting_study_ids": [
        "E10"
      ],
      "verified": true
    },
    {
      "id": "R13",
      "type": "CAUSES",
      "source_entity_id": "E3",
      "target_entity_id": "E8",
      "attributes": {
        "context": "clinical",
        "severity": "common"
      },
      "confidence": 0.7,
      "evidence": "roflumilast-related adverse events included diarrhea",
      "source_chunk_ids": [
        "fd7aebf77c1caac407be5ee5c8a6a308"
      ],
      "supporting_study_ids": [
        "E10"
      ],
      "verified": true
    },
    {
      "id": "R14",
      "type": "CAUSES",
      "source_entity_id": "E3",
      "target_entity_id": "E9",
      "attributes": {
        "context": "clinical",
        "severity": "modest",
        "verification_needed": true
      },
      "confidence": 0.65,
      "evidence": "roflumilast-related adverse events included weight loss",
      "source_chunk_ids": [
        "fd7aebf77c1caac407be5ee5c8a6a308"
      ],
      "supporting_study_ids": [
        "E10"
      ],
      "verified": false
    },
    {
      "id": "R1",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E1",
      "target_entity_id": "E3",
      "attributes": {},
      "confidence": 0.85,
      "evidence": "pooled data analysis of the M2-124/125 studies",
      "source_chunk_ids": [
        "5924c502444e71f851db89ce6bbf22a9"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E2",
      "target_entity_id": "E3",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "M2-127/128 studies",
      "source_chunk_ids": [
        "5924c502444e71f851db89ce6bbf22a9"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "REPORTS",
      "source_entity_id": "E1",
      "target_entity_id": "E4",
      "attributes": {
        "outcome": "observed"
      },
      "confidence": 0.9,
      "evidence": "most common side effects were diarrhea",
      "source_chunk_ids": [
        "5924c502444e71f851db89ce6bbf22a9"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R4",
      "type": "REPORTS",
      "source_entity_id": "E1",
      "target_entity_id": "E5",
      "attributes": {
        "outcome": "observed"
      },
      "confidence": 0.9,
      "evidence": "most common side effects were weight loss",
      "source_chunk_ids": [
        "5924c502444e71f851db89ce6bbf22a9"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R5",
      "type": "REPORTS",
      "source_entity_id": "E1",
      "target_entity_id": "E6",
      "attributes": {
        "outcome": "observed"
      },
      "confidence": 0.8,
      "evidence": "serious side effects were noted",
      "source_chunk_ids": [
        "5924c502444e71f851db89ce6bbf22a9"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R6",
      "type": "REPORTS",
      "source_entity_id": "E1",
      "target_entity_id": "E7",
      "attributes": {
        "outcome": "observed"
      },
      "confidence": 0.75,
      "evidence": "drop-outs due to side effects",
      "source_chunk_ids": [
        "5924c502444e71f851db89ce6bbf22a9"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R7",
      "type": "REPORTS",
      "source_entity_id": "E2",
      "target_entity_id": "E5",
      "attributes": {
        "outcome": "observed"
      },
      "confidence": 0.85,
      "evidence": "weight loss was reported in M2-127/128 studies",
      "source_chunk_ids": [
        "5924c502444e71f851db89ce6bbf22a9"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R1",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E1",
      "target_entity_id": "E2",
      "attributes": {},
      "confidence": 0.9,
      "evidence": "pooled analysis, including over 12,000 COPD patients from several RCT trials",
      "source_chunk_ids": [
        "a1f64eddcf4fe4ff7c23eb53177b72df"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "STUDIES",
      "source_entity_id": "E1",
      "target_entity_id": "E3",
      "attributes": {
        "role": "intervention"
      },
      "confidence": 0.9,
      "evidence": "patients on roflumilast 250 \u00b5g, patients on roflumilast 500 \u00b5g",
      "source_chunk_ids": [
        "a1f64eddcf4fe4ff7c23eb53177b72df"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "TESTED_AT",
      "source_entity_id": "E1",
      "target_entity_id": "E4",
      "attributes": {},
      "confidence": 0.85,
      "evidence": "797 patients on roflumilast 250 \u00b5g",
      "source_chunk_ids": [
        "a1f64eddcf4fe4ff7c23eb53177b72df"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R4",
      "type": "TESTED_AT",
      "source_entity_id": "E1",
      "target_entity_id": "E5",
      "attributes": {},
      "confidence": 0.85,
      "evidence": "5766 patients on roflumilast 500 \u00b5g",
      "source_chunk_ids": [
        "a1f64eddcf4fe4ff7c23eb53177b72df"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R5",
      "type": "REPORTS",
      "source_entity_id": "E1",
      "target_entity_id": "E6",
      "attributes": {
        "outcome": "studied"
      },
      "confidence": 0.9,
      "evidence": "COPD safety pooled analysis, including over 12,000 COPD patients",
      "source_chunk_ids": [
        "a1f64eddcf4fe4ff7c23eb53177b72df"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R6",
      "type": "REPORTS",
      "source_entity_id": "E1",
      "target_entity_id": "E7",
      "attributes": {
        "outcome": "observed"
      },
      "confidence": 0.85,
      "evidence": "3 cases of suicides were reported",
      "source_chunk_ids": [
        "a1f64eddcf4fe4ff7c23eb53177b72df"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R7",
      "type": "CAUSES",
      "source_entity_id": "E3",
      "target_entity_id": "E7",
      "attributes": {
        "context": "clinical",
        "severity": "severe"
      },
      "confidence": 0.75,
      "evidence": "all receiving roflumilast treatment",
      "source_chunk_ids": [
        "a1f64eddcf4fe4ff7c23eb53177b72df"
      ],
      "supporting_study_ids": [
        "E1"
      ],
      "verified": true
    },
    {
      "id": "R8",
      "type": "REPORTS",
      "source_entity_id": "E1",
      "target_entity_id": "E8",
      "attributes": {
        "outcome": "mentioned"
      },
      "confidence": 0.7,
      "evidence": "potentially pre-existent depression among these patients",
      "source_chunk_ids": [
        "a1f64eddcf4fe4ff7c23eb53177b72df"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R1",
      "type": "ACTS_ON",
      "source_entity_id": "E1",
      "target_entity_id": "E2",
      "attributes": {
        "action": "inhibits"
      },
      "confidence": 0.9,
      "evidence": "PDE4-inhibition",
      "source_chunk_ids": [
        "7427d3098ef3b448f43c2f4abff2c963"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "PRODUCES",
      "source_entity_id": "E1",
      "target_entity_id": "E3",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "roflumilast promoted IL-8 secretion",
      "source_chunk_ids": [
        "7427d3098ef3b448f43c2f4abff2c963"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "PRODUCES",
      "source_entity_id": "E1",
      "target_entity_id": "E4",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "roflumilast induced neutrophil recruitment",
      "source_chunk_ids": [
        "7427d3098ef3b448f43c2f4abff2c963"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R4",
      "type": "PRODUCES",
      "source_entity_id": "E2",
      "target_entity_id": "E5",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "PDE4-inhibition promoted chemokine expression",
      "source_chunk_ids": [
        "7427d3098ef3b448f43c2f4abff2c963"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R5",
      "type": "PRODUCES",
      "source_entity_id": "E5",
      "target_entity_id": "E6",
      "attributes": {},
      "confidence": 0.75,
      "evidence": "suggesting that this drug class might promote inflammation",
      "source_chunk_ids": [
        "7427d3098ef3b448f43c2f4abff2c963"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R6",
      "type": "PRODUCES",
      "source_entity_id": "E2",
      "target_entity_id": "E7",
      "attributes": {},
      "confidence": 0.85,
      "evidence": "anti-inflammatory effects of PDE4-inhibitors",
      "source_chunk_ids": [
        "7427d3098ef3b448f43c2f4abff2c963"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R7",
      "type": "TREATS",
      "source_entity_id": "E1",
      "target_entity_id": "E8",
      "attributes": {
        "context": "preclinical"
      },
      "confidence": 0.8,
      "evidence": "roflumilast reduced the rise in cell numbers caused by cigarette smoke",
      "source_chunk_ids": [
        "7427d3098ef3b448f43c2f4abff2c963"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R8",
      "type": "PRODUCES",
      "source_entity_id": "E1",
      "target_entity_id": "E9",
      "attributes": {},
      "confidence": 0.85,
      "evidence": "roflumilast reduced the rise in macrophage and neutrophil cell numbers",
      "source_chunk_ids": [
        "7427d3098ef3b448f43c2f4abff2c963"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R9",
      "type": "ACTS_ON",
      "source_entity_id": "E10",
      "target_entity_id": "E2",
      "attributes": {
        "action": "inhibits"
      },
      "confidence": 0.9,
      "evidence": "PDE4-inhibitors, cilomilast and roflumilast",
      "source_chunk_ids": [
        "7427d3098ef3b448f43c2f4abff2c963"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R10",
      "type": "PRODUCES",
      "source_entity_id": "E10",
      "target_entity_id": "E11",
      "attributes": {},
      "confidence": 0.85,
      "evidence": "cilomilast and roflumilast reduce inflammatory cell numbers",
      "source_chunk_ids": [
        "7427d3098ef3b448f43c2f4abff2c963"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R11",
      "type": "TREATS",
      "source_entity_id": "E10",
      "target_entity_id": "E12",
      "attributes": {
        "context": "clinical"
      },
      "confidence": 0.85,
      "evidence": "PDE4-inhibitors reduce airway inflammation",
      "source_chunk_ids": [
        "7427d3098ef3b448f43c2f4abff2c963"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R12",
      "type": "TREATS",
      "source_entity_id": "E1",
      "target_entity_id": "E12",
      "attributes": {
        "context": "clinical"
      },
      "confidence": 0.85,
      "evidence": "PDE4-inhibitors reduce airway inflammation",
      "source_chunk_ids": [
        "7427d3098ef3b448f43c2f4abff2c963"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R13",
      "type": "REPORTS",
      "source_entity_id": "E13",
      "target_entity_id": "E3",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "cell culture experiments that roflumilast promoted IL-8 secretion",
      "source_chunk_ids": [
        "7427d3098ef3b448f43c2f4abff2c963"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R14",
      "type": "REPORTS",
      "source_entity_id": "E14",
      "target_entity_id": "E9",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "preclinical model of smoke-induced inflammation",
      "source_chunk_ids": [
        "7427d3098ef3b448f43c2f4abff2c963"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R15",
      "type": "REPORTS",
      "source_entity_id": "E15",
      "target_entity_id": "E11",
      "attributes": {},
      "confidence": 0.85,
      "evidence": "human clinical data shows that PDE4-inhibitors reduce inflammatory cell numbers",
      "source_chunk_ids": [
        "7427d3098ef3b448f43c2f4abff2c963"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R1",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E1",
      "target_entity_id": "E2",
      "attributes": {},
      "confidence": 0.9,
      "evidence": "RCTs",
      "source_chunk_ids": [
        "83928fa24d30d5f0aa90872b012a3c3b"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "STUDIES",
      "source_entity_id": "E1",
      "target_entity_id": "E3",
      "attributes": {
        "role": "intervention"
      },
      "confidence": 0.9,
      "evidence": "roflumilast",
      "source_chunk_ids": [
        "83928fa24d30d5f0aa90872b012a3c3b"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "ACTS_ON",
      "source_entity_id": "E3",
      "target_entity_id": "E4",
      "attributes": {
        "action": "inhibits"
      },
      "confidence": 0.9,
      "evidence": "PDE4-inhibitor",
      "source_chunk_ids": [
        "83928fa24d30d5f0aa90872b012a3c3b"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R4",
      "type": "TREATS",
      "source_entity_id": "E3",
      "target_entity_id": "E5",
      "attributes": {
        "context": "clinical"
      },
      "confidence": 0.85,
      "evidence": "targeted approach to COPD",
      "source_chunk_ids": [
        "83928fa24d30d5f0aa90872b012a3c3b"
      ],
      "supporting_study_ids": [
        "E1"
      ],
      "verified": true
    },
    {
      "id": "R5",
      "type": "REPORTS",
      "source_entity_id": "E1",
      "target_entity_id": "E6",
      "attributes": {
        "outcome": "improves"
      },
      "confidence": 0.8,
      "evidence": "bronchodilation",
      "source_chunk_ids": [
        "83928fa24d30d5f0aa90872b012a3c3b"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R6",
      "type": "REPORTS",
      "source_entity_id": "E1",
      "target_entity_id": "E7",
      "attributes": {
        "outcome": "improves"
      },
      "confidence": 0.85,
      "evidence": "decrease in exacerbation rates",
      "source_chunk_ids": [
        "83928fa24d30d5f0aa90872b012a3c3b"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R7",
      "type": "REPORTS",
      "source_entity_id": "E1",
      "target_entity_id": "E8",
      "attributes": {
        "outcome": "improves"
      },
      "confidence": 0.85,
      "evidence": "improvements in lung function",
      "source_chunk_ids": [
        "83928fa24d30d5f0aa90872b012a3c3b"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R8",
      "type": "PRODUCES",
      "source_entity_id": "E3",
      "target_entity_id": "E9",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "suggests anti-inflammatory activity",
      "source_chunk_ids": [
        "83928fa24d30d5f0aa90872b012a3c3b"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R9",
      "type": "CAUSES",
      "source_entity_id": "E3",
      "target_entity_id": "E10",
      "attributes": {
        "context": "clinical",
        "severity": "mild to moderate"
      },
      "confidence": 0.8,
      "evidence": "nausea",
      "source_chunk_ids": [
        "83928fa24d30d5f0aa90872b012a3c3b"
      ],
      "supporting_study_ids": [
        "E1"
      ],
      "verified": true
    },
    {
      "id": "R10",
      "type": "CAUSES",
      "source_entity_id": "E3",
      "target_entity_id": "E11",
      "attributes": {
        "context": "clinical",
        "severity": "mild to moderate"
      },
      "confidence": 0.8,
      "evidence": "headache",
      "source_chunk_ids": [
        "83928fa24d30d5f0aa90872b012a3c3b"
      ],
      "supporting_study_ids": [
        "E1"
      ],
      "verified": true
    },
    {
      "id": "R11",
      "type": "CAUSES",
      "source_entity_id": "E3",
      "target_entity_id": "E12",
      "attributes": {
        "context": "clinical",
        "severity": "mild to moderate"
      },
      "confidence": 0.8,
      "evidence": "diarrhea",
      "source_chunk_ids": [
        "83928fa24d30d5f0aa90872b012a3c3b"
      ],
      "supporting_study_ids": [
        "E1"
      ],
      "verified": true
    },
    {
      "id": "R12",
      "type": "CAUSES",
      "source_entity_id": "E3",
      "target_entity_id": "E13",
      "attributes": {
        "context": "clinical",
        "severity": "mild to moderate"
      },
      "confidence": 0.8,
      "evidence": "weight loss",
      "source_chunk_ids": [
        "83928fa24d30d5f0aa90872b012a3c3b"
      ],
      "supporting_study_ids": [
        "E1"
      ],
      "verified": true
    },
    {
      "id": "R1",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E1",
      "target_entity_id": "E2",
      "attributes": {},
      "confidence": 0.9,
      "evidence": "mice chronically exposed to cigarette smoke",
      "source_chunk_ids": [
        "02bfdb1a471d34d508cc70fe28bfefbc"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "STUDIES",
      "source_entity_id": "E1",
      "target_entity_id": "E3",
      "attributes": {
        "role": "intervention"
      },
      "confidence": 0.9,
      "evidence": "Roflumilast fully prevents emphysema",
      "source_chunk_ids": [
        "02bfdb1a471d34d508cc70fe28bfefbc"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "REPORTS",
      "source_entity_id": "E1",
      "target_entity_id": "E4",
      "attributes": {
        "outcome": "prevents"
      },
      "confidence": 0.85,
      "evidence": "fully prevents emphysema",
      "source_chunk_ids": [
        "02bfdb1a471d34d508cc70fe28bfefbc"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R4",
      "type": "TREATS",
      "source_entity_id": "E3",
      "target_entity_id": "E4",
      "attributes": {
        "context": "preclinical"
      },
      "confidence": 0.8,
      "evidence": "Roflumilast fully prevents emphysema",
      "source_chunk_ids": [
        "02bfdb1a471d34d508cc70fe28bfefbc"
      ],
      "supporting_study_ids": [
        "E1"
      ],
      "verified": true
    },
    {
      "id": "R1",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E1",
      "target_entity_id": "E2",
      "attributes": {},
      "confidence": 0.9,
      "evidence": "cigarette smoke-induced inflammation in mice",
      "source_chunk_ids": [
        "9406d882d2f995fe6c1e382a7a3f7f6e"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "REPORTS",
      "source_entity_id": "E1",
      "target_entity_id": "E3",
      "attributes": {
        "outcome": "involvement"
      },
      "confidence": 0.85,
      "evidence": "Involvement of MMP-12",
      "source_chunk_ids": [
        "9406d882d2f995fe6c1e382a7a3f7f6e"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "REPORTS",
      "source_entity_id": "E1",
      "target_entity_id": "E4",
      "attributes": {
        "outcome": "involvement"
      },
      "confidence": 0.85,
      "evidence": "phosphodiesterase type 4",
      "source_chunk_ids": [
        "9406d882d2f995fe6c1e382a7a3f7f6e"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R4",
      "type": "REPORTS",
      "source_entity_id": "E1",
      "target_entity_id": "E5",
      "attributes": {
        "outcome": "induces"
      },
      "confidence": 0.9,
      "evidence": "cigarette smoke-induced inflammation",
      "source_chunk_ids": [
        "9406d882d2f995fe6c1e382a7a3f7f6e"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R1",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E1",
      "target_entity_id": "E2",
      "attributes": {},
      "confidence": 0.9,
      "evidence": "A multi-target antisense approach against PDE4 and PDE7 reduces smoke-induced lung inflammation in mice",
      "source_chunk_ids": [
        "852cf327078a543563d0bbb0fbd1ce4f"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "REPORTS",
      "source_entity_id": "E1",
      "target_entity_id": "E3",
      "attributes": {
        "outcome": "targeted"
      },
      "confidence": 0.85,
      "evidence": "multi-target antisense approach against PDE4",
      "source_chunk_ids": [
        "852cf327078a543563d0bbb0fbd1ce4f"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "REPORTS",
      "source_entity_id": "E1",
      "target_entity_id": "E4",
      "attributes": {
        "outcome": "targeted"
      },
      "confidence": 0.85,
      "evidence": "multi-target antisense approach against PDE7",
      "source_chunk_ids": [
        "852cf327078a543563d0bbb0fbd1ce4f"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R4",
      "type": "REPORTS",
      "source_entity_id": "E1",
      "target_entity_id": "E5",
      "attributes": {
        "outcome": "reduces"
      },
      "confidence": 0.9,
      "evidence": "reduces smoke-induced lung inflammation",
      "source_chunk_ids": [
        "852cf327078a543563d0bbb0fbd1ce4f"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R1",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E1",
      "target_entity_id": "E2",
      "attributes": {},
      "confidence": 0.9,
      "evidence": "clinical trial",
      "source_chunk_ids": [
        "feaeb3b686cde5cb4689ee112496f99e"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "STUDIES",
      "source_entity_id": "E1",
      "target_entity_id": "E3",
      "attributes": {
        "role": "intervention"
      },
      "confidence": 0.9,
      "evidence": "CDP840",
      "source_chunk_ids": [
        "feaeb3b686cde5cb4689ee112496f99e"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "ACTS_ON",
      "source_entity_id": "E3",
      "target_entity_id": "E4",
      "attributes": {
        "action": "inhibits"
      },
      "confidence": 0.85,
      "evidence": "selective PDE4 isoenzyme inhibitor",
      "source_chunk_ids": [
        "feaeb3b686cde5cb4689ee112496f99e"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R4",
      "type": "REPORTS",
      "source_entity_id": "E1",
      "target_entity_id": "E5",
      "attributes": {
        "outcome": "studied"
      },
      "confidence": 0.85,
      "evidence": "asthmatic subjects",
      "source_chunk_ids": [
        "feaeb3b686cde5cb4689ee112496f99e"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R1",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E1",
      "target_entity_id": "E2",
      "attributes": {},
      "confidence": 0.9,
      "evidence": "Anti-inflammatory effects of low-dose oral theophylline in atopic asthma",
      "source_chunk_ids": [
        "edf74691ddc1d4670fa27a294451132b"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "STUDIES",
      "source_entity_id": "E1",
      "target_entity_id": "E3",
      "attributes": {
        "role": "intervention"
      },
      "confidence": 0.9,
      "evidence": "low-dose oral theophylline",
      "source_chunk_ids": [
        "edf74691ddc1d4670fa27a294451132b"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "TESTED_AT",
      "source_entity_id": "E1",
      "target_entity_id": "E4",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "low-dose oral theophylline",
      "source_chunk_ids": [
        "edf74691ddc1d4670fa27a294451132b"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R4",
      "type": "REPORTS",
      "source_entity_id": "E1",
      "target_entity_id": "E5",
      "attributes": {
        "outcome": "improves"
      },
      "confidence": 0.85,
      "evidence": "in atopic asthma",
      "source_chunk_ids": [
        "edf74691ddc1d4670fa27a294451132b"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R5",
      "type": "REPORTS",
      "source_entity_id": "E1",
      "target_entity_id": "E6",
      "attributes": {
        "outcome": "positive"
      },
      "confidence": 0.9,
      "evidence": "Anti-inflammatory effects",
      "source_chunk_ids": [
        "edf74691ddc1d4670fa27a294451132b"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R6",
      "type": "TREATS",
      "source_entity_id": "E3",
      "target_entity_id": "E5",
      "attributes": {
        "context": "clinical"
      },
      "confidence": 0.8,
      "evidence": "Anti-inflammatory effects of low-dose oral theophylline in atopic asthma",
      "source_chunk_ids": [
        "edf74691ddc1d4670fa27a294451132b"
      ],
      "supporting_study_ids": [
        "E1"
      ],
      "verified": true
    },
    {
      "id": "R7",
      "type": "PRODUCES",
      "source_entity_id": "E3",
      "target_entity_id": "E6",
      "attributes": {},
      "confidence": 0.75,
      "evidence": "Anti-inflammatory effects of low-dose oral theophylline",
      "source_chunk_ids": [
        "edf74691ddc1d4670fa27a294451132b"
      ],
      "supporting_study_ids": [
        "E1"
      ],
      "verified": true
    },
    {
      "id": "R1",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E1",
      "target_entity_id": "E2",
      "attributes": {},
      "confidence": 0.9,
      "evidence": "single dose study in patients with chronic obstructive pulmonary disease",
      "source_chunk_ids": [
        "1a23212ad32defc30b5b3252ee96f4b2"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "STUDIES",
      "source_entity_id": "E1",
      "target_entity_id": "E3",
      "attributes": {
        "role": "intervention"
      },
      "confidence": 0.9,
      "evidence": "cilomilast (15 mg)",
      "source_chunk_ids": [
        "1a23212ad32defc30b5b3252ee96f4b2"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "TESTED_AT",
      "source_entity_id": "E1",
      "target_entity_id": "E5",
      "attributes": {},
      "confidence": 0.9,
      "evidence": "cilomilast (15 mg)",
      "source_chunk_ids": [
        "1a23212ad32defc30b5b3252ee96f4b2"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R4",
      "type": "REPORTS",
      "source_entity_id": "E1",
      "target_entity_id": "E6",
      "attributes": {
        "outcome": "studied"
      },
      "confidence": 0.9,
      "evidence": "patients with chronic obstructive pulmonary disease",
      "source_chunk_ids": [
        "1a23212ad32defc30b5b3252ee96f4b2"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R5",
      "type": "REPORTS",
      "source_entity_id": "E1",
      "target_entity_id": "E7",
      "attributes": {
        "outcome": "investigated"
      },
      "confidence": 0.85,
      "evidence": "induce bronchodilation",
      "source_chunk_ids": [
        "1a23212ad32defc30b5b3252ee96f4b2"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R6",
      "type": "ACTS_ON",
      "source_entity_id": "E3",
      "target_entity_id": "E4",
      "attributes": {
        "action": "inhibits"
      },
      "confidence": 0.9,
      "evidence": "phosphodiesterase 4 inhibitor",
      "source_chunk_ids": [
        "1a23212ad32defc30b5b3252ee96f4b2"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R7",
      "type": "PRODUCES",
      "source_entity_id": "E3",
      "target_entity_id": "E7",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "induce bronchodilation",
      "source_chunk_ids": [
        "1a23212ad32defc30b5b3252ee96f4b2"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R8",
      "type": "TREATS",
      "source_entity_id": "E3",
      "target_entity_id": "E6",
      "attributes": {
        "context": "clinical"
      },
      "confidence": 0.75,
      "evidence": "induce bronchodilation in patients with chronic obstructive pulmonary disease",
      "source_chunk_ids": [
        "1a23212ad32defc30b5b3252ee96f4b2"
      ],
      "supporting_study_ids": [
        "E1"
      ],
      "verified": true
    },
    {
      "id": "R1",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E1",
      "target_entity_id": "E2",
      "attributes": {},
      "confidence": 0.9,
      "evidence": "passively sensitized human airways",
      "source_chunk_ids": [
        "09eae867b613fcf41c04abba4faf3cf4"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "STUDIES",
      "source_entity_id": "E1",
      "target_entity_id": "E3",
      "attributes": {
        "role": "target"
      },
      "confidence": 0.9,
      "evidence": "phosphodiesterase inhibitors",
      "source_chunk_ids": [
        "09eae867b613fcf41c04abba4faf3cf4"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "REPORTS",
      "source_entity_id": "E1",
      "target_entity_id": "E4",
      "attributes": {
        "outcome": "modulates"
      },
      "confidence": 0.85,
      "evidence": "allergen- and leukotriene C(4)-induced contractions",
      "source_chunk_ids": [
        "09eae867b613fcf41c04abba4faf3cf4"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R4",
      "type": "REPORTS",
      "source_entity_id": "E1",
      "target_entity_id": "E5",
      "attributes": {
        "outcome": "inhibits"
      },
      "confidence": 0.8,
      "evidence": "The effect of selective and non-selective phosphodiesterase inhibitors",
      "source_chunk_ids": [
        "09eae867b613fcf41c04abba4faf3cf4"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R1",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E1",
      "target_entity_id": "E2",
      "attributes": {},
      "confidence": 0.9,
      "evidence": "in human airway smooth muscle cells",
      "source_chunk_ids": [
        "5561f3ec3037001fe3ba570909b12152"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "REPORTS",
      "source_entity_id": "E1",
      "target_entity_id": "E3",
      "attributes": {
        "outcome": "functional role"
      },
      "confidence": 0.85,
      "evidence": "A major functional role for phosphodiesterase 4D5",
      "source_chunk_ids": [
        "5561f3ec3037001fe3ba570909b12152"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "REPORTS",
      "source_entity_id": "E1",
      "target_entity_id": "E4",
      "attributes": {
        "outcome": "describes"
      },
      "confidence": 0.8,
      "evidence": "A major functional role for phosphodiesterase 4D5 in human airway smooth muscle cells",
      "source_chunk_ids": [
        "5561f3ec3037001fe3ba570909b12152"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R1",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E1",
      "target_entity_id": "E2",
      "attributes": {},
      "confidence": 0.9,
      "evidence": "identification and characterization",
      "source_chunk_ids": [
        "59dc58c6e7f2d089a9f39db1e2ada317"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "REPORTS",
      "source_entity_id": "E1",
      "target_entity_id": "E3",
      "attributes": {},
      "confidence": 0.9,
      "evidence": "Phosphodiesterase isozymes",
      "source_chunk_ids": [
        "59dc58c6e7f2d089a9f39db1e2ada317"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "REPORTS",
      "source_entity_id": "E1",
      "target_entity_id": "E4",
      "attributes": {},
      "confidence": 0.85,
      "evidence": "inherent tone in human airways",
      "source_chunk_ids": [
        "59dc58c6e7f2d089a9f39db1e2ada317"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R1",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E1",
      "target_entity_id": "E2",
      "attributes": {},
      "confidence": 0.9,
      "evidence": "Identification, characterization and functional role of phosphodiesterase isozymes in human airway smooth muscle",
      "source_chunk_ids": [
        "72c4c562d6f1298f0247a37cdea5be1c"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "STUDIES",
      "source_entity_id": "E1",
      "target_entity_id": "E3",
      "attributes": {
        "role": "target"
      },
      "confidence": 0.9,
      "evidence": "phosphodiesterase isozymes",
      "source_chunk_ids": [
        "72c4c562d6f1298f0247a37cdea5be1c"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "REPORTS",
      "source_entity_id": "E1",
      "target_entity_id": "E4",
      "attributes": {
        "outcome": "characterizes"
      },
      "confidence": 0.7,
      "evidence": "human airway smooth muscle",
      "source_chunk_ids": [
        "72c4c562d6f1298f0247a37cdea5be1c"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R1",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E1",
      "target_entity_id": "E2",
      "attributes": {},
      "confidence": 0.9,
      "evidence": "Does a single dose... induce bronchodilation",
      "source_chunk_ids": [
        "17c1ee2f2ae3cf1232090ce9cf825084"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "STUDIES",
      "source_entity_id": "E1",
      "target_entity_id": "E3",
      "attributes": {
        "role": "intervention"
      },
      "confidence": 0.9,
      "evidence": "cilomilast (15 mg)",
      "source_chunk_ids": [
        "17c1ee2f2ae3cf1232090ce9cf825084"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "ACTS_ON",
      "source_entity_id": "E3",
      "target_entity_id": "E4",
      "attributes": {
        "action": "inhibits"
      },
      "confidence": 0.85,
      "evidence": "phosphodiesterase 4 inhibitor, cilomilast",
      "source_chunk_ids": [
        "17c1ee2f2ae3cf1232090ce9cf825084"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R4",
      "type": "TESTED_AT",
      "source_entity_id": "E1",
      "target_entity_id": "E5",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "cilomilast (15 mg)",
      "source_chunk_ids": [
        "17c1ee2f2ae3cf1232090ce9cf825084"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R5",
      "type": "REPORTS",
      "source_entity_id": "E1",
      "target_entity_id": "E6",
      "attributes": {
        "outcome": "investigates"
      },
      "confidence": 0.9,
      "evidence": "patients with chronic obstructive pulmonary disease",
      "source_chunk_ids": [
        "17c1ee2f2ae3cf1232090ce9cf825084"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R6",
      "type": "REPORTS",
      "source_entity_id": "E1",
      "target_entity_id": "E7",
      "attributes": {
        "outcome": "investigates"
      },
      "confidence": 0.85,
      "evidence": "induce bronchodilation",
      "source_chunk_ids": [
        "17c1ee2f2ae3cf1232090ce9cf825084"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R7",
      "type": "TREATS",
      "source_entity_id": "E3",
      "target_entity_id": "E6",
      "attributes": {
        "context": "clinical"
      },
      "confidence": 0.7,
      "evidence": "induce bronchodilation in patients with chronic obstructive pulmonary disease",
      "source_chunk_ids": [
        "17c1ee2f2ae3cf1232090ce9cf825084"
      ],
      "supporting_study_ids": [
        "E1"
      ],
      "verified": true
    },
    {
      "id": "R8",
      "type": "PRODUCES",
      "source_entity_id": "E3",
      "target_entity_id": "E7",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "induce bronchodilation",
      "source_chunk_ids": [
        "17c1ee2f2ae3cf1232090ce9cf825084"
      ],
      "supporting_study_ids": [
        "E1"
      ],
      "verified": true
    },
    {
      "id": "R1",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E1",
      "target_entity_id": "E2",
      "attributes": {},
      "confidence": 0.9,
      "evidence": "placebo-controlled study",
      "source_chunk_ids": [
        "eb9b577f7044f90f2ba8ea427361c0fd"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "STUDIES",
      "source_entity_id": "E1",
      "target_entity_id": "E3",
      "attributes": {
        "role": "intervention"
      },
      "confidence": 0.9,
      "evidence": "Cilomilast for COPD",
      "source_chunk_ids": [
        "eb9b577f7044f90f2ba8ea427361c0fd"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "REPORTS",
      "source_entity_id": "E1",
      "target_entity_id": "E4",
      "attributes": {
        "outcome": "studied"
      },
      "confidence": 0.85,
      "evidence": "Cilomilast for COPD",
      "source_chunk_ids": [
        "eb9b577f7044f90f2ba8ea427361c0fd"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R4",
      "type": "ACTS_ON",
      "source_entity_id": "E3",
      "target_entity_id": "E5",
      "attributes": {
        "action": "inhibits"
      },
      "confidence": 0.85,
      "evidence": "selective inhibitor of phosphodiesterase 4",
      "source_chunk_ids": [
        "eb9b577f7044f90f2ba8ea427361c0fd"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R1",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E1",
      "target_entity_id": "E2",
      "attributes": {},
      "confidence": 0.9,
      "evidence": "Antiinflammatory effects in chronic obstructive pulmonary disease",
      "source_chunk_ids": [
        "01e25bc254035d1a46722b5dfd544939"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "STUDIES",
      "source_entity_id": "E1",
      "target_entity_id": "E3",
      "attributes": {
        "role": "intervention"
      },
      "confidence": 0.9,
      "evidence": "phosphodiesterase-4 inhibitor cilomilast",
      "source_chunk_ids": [
        "01e25bc254035d1a46722b5dfd544939"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "REPORTS",
      "source_entity_id": "E1",
      "target_entity_id": "E5",
      "attributes": {
        "outcome": "improves"
      },
      "confidence": 0.85,
      "evidence": "Antiinflammatory effects in chronic obstructive pulmonary disease",
      "source_chunk_ids": [
        "01e25bc254035d1a46722b5dfd544939"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R4",
      "type": "REPORTS",
      "source_entity_id": "E1",
      "target_entity_id": "E6",
      "attributes": {
        "outcome": "positive"
      },
      "confidence": 0.85,
      "evidence": "Antiinflammatory effects",
      "source_chunk_ids": [
        "01e25bc254035d1a46722b5dfd544939"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R5",
      "type": "ACTS_ON",
      "source_entity_id": "E3",
      "target_entity_id": "E4",
      "attributes": {
        "action": "inhibits"
      },
      "confidence": 0.9,
      "evidence": "phosphodiesterase-4 inhibitor cilomilast",
      "source_chunk_ids": [
        "01e25bc254035d1a46722b5dfd544939"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R6",
      "type": "TREATS",
      "source_entity_id": "E3",
      "target_entity_id": "E5",
      "attributes": {
        "context": "clinical"
      },
      "confidence": 0.8,
      "evidence": "Antiinflammatory effects in chronic obstructive pulmonary disease",
      "source_chunk_ids": [
        "01e25bc254035d1a46722b5dfd544939"
      ],
      "supporting_study_ids": [
        "E1"
      ],
      "verified": true
    },
    {
      "id": "R7",
      "type": "PRODUCES",
      "source_entity_id": "E3",
      "target_entity_id": "E6",
      "attributes": {},
      "confidence": 0.75,
      "evidence": "Antiinflammatory effects of cilomilast",
      "source_chunk_ids": [
        "01e25bc254035d1a46722b5dfd544939"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R1",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E1",
      "target_entity_id": "E2",
      "attributes": {},
      "confidence": 0.9,
      "evidence": "Inhibition of neurally mediated nonadrenergic, noncholinergic contractions",
      "source_chunk_ids": [
        "4359b4c9ed96903c8f384a4e15da0f4e"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "REPORTS",
      "source_entity_id": "E1",
      "target_entity_id": "E3",
      "attributes": {},
      "confidence": 0.85,
      "evidence": "isozyme-selective phosphodiesterase inhibitors",
      "source_chunk_ids": [
        "4359b4c9ed96903c8f384a4e15da0f4e"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "REPORTS",
      "source_entity_id": "E1",
      "target_entity_id": "E4",
      "attributes": {
        "outcome": "inhibits"
      },
      "confidence": 0.9,
      "evidence": "Inhibition of neurally mediated nonadrenergic, noncholinergic contractions",
      "source_chunk_ids": [
        "4359b4c9ed96903c8f384a4e15da0f4e"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R1",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E1",
      "target_entity_id": "E2",
      "attributes": {},
      "confidence": 0.9,
      "evidence": "guinea-pig isolated main bronchus",
      "source_chunk_ids": [
        "361074e7a8013654488b85851f300853"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "REPORTS",
      "source_entity_id": "E1",
      "target_entity_id": "E3",
      "attributes": {},
      "confidence": 0.85,
      "evidence": "Regulation by phosphodiesterase isoenzymes",
      "source_chunk_ids": [
        "361074e7a8013654488b85851f300853"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "REPORTS",
      "source_entity_id": "E1",
      "target_entity_id": "E4",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "non-adrenergic non- cholinergic contraction",
      "source_chunk_ids": [
        "361074e7a8013654488b85851f300853"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R1",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E1",
      "target_entity_id": "E2",
      "attributes": {},
      "confidence": 0.9,
      "evidence": "in vitro study",
      "source_chunk_ids": [
        "11a44f329fcd36113c0e17e623392e5b"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "STUDIES",
      "source_entity_id": "E1",
      "target_entity_id": "E4",
      "attributes": {
        "role": "intervention"
      },
      "confidence": 0.8,
      "evidence": "type 3 phosphodiesterase inhibitors",
      "source_chunk_ids": [
        "11a44f329fcd36113c0e17e623392e5b"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "STUDIES",
      "source_entity_id": "E1",
      "target_entity_id": "E5",
      "attributes": {
        "role": "intervention"
      },
      "confidence": 0.8,
      "evidence": "type 4D phosphodiesterase inhibitors",
      "source_chunk_ids": [
        "11a44f329fcd36113c0e17e623392e5b"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R4",
      "type": "REPORTS",
      "source_entity_id": "E1",
      "target_entity_id": "E3",
      "attributes": {
        "outcome": "target identified"
      },
      "confidence": 0.9,
      "evidence": "cystic fibrosis transmembrane conductance regulator",
      "source_chunk_ids": [
        "11a44f329fcd36113c0e17e623392e5b"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R5",
      "type": "REPORTS",
      "source_entity_id": "E1",
      "target_entity_id": "E6",
      "attributes": {
        "outcome": "activates"
      },
      "confidence": 0.85,
      "evidence": "Dynamic activation of cystic fibrosis transmembrane conductance regulator",
      "source_chunk_ids": [
        "11a44f329fcd36113c0e17e623392e5b"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R6",
      "type": "ACTS_ON",
      "source_entity_id": "E4",
      "target_entity_id": "E3",
      "attributes": {
        "action": "activates"
      },
      "confidence": 0.75,
      "evidence": "type 3 phosphodiesterase inhibitors activate cystic fibrosis transmembrane conductance regulator",
      "source_chunk_ids": [
        "11a44f329fcd36113c0e17e623392e5b"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R7",
      "type": "ACTS_ON",
      "source_entity_id": "E5",
      "target_entity_id": "E3",
      "attributes": {
        "action": "activates"
      },
      "confidence": 0.75,
      "evidence": "type 4D phosphodiesterase inhibitors activate cystic fibrosis transmembrane conductance regulator",
      "source_chunk_ids": [
        "11a44f329fcd36113c0e17e623392e5b"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R8",
      "type": "PRODUCES",
      "source_entity_id": "E4",
      "target_entity_id": "E6",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "type 3 phosphodiesterase inhibitors cause activation",
      "source_chunk_ids": [
        "11a44f329fcd36113c0e17e623392e5b"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R9",
      "type": "PRODUCES",
      "source_entity_id": "E5",
      "target_entity_id": "E6",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "type 4D phosphodiesterase inhibitors cause activation",
      "source_chunk_ids": [
        "11a44f329fcd36113c0e17e623392e5b"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R1",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E1",
      "target_entity_id": "E2",
      "attributes": {},
      "confidence": 0.9,
      "evidence": "in vitro",
      "source_chunk_ids": [
        "c49b4d51cc23f718748f08945558e701"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E3",
      "target_entity_id": "E2",
      "attributes": {},
      "confidence": 0.85,
      "evidence": "in vitro",
      "source_chunk_ids": [
        "c49b4d51cc23f718748f08945558e701"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E4",
      "target_entity_id": "E5",
      "attributes": {},
      "confidence": 0.85,
      "evidence": "clinical trial",
      "source_chunk_ids": [
        "c49b4d51cc23f718748f08945558e701"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R4",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E6",
      "target_entity_id": "E7",
      "attributes": {},
      "confidence": 0.9,
      "evidence": "preclinical pharmacology",
      "source_chunk_ids": [
        "c49b4d51cc23f718748f08945558e701"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R5",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E8",
      "target_entity_id": "E5",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "clinical study",
      "source_chunk_ids": [
        "c49b4d51cc23f718748f08945558e701"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R6",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E9",
      "target_entity_id": "E5",
      "attributes": {},
      "confidence": 0.9,
      "evidence": "randomised controlled trial",
      "source_chunk_ids": [
        "c49b4d51cc23f718748f08945558e701"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R7",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E10",
      "target_entity_id": "E5",
      "attributes": {},
      "confidence": 0.85,
      "evidence": "clinical trial",
      "source_chunk_ids": [
        "c49b4d51cc23f718748f08945558e701"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R8",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E11",
      "target_entity_id": "E5",
      "attributes": {},
      "confidence": 0.9,
      "evidence": "randomised clinical trials",
      "source_chunk_ids": [
        "c49b4d51cc23f718748f08945558e701"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R9",
      "type": "STUDIES",
      "source_entity_id": "E4",
      "target_entity_id": "E12",
      "attributes": {
        "role": "intervention"
      },
      "confidence": 0.9,
      "evidence": "cilomilast",
      "source_chunk_ids": [
        "c49b4d51cc23f718748f08945558e701"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R10",
      "type": "STUDIES",
      "source_entity_id": "E6",
      "target_entity_id": "E13",
      "attributes": {
        "role": "intervention"
      },
      "confidence": 0.9,
      "evidence": "roflumilast",
      "source_chunk_ids": [
        "c49b4d51cc23f718748f08945558e701"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R11",
      "type": "STUDIES",
      "source_entity_id": "E8",
      "target_entity_id": "E13",
      "attributes": {
        "role": "intervention"
      },
      "confidence": 0.85,
      "evidence": "roflumilast",
      "source_chunk_ids": [
        "c49b4d51cc23f718748f08945558e701"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R12",
      "type": "STUDIES",
      "source_entity_id": "E9",
      "target_entity_id": "E13",
      "attributes": {
        "role": "intervention"
      },
      "confidence": 0.9,
      "evidence": "roflumilast",
      "source_chunk_ids": [
        "c49b4d51cc23f718748f08945558e701"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R13",
      "type": "STUDIES",
      "source_entity_id": "E10",
      "target_entity_id": "E13",
      "attributes": {
        "role": "intervention"
      },
      "confidence": 0.85,
      "evidence": "roflumilast",
      "source_chunk_ids": [
        "c49b4d51cc23f718748f08945558e701"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R14",
      "type": "STUDIES",
      "source_entity_id": "E11",
      "target_entity_id": "E13",
      "attributes": {
        "role": "intervention"
      },
      "confidence": 0.9,
      "evidence": "roflumilast",
      "source_chunk_ids": [
        "c49b4d51cc23f718748f08945558e701"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R15",
      "type": "ACTS_ON",
      "source_entity_id": "E13",
      "target_entity_id": "E14",
      "attributes": {
        "action": "inhibits"
      },
      "confidence": 0.8,
      "evidence": "selective phosphodiesterase 4 inhibitor",
      "source_chunk_ids": [
        "c49b4d51cc23f718748f08945558e701"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R16",
      "type": "REPORTS",
      "source_entity_id": "E3",
      "target_entity_id": "E16",
      "attributes": {
        "outcome": "observed"
      },
      "confidence": 0.75,
      "evidence": "decreases MUC5AC expression",
      "source_chunk_ids": [
        "c49b4d51cc23f718748f08945558e701"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R17",
      "type": "REPORTS",
      "source_entity_id": "E9",
      "target_entity_id": "E17",
      "attributes": {
        "outcome": "observed"
      },
      "confidence": 0.7,
      "evidence": "anti-inflammatory treatment",
      "source_chunk_ids": [
        "c49b4d51cc23f718748f08945558e701"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R18",
      "type": "REPORTS",
      "source_entity_id": "E4",
      "target_entity_id": "E15",
      "attributes": {
        "outcome": "studied"
      },
      "confidence": 0.85,
      "evidence": "COPD",
      "source_chunk_ids": [
        "c49b4d51cc23f718748f08945558e701"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R19",
      "type": "REPORTS",
      "source_entity_id": "E8",
      "target_entity_id": "E15",
      "attributes": {
        "outcome": "studied"
      },
      "confidence": 0.85,
      "evidence": "COPD",
      "source_chunk_ids": [
        "c49b4d51cc23f718748f08945558e701"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R20",
      "type": "REPORTS",
      "source_entity_id": "E9",
      "target_entity_id": "E15",
      "attributes": {
        "outcome": "studied"
      },
      "confidence": 0.9,
      "evidence": "COPD",
      "source_chunk_ids": [
        "c49b4d51cc23f718748f08945558e701"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R21",
      "type": "REPORTS",
      "source_entity_id": "E10",
      "target_entity_id": "E15",
      "attributes": {
        "outcome": "studied"
      },
      "confidence": 0.85,
      "evidence": "COPD",
      "source_chunk_ids": [
        "c49b4d51cc23f718748f08945558e701"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R22",
      "type": "REPORTS",
      "source_entity_id": "E11",
      "target_entity_id": "E15",
      "attributes": {
        "outcome": "studied"
      },
      "confidence": 0.9,
      "evidence": "COPD",
      "source_chunk_ids": [
        "c49b4d51cc23f718748f08945558e701"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R23",
      "type": "TREATS",
      "source_entity_id": "E13",
      "target_entity_id": "E15",
      "attributes": {
        "context": "clinical"
      },
      "confidence": 0.75,
      "evidence": "Treatment of COPD with roflumilast",
      "source_chunk_ids": [
        "c49b4d51cc23f718748f08945558e701"
      ],
      "supporting_study_ids": [
        "E8",
        "E9",
        "E10",
        "E11"
      ],
      "verified": true
    },
    {
      "id": "R1",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E1",
      "target_entity_id": "E2",
      "attributes": {},
      "confidence": 0.95,
      "evidence": "two randomised clinical trials",
      "source_chunk_ids": [
        "6cc6e7e03a095713ef7c4d3c9ec42092"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "REPORTS",
      "source_entity_id": "E1",
      "target_entity_id": "E3",
      "attributes": {
        "outcome": "studied"
      },
      "confidence": 0.9,
      "evidence": "moderate-to-severe chronic obstructive pulmonary disease",
      "source_chunk_ids": [
        "6cc6e7e03a095713ef7c4d3c9ec42092"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R1",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E1",
      "target_entity_id": "E2",
      "attributes": {},
      "confidence": 0.9,
      "evidence": "Reduction in sputum neutrophil and eosinophil numbers by the PDE4 inhibitor roflumilast in patients with COPD",
      "source_chunk_ids": [
        "948cf060b565040a6e42486beef08481"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "STUDIES",
      "source_entity_id": "E1",
      "target_entity_id": "E3",
      "attributes": {
        "role": "intervention"
      },
      "confidence": 0.9,
      "evidence": "PDE4 inhibitor roflumilast",
      "source_chunk_ids": [
        "948cf060b565040a6e42486beef08481"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "REPORTS",
      "source_entity_id": "E1",
      "target_entity_id": "E4",
      "attributes": {
        "outcome": "improves"
      },
      "confidence": 0.85,
      "evidence": "patients with COPD",
      "source_chunk_ids": [
        "948cf060b565040a6e42486beef08481"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R4",
      "type": "REPORTS",
      "source_entity_id": "E1",
      "target_entity_id": "E5",
      "attributes": {
        "outcome": "improves"
      },
      "confidence": 0.8,
      "evidence": "Reduction in sputum neutrophil numbers",
      "source_chunk_ids": [
        "948cf060b565040a6e42486beef08481"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R5",
      "type": "REPORTS",
      "source_entity_id": "E1",
      "target_entity_id": "E6",
      "attributes": {
        "outcome": "improves"
      },
      "confidence": 0.8,
      "evidence": "Reduction in sputum eosinophil numbers",
      "source_chunk_ids": [
        "948cf060b565040a6e42486beef08481"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R6",
      "type": "TREATS",
      "source_entity_id": "E3",
      "target_entity_id": "E4",
      "attributes": {
        "context": "clinical"
      },
      "confidence": 0.75,
      "evidence": "Reduction in sputum neutrophil and eosinophil numbers by the PDE4 inhibitor roflumilast in patients with COPD",
      "source_chunk_ids": [
        "948cf060b565040a6e42486beef08481"
      ],
      "supporting_study_ids": [
        "E1"
      ],
      "verified": true
    },
    {
      "id": "R1",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E1",
      "target_entity_id": "E2",
      "attributes": {},
      "confidence": 0.95,
      "evidence": "randomized placebo-controlled trial",
      "source_chunk_ids": [
        "0c739efb94b8e9c2390c4ec066ebd0cf"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "STUDIES",
      "source_entity_id": "E1",
      "target_entity_id": "E3",
      "attributes": {
        "role": "intervention"
      },
      "confidence": 0.9,
      "evidence": "Roflumilast attenuates",
      "source_chunk_ids": [
        "0c739efb94b8e9c2390c4ec066ebd0cf"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "REPORTS",
      "source_entity_id": "E1",
      "target_entity_id": "E4",
      "attributes": {
        "outcome": "improves"
      },
      "confidence": 0.85,
      "evidence": "attenuates pulmonary inflammation",
      "source_chunk_ids": [
        "0c739efb94b8e9c2390c4ec066ebd0cf"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R4",
      "type": "REPORTS",
      "source_entity_id": "E1",
      "target_entity_id": "E5",
      "attributes": {
        "outcome": "positive"
      },
      "confidence": 0.8,
      "evidence": "attenuates pulmonary inflammation",
      "source_chunk_ids": [
        "0c739efb94b8e9c2390c4ec066ebd0cf"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R5",
      "type": "TREATS",
      "source_entity_id": "E3",
      "target_entity_id": "E4",
      "attributes": {
        "context": "clinical"
      },
      "confidence": 0.8,
      "evidence": "attenuates pulmonary inflammation",
      "source_chunk_ids": [
        "0c739efb94b8e9c2390c4ec066ebd0cf"
      ],
      "supporting_study_ids": [
        "E1"
      ],
      "verified": true
    },
    {
      "id": "R6",
      "type": "PRODUCES",
      "source_entity_id": "E3",
      "target_entity_id": "E5",
      "attributes": {},
      "confidence": 0.75,
      "evidence": "attenuates pulmonary inflammation",
      "source_chunk_ids": [
        "0c739efb94b8e9c2390c4ec066ebd0cf"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R1",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E1",
      "target_entity_id": "E2",
      "attributes": {},
      "confidence": 0.9,
      "evidence": "Effect of cilomilast on TNF-alpha, IL-8, and GM-CSF release",
      "source_chunk_ids": [
        "049d1bee9df30c07fd34918b3cc69cfb"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "STUDIES",
      "source_entity_id": "E1",
      "target_entity_id": "E3",
      "attributes": {
        "role": "intervention"
      },
      "confidence": 0.9,
      "evidence": "Effect of cilomilast",
      "source_chunk_ids": [
        "049d1bee9df30c07fd34918b3cc69cfb"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "STUDIES",
      "source_entity_id": "E1",
      "target_entity_id": "E8",
      "attributes": {
        "role": "condition"
      },
      "confidence": 0.85,
      "evidence": "patients with COPD",
      "source_chunk_ids": [
        "049d1bee9df30c07fd34918b3cc69cfb"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R4",
      "type": "REPORTS",
      "source_entity_id": "E1",
      "target_entity_id": "E5",
      "attributes": {
        "outcome": "effect on release"
      },
      "confidence": 0.8,
      "evidence": "TNF-alpha release",
      "source_chunk_ids": [
        "049d1bee9df30c07fd34918b3cc69cfb"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R5",
      "type": "REPORTS",
      "source_entity_id": "E1",
      "target_entity_id": "E6",
      "attributes": {
        "outcome": "effect on release"
      },
      "confidence": 0.8,
      "evidence": "IL-8 release",
      "source_chunk_ids": [
        "049d1bee9df30c07fd34918b3cc69cfb"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R6",
      "type": "REPORTS",
      "source_entity_id": "E1",
      "target_entity_id": "E7",
      "attributes": {
        "outcome": "effect on release"
      },
      "confidence": 0.8,
      "evidence": "GM-CSF release",
      "source_chunk_ids": [
        "049d1bee9df30c07fd34918b3cc69cfb"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R7",
      "type": "ACTS_ON",
      "source_entity_id": "E3",
      "target_entity_id": "E5",
      "attributes": {
        "action": "modulates"
      },
      "confidence": 0.7,
      "evidence": "Effect of cilomilast on TNF-alpha release",
      "source_chunk_ids": [
        "049d1bee9df30c07fd34918b3cc69cfb"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R8",
      "type": "ACTS_ON",
      "source_entity_id": "E3",
      "target_entity_id": "E6",
      "attributes": {
        "action": "modulates"
      },
      "confidence": 0.7,
      "evidence": "Effect of cilomilast on IL-8 release",
      "source_chunk_ids": [
        "049d1bee9df30c07fd34918b3cc69cfb"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R9",
      "type": "ACTS_ON",
      "source_entity_id": "E3",
      "target_entity_id": "E7",
      "attributes": {
        "action": "modulates"
      },
      "confidence": 0.7,
      "evidence": "Effect of cilomilast on GM-CSF release",
      "source_chunk_ids": [
        "049d1bee9df30c07fd34918b3cc69cfb"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R10",
      "type": "TREATS",
      "source_entity_id": "E3",
      "target_entity_id": "E8",
      "attributes": {
        "context": "in vitro",
        "verification_needed": true
      },
      "confidence": 0.65,
      "evidence": "Effect of cilomilast on airway cells of patients with COPD",
      "source_chunk_ids": [
        "049d1bee9df30c07fd34918b3cc69cfb"
      ],
      "supporting_study_ids": [
        "E1"
      ],
      "verified": false
    },
    {
      "id": "R1",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E1",
      "target_entity_id": "E2",
      "attributes": {},
      "confidence": 0.9,
      "evidence": "Effect of tiotropium on sputum and serum inflammatory markers and exacerbations in COPD",
      "source_chunk_ids": [
        "8cadbf95b6dada0e049f53377a8c2d8a"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "STUDIES",
      "source_entity_id": "E1",
      "target_entity_id": "E3",
      "attributes": {
        "role": "intervention"
      },
      "confidence": 0.9,
      "evidence": "Effect of tiotropium",
      "source_chunk_ids": [
        "8cadbf95b6dada0e049f53377a8c2d8a"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "REPORTS",
      "source_entity_id": "E1",
      "target_entity_id": "E4",
      "attributes": {
        "outcome": "improves"
      },
      "confidence": 0.85,
      "evidence": "exacerbations in COPD",
      "source_chunk_ids": [
        "8cadbf95b6dada0e049f53377a8c2d8a"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R4",
      "type": "REPORTS",
      "source_entity_id": "E1",
      "target_entity_id": "E5",
      "attributes": {
        "outcome": "improves"
      },
      "confidence": 0.8,
      "evidence": "Effect of tiotropium on sputum and serum inflammatory markers",
      "source_chunk_ids": [
        "8cadbf95b6dada0e049f53377a8c2d8a"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R5",
      "type": "REPORTS",
      "source_entity_id": "E1",
      "target_entity_id": "E6",
      "attributes": {
        "outcome": "improves"
      },
      "confidence": 0.8,
      "evidence": "exacerbations in COPD",
      "source_chunk_ids": [
        "8cadbf95b6dada0e049f53377a8c2d8a"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R6",
      "type": "TREATS",
      "source_entity_id": "E3",
      "target_entity_id": "E4",
      "attributes": {
        "context": "clinical"
      },
      "confidence": 0.8,
      "evidence": "Effect of tiotropium on sputum and serum inflammatory markers and exacerbations in COPD",
      "source_chunk_ids": [
        "8cadbf95b6dada0e049f53377a8c2d8a"
      ],
      "supporting_study_ids": [
        "E1"
      ],
      "verified": true
    },
    {
      "id": "R1",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E1",
      "target_entity_id": "E2",
      "attributes": {},
      "confidence": 0.9,
      "evidence": "Anti-inflammatory effects of salmeterol/fluticasone, tiotropium/fluticasone or tiotropium in COPD",
      "source_chunk_ids": [
        "05ed8adf6fdbe0c5d48ccfb61f912859"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "REPORTS",
      "source_entity_id": "E1",
      "target_entity_id": "E3",
      "attributes": {
        "outcome": "studied"
      },
      "confidence": 0.85,
      "evidence": "in COPD",
      "source_chunk_ids": [
        "05ed8adf6fdbe0c5d48ccfb61f912859"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "REPORTS",
      "source_entity_id": "E1",
      "target_entity_id": "E4",
      "attributes": {
        "outcome": "observed"
      },
      "confidence": 0.85,
      "evidence": "Anti-inflammatory effects",
      "source_chunk_ids": [
        "05ed8adf6fdbe0c5d48ccfb61f912859"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R1",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E1",
      "target_entity_id": "E2",
      "attributes": {},
      "confidence": 0.9,
      "evidence": "Effect of fluticasone with and without salmeterol on pulmonary outcomes",
      "source_chunk_ids": [
        "0a9e34fed0d9214e0939ccf1189daf17"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "REPORTS",
      "source_entity_id": "E1",
      "target_entity_id": "E3",
      "attributes": {
        "outcome": "studies"
      },
      "confidence": 0.85,
      "evidence": "on pulmonary outcomes in chronic obstructive pulmonary disease",
      "source_chunk_ids": [
        "0a9e34fed0d9214e0939ccf1189daf17"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R1",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E1",
      "target_entity_id": "E2",
      "attributes": {},
      "confidence": 0.95,
      "evidence": "randomised controlled trial",
      "source_chunk_ids": [
        "52048991eb853d98cc8bfeb718b8608a"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "STUDIES",
      "source_entity_id": "E1",
      "target_entity_id": "E3",
      "attributes": {
        "role": "intervention"
      },
      "confidence": 0.95,
      "evidence": "Effect of salmeterol/fluticasone propionate",
      "source_chunk_ids": [
        "52048991eb853d98cc8bfeb718b8608a"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "REPORTS",
      "source_entity_id": "E1",
      "target_entity_id": "E4",
      "attributes": {
        "outcome": "studied"
      },
      "confidence": 0.9,
      "evidence": "airway inflammation in COPD",
      "source_chunk_ids": [
        "52048991eb853d98cc8bfeb718b8608a"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R4",
      "type": "REPORTS",
      "source_entity_id": "E1",
      "target_entity_id": "E5",
      "attributes": {
        "outcome": "studied"
      },
      "confidence": 0.8,
      "evidence": "Effect on airway inflammation",
      "source_chunk_ids": [
        "52048991eb853d98cc8bfeb718b8608a"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R5",
      "type": "TREATS",
      "source_entity_id": "E3",
      "target_entity_id": "E4",
      "attributes": {
        "context": "clinical"
      },
      "confidence": 0.7,
      "evidence": "Effect on airway inflammation in COPD",
      "source_chunk_ids": [
        "52048991eb853d98cc8bfeb718b8608a"
      ],
      "supporting_study_ids": [
        "E1"
      ],
      "verified": true
    },
    {
      "id": "R1",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E1",
      "target_entity_id": "E2",
      "attributes": {},
      "confidence": 0.9,
      "evidence": "Design of phosphodiesterase 4D (PDE4D) allosteric modulators",
      "source_chunk_ids": [
        "b5bc78602466937ee5f50e899808a7a0"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "STUDIES",
      "source_entity_id": "E1",
      "target_entity_id": "E3",
      "attributes": {
        "role": "target"
      },
      "confidence": 0.9,
      "evidence": "phosphodiesterase 4D (PDE4D)",
      "source_chunk_ids": [
        "b5bc78602466937ee5f50e899808a7a0"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "REPORTS",
      "source_entity_id": "E1",
      "target_entity_id": "E4",
      "attributes": {
        "outcome": "improves"
      },
      "confidence": 0.85,
      "evidence": "enhancing cognition",
      "source_chunk_ids": [
        "b5bc78602466937ee5f50e899808a7a0"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R4",
      "type": "REPORTS",
      "source_entity_id": "E1",
      "target_entity_id": "E5",
      "attributes": {
        "outcome": "improves"
      },
      "confidence": 0.85,
      "evidence": "improved safety",
      "source_chunk_ids": [
        "b5bc78602466937ee5f50e899808a7a0"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R1",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E1",
      "target_entity_id": "E2",
      "attributes": {},
      "confidence": 0.9,
      "evidence": "controlled trial",
      "source_chunk_ids": [
        "0aa623c11cf813c715d3df311191096d"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "STUDIES",
      "source_entity_id": "E1",
      "target_entity_id": "E3",
      "attributes": {
        "role": "intervention"
      },
      "confidence": 0.9,
      "evidence": "novel inhaled phosphodiesterase type-4 inhibitor",
      "source_chunk_ids": [
        "0aa623c11cf813c715d3df311191096d"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "REPORTS",
      "source_entity_id": "E1",
      "target_entity_id": "E4",
      "attributes": {
        "outcome": "tested"
      },
      "confidence": 0.85,
      "evidence": "in COPD",
      "source_chunk_ids": [
        "0aa623c11cf813c715d3df311191096d"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R1",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E1",
      "target_entity_id": "E2",
      "attributes": {},
      "confidence": 0.9,
      "evidence": "allergen challenge study",
      "source_chunk_ids": [
        "f00830d2dd322fac2e728aa9e107196a"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "STUDIES",
      "source_entity_id": "E1",
      "target_entity_id": "E3",
      "attributes": {
        "role": "intervention"
      },
      "confidence": 0.9,
      "evidence": "GSK256066",
      "source_chunk_ids": [
        "f00830d2dd322fac2e728aa9e107196a"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "ACTS_ON",
      "source_entity_id": "E3",
      "target_entity_id": "E4",
      "attributes": {
        "action": "inhibits"
      },
      "confidence": 0.85,
      "evidence": "phosphodiesterase 4 inhibitor",
      "source_chunk_ids": [
        "f00830d2dd322fac2e728aa9e107196a"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R4",
      "type": "REPORTS",
      "source_entity_id": "E1",
      "target_entity_id": "E5",
      "attributes": {
        "outcome": "improves"
      },
      "confidence": 0.85,
      "evidence": "reduces allergen challenge responses in asthma",
      "source_chunk_ids": [
        "f00830d2dd322fac2e728aa9e107196a"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R5",
      "type": "REPORTS",
      "source_entity_id": "E1",
      "target_entity_id": "E6",
      "attributes": {
        "outcome": "positive"
      },
      "confidence": 0.85,
      "evidence": "reduces allergen challenge responses",
      "source_chunk_ids": [
        "f00830d2dd322fac2e728aa9e107196a"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R6",
      "type": "TREATS",
      "source_entity_id": "E3",
      "target_entity_id": "E5",
      "attributes": {
        "context": "clinical"
      },
      "confidence": 0.8,
      "evidence": "reduces allergen challenge responses in asthma",
      "source_chunk_ids": [
        "f00830d2dd322fac2e728aa9e107196a"
      ],
      "supporting_study_ids": [
        "E1"
      ],
      "verified": true
    },
    {
      "id": "R7",
      "type": "PRODUCES",
      "source_entity_id": "E3",
      "target_entity_id": "E6",
      "attributes": {},
      "confidence": 0.75,
      "evidence": "reduces allergen challenge responses",
      "source_chunk_ids": [
        "f00830d2dd322fac2e728aa9e107196a"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R1",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E1",
      "target_entity_id": "E2",
      "attributes": {},
      "confidence": 0.9,
      "evidence": "primary human lung fibroblasts",
      "source_chunk_ids": [
        "38e9263045a01a1ebdba8acb990a4e15"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "REPORTS",
      "source_entity_id": "E1",
      "target_entity_id": "E3",
      "attributes": {
        "outcome": "inhibition"
      },
      "confidence": 0.85,
      "evidence": "phosphodiesterase 4 inhibition",
      "source_chunk_ids": [
        "38e9263045a01a1ebdba8acb990a4e15"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "REPORTS",
      "source_entity_id": "E1",
      "target_entity_id": "E4",
      "attributes": {
        "outcome": "related"
      },
      "confidence": 0.8,
      "evidence": "related to cyclic AMP signaling",
      "source_chunk_ids": [
        "38e9263045a01a1ebdba8acb990a4e15"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R4",
      "type": "REPORTS",
      "source_entity_id": "E1",
      "target_entity_id": "E5",
      "attributes": {
        "outcome": "balance"
      },
      "confidence": 0.75,
      "evidence": "balance of mitogenic effects",
      "source_chunk_ids": [
        "38e9263045a01a1ebdba8acb990a4e15"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R1",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E1",
      "target_entity_id": "E2",
      "attributes": {},
      "confidence": 0.9,
      "evidence": "Bronchodilatory effect of inhaled zardaverine",
      "source_chunk_ids": [
        "0639a30770cfda8a03530e87691800c0"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "STUDIES",
      "source_entity_id": "E1",
      "target_entity_id": "E3",
      "attributes": {
        "role": "intervention"
      },
      "confidence": 0.9,
      "evidence": "zardaverine",
      "source_chunk_ids": [
        "0639a30770cfda8a03530e87691800c0"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "ACTS_ON",
      "source_entity_id": "E3",
      "target_entity_id": "E4",
      "attributes": {
        "action": "inhibits"
      },
      "confidence": 0.85,
      "evidence": "phosphodiesterase III and IV inhibitor",
      "source_chunk_ids": [
        "0639a30770cfda8a03530e87691800c0"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R4",
      "type": "ACTS_ON",
      "source_entity_id": "E3",
      "target_entity_id": "E5",
      "attributes": {
        "action": "inhibits"
      },
      "confidence": 0.85,
      "evidence": "phosphodiesterase III and IV inhibitor",
      "source_chunk_ids": [
        "0639a30770cfda8a03530e87691800c0"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R5",
      "type": "REPORTS",
      "source_entity_id": "E1",
      "target_entity_id": "E6",
      "attributes": {
        "outcome": "improves"
      },
      "confidence": 0.85,
      "evidence": "patients with asthma",
      "source_chunk_ids": [
        "0639a30770cfda8a03530e87691800c0"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R6",
      "type": "REPORTS",
      "source_entity_id": "E1",
      "target_entity_id": "E7",
      "attributes": {
        "outcome": "positive"
      },
      "confidence": 0.9,
      "evidence": "Bronchodilatory effect",
      "source_chunk_ids": [
        "0639a30770cfda8a03530e87691800c0"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R7",
      "type": "TREATS",
      "source_entity_id": "E3",
      "target_entity_id": "E6",
      "attributes": {
        "context": "clinical"
      },
      "confidence": 0.8,
      "evidence": "Bronchodilatory effect in patients with asthma",
      "source_chunk_ids": [
        "0639a30770cfda8a03530e87691800c0"
      ],
      "supporting_study_ids": [
        "E1"
      ],
      "verified": true
    },
    {
      "id": "R8",
      "type": "PRODUCES",
      "source_entity_id": "E3",
      "target_entity_id": "E7",
      "attributes": {},
      "confidence": 0.75,
      "evidence": "Bronchodilatory effect of inhaled zardaverine",
      "source_chunk_ids": [
        "0639a30770cfda8a03530e87691800c0"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R1",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E1",
      "target_entity_id": "E2",
      "attributes": {},
      "confidence": 0.9,
      "evidence": "Effects of the mixed phosphodiesterase III/IV inhibitor, zardaverine, on airway function in patients with chronic airflow obstruction",
      "source_chunk_ids": [
        "2ceab326b96221c13f60c9a0ca1d6e33"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "STUDIES",
      "source_entity_id": "E1",
      "target_entity_id": "E3",
      "attributes": {
        "role": "intervention"
      },
      "confidence": 0.9,
      "evidence": "zardaverine",
      "source_chunk_ids": [
        "2ceab326b96221c13f60c9a0ca1d6e33"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "ACTS_ON",
      "source_entity_id": "E3",
      "target_entity_id": "E4",
      "attributes": {
        "action": "inhibits"
      },
      "confidence": 0.85,
      "evidence": "mixed phosphodiesterase III/IV inhibitor",
      "source_chunk_ids": [
        "2ceab326b96221c13f60c9a0ca1d6e33"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R4",
      "type": "ACTS_ON",
      "source_entity_id": "E3",
      "target_entity_id": "E5",
      "attributes": {
        "action": "inhibits"
      },
      "confidence": 0.85,
      "evidence": "mixed phosphodiesterase III/IV inhibitor",
      "source_chunk_ids": [
        "2ceab326b96221c13f60c9a0ca1d6e33"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R5",
      "type": "REPORTS",
      "source_entity_id": "E1",
      "target_entity_id": "E6",
      "attributes": {
        "outcome": "studied"
      },
      "confidence": 0.9,
      "evidence": "patients with chronic airflow obstruction",
      "source_chunk_ids": [
        "2ceab326b96221c13f60c9a0ca1d6e33"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R1",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E1",
      "target_entity_id": "E2",
      "attributes": {},
      "confidence": 0.9,
      "evidence": "The pharmacology of two novel long-acting phosphodiesterase 3/4 inhibitors",
      "source_chunk_ids": [
        "a5d0c29d4ce8db8f32c8eab4151136de"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "STUDIES",
      "source_entity_id": "E1",
      "target_entity_id": "E3",
      "attributes": {
        "role": "intervention"
      },
      "confidence": 0.9,
      "evidence": "RPL554",
      "source_chunk_ids": [
        "a5d0c29d4ce8db8f32c8eab4151136de"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "STUDIES",
      "source_entity_id": "E1",
      "target_entity_id": "E4",
      "attributes": {
        "role": "intervention"
      },
      "confidence": 0.9,
      "evidence": "RPL565",
      "source_chunk_ids": [
        "a5d0c29d4ce8db8f32c8eab4151136de"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R4",
      "type": "ACTS_ON",
      "source_entity_id": "E3",
      "target_entity_id": "E5",
      "attributes": {
        "action": "inhibits"
      },
      "confidence": 0.75,
      "evidence": "phosphodiesterase 3/4 inhibitors",
      "source_chunk_ids": [
        "a5d0c29d4ce8db8f32c8eab4151136de"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R5",
      "type": "ACTS_ON",
      "source_entity_id": "E3",
      "target_entity_id": "E6",
      "attributes": {
        "action": "inhibits"
      },
      "confidence": 0.75,
      "evidence": "phosphodiesterase 3/4 inhibitors",
      "source_chunk_ids": [
        "a5d0c29d4ce8db8f32c8eab4151136de"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R6",
      "type": "ACTS_ON",
      "source_entity_id": "E4",
      "target_entity_id": "E5",
      "attributes": {
        "action": "inhibits"
      },
      "confidence": 0.75,
      "evidence": "phosphodiesterase 3/4 inhibitors",
      "source_chunk_ids": [
        "a5d0c29d4ce8db8f32c8eab4151136de"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R7",
      "type": "ACTS_ON",
      "source_entity_id": "E4",
      "target_entity_id": "E6",
      "attributes": {
        "action": "inhibits"
      },
      "confidence": 0.75,
      "evidence": "phosphodiesterase 3/4 inhibitors",
      "source_chunk_ids": [
        "a5d0c29d4ce8db8f32c8eab4151136de"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R1",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E1",
      "target_entity_id": "E2",
      "attributes": {},
      "confidence": 0.9,
      "evidence": "Ubiquitous expression of phosphodiesterase 7A in human proinflammatory and immune cells",
      "source_chunk_ids": [
        "7949872a54d13aa8a93f2554b6522bbd"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "REPORTS",
      "source_entity_id": "E1",
      "target_entity_id": "E3",
      "attributes": {
        "outcome": "expression"
      },
      "confidence": 0.85,
      "evidence": "Ubiquitous expression of phosphodiesterase 7A",
      "source_chunk_ids": [
        "7949872a54d13aa8a93f2554b6522bbd"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R1",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E1",
      "target_entity_id": "E2",
      "attributes": {},
      "confidence": 0.95,
      "evidence": "Phosphodiesterase type 4 inhibitors cause proinflammatory effects in vivo",
      "source_chunk_ids": [
        "0e69cb76d1afa7d5470bf5357aaaf0ad"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "STUDIES",
      "source_entity_id": "E1",
      "target_entity_id": "E3",
      "attributes": {
        "role": "intervention"
      },
      "confidence": 0.9,
      "evidence": "Phosphodiesterase type 4 inhibitors",
      "source_chunk_ids": [
        "0e69cb76d1afa7d5470bf5357aaaf0ad"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "REPORTS",
      "source_entity_id": "E1",
      "target_entity_id": "E4",
      "attributes": {
        "outcome": "causes"
      },
      "confidence": 0.9,
      "evidence": "cause proinflammatory effects",
      "source_chunk_ids": [
        "0e69cb76d1afa7d5470bf5357aaaf0ad"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R1",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E1",
      "target_entity_id": "E2",
      "attributes": {},
      "confidence": 0.9,
      "evidence": "in human monocyte-derived macrophages",
      "source_chunk_ids": [
        "941177bcd34d6994d1cfbd541d2ce611"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "REPORTS",
      "source_entity_id": "E1",
      "target_entity_id": "E3",
      "attributes": {
        "outcome": "inhibition"
      },
      "confidence": 0.85,
      "evidence": "PDE4 inhibition",
      "source_chunk_ids": [
        "941177bcd34d6994d1cfbd541d2ce611"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "REPORTS",
      "source_entity_id": "E1",
      "target_entity_id": "E4",
      "attributes": {
        "outcome": "induces"
      },
      "confidence": 0.9,
      "evidence": "induce chemokine expression",
      "source_chunk_ids": [
        "941177bcd34d6994d1cfbd541d2ce611"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R1",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E1",
      "target_entity_id": "E2",
      "attributes": {},
      "confidence": 0.9,
      "evidence": "cigarette smoke-exposed mice",
      "source_chunk_ids": [
        "ae95eede0920c33e4d35e253a10eb44f"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "STUDIES",
      "source_entity_id": "E1",
      "target_entity_id": "E3",
      "attributes": {
        "role": "intervention"
      },
      "confidence": 0.95,
      "evidence": "Effect of roflumilast",
      "source_chunk_ids": [
        "ae95eede0920c33e4d35e253a10eb44f"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "REPORTS",
      "source_entity_id": "E1",
      "target_entity_id": "E4",
      "attributes": {
        "outcome": "studies"
      },
      "confidence": 0.85,
      "evidence": "inflammatory cells in the lungs",
      "source_chunk_ids": [
        "ae95eede0920c33e4d35e253a10eb44f"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R4",
      "type": "REPORTS",
      "source_entity_id": "E1",
      "target_entity_id": "E5",
      "attributes": {
        "outcome": "studies"
      },
      "confidence": 0.8,
      "evidence": "inflammatory cells in the lungs",
      "source_chunk_ids": [
        "ae95eede0920c33e4d35e253a10eb44f"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R5",
      "type": "ACTS_ON",
      "source_entity_id": "E3",
      "target_entity_id": "E5",
      "attributes": {
        "action": "modulates"
      },
      "confidence": 0.75,
      "evidence": "Effect of roflumilast on inflammatory cells",
      "source_chunk_ids": [
        "ae95eede0920c33e4d35e253a10eb44f"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R6",
      "type": "TREATS",
      "source_entity_id": "E3",
      "target_entity_id": "E4",
      "attributes": {
        "context": "experimental"
      },
      "confidence": 0.7,
      "evidence": "Effect of roflumilast on inflammatory cells",
      "source_chunk_ids": [
        "ae95eede0920c33e4d35e253a10eb44f"
      ],
      "supporting_study_ids": [
        "E1"
      ],
      "verified": true
    },
    {
      "id": "R1",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E1",
      "target_entity_id": "E2",
      "attributes": {},
      "confidence": 0.95,
      "evidence": "double-blind placebo-controlled, parallel-group quantitative study",
      "source_chunk_ids": [
        "5697ce8ba96c3e8cef46bff87e6ec1e3"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "STUDIES",
      "source_entity_id": "E1",
      "target_entity_id": "E3",
      "attributes": {
        "role": "intervention"
      },
      "confidence": 0.95,
      "evidence": "Cilomilast reduces CD8+ T-lymphocytes and macrophages",
      "source_chunk_ids": [
        "5697ce8ba96c3e8cef46bff87e6ec1e3"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "REPORTS",
      "source_entity_id": "E1",
      "target_entity_id": "E4",
      "attributes": {
        "outcome": "studied"
      },
      "confidence": 0.9,
      "evidence": "patients with chronic obstructive pulmonary disease (COPD)",
      "source_chunk_ids": [
        "5697ce8ba96c3e8cef46bff87e6ec1e3"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R4",
      "type": "REPORTS",
      "source_entity_id": "E1",
      "target_entity_id": "E5",
      "attributes": {
        "outcome": "reduces"
      },
      "confidence": 0.85,
      "evidence": "reduces CD8+ T-lymphocytes",
      "source_chunk_ids": [
        "5697ce8ba96c3e8cef46bff87e6ec1e3"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R5",
      "type": "REPORTS",
      "source_entity_id": "E1",
      "target_entity_id": "E6",
      "attributes": {
        "outcome": "reduces"
      },
      "confidence": 0.85,
      "evidence": "reduces macrophages",
      "source_chunk_ids": [
        "5697ce8ba96c3e8cef46bff87e6ec1e3"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R6",
      "type": "REPORTS",
      "source_entity_id": "E1",
      "target_entity_id": "E7",
      "attributes": {
        "outcome": "reduces"
      },
      "confidence": 0.8,
      "evidence": "reduces CD8+ T-lymphocytes",
      "source_chunk_ids": [
        "5697ce8ba96c3e8cef46bff87e6ec1e3"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R7",
      "type": "REPORTS",
      "source_entity_id": "E1",
      "target_entity_id": "E8",
      "attributes": {
        "outcome": "reduces"
      },
      "confidence": 0.8,
      "evidence": "reduces macrophages",
      "source_chunk_ids": [
        "5697ce8ba96c3e8cef46bff87e6ec1e3"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R8",
      "type": "TREATS",
      "source_entity_id": "E3",
      "target_entity_id": "E4",
      "attributes": {
        "context": "clinical"
      },
      "confidence": 0.75,
      "evidence": "Cilomilast reduces CD8+ T-lymphocytes and macrophages in patients with COPD",
      "source_chunk_ids": [
        "5697ce8ba96c3e8cef46bff87e6ec1e3"
      ],
      "supporting_study_ids": [
        "E1"
      ],
      "verified": true
    },
    {
      "id": "R9",
      "type": "ACTS_ON",
      "source_entity_id": "E3",
      "target_entity_id": "E5",
      "attributes": {
        "action": "reduces"
      },
      "confidence": 0.8,
      "evidence": "reduces CD8+ T-lymphocytes",
      "source_chunk_ids": [
        "5697ce8ba96c3e8cef46bff87e6ec1e3"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R10",
      "type": "ACTS_ON",
      "source_entity_id": "E3",
      "target_entity_id": "E6",
      "attributes": {
        "action": "reduces"
      },
      "confidence": 0.8,
      "evidence": "reduces macrophages",
      "source_chunk_ids": [
        "5697ce8ba96c3e8cef46bff87e6ec1e3"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R11",
      "type": "PRODUCES",
      "source_entity_id": "E3",
      "target_entity_id": "E7",
      "attributes": {},
      "confidence": 0.75,
      "evidence": "reduces CD8+ T-lymphocytes",
      "source_chunk_ids": [
        "5697ce8ba96c3e8cef46bff87e6ec1e3"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R12",
      "type": "PRODUCES",
      "source_entity_id": "E3",
      "target_entity_id": "E8",
      "attributes": {},
      "confidence": 0.75,
      "evidence": "reduces macrophages",
      "source_chunk_ids": [
        "5697ce8ba96c3e8cef46bff87e6ec1e3"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R1",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E1",
      "target_entity_id": "E2",
      "attributes": {},
      "confidence": 0.9,
      "evidence": "Phosphodiesterase profiles of highly purified human peripheral blood leukocyte populations",
      "source_chunk_ids": [
        "bc39ce905dc631263982061cf7e0bf91"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "STUDIES",
      "source_entity_id": "E1",
      "target_entity_id": "E3",
      "attributes": {
        "role": "target"
      },
      "confidence": 0.85,
      "evidence": "Phosphodiesterase profiles",
      "source_chunk_ids": [
        "bc39ce905dc631263982061cf7e0bf91"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "REPORTS",
      "source_entity_id": "E1",
      "target_entity_id": "E4",
      "attributes": {
        "outcome": "characterizes"
      },
      "confidence": 0.8,
      "evidence": "atopic individuals",
      "source_chunk_ids": [
        "bc39ce905dc631263982061cf7e0bf91"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R1",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E1",
      "target_entity_id": "E2",
      "attributes": {},
      "confidence": 0.9,
      "evidence": "in vitro",
      "source_chunk_ids": [
        "b5ffaf7ab1f0233a248df8e0be7855ef"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "STUDIES",
      "source_entity_id": "E1",
      "target_entity_id": "E3",
      "attributes": {
        "role": "intervention"
      },
      "confidence": 0.9,
      "evidence": "roflumilast",
      "source_chunk_ids": [
        "b5ffaf7ab1f0233a248df8e0be7855ef"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "ACTS_ON",
      "source_entity_id": "E3",
      "target_entity_id": "E4",
      "attributes": {
        "action": "inhibits"
      },
      "confidence": 0.85,
      "evidence": "PDE4 inhibitor",
      "source_chunk_ids": [
        "b5ffaf7ab1f0233a248df8e0be7855ef"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R4",
      "type": "REPORTS",
      "source_entity_id": "E1",
      "target_entity_id": "E5",
      "attributes": {
        "outcome": "positive"
      },
      "confidence": 0.8,
      "evidence": "Anti-inflammatory",
      "source_chunk_ids": [
        "b5ffaf7ab1f0233a248df8e0be7855ef"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R5",
      "type": "REPORTS",
      "source_entity_id": "E1",
      "target_entity_id": "E6",
      "attributes": {
        "outcome": "positive"
      },
      "confidence": 0.8,
      "evidence": "immunomodulatory potential",
      "source_chunk_ids": [
        "b5ffaf7ab1f0233a248df8e0be7855ef"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R1",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E1",
      "target_entity_id": "E2",
      "attributes": {},
      "confidence": 0.9,
      "evidence": "human primary CD4+ T cells",
      "source_chunk_ids": [
        "6c73b4f133f163528a6a109ecab7e777"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "REPORTS",
      "source_entity_id": "E1",
      "target_entity_id": "E3",
      "attributes": {},
      "confidence": 0.85,
      "evidence": "phosphodiesterase 4 (PDE4) subtypes",
      "source_chunk_ids": [
        "6c73b4f133f163528a6a109ecab7e777"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "REPORTS",
      "source_entity_id": "E1",
      "target_entity_id": "E4",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "predominant role of PDE4D",
      "source_chunk_ids": [
        "6c73b4f133f163528a6a109ecab7e777"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R1",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E1",
      "target_entity_id": "E2",
      "attributes": {},
      "confidence": 0.9,
      "evidence": "Differential regulation of human antigen-specific Th1 and Th2 lymphocyte responses",
      "source_chunk_ids": [
        "38e3828512e60dcbb82231d02c1956d7"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "STUDIES",
      "source_entity_id": "E1",
      "target_entity_id": "E5",
      "attributes": {
        "role": "intervention"
      },
      "confidence": 0.85,
      "evidence": "isozyme selective cyclic nucleotide phosphodiesterase inhibitors",
      "source_chunk_ids": [
        "38e3828512e60dcbb82231d02c1956d7"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "REPORTS",
      "source_entity_id": "E1",
      "target_entity_id": "E3",
      "attributes": {
        "outcome": "regulated"
      },
      "confidence": 0.8,
      "evidence": "Th1 lymphocyte responses",
      "source_chunk_ids": [
        "38e3828512e60dcbb82231d02c1956d7"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R4",
      "type": "REPORTS",
      "source_entity_id": "E1",
      "target_entity_id": "E4",
      "attributes": {
        "outcome": "regulated"
      },
      "confidence": 0.8,
      "evidence": "Th2 lymphocyte responses",
      "source_chunk_ids": [
        "38e3828512e60dcbb82231d02c1956d7"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R1",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E1",
      "target_entity_id": "E2",
      "attributes": {},
      "confidence": 0.9,
      "evidence": "A selective phosphodiesterase 4 (PDE4) inhibitor ZI-n-91 suppresses IL-17 production by human memory Th17 cells",
      "source_chunk_ids": [
        "3f52a6af43a5aadec2501dc1c25dc57d"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "STUDIES",
      "source_entity_id": "E1",
      "target_entity_id": "E3",
      "attributes": {
        "role": "intervention"
      },
      "confidence": 0.9,
      "evidence": "ZI-n-91",
      "source_chunk_ids": [
        "3f52a6af43a5aadec2501dc1c25dc57d"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "ACTS_ON",
      "source_entity_id": "E3",
      "target_entity_id": "E4",
      "attributes": {
        "action": "inhibits"
      },
      "confidence": 0.85,
      "evidence": "selective phosphodiesterase 4 (PDE4) inhibitor",
      "source_chunk_ids": [
        "3f52a6af43a5aadec2501dc1c25dc57d"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R4",
      "type": "REPORTS",
      "source_entity_id": "E1",
      "target_entity_id": "E5",
      "attributes": {
        "outcome": "observed"
      },
      "confidence": 0.85,
      "evidence": "suppresses IL-17 production",
      "source_chunk_ids": [
        "3f52a6af43a5aadec2501dc1c25dc57d"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R5",
      "type": "PRODUCES",
      "source_entity_id": "E3",
      "target_entity_id": "E5",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "ZI-n-91 suppresses IL-17 production",
      "source_chunk_ids": [
        "3f52a6af43a5aadec2501dc1c25dc57d"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R6",
      "type": "REPORTS",
      "source_entity_id": "E1",
      "target_entity_id": "E6",
      "attributes": {
        "outcome": "targeted"
      },
      "confidence": 0.8,
      "evidence": "human memory Th17 cells",
      "source_chunk_ids": [
        "3f52a6af43a5aadec2501dc1c25dc57d"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R1",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E1",
      "target_entity_id": "E2",
      "attributes": {},
      "confidence": 0.9,
      "evidence": "Phosphodiesterase profile of human B lymphocytes",
      "source_chunk_ids": [
        "c6f94c44d89487b5622bd86510d3dc74"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "REPORTS",
      "source_entity_id": "E1",
      "target_entity_id": "E3",
      "attributes": {},
      "confidence": 0.85,
      "evidence": "Phosphodiesterase profile",
      "source_chunk_ids": [
        "c6f94c44d89487b5622bd86510d3dc74"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "REPORTS",
      "source_entity_id": "E1",
      "target_entity_id": "E4",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "effects of PDE inhibition on B cell proliferation",
      "source_chunk_ids": [
        "c6f94c44d89487b5622bd86510d3dc74"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R1",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E1",
      "target_entity_id": "E2",
      "attributes": {},
      "confidence": 0.9,
      "evidence": "Phosphodiesterase 4 inhibitors delay human eosinophil and neutrophil apoptosis",
      "source_chunk_ids": [
        "809e8182aea21fb055ecd9f3c97daa3e"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "STUDIES",
      "source_entity_id": "E1",
      "target_entity_id": "E3",
      "attributes": {
        "role": "intervention"
      },
      "confidence": 0.85,
      "evidence": "Phosphodiesterase 4 inhibitors",
      "source_chunk_ids": [
        "809e8182aea21fb055ecd9f3c97daa3e"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "REPORTS",
      "source_entity_id": "E1",
      "target_entity_id": "E4",
      "attributes": {
        "outcome": "observed"
      },
      "confidence": 0.9,
      "evidence": "delay human eosinophil and neutrophil apoptosis",
      "source_chunk_ids": [
        "809e8182aea21fb055ecd9f3c97daa3e"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R4",
      "type": "REPORTS",
      "source_entity_id": "E1",
      "target_entity_id": "E5",
      "attributes": {
        "outcome": "targeted"
      },
      "confidence": 0.8,
      "evidence": "human eosinophil",
      "source_chunk_ids": [
        "809e8182aea21fb055ecd9f3c97daa3e"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R5",
      "type": "REPORTS",
      "source_entity_id": "E1",
      "target_entity_id": "E6",
      "attributes": {
        "outcome": "targeted"
      },
      "confidence": 0.8,
      "evidence": "neutrophil apoptosis",
      "source_chunk_ids": [
        "809e8182aea21fb055ecd9f3c97daa3e"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R1",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E1",
      "target_entity_id": "E2",
      "attributes": {},
      "confidence": 0.9,
      "evidence": "in vitro",
      "source_chunk_ids": [
        "d6d778e85c5d5c0847f77fbe1f6843b0"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "REPORTS",
      "source_entity_id": "E1",
      "target_entity_id": "E3",
      "attributes": {},
      "confidence": 0.85,
      "evidence": "selective phosphodiesterase isoenzyme inhibition",
      "source_chunk_ids": [
        "d6d778e85c5d5c0847f77fbe1f6843b0"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "REPORTS",
      "source_entity_id": "E1",
      "target_entity_id": "E4",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "neutrophil function",
      "source_chunk_ids": [
        "d6d778e85c5d5c0847f77fbe1f6843b0"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R1",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E1",
      "target_entity_id": "E2",
      "attributes": {},
      "confidence": 0.9,
      "evidence": "Phosphodiesterase 4 inhibitors reduce human dendritic cell inflammatory cytokine production and Th1-polarizing capacity",
      "source_chunk_ids": [
        "9a1a3a2fd07bb01ab29d4f610d5f8415"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "STUDIES",
      "source_entity_id": "E1",
      "target_entity_id": "E3",
      "attributes": {
        "role": "intervention"
      },
      "confidence": 0.9,
      "evidence": "Phosphodiesterase 4 inhibitors",
      "source_chunk_ids": [
        "9a1a3a2fd07bb01ab29d4f610d5f8415"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "ACTS_ON",
      "source_entity_id": "E3",
      "target_entity_id": "E4",
      "attributes": {
        "action": "inhibits"
      },
      "confidence": 0.85,
      "evidence": "Phosphodiesterase 4 inhibitors",
      "source_chunk_ids": [
        "9a1a3a2fd07bb01ab29d4f610d5f8415"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R4",
      "type": "REPORTS",
      "source_entity_id": "E1",
      "target_entity_id": "E5",
      "attributes": {
        "outcome": "reduces"
      },
      "confidence": 0.85,
      "evidence": "reduce human dendritic cell inflammatory cytokine production",
      "source_chunk_ids": [
        "9a1a3a2fd07bb01ab29d4f610d5f8415"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R5",
      "type": "REPORTS",
      "source_entity_id": "E1",
      "target_entity_id": "E6",
      "attributes": {
        "outcome": "reduces"
      },
      "confidence": 0.85,
      "evidence": "reduce Th1-polarizing capacity",
      "source_chunk_ids": [
        "9a1a3a2fd07bb01ab29d4f610d5f8415"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R1",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E1",
      "target_entity_id": "E2",
      "attributes": {},
      "confidence": 0.9,
      "evidence": "In vitro differentiation of human monocytes to macrophages",
      "source_chunk_ids": [
        "c7a9ab5c46d4c2e3f87017fd63698705"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "REPORTS",
      "source_entity_id": "E1",
      "target_entity_id": "E3",
      "attributes": {
        "outcome": "profile change"
      },
      "confidence": 0.8,
      "evidence": "Change of PDE profile",
      "source_chunk_ids": [
        "c7a9ab5c46d4c2e3f87017fd63698705"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "REPORTS",
      "source_entity_id": "E1",
      "target_entity_id": "E4",
      "attributes": {
        "outcome": "suppression"
      },
      "confidence": 0.85,
      "evidence": "suppression of tumour necrosis factor-alpha release",
      "source_chunk_ids": [
        "c7a9ab5c46d4c2e3f87017fd63698705"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R4",
      "type": "REPORTS",
      "source_entity_id": "E1",
      "target_entity_id": "E5",
      "attributes": {
        "outcome": "observed"
      },
      "confidence": 0.85,
      "evidence": "suppression of tumour necrosis factor-alpha release",
      "source_chunk_ids": [
        "c7a9ab5c46d4c2e3f87017fd63698705"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R1",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E1",
      "target_entity_id": "E2",
      "attributes": {},
      "confidence": 0.9,
      "evidence": "cultured human mast cells",
      "source_chunk_ids": [
        "5b988a712f198d2726111ac597494a61"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "REPORTS",
      "source_entity_id": "E1",
      "target_entity_id": "E3",
      "attributes": {},
      "confidence": 0.85,
      "evidence": "cultured human mast cells",
      "source_chunk_ids": [
        "5b988a712f198d2726111ac597494a61"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "REPORTS",
      "source_entity_id": "E1",
      "target_entity_id": "E4",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "mediator release",
      "source_chunk_ids": [
        "5b988a712f198d2726111ac597494a61"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R1",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E1",
      "target_entity_id": "E2",
      "attributes": {},
      "confidence": 0.9,
      "evidence": "Immunopharmacological potential of selective phosphodiesterase inhibition",
      "source_chunk_ids": [
        "8f8c0147f4712b5c8b194c46ee2dcef0"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "REPORTS",
      "source_entity_id": "E1",
      "target_entity_id": "E3",
      "attributes": {
        "outcome": "inhibition"
      },
      "confidence": 0.85,
      "evidence": "selective phosphodiesterase inhibition",
      "source_chunk_ids": [
        "8f8c0147f4712b5c8b194c46ee2dcef0"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "REPORTS",
      "source_entity_id": "E1",
      "target_entity_id": "E4",
      "attributes": {
        "outcome": "regulation"
      },
      "confidence": 0.85,
      "evidence": "interleukin-6",
      "source_chunk_ids": [
        "8f8c0147f4712b5c8b194c46ee2dcef0"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R4",
      "type": "REPORTS",
      "source_entity_id": "E1",
      "target_entity_id": "E5",
      "attributes": {
        "outcome": "regulation"
      },
      "confidence": 0.85,
      "evidence": "tumor necrosis factor-alpha",
      "source_chunk_ids": [
        "8f8c0147f4712b5c8b194c46ee2dcef0"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R5",
      "type": "REPORTS",
      "source_entity_id": "E1",
      "target_entity_id": "E6",
      "attributes": {
        "outcome": "regulation"
      },
      "confidence": 0.8,
      "evidence": "regulation of proinflammatory cytokine biosynthesis",
      "source_chunk_ids": [
        "8f8c0147f4712b5c8b194c46ee2dcef0"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R1",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E1",
      "target_entity_id": "E2",
      "attributes": {},
      "confidence": 0.9,
      "evidence": "Br J Pharmacol. 2007;152:481-92",
      "source_chunk_ids": [
        "15c106a338f97b45a48b612a36b4b71a"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "STUDIES",
      "source_entity_id": "E1",
      "target_entity_id": "E3",
      "attributes": {
        "role": "intervention"
      },
      "confidence": 0.9,
      "evidence": "Roflumilast inhibits",
      "source_chunk_ids": [
        "15c106a338f97b45a48b612a36b4b71a"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "REPORTS",
      "source_entity_id": "E1",
      "target_entity_id": "E4",
      "attributes": {
        "outcome": "inhibits"
      },
      "confidence": 0.85,
      "evidence": "inhibits leukocyte-endothelial cell interactions",
      "source_chunk_ids": [
        "15c106a338f97b45a48b612a36b4b71a"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R4",
      "type": "REPORTS",
      "source_entity_id": "E1",
      "target_entity_id": "E5",
      "attributes": {
        "outcome": "inhibits"
      },
      "confidence": 0.85,
      "evidence": "expression of adhesion molecules",
      "source_chunk_ids": [
        "15c106a338f97b45a48b612a36b4b71a"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R5",
      "type": "REPORTS",
      "source_entity_id": "E1",
      "target_entity_id": "E6",
      "attributes": {
        "outcome": "inhibits"
      },
      "confidence": 0.85,
      "evidence": "microvascular permeability",
      "source_chunk_ids": [
        "15c106a338f97b45a48b612a36b4b71a"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R6",
      "type": "ACTS_ON",
      "source_entity_id": "E3",
      "target_entity_id": "E4",
      "attributes": {
        "action": "inhibits"
      },
      "confidence": 0.8,
      "evidence": "Roflumilast inhibits leukocyte-endothelial cell interactions",
      "source_chunk_ids": [
        "15c106a338f97b45a48b612a36b4b71a"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R7",
      "type": "ACTS_ON",
      "source_entity_id": "E3",
      "target_entity_id": "E5",
      "attributes": {
        "action": "inhibits"
      },
      "confidence": 0.8,
      "evidence": "inhibits expression of adhesion molecules",
      "source_chunk_ids": [
        "15c106a338f97b45a48b612a36b4b71a"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R8",
      "type": "ACTS_ON",
      "source_entity_id": "E3",
      "target_entity_id": "E6",
      "attributes": {
        "action": "inhibits"
      },
      "confidence": 0.8,
      "evidence": "inhibits microvascular permeability",
      "source_chunk_ids": [
        "15c106a338f97b45a48b612a36b4b71a"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R1",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E1",
      "target_entity_id": "E2",
      "attributes": {},
      "confidence": 0.9,
      "evidence": "inhibits fibroblast-mediated collagen gel degradation",
      "source_chunk_ids": [
        "c2c52b4ee3fdd6ebe682afd8de05c7fa"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "STUDIES",
      "source_entity_id": "E1",
      "target_entity_id": "E3",
      "attributes": {
        "role": "intervention"
      },
      "confidence": 0.95,
      "evidence": "Phosphodiesterase 4 inhibitor cilomilast",
      "source_chunk_ids": [
        "c2c52b4ee3fdd6ebe682afd8de05c7fa"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "ACTS_ON",
      "source_entity_id": "E3",
      "target_entity_id": "E4",
      "attributes": {
        "action": "inhibits"
      },
      "confidence": 0.9,
      "evidence": "Phosphodiesterase 4 inhibitor cilomilast",
      "source_chunk_ids": [
        "c2c52b4ee3fdd6ebe682afd8de05c7fa"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R4",
      "type": "REPORTS",
      "source_entity_id": "E1",
      "target_entity_id": "E5",
      "attributes": {
        "outcome": "inhibits"
      },
      "confidence": 0.85,
      "evidence": "inhibits fibroblast-mediated collagen gel degradation",
      "source_chunk_ids": [
        "c2c52b4ee3fdd6ebe682afd8de05c7fa"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R5",
      "type": "PRODUCES",
      "source_entity_id": "E3",
      "target_entity_id": "E5",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "cilomilast inhibits fibroblast-mediated collagen gel degradation",
      "source_chunk_ids": [
        "c2c52b4ee3fdd6ebe682afd8de05c7fa"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R6",
      "type": "REPORTS",
      "source_entity_id": "E1",
      "target_entity_id": "E6",
      "attributes": {
        "role": "inducer"
      },
      "confidence": 0.8,
      "evidence": "induced by tumor necrosis factor-alpha",
      "source_chunk_ids": [
        "c2c52b4ee3fdd6ebe682afd8de05c7fa"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R7",
      "type": "REPORTS",
      "source_entity_id": "E1",
      "target_entity_id": "E7",
      "attributes": {
        "role": "inducer"
      },
      "confidence": 0.8,
      "evidence": "and neutrophil elastase",
      "source_chunk_ids": [
        "c2c52b4ee3fdd6ebe682afd8de05c7fa"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R1",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E1",
      "target_entity_id": "E2",
      "attributes": {},
      "confidence": 0.9,
      "evidence": "Modulation of matrix metalloproteinase production from human lung fibroblasts",
      "source_chunk_ids": [
        "8c799fd0fdc47dee4b8745217c999baf"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "STUDIES",
      "source_entity_id": "E1",
      "target_entity_id": "E3",
      "attributes": {
        "role": "target"
      },
      "confidence": 0.85,
      "evidence": "type 4 phosphodiesterase inhibitors",
      "source_chunk_ids": [
        "8c799fd0fdc47dee4b8745217c999baf"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "REPORTS",
      "source_entity_id": "E1",
      "target_entity_id": "E4",
      "attributes": {
        "outcome": "modulates"
      },
      "confidence": 0.8,
      "evidence": "Modulation of matrix metalloproteinase production",
      "source_chunk_ids": [
        "8c799fd0fdc47dee4b8745217c999baf"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R1",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E1",
      "target_entity_id": "E2",
      "attributes": {},
      "confidence": 0.9,
      "evidence": "Inhibition of TGF-beta induced lung fibroblast to myofibroblast conversion",
      "source_chunk_ids": [
        "05b03484accfb112df01bd4673317e6e"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "REPORTS",
      "source_entity_id": "E1",
      "target_entity_id": "E3",
      "attributes": {},
      "confidence": 0.85,
      "evidence": "TGF-beta induced lung fibroblast to myofibroblast conversion",
      "source_chunk_ids": [
        "05b03484accfb112df01bd4673317e6e"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "REPORTS",
      "source_entity_id": "E1",
      "target_entity_id": "E4",
      "attributes": {
        "outcome": "inhibition"
      },
      "confidence": 0.85,
      "evidence": "Inhibition of TGF-beta induced lung fibroblast to myofibroblast conversion",
      "source_chunk_ids": [
        "05b03484accfb112df01bd4673317e6e"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R4",
      "type": "STUDIES",
      "source_entity_id": "E1",
      "target_entity_id": "E5",
      "attributes": {
        "role": "intervention"
      },
      "confidence": 0.8,
      "evidence": "phosphodiesterase inhibiting drugs",
      "source_chunk_ids": [
        "05b03484accfb112df01bd4673317e6e"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R5",
      "type": "STUDIES",
      "source_entity_id": "E1",
      "target_entity_id": "E6",
      "attributes": {
        "role": "intervention"
      },
      "confidence": 0.8,
      "evidence": "activators of soluble guanylyl cyclase",
      "source_chunk_ids": [
        "05b03484accfb112df01bd4673317e6e"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R1",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E1",
      "target_entity_id": "E2",
      "attributes": {},
      "confidence": 0.9,
      "evidence": "inhibits human lung fibroblast functions in vitro",
      "source_chunk_ids": [
        "842552a6ce29cd889db78676fe57a657"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "STUDIES",
      "source_entity_id": "E1",
      "target_entity_id": "E3",
      "attributes": {
        "role": "intervention"
      },
      "confidence": 0.9,
      "evidence": "roflumilast N-oxide",
      "source_chunk_ids": [
        "842552a6ce29cd889db78676fe57a657"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "ACTS_ON",
      "source_entity_id": "E3",
      "target_entity_id": "E4",
      "attributes": {
        "action": "inhibits"
      },
      "confidence": 0.85,
      "evidence": "phosphodiesterase 4 inhibitor",
      "source_chunk_ids": [
        "842552a6ce29cd889db78676fe57a657"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R4",
      "type": "REPORTS",
      "source_entity_id": "E1",
      "target_entity_id": "E5",
      "attributes": {
        "outcome": "inhibits"
      },
      "confidence": 0.85,
      "evidence": "inhibits human lung fibroblast functions",
      "source_chunk_ids": [
        "842552a6ce29cd889db78676fe57a657"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R5",
      "type": "PRODUCES",
      "source_entity_id": "E3",
      "target_entity_id": "E5",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "roflumilast N-oxide inhibits human lung fibroblast functions",
      "source_chunk_ids": [
        "842552a6ce29cd889db78676fe57a657"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R1",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E1",
      "target_entity_id": "E2",
      "attributes": {},
      "confidence": 0.9,
      "evidence": "BiolPharmBull. 2009;32:1844-8.",
      "source_chunk_ids": [
        "f3a78800fa6a7ca67a9a9f0ad8505069"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "REPORTS",
      "source_entity_id": "E1",
      "target_entity_id": "E3",
      "attributes": {
        "outcome": "regulates"
      },
      "confidence": 0.85,
      "evidence": "Phosphodiesterase 3 and 4 negatively regulate",
      "source_chunk_ids": [
        "f3a78800fa6a7ca67a9a9f0ad8505069"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "REPORTS",
      "source_entity_id": "E1",
      "target_entity_id": "E4",
      "attributes": {
        "outcome": "regulates"
      },
      "confidence": 0.85,
      "evidence": "Phosphodiesterase 3 and 4 negatively regulate",
      "source_chunk_ids": [
        "f3a78800fa6a7ca67a9a9f0ad8505069"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R4",
      "type": "REPORTS",
      "source_entity_id": "E1",
      "target_entity_id": "E5",
      "attributes": {
        "outcome": "mediated"
      },
      "confidence": 0.8,
      "evidence": "receptor activator of nuclear factor-kappaB ligand-mediated",
      "source_chunk_ids": [
        "f3a78800fa6a7ca67a9a9f0ad8505069"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R5",
      "type": "REPORTS",
      "source_entity_id": "E1",
      "target_entity_id": "E6",
      "attributes": {
        "outcome": "negatively regulates"
      },
      "confidence": 0.8,
      "evidence": "negatively regulate ... osteoclast formation",
      "source_chunk_ids": [
        "f3a78800fa6a7ca67a9a9f0ad8505069"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R6",
      "type": "REPORTS",
      "source_entity_id": "E1",
      "target_entity_id": "E7",
      "attributes": {
        "outcome": "involves"
      },
      "confidence": 0.75,
      "evidence": "by prostaglandin E2",
      "source_chunk_ids": [
        "f3a78800fa6a7ca67a9a9f0ad8505069"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R7",
      "type": "ACTS_ON",
      "source_entity_id": "E7",
      "target_entity_id": "E3",
      "attributes": {
        "action": "modulates"
      },
      "confidence": 0.7,
      "evidence": "by prostaglandin E2",
      "source_chunk_ids": [
        "f3a78800fa6a7ca67a9a9f0ad8505069"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R8",
      "type": "ACTS_ON",
      "source_entity_id": "E7",
      "target_entity_id": "E4",
      "attributes": {
        "action": "modulates"
      },
      "confidence": 0.7,
      "evidence": "by prostaglandin E2",
      "source_chunk_ids": [
        "f3a78800fa6a7ca67a9a9f0ad8505069"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R9",
      "type": "PRODUCES",
      "source_entity_id": "E7",
      "target_entity_id": "E6",
      "attributes": {
        "context": "in vitro",
        "verification_needed": true
      },
      "confidence": 0.65,
      "evidence": "by prostaglandin E2",
      "source_chunk_ids": [
        "f3a78800fa6a7ca67a9a9f0ad8505069"
      ],
      "supporting_study_ids": [],
      "verified": false
    },
    {
      "id": "R1",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E1",
      "target_entity_id": "E2",
      "attributes": {},
      "confidence": 0.9,
      "evidence": "Phosphodiesterase isoenzyme families in human osteoarthritis chondrocytes",
      "source_chunk_ids": [
        "adbc71628f4796d6ce1adc55aecdebba"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "REPORTS",
      "source_entity_id": "E1",
      "target_entity_id": "E3",
      "attributes": {
        "outcome": "studied"
      },
      "confidence": 0.85,
      "evidence": "human osteoarthritis chondrocytes",
      "source_chunk_ids": [
        "adbc71628f4796d6ce1adc55aecdebba"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "REPORTS",
      "source_entity_id": "E1",
      "target_entity_id": "E4",
      "attributes": {
        "outcome": "studied"
      },
      "confidence": 0.85,
      "evidence": "functional importance of phosphodiesterase 4",
      "source_chunk_ids": [
        "adbc71628f4796d6ce1adc55aecdebba"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R1",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E1",
      "target_entity_id": "E2",
      "attributes": {},
      "confidence": 0.9,
      "evidence": "in INS-1 (832/13) cells and rat islets",
      "source_chunk_ids": [
        "149e026769c9c50f949729918cf141ef"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "REPORTS",
      "source_entity_id": "E1",
      "target_entity_id": "E3",
      "attributes": {
        "outcome": "identifies"
      },
      "confidence": 0.85,
      "evidence": "Phosphodiesterase 3",
      "source_chunk_ids": [
        "149e026769c9c50f949729918cf141ef"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "REPORTS",
      "source_entity_id": "E1",
      "target_entity_id": "E4",
      "attributes": {
        "outcome": "identifies"
      },
      "confidence": 0.85,
      "evidence": "Phosphodiesterase 4",
      "source_chunk_ids": [
        "149e026769c9c50f949729918cf141ef"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R4",
      "type": "REPORTS",
      "source_entity_id": "E1",
      "target_entity_id": "E5",
      "attributes": {
        "outcome": "responsible"
      },
      "confidence": 0.85,
      "evidence": "responsible for insulin secretion",
      "source_chunk_ids": [
        "149e026769c9c50f949729918cf141ef"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R1",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E1",
      "target_entity_id": "E2",
      "attributes": {},
      "confidence": 0.9,
      "evidence": "trial of tiotropium",
      "source_chunk_ids": [
        "c5a676cfad3cb843b531204b89815ae7"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "REPORTS",
      "source_entity_id": "E1",
      "target_entity_id": "E3",
      "attributes": {
        "outcome": "studied"
      },
      "confidence": 0.85,
      "evidence": "trial of tiotropium in chronic obstructive pulmonary disease",
      "source_chunk_ids": [
        "c5a676cfad3cb843b531204b89815ae7"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R1",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E1",
      "target_entity_id": "E2",
      "attributes": {},
      "confidence": 0.9,
      "evidence": "clinical trial in Ann Intern Med",
      "source_chunk_ids": [
        "7897de50955264e9f142a39d35bcd9db"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "STUDIES",
      "source_entity_id": "E1",
      "target_entity_id": "E4",
      "attributes": {
        "role": "intervention"
      },
      "confidence": 0.9,
      "evidence": "Tiotropium in combination with",
      "source_chunk_ids": [
        "7897de50955264e9f142a39d35bcd9db"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "STUDIES",
      "source_entity_id": "E1",
      "target_entity_id": "E5",
      "attributes": {
        "role": "intervention"
      },
      "confidence": 0.85,
      "evidence": "salmeterol",
      "source_chunk_ids": [
        "7897de50955264e9f142a39d35bcd9db"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R4",
      "type": "STUDIES",
      "source_entity_id": "E1",
      "target_entity_id": "E6",
      "attributes": {
        "role": "intervention"
      },
      "confidence": 0.8,
      "evidence": "fluticasone-salmeterol",
      "source_chunk_ids": [
        "7897de50955264e9f142a39d35bcd9db"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R5",
      "type": "REPORTS",
      "source_entity_id": "E1",
      "target_entity_id": "E3",
      "attributes": {
        "outcome": "studied"
      },
      "confidence": 0.9,
      "evidence": "treatment of chronic obstructive pulmonary disease",
      "source_chunk_ids": [
        "7897de50955264e9f142a39d35bcd9db"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R1",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E1",
      "target_entity_id": "E2",
      "attributes": {},
      "confidence": 0.9,
      "evidence": "Efficacy and safety of budesonide/formoterol",
      "source_chunk_ids": [
        "38a6b974f636ca8be20de4eac5403014"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "STUDIES",
      "source_entity_id": "E1",
      "target_entity_id": "E3",
      "attributes": {
        "role": "intervention"
      },
      "confidence": 0.9,
      "evidence": "budesonide/formoterol",
      "source_chunk_ids": [
        "38a6b974f636ca8be20de4eac5403014"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "REPORTS",
      "source_entity_id": "E1",
      "target_entity_id": "E4",
      "attributes": {
        "outcome": "efficacy and safety"
      },
      "confidence": 0.85,
      "evidence": "management of chronic obstructive pulmonary disease",
      "source_chunk_ids": [
        "38a6b974f636ca8be20de4eac5403014"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R4",
      "type": "TREATS",
      "source_entity_id": "E3",
      "target_entity_id": "E4",
      "attributes": {
        "context": "clinical"
      },
      "confidence": 0.8,
      "evidence": "Efficacy and safety of budesonide/formoterol in the management of chronic obstructive pulmonary disease",
      "source_chunk_ids": [
        "38a6b974f636ca8be20de4eac5403014"
      ],
      "supporting_study_ids": [
        "E1"
      ],
      "verified": true
    },
    {
      "id": "R1",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E1",
      "target_entity_id": "E4",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "Reference 6 weeks",
      "source_chunk_ids": [
        "4d392be27b2149bd3cf1077899a18770"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E2",
      "target_entity_id": "E4",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "Reference 27",
      "source_chunk_ids": [
        "4d392be27b2149bd3cf1077899a18770"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E3",
      "target_entity_id": "E4",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "Reference 35",
      "source_chunk_ids": [
        "4d392be27b2149bd3cf1077899a18770"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R4",
      "type": "STUDIES",
      "source_entity_id": "E1",
      "target_entity_id": "E5",
      "attributes": {
        "role": "intervention"
      },
      "confidence": 0.8,
      "evidence": "Cilomilast 5 mg bid",
      "source_chunk_ids": [
        "4d392be27b2149bd3cf1077899a18770"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R5",
      "type": "STUDIES",
      "source_entity_id": "E2",
      "target_entity_id": "E5",
      "attributes": {
        "role": "intervention"
      },
      "confidence": 0.8,
      "evidence": "Cilomilast 15 mg bid",
      "source_chunk_ids": [
        "4d392be27b2149bd3cf1077899a18770"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R6",
      "type": "STUDIES",
      "source_entity_id": "E3",
      "target_entity_id": "E6",
      "attributes": {
        "role": "intervention"
      },
      "confidence": 0.8,
      "evidence": "Roflumilast 0.25 mg",
      "source_chunk_ids": [
        "4d392be27b2149bd3cf1077899a18770"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R7",
      "type": "TESTED_AT",
      "source_entity_id": "E1",
      "target_entity_id": "E7",
      "attributes": {},
      "confidence": 0.75,
      "evidence": "Cilomilast 5 mg bid",
      "source_chunk_ids": [
        "4d392be27b2149bd3cf1077899a18770"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R8",
      "type": "TESTED_AT",
      "source_entity_id": "E1",
      "target_entity_id": "E8",
      "attributes": {},
      "confidence": 0.75,
      "evidence": "Cilomilast 10 mg bid",
      "source_chunk_ids": [
        "4d392be27b2149bd3cf1077899a18770"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R9",
      "type": "TESTED_AT",
      "source_entity_id": "E1",
      "target_entity_id": "E9",
      "attributes": {},
      "confidence": 0.75,
      "evidence": "Cilomilast 15 mg bid",
      "source_chunk_ids": [
        "4d392be27b2149bd3cf1077899a18770"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R10",
      "type": "TESTED_AT",
      "source_entity_id": "E2",
      "target_entity_id": "E9",
      "attributes": {},
      "confidence": 0.75,
      "evidence": "Cilomilast 15 mg bid",
      "source_chunk_ids": [
        "4d392be27b2149bd3cf1077899a18770"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R11",
      "type": "TESTED_AT",
      "source_entity_id": "E3",
      "target_entity_id": "E10",
      "attributes": {},
      "confidence": 0.75,
      "evidence": "Roflumilast 0.25 mg",
      "source_chunk_ids": [
        "4d392be27b2149bd3cf1077899a18770"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R12",
      "type": "TESTED_AT",
      "source_entity_id": "E3",
      "target_entity_id": "E11",
      "attributes": {},
      "confidence": 0.75,
      "evidence": "Roflumilast 0.5 mg",
      "source_chunk_ids": [
        "4d392be27b2149bd3cf1077899a18770"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R13",
      "type": "REPORTS",
      "source_entity_id": "E1",
      "target_entity_id": "E12",
      "attributes": {
        "outcome": "improves"
      },
      "confidence": 0.8,
      "evidence": "160 mL increase over placebo",
      "source_chunk_ids": [
        "4d392be27b2149bd3cf1077899a18770"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R14",
      "type": "REPORTS",
      "source_entity_id": "E1",
      "target_entity_id": "E13",
      "attributes": {
        "outcome": "no_effect"
      },
      "confidence": 0.8,
      "evidence": "3.9 units cf placebo (NS)",
      "source_chunk_ids": [
        "4d392be27b2149bd3cf1077899a18770"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R15",
      "type": "REPORTS",
      "source_entity_id": "E2",
      "target_entity_id": "E14",
      "attributes": {
        "outcome": "improves"
      },
      "confidence": 0.8,
      "evidence": "40 mL increase over placebo",
      "source_chunk_ids": [
        "4d392be27b2149bd3cf1077899a18770"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R16",
      "type": "REPORTS",
      "source_entity_id": "E2",
      "target_entity_id": "E15",
      "attributes": {
        "outcome": "no_effect"
      },
      "confidence": 0.8,
      "evidence": "4.1 units cf placebo",
      "source_chunk_ids": [
        "4d392be27b2149bd3cf1077899a18770"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R17",
      "type": "REPORTS",
      "source_entity_id": "E2",
      "target_entity_id": "E16",
      "attributes": {
        "outcome": "improves"
      },
      "confidence": 0.8,
      "evidence": "39% decrease",
      "source_chunk_ids": [
        "4d392be27b2149bd3cf1077899a18770"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R18",
      "type": "REPORTS",
      "source_entity_id": "E3",
      "target_entity_id": "E17",
      "attributes": {
        "outcome": "improves"
      },
      "confidence": 0.8,
      "evidence": "64 and 88 ml increase over placebo",
      "source_chunk_ids": [
        "4d392be27b2149bd3cf1077899a18770"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R19",
      "type": "REPORTS",
      "source_entity_id": "E3",
      "target_entity_id": "E18",
      "attributes": {
        "outcome": "improves"
      },
      "confidence": 0.8,
      "evidence": "74 and 97 ml increase over placebo",
      "source_chunk_ids": [
        "4d392be27b2149bd3cf1077899a18770"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R20",
      "type": "REPORTS",
      "source_entity_id": "E3",
      "target_entity_id": "E19",
      "attributes": {
        "outcome": "no_effect"
      },
      "confidence": 0.8,
      "evidence": "1.7 units cf placebo",
      "source_chunk_ids": [
        "4d392be27b2149bd3cf1077899a18770"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R1",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E1",
      "target_entity_id": "E3",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "randomized controlled trial",
      "source_chunk_ids": [
        "545e791f7c21d448db7de6e97f7e3c73"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E2",
      "target_entity_id": "E3",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "randomized controlled trial",
      "source_chunk_ids": [
        "545e791f7c21d448db7de6e97f7e3c73"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "STUDIES",
      "source_entity_id": "E1",
      "target_entity_id": "E4",
      "attributes": {
        "role": "intervention"
      },
      "confidence": 0.85,
      "evidence": "Roflumilast 0.5 mg od",
      "source_chunk_ids": [
        "545e791f7c21d448db7de6e97f7e3c73"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R4",
      "type": "STUDIES",
      "source_entity_id": "E2",
      "target_entity_id": "E4",
      "attributes": {
        "role": "intervention"
      },
      "confidence": 0.85,
      "evidence": "Roflumilast 0.5 mg od",
      "source_chunk_ids": [
        "545e791f7c21d448db7de6e97f7e3c73"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R5",
      "type": "TESTED_AT",
      "source_entity_id": "E1",
      "target_entity_id": "E5",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "Roflumilast 0.5 mg od",
      "source_chunk_ids": [
        "545e791f7c21d448db7de6e97f7e3c73"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R6",
      "type": "TESTED_AT",
      "source_entity_id": "E2",
      "target_entity_id": "E5",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "Roflumilast 0.5 mg od",
      "source_chunk_ids": [
        "545e791f7c21d448db7de6e97f7e3c73"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R7",
      "type": "REPORTS",
      "source_entity_id": "E1",
      "target_entity_id": "E6",
      "attributes": {
        "outcome": "improves"
      },
      "confidence": 0.7,
      "evidence": "GOLD IV",
      "source_chunk_ids": [
        "545e791f7c21d448db7de6e97f7e3c73"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R8",
      "type": "REPORTS",
      "source_entity_id": "E2",
      "target_entity_id": "E6",
      "attributes": {
        "outcome": "improves"
      },
      "confidence": 0.7,
      "evidence": "GOLD IV",
      "source_chunk_ids": [
        "545e791f7c21d448db7de6e97f7e3c73"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R9",
      "type": "REPORTS",
      "source_entity_id": "E1",
      "target_entity_id": "E7",
      "attributes": {
        "outcome": "improves"
      },
      "confidence": 0.75,
      "evidence": "FEV1 increase over placebo",
      "source_chunk_ids": [
        "545e791f7c21d448db7de6e97f7e3c73"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R10",
      "type": "REPORTS",
      "source_entity_id": "E2",
      "target_entity_id": "E7",
      "attributes": {
        "outcome": "improves"
      },
      "confidence": 0.75,
      "evidence": "FEV1 increase over placebo",
      "source_chunk_ids": [
        "545e791f7c21d448db7de6e97f7e3c73"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R11",
      "type": "REPORTS",
      "source_entity_id": "E1",
      "target_entity_id": "E8",
      "attributes": {
        "outcome": "improves"
      },
      "confidence": 0.8,
      "evidence": "Exacerbations 34% decrease",
      "source_chunk_ids": [
        "545e791f7c21d448db7de6e97f7e3c73"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R12",
      "type": "REPORTS",
      "source_entity_id": "E2",
      "target_entity_id": "E9",
      "attributes": {
        "outcome": "no_effect"
      },
      "confidence": 0.7,
      "evidence": "NS cf placebo/salmeterol",
      "source_chunk_ids": [
        "545e791f7c21d448db7de6e97f7e3c73"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R13",
      "type": "TREATS",
      "source_entity_id": "E4",
      "target_entity_id": "E6",
      "attributes": {
        "context": "clinical"
      },
      "confidence": 0.75,
      "evidence": "GOLD IV",
      "source_chunk_ids": [
        "545e791f7c21d448db7de6e97f7e3c73"
      ],
      "supporting_study_ids": [
        "E1",
        "E2"
      ],
      "verified": true
    },
    {
      "id": "R14",
      "type": "PRODUCES",
      "source_entity_id": "E4",
      "target_entity_id": "E7",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "FEV1 increase over placebo",
      "source_chunk_ids": [
        "545e791f7c21d448db7de6e97f7e3c73"
      ],
      "supporting_study_ids": [
        "E1",
        "E2"
      ],
      "verified": true
    },
    {
      "id": "R15",
      "type": "PRODUCES",
      "source_entity_id": "E4",
      "target_entity_id": "E8",
      "attributes": {},
      "confidence": 0.75,
      "evidence": "Exacerbations 34% decrease",
      "source_chunk_ids": [
        "545e791f7c21d448db7de6e97f7e3c73"
      ],
      "supporting_study_ids": [
        "E1"
      ],
      "verified": true
    },
    {
      "id": "R1",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E1",
      "target_entity_id": "E2",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "clinical trial",
      "source_chunk_ids": [
        "d0a5faf93b3b21951f93e0e2728612ad"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "REPORTS",
      "source_entity_id": "E1",
      "target_entity_id": "E3",
      "attributes": {
        "outcome": "decline"
      },
      "confidence": 0.75,
      "evidence": "Rate of decline in lung function",
      "source_chunk_ids": [
        "d0a5faf93b3b21951f93e0e2728612ad"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "REPORTS",
      "source_entity_id": "E1",
      "target_entity_id": "E4",
      "attributes": {
        "outcome": "reduced"
      },
      "confidence": 0.7,
      "evidence": "Exacerbations",
      "source_chunk_ids": [
        "d0a5faf93b3b21951f93e0e2728612ad"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R4",
      "type": "REPORTS",
      "source_entity_id": "E1",
      "target_entity_id": "E5",
      "attributes": {
        "outcome": "reduced"
      },
      "confidence": 0.7,
      "evidence": "Hospitalizations",
      "source_chunk_ids": [
        "d0a5faf93b3b21951f93e0e2728612ad"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R5",
      "type": "REPORTS",
      "source_entity_id": "E1",
      "target_entity_id": "E6",
      "attributes": {
        "outcome": "improved"
      },
      "confidence": 0.7,
      "evidence": "Dyspnea",
      "source_chunk_ids": [
        "d0a5faf93b3b21951f93e0e2728612ad"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R6",
      "type": "REPORTS",
      "source_entity_id": "E1",
      "target_entity_id": "E7",
      "attributes": {
        "outcome": "improves",
        "verification_needed": true
      },
      "confidence": 0.65,
      "evidence": "27 ml increase in Tio/placebo group",
      "source_chunk_ids": [
        "d0a5faf93b3b21951f93e0e2728612ad"
      ],
      "supporting_study_ids": [],
      "verified": false
    },
    {
      "id": "R7",
      "type": "REPORTS",
      "source_entity_id": "E1",
      "target_entity_id": "E8",
      "attributes": {
        "outcome": "improves",
        "verification_needed": true
      },
      "confidence": 0.65,
      "evidence": "Combination therapy reduced incidence",
      "source_chunk_ids": [
        "d0a5faf93b3b21951f93e0e2728612ad"
      ],
      "supporting_study_ids": [],
      "verified": false
    },
    {
      "id": "R8",
      "type": "REPORTS",
      "source_entity_id": "E1",
      "target_entity_id": "E9",
      "attributes": {
        "outcome": "improves",
        "verification_needed": true
      },
      "confidence": 0.65,
      "evidence": "Tio/placebo (-4.5 units)",
      "source_chunk_ids": [
        "d0a5faf93b3b21951f93e0e2728612ad"
      ],
      "supporting_study_ids": [],
      "verified": false
    },
    {
      "id": "R1",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E1",
      "target_entity_id": "E2",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "randomized controlled trial",
      "source_chunk_ids": [
        "116620b4a25e8274c079fbf67c70b44f"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "REPORTS",
      "source_entity_id": "E1",
      "target_entity_id": "E3",
      "attributes": {
        "outcome": "mortality"
      },
      "confidence": 0.85,
      "evidence": "Mortality (COPD related)",
      "source_chunk_ids": [
        "116620b4a25e8274c079fbf67c70b44f"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "REPORTS",
      "source_entity_id": "E1",
      "target_entity_id": "E4",
      "attributes": {
        "outcome": "improves"
      },
      "confidence": 0.7,
      "evidence": "Postbronchodilator FEV1",
      "source_chunk_ids": [
        "116620b4a25e8274c079fbf67c70b44f"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R4",
      "type": "REPORTS",
      "source_entity_id": "E1",
      "target_entity_id": "E5",
      "attributes": {
        "outcome": "improves"
      },
      "confidence": 0.7,
      "evidence": "Exacerbations",
      "source_chunk_ids": [
        "116620b4a25e8274c079fbf67c70b44f"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R5",
      "type": "REPORTS",
      "source_entity_id": "E1",
      "target_entity_id": "E6",
      "attributes": {
        "outcome": "improves"
      },
      "confidence": 0.7,
      "evidence": "SGRQ",
      "source_chunk_ids": [
        "116620b4a25e8274c079fbf67c70b44f"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R6",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E7",
      "target_entity_id": "E8",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "randomized controlled trial",
      "source_chunk_ids": [
        "116620b4a25e8274c079fbf67c70b44f"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R7",
      "type": "REPORTS",
      "source_entity_id": "E7",
      "target_entity_id": "E9",
      "attributes": {
        "outcome": "exacerbations"
      },
      "confidence": 0.85,
      "evidence": "Exacerbations",
      "source_chunk_ids": [
        "116620b4a25e8274c079fbf67c70b44f"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R8",
      "type": "REPORTS",
      "source_entity_id": "E7",
      "target_entity_id": "E10",
      "attributes": {
        "outcome": "improves"
      },
      "confidence": 0.7,
      "evidence": "Prebronchodilator FEV1",
      "source_chunk_ids": [
        "116620b4a25e8274c079fbf67c70b44f"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R9",
      "type": "REPORTS",
      "source_entity_id": "E7",
      "target_entity_id": "E11",
      "attributes": {
        "outcome": "improves"
      },
      "confidence": 0.7,
      "evidence": "reduced mean severe exacerbation rate",
      "source_chunk_ids": [
        "116620b4a25e8274c079fbf67c70b44f"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R10",
      "type": "REPORTS",
      "source_entity_id": "E7",
      "target_entity_id": "E12",
      "attributes": {
        "outcome": "improves"
      },
      "confidence": 0.7,
      "evidence": "SGRQ",
      "source_chunk_ids": [
        "116620b4a25e8274c079fbf67c70b44f"
      ],
      "supporting_study_ids": [],
      "verified": true
    }
  ]
}